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Abstract 
Background 
As one of the most common types of shoulder pain, subacromial impingement / rotator cuff 
tendinopathy (SIS/RCTendinopathy) is frequently treated with physiotherapy. However there is 
uncertainty as to which patients do and do not improve with this approach. 
 
Aim 
To identify baseline factors that predict outcome in SIS/RCTendinopathy patients following 
treatment with physiotherapy.  
 
Method 
Patients with a clinical diagnosis of SIS/RCTendinopathy referred for physiotherapy were recruited. 
Baseline potential prognostic factors (demographics, clinical history, patient reported measures, 
clinical measures and structural pathology) were recorded immediately prior to the first 
physiotherapy appointment. Treatment was pragmatic as determined by the treating clinician. 
Outcome was determined by the change in a patient reported outcome measure (Oxford Shoulder 
Score, OSS) from baseline. Time points for analysis were at discharge and three months post-
discharge.   
 
Findings 
Seventy-six patients fulfilling the inclusion and exclusion criteria were recruited and outcome data 
were available from 73 subjects at discharge and 62 subjects at three months post discharge. The 
number of candidate variables were trimmed using a sequential decision process comprising 
methodological, conceptual and statistical methods. Multivariate regression analysis comprising 
forward selection and backward elimination was applied. Baseline function (measured by the total 
SPADI; higher SPADI = greater pain and disability) and (younger) age predicted 15.7% of the outcome 
(greater improvement in function) from baseline to discharge. Total SPADI (higher SPADI = greater 
pain and disability) predicted 9.6% of the outcome (greater improvement in function) from baseline 
to three months post-discharge.  
 
Conclusion 
The study findings provide evidence of a limited ability to predict outcome. Potential reasons for this 
include the multifactorial nature of the condition and the high degree of heterogeneity in the 
treatment of the cohort. The limited sample size and lack of consideration of variable types such as 
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patient or clinician expectation are also noteworthy limitations of the study. Nonetheless, the 
regression findings indicate the value of considering baseline function and age for informing the 
likely change in patient reported pain and disability across the period of treatment and up to three 
months post discharge. 
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1 INTRODUCTION 
1.1 The relevance of shoulder pain and its associated burden  
 
Shoulder pain affects around 1 in 3 individuals during their lifetime (van der Heijden 1999), with 
reports of an annual prevalence of 41.2 to 48.4 per 1000 person-years (Greving et al. 2012) and 
point prevalence reported between 7% and 26% (Luime et al. 2004). Furthermore high rates of 
recurrence are reported (Luime et al. 2004).  Together these reflect a high burden in the form of 
General Practitioner (GP) consultations and contact with treatment providers such as physiotherapy.  
 
Shoulder pain can impact on upper limb function due to an inability or reticence to use the limb for 
activities of daily living, recreational or occupational tasks (Dong et al. 2015). With activities of daily 
living, the impact can therefore be on the individual (Gartsman et al. 1998) and those who the 
person cares for or is cared for by. With recreational activities, this can impact on the ability of the 
patient to participate; and therefore negatively influence the social, physical and mental health 
benefits often derived from such activities. From an occupational perspective, it can impact on the 
patient’s ability to remain in employment which in turn can have economic, social and mental health 
consequences (Linaker and Walker-Bone 2015). Similarly, the impact can be upon employers and 
wider society (Holtermann et al. 2010). Optimising the management of patients with shoulder pain is 
therefore a high priority for the individual, healthcare providers and society.   
 
1.2 Shoulder pain, Subacromial Impingement Syndrome and Rotator Cuff 
Tendinopathy  
 
Shoulder pain can be of a variety of sources, including referral from the viscera and spinal structures 
into the shoulder (Linaker and Walker-Bone 2015). Separately, numerous categories of local 
shoulder pain are described, of which Subacromial Impingement Syndrome (SIS) and Rotator Cuff 
Tendinopathy (RCTendinopathy) are reported as being the most commonly assigned clinical 
diagnoses (van der Windt et al. 1995; Ostor et al. 2005). However there is widespread controversy in 
the literature as to the aetiology of SIS and RCTendinopathy, including what structures are at fault 
and how best to identify the pathology.  
 
In light of this, alternative approaches to describing such patients have been proposed that focus 
more on the clinical presentation of shoulder disorders rather than the specific theorised aetiological 
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processes (Lewis 2009). Given the lack of consensus as to a definitive approach to categorising such 
patients and the likely overlap between SIS and RCTendinopathy (van der Windt et al. 1995; Jia et al. 
2009; Hanchard et al. 2013), use of SIS/RCTendinopathy as a description of such patients has merit.  
 
1.3 Treatment approaches including physiotherapy for patients with 
SIS/RCTendinopathy  
 
The treatment approaches used for patients with SIS/RCTendinopathy can take many forms (Dong et 
al. 2015) but uncertainty persists as to which patients respond best to what treatment approaches 
and what aspects of the available care pathway. Indeed the uncertain nature of SIS/RCTendinopathy 
combined with the myriad treatment approaches available indicate that uncertainty remains 
regarding the relevance of underlying pathological processes to patient symptoms and their optimal 
management.  
 
Physiotherapy is one of several treatment approaches that may be used and may include 
approaches such as education and advice, exercise based therapy and hands-on techniques such as 
manual therapy, taping and electrotherapy. The content of physiotherapy can vary greatly and may 
reflect the experience and preference of the clinician, the presenting nature of the shoulder 
complaint or patient preference (Kromer et al. 2013). 
 
Evidence of the effectiveness of physiotherapy for SIS/RCTendinopathy is limited (Saltychev et al. 
2015). Epidemiological, diagnostic and trial data (Green et al. 2003) can be viewed as providing 
evidence in this area although uncertainty persists as to which patients do and do not respond to 
different treatment approaches. One methodological approach that could shed light on this is 
prognostic research (Dinant et al. 2007).   
 
1.4 The role prognostic research can play in informing clinical management of 
musculoskeletal disorders   
 
Prognostic research is concerned with the identification of factors that predict a particular outcome 
(Moons et al. 2009a). Recognising the merit of developing targeted interventions (Selfe et al. 2016), 
a prognostic approach has the advantage of not being constrained by the requirements of diagnosis 
per se.  Instead this approach allows for the potential inclusion of multiple and often disparate 
factors to explore their individual and collective influence on outcome (Royston et al. 2009).  
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Whilst prognostic research has been published across different medical specialities, including 
rehabilitation, musculoskeletal disorders and shoulder pain, the robustness and relative value of 
these studies has been variable (Hemingway et al. 2013). This has led researchers to highlight the 
limited value of some previously published prognostic research and thus the importance of 
establishing higher standards with the undertaking, reporting and interpreting of prognostic 
research (Kent et al. 2010).  
 
Key factors to consider here include establishing the reliability of the measurement tools used, 
incorporating clinically applicable measurement approaches, ensuring alignment between the 
number of variables and the sample size and using a clinically relevant timescale for follow up 
(Altman et al. 2009). Alongside this, the viewing of prognostic research within a method framework 
in order to reflect the nature of the evidence provided has been advocated. This includes 
exploratory hypothesis-setting studies, hypothesis-testing (confirmatory) studies in independent 
samples and subsequent validation studies (Kent et al. 2010). 
 
This thesis will therefore seek to address some of the above methodological concerns regarding 
prognostic research in exploring predictors of outcome in patients with SIS/RCTendinopathy treated 
with physiotherapy.  
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2 LITERATURE REVIEW 
2.1 Overview 
The following is a critical review of the relevant literature relating to this study. Conceptual 
frameworks relating to subacromial impingement and rotator cuff tendinopathy will firstly be 
presented. The strategy by which the prognostic studies to be critiqued were identified will then be 
described. Key aspects of study design, pathology, patient care pathway and sample will be 
explored, leading onto a consideration of the potential prognostic factors considered by previous 
studies. The treatment approaches will be discussed along with how outcome can be defined. The 
prognostic analysis approaches used and the prognostic findings for each variable type and study will 
be presented along with a consideration of the strength of evidence. These will culminate in the 
study to be undertaken.  
 
Recent systematic reviews in this area have looked at response to physiotherapy treatment for 
musculoskeletal shoulder pain (Chester et al. 2013) and adults undergoing physical therapy for 
rotator cuff disorders (Braun et al. 2016). As with the previous systematic reviews in this area by van 
der Heijden (1999) and Kuijpers et al. (2004), high levels of study heterogeneity were identified and 
so all previous reviews have undertaken narrative analyses. The most recent review (Braun et al. 
2016) emphasised the short-comings of attempting to synthesise evidence regarding individual 
prognostic factors rather than actual prognostic models. In addition they identified all studies in 
their review as being at high risk of bias when assessed by the ‘Prediction Study Risk of Bias 
Assessment Tool; PROBAST’ (Wolff (2017) personal communication).  
 
2.2 Conceptual frameworks relating to subacromial impingement and rotator cuff 
tendinopathy 
Various theoretical models of subacromial impingement and rotator cuff tendinopathy disease have 
been proposed in the literature. These provide parallel frameworks for the diagnosis, treatment and 
potentially prognosis of SIS/RCTendinopathy.  
 
2.2.1 Patho-anatomical model: intrinsic and extrinsic factors 
The patho-anatomical model is based upon structural and anatomical factors as the precipitator or 
source of pathology leading to a symptomatic presentation (Ludewig et al. 2013). Various elements 
have been proposed including intrinsic versus extrinsic factors.  
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Intrinsic factors are those which are concerned with the rotator cuff, including tendon morphology, 
biology and mechanical properties (Seitz et al. 2011). Conversely, extrinsic factors such as acromial 
architecture (primary impingement) and altered glenohumeral and scapular kinematics (secondary 
impingement) are seen as potentially precipitating or perpetuating pathology (Michener et al. 2003). 
Alongside these are scapular muscle and rotator cuff performance (Seitz et al. 2011). However there 
is acknowledgement that both intrinsic and extrinsic factors likely operate in unison as part of this 
multi-factorial pathology (Soslowsky et al. 2002; Seitz et al. 2011).  
 
The model of compression and impingement is historically linked with sub-optimal acromion 
morphology leading to catching of tissues in the subacromial space for which excision of the lateral 
acromion and subacromial bursae can be advocated to provide sufficient subacromial clearance of 
the supraspinatus tendon (Neer 1972). However, altered scapular control could similarly give rise to 
tissue compression or insufficiency of the rotator cuff due to altered length-tension ratios (Pandey et 
al. 2016). Calcific deposits within the supraspinatus tendon may be considered to lead to 
impingement, whilst in their immature state calcific deposits can themselves be considered highly 
symptomatic (Micheroli et al. 2015). However, the non-definitive link between structural pathology 
and symptoms (Girish et al. 2011) complicates the drawing of such conclusions.  
 
In addition, there has been increasing emphasis on movement system diagnoses rather than reliance 
upon patho-anatomic diagnoses (Lewis 2009; Ludewig et al. 2013). One of the drivers for this is the 
consistent reporting of poor specificity of orthopaedic tests commonly used to identify 
SIS/RCTendinopathy (Calis et al. 2000; Hegedus et al. 2008; Hegedus et al. 2012) which poses a 
challenge to the traditional diagnostic process of identifying SIS/RCTendinopathy patients.  
 
2.2.2 Psycho-social model 
The psychosocial model considers psychological and work-related factors as being critical 
components in the precipitating or perpetuating of symptoms (Waddell 2004). Psychological factors 
such as anxiety, depression or distress can potentially have a widespread impact on willingness to 
use the shoulder in work or recreational activities and could impair treatment effectiveness (Vargas-
Prada and Coggon 2015). Work-related elements can either predispose to or perpetuate chronic 
shoulder symptoms (van Rijn et al. 2010), including SIS/RCTendinopathy.  As such the psychosocial 
model is recognised across musculoskeletal pathologies as highly relevant (Hill and Fritz 2011; 
Phyomaung et al. 2014) despite being potentially at odds with a strictly patho-anatomical model.  
 
25 
 
2.2.3 ICF classification 
The International Classification of Functioning, Disability and Health (ICF) (WHO 2001) however 
provides a conceptual framework for functional measures within a bio-psycho-social context (Roe et 
al. 2013). As such it has the potential to classify according to a variety of inter-relationships (Lakke et 
al. 2009) as illustrated below:  
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Figure 2-1: ICF (WHO 2001) 
 
 
 
These are further defined: 
 Body Functions are physiological functions of body systems (including psychological 
functions). 
 Body Structures are anatomical parts of the body such as organs, limbs and their 
components. 
 Impairments are problems in body function or structure such as a significant deviation or 
loss. 
 Activity is the execution of a task or action by an individual. 
 Participation is involvement in a life situation. 
 Activity Limitations are difficulties an individual may have in executing activities. 
 Participation Restrictions are problems an individual may experience in involvement in life 
situations. 
 Environmental Factors make up the physical, social and attitudinal environment in which 
people live and conduct their lives. 
 
The ICF therefore provides a generic mechanism to capture a wide range of elements linked to 
shoulder pain, including SIS/RCTendinopathy (Roe et al. 2013).  
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2.3 Evidence regarding prognostic indicators of successful rehabilitation outcome in 
patients with SIS/RCTendinopathy 
2.3.1 Search strategy 
In order to identify research pertaining to the topic of ‘prognostic indicators of successful 
rehabilitation outcome in patients with SIS/RCTendinopathy’ the following databases were searched: 
AMED (Allied & Complementary Medicine), Biomed Central, CINAHL, The Cochrane Library, EMBASE, 
Google Scholar, Medline / PubMed, Medline via Ovid, PubMed, Scopus, Web of Science. For the 
purposes of this study, rehabilitation was defined as “non-invasive, multimodal physiotherapy”.  
 
The search terms and combinations were as follows: 1. exp Shoulder Impingement Syndrome/, 2. 
exp Shoulder/, 3. exp Shoulder Joint/, 4. exp Shoulder Pain/, 5. exp Rotator Cuff/, 6. exp Bursa, 
Synovial/, 7. exp Bursitis/, 8. exp Acromion/, 9. exp Tendinopathy/, 10. subacromial 
impingement.tw., 11. Shoulder Impingement.tw., 12. (Shoulder adj Pain).tw., 13. Rotator Cuff.tw., 
14. (shoulder adj3 Bursitis).tw., 15. or/1-14, 16. exp Physical Therapy Specialty/, 17. exp Exercise 
Therapy/, 18. exp Physical Therapy Modalities/, 19. exp Rehabilitation/, 20. rehabilitat*.mp., 21. 
Physiotherap*.mp., 22. (physical adj therap*).mp., 23. or/16-22 24., cohort.mp. 25., prognostic 
factors.tw., 26. incidence.sh., 27. follow-up studies.sh., 28. prognos:.tw., 29. predict:.tw., 30. 
course:.tw., 31. or/24-30, 32. 15 and 23 and 31.  
 
In parallel to the above main search, reference list screening and citation tracking was used as well 
as generalised web searching to identify potential ‘grey’ literature.  The above searching was 
performed at the initiation of the project and the final search was undertaken on 3rd October 2016.  
 
2.3.2 Identification of relevant studies 
In relation to the topic of ‘prognostic indicators of successful rehabilitation outcome in patients with 
SIS/RCTendinopathy’, studies were considered relevant if they provided evidence relating to 
predicting outcome, i.e. prognosis. However identifying studies which could provide relevant 
evidence in relation to treatment and pathology was more difficult to definitively define.  
 
In order to avoid an overly narrow review process but still ensure relevance, studies were included if 
they matched one of the following criteria: 
(i) presented data relating to patients with SIS/RCTendinopathy who had been treated with 
non-invasive, multimodal physiotherapy 
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(ii) presented data relating to patients with non-specific shoulder pain who had been treated 
with non-invasive, multimodal physiotherapy 
(iii) investigated patients with SIS/ RCTendinopathy or non-specific shoulder pain where 
treatments included non-invasive, multimodal physiotherapy AND outcome for those treated with 
non-invasive, multimodal physiotherapy could be identified from outcome where different 
interventions were applied.  
Criteria (ii) and (iii) were included because there is controversy in the literature regarding the signs 
and symptoms of SIS/RCTendinopathy. Non-specific shoulder pain cohorts are highly likely to include 
patients with SIS/RCTendinopathy due to the high prevalence of SIS/RCTendinopathy in the general 
shoulder pain population (Ostor et al. 2005).  
 
Table 2-1: Table of excluded studies and rationale  
Rationale for exclusion Studies excluded 
Studies that were demonstrably concerned 
with shoulder pathologies that were discrete 
from SIS/RCTendinopathy; adhesive capsulitis 
Binder et al. (1984), Shaffer et al. (1992), Mao 
et al. (1997), Griggs et al. (2000), Aydogan et al. 
(2003), Yang et al. (2008), Tanaka et al. (2010), 
Ando et al. (2013). 
Studies that were demonstrably concerned 
with shoulder pathologies that were discrete 
from SIS/RCTendinopathy; atraumatic shoulder 
instability 
Kuroda et al. (2001), Kim et al. (2004). 
Studies that did not report segregated findings 
for the shoulder because these authors 
considered patients with pain in multiple, 
different body segments 
Karels et al. (2007), Ryall et al. (2007).  
 
Studies that did not present results segregated 
for those patients who were treated with non-
invasive, multimodal physiotherapy, i.e. 
patients were managed with a variety of 
primary care approaches such as a 'wait-and-
see policy', advice on avoidance of aggravating 
activities, oral medication, local injections of a 
steroid or anaesthetic or referral on for 
physiotherapy or surgery 
Chard et al. (1988), Croft et al. (1996), van der 
Windt et al. (1996), Kuijpers et al. (2006a), 
Kuijpers et al. (2006b), van der Windt et al. 
(2007), Reilingh et al. (2008) 
Studies where the intervention was steroid 
injection +/- non-invasive, multimodal 
physiotherapy and where results were not 
segregated for those patients who were treated 
solely with non-invasive, multimodal 
physiotherapy 
Ginn and Cohen (2004), Zheng et al. (2005), 
Cummins et al. (2009), Ekeberg et al. (2010a), 
Cadogan et al. (2012), Contreras et al. (2013), 
Laslett et al. (2015) 
Studies that were concerned with assessing 
outcome in occupational settings without 
consideration of if or how pathology was 
treated and/or where treatment details were 
Macfarlane et al. (1998), Kaergaard and 
Andersen (2000), Viikari-Juntura et al. (2000), 
Miranda et al. (2001), Solomon et al. (2001), 
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not provided in sufficient detail to determine 
outcome in those treated with non-invasive, 
multimodal physiotherapy 
Cassou et al. (2002), van Eijsden-Besseling et al. 
(2010). 
* = examples: Kaergaard and Andersen (2000) explored the prognostic factors for continued 
musculoskeletal symptoms in sewing machine operators, but cases were not treated; instead 
differences were explored based on remaining in or leaving that type of work.  
Miranda et al (2001) explored the prognostic factors for shoulder pain in Finnish forestry workers, 
but no details of treatment type was provided. 
 
 
2.3.3 Relevant studies 
Following the above processes, the studies by Bartolozzi et al. (1994), Morrison et al. (1997), Conroy 
and Hayes (1998), Kennedy et al. (2006), Deutscher et al. (2009), Ogon et al. (2009), Virta et al. 
(2009), Engebretsen et al. (2010), Hung et al. (2010), Mintken et al. (2010), Tyler et al. (2010), Sindhu 
et al. (2012), Kromer et al (2014) and Chester et al (2016) were identified. A critical assessment of 
the findings from these studies in relation to ‘prognostic indicators of successful rehabilitation 
outcome in patients with SIS/RCTendinopathy’ subsequently forms a large proportion of this 
literature review.     
 
To complement the following critique of the literature, the characteristics of the studies are 
summarised in table form in appendix 2, mirroring the approach of Braun et al (2016).  
 
2.3.4 Systematic approach to critical appraisal of the included studies 
 
In order to provide a transparent, reproducible and systematic consideration of the strength of the 
evidence provided by each study, a recognised quality appraisal tool to assess study quality was 
used. Previous systematic reviews in this areas such as Chester et al (2013) have used bespoke 
checklists. However a formal checklist (PROBAST; Prediction model study Risk Of Bias Assessment 
Tool 2015) for assessing the risk of bias and assessing applicability was used in the most recent 
review in this area (Braun et al. 2016) and so this was also used to support the current literature 
review.  
 
Details of how to complete the PROBAST assessment are provided in appendix II (PROBAST process), 
but in summary it provides a framework for assessing risk of bias and applicability of primary studies 
evaluating prognostic models. It comprises 5 domains that cover participant selection, predictors, 
outcome, sample size and participant flow and analysis (PROBAST 2015). The outcomes for steps 1-5 
of the PROBAST process in relation to this literature review are provided in appendix II (PROBAST 
outcomes) and appendix II (Overall judgement on usability of the model).  
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As illustrated by appendix II (PROBAST Overall judgement), all studies were rated as being at high 
risk of bias and in two-thirds of studies there was high level concern regarding applicability to the 
research question. In addition, no studies were identified as being useable in the context of the 
intended context and target population. Although the systematic review by Braun et al. (2016) did 
not mirror exactly the studies included in the current literature review (the authors included studies 
of cuff tears and they did not exclude studies combining physiotherapy with other modalities), Braun 
et al. (2016) arrived at the same conclusion – namely that all studies were rated as being at high risk 
of bias and none were deemed usable in clinical practice. Consequently Braun et al. (2016) – and the 
previous systematic reviews in this area by van der Heijden (1999), Kuijpers et al. (2004) and Chester 
et al. (2013) – all undertook narrative analyses. Given the PROBAST findings in appendix II, this 
literature review will also adopt a narrative approach.    
 
This critique of the literature has therefore been structured according to the key components of 
prognostic studies (Hemingway et al. 2013; Hingorani et al. 2013; Riley et al. 2013), as detailed 
below. This is to facilitate alignment of common elements across the chapters. 
 the study design, including details of the pathology being investigated and where in the 
patient care pathway subjects were recruited; the sample size and nature of those who did 
and did not consent 
 the potential prognostic factors and how they were measured  
 the treatment intervention 
 the outcome measures and how they were measured   
 the analysis approach and the subsequent prognostic findings 
 
 
2.4 Study design, pathology, patient care pathway and sample 
2.4.1 Study design 
Prognostic data can be derived from various study design formats. The studies by Conroy and Hayes 
(1998), Engebretsen et al. (2010) and Kromer et al. (2014) used secondary analysis of randomised 
control trialled (RCT) data. Whilst such data has value in the context of prognosis, RCTs can provide 
findings of limited transferability due to often high rates of non-recruitment to the study and the 
specified nature of the treatment (Moons et al. 2009a).  
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Bartolozzi et al. (1994), Morrison et al. (1997) and Sindhu et al. (2012) undertook retrospective 
studies but no mention was made of blinding, which raises the spectre of intentional or 
unintentional bias due to knowing the outcome prior to collecting and analysing the data. Mintken 
et al. (2010) performed prognostic analysis on data from their single-arm trial on a non-specific 
shoulder pain sample. Although this can be considered a cohort study design, the prescriptive 
intervention limits transferability to routine practice. Conversely the studies by Kennedy et al. 
(2006), Deutscher et al. (2009), Ogon et al. (2009), Virta et al. (2009), Hung et al. (2010), Tyler et al. 
(2010) and Chester et al. (2016) used prospective cohort designs which are ideal for maximising the 
prognostic rigour whilst controlling for potential bias (Moons et al. 2009a). In addition they allow for 
maximal clinical applicability because their inclusion criteria and treatment approaches are typically 
less narrowly defined compared to RCTs. Further aspects of the above studies will be considered 
before an overall judgment on quality is made.  
 
2.4.2 Pathology (including inclusion and exclusion criteria) 
The patient sample to be selected and specifically the pathology under investigation have clear 
ramifications for the design and interpretation of the research (Hemingway et al. 2013). As noted in 
the introduction chapter, pain experienced in the shoulder can be referred from the viscera and 
spinal structures (Linaker and Walker-Bone 2015) but it can be argued that this is discrete from pain 
originating from shoulder structures. Structures implicated in pain originating from the shoulder are 
the peripheral receptors (particularly within the highly innervated subacromial bursae), peripheral 
pain processing, the spinal cord and the brain (Dean et al. 2013)). Pain originating from shoulder 
structures can encompass non-specific shoulder pain alongside attempts to categorise the nature of 
the pain. Numerous such categories of local shoulder pain are described, comprising instability, 
adhesive capsulitis, acromioclavicular joint (ACJ) pain, osteoarthritis, rotator cuff disease and 
impingement type symptoms (Schellingerhout et al. 2008). 
 
Gross shoulder instability can be viewed as a relatively discrete clinical and aetiological condition 
whereby structural or muscle patterning alterations can give rise to observable instability at the 
glenohumeral joint (GHJ) (Hayes et al. 2002). Adhesive capsulitis is typically characterised by 
stiffness of the shoulder complex, particularly the GHJ. Although the aetiology of adhesive capsulitis 
remains uncertain (Linaker and Walker-Bone 2015), the clinical presentation of adhesive capsulitis 
with its characteristic freeze and thaw phases is reported. ACJ pain whereby symptoms are localised 
to the ACJ and replicated upon approximation of the joint surfaces (Armstrong 2014) can also be 
seen as a relatively discrete condition. Osteoarthritis of the GHJ is typically a radiological diagnosis 
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(Parsons et al. 2004) and whilst it accounts for only a limited percentage of shoulder pain patients, it 
can be readily classified.  
 
However, there is arguably greater uncertainty regarding SIS/RCTendinopathy type symptoms 
(Walker-Bone et al. 2003). In SIS/RCTendinopathy the classical concept of impingement describes 
the compression of tissues within the subacromial space and the local generation of painful stimuli 
(Neer 1983). These provide the rationale for orthopaedic symptom reproduction tests such as the 
Hawkins-Kennedy test, Neer's sign and the Empty Can test (Alqunaee et al. 2012). These tests are 
often described as compressing the irritated, tendinopathic or torn tendon tissue that lies in this 
space. However, the identification of high levels of nociceptors in the bursae lining this region 
provides a rationale for bursal tissue as being a primary source of symptom production (Lewis 2009). 
Furthermore, long-term exposure to pain can arguably give rise to symptoms that have limited if any 
local source but instead are centrally generated (Kooijman et al. 2015).  
 
Whilst the importance of the rotator cuff from a neuromotor control perspective is widely accepted, 
its role in pathology is more controversial (Seitz et al. 2011). Sonographically the presence of hypo 
and hypertrophy of the rotator cuff tendon may be theorised to be associated with under or over-
use, respectively. Tendinopathic changes such as decreased echogenicity and internal architecture 
heterogeneity can lead to a diagnosis of rotator cuff tendinopathy (Smith et al 2015). However, the 
relative relevance of calcific deposits (Gosens and Hofstee 2009) and associated findings such as 
bursal thickening and increased fluid are areas of controversy. The theorised linking of such findings 
with mechanical ‘impingement’ is often proposed, with this historically being linked to acromion 
morphology (Pandey et al. 2016). The presence of rotator cuff tears could be viewed as a 
progression of such rotator cuff disease (Lewis 2010) although the mechanisms by which this might 
occur are debatable, as are the symptomatic relevance of such tears. In light of the uncertainties as 
to the aetiology and patho-anatomical processes involved in SIS/RCTendinopathy, defining this 
pathology via inclusion and exclusion criteria is therefore an area of controversy. 
 
For the studies by Kennedy et al. (2006), Deutscher et al. (2009), Mintken et al. (2010) and Chester 
et al. (2016) which were concerned with non-specific shoulder patient populations then 
identification was typically via exclusion of visceral, systemic or spinal sources of symptoms. This 
leaves local shoulder reproduced symptoms, which is a relatively easily defined population. However 
in terms of the likely predictors of outcome and particularly the clinical application of the findings, a 
generalist approach can be argued to be of limited utility. This is further compounded by the 
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potential that quite different treatment approaches may be applied to distinctly different 
pathologies, e.g. excessive stiffness (e.g. adhesive capsulitis) versus excessive movement (e.g. gross 
instability). This additional heterogeneity within the data could theoretically make it less likely to 
identify clinical or pathology-related factors as predictors. Nonetheless, these studies would likely 
include a substantial number of SIS/RCTendinopathy patients due to their consideration of non-
specific shoulder pain populations (van der Windt et al. 1995; Ostor et al. 2005). As such they were 
included in the review so as to avoid omitting potentially useful evidence. 
 
An alternative approach was taken by Sindhu et al. (2012) who used the diagnosis codes based on 
the International Classification of Diseases, Ninth Revision (ICD-9) to identify different categories of 
non-specific shoulder pain, of which the ‘muscle, tendon and soft tissues disorders’ were deemed 
most comparable to the pathologies under consideration in this study. However the limited inter-
rater agreement for the ICD-9 system (Dixon et al. 1998) raises questions as to the merit of such an 
approach.  
 
Conversely where studies specified particular pathologies these included the labels of subacromial 
impingement (Morrison et al. 1997; Virta et al. 2009; Hung et al. 2010), subacromial shoulder pain 
(Engebretsen et al. 2010), shoulder impingement syndrome (Conroy and Hayes 1998), subacromial 
pain syndrome (Kromer et al. 2014), rotator cuff disease (Bartolozzi et al. 1994) and calcific 
tendonitis (Ogon et al. 2009). This reflects uncertainty as to the nature of the pathology and 
associated variation in the terminology used.  
 
However when looking at the actual inclusion and exclusion criteria there were areas of 
commonality. Typically, inclusion criteria involved orthopaedic tests results with Morrison et al. 
(1997) requiring a positive Neer's sign and Engebretsen et al. (2010) requiring a positive Hawkins-
Kennedy test. Other studies such as Kromer et al. (2014) required presence of 1 positive test from a 
battery of tests (Neer's sign, Hawkins-Kennedy test, or painful arc with active abduction or flexion) 
while Bartolozzi et al. (1994) required a positive Neer's sign, Hawkins-Kennedy test and a painful arc 
in those who did not have imaging. Hung et al. (2010) also used a battery of tests (Neer's sign, 
Hawkins-Kennedy test, painful arc, pain with palpation of rotator cuff tendons and pain with active 
shoulder elevation) but required 3 or more to be positive for inclusion in the study. 
 
However the sensitivity and specificity of orthopaedic tests has been consistently identified as being 
limited (Calis et al. (2000); Alqunaee et al. (2012)). Such findings emphasise that even using a battery 
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of tests, identifying a patient population where orthopaedic test results are an inclusion criterion is 
arguably flawed. As a consequence, identification of a sample based on clinical history and clinical 
examination (but not on orthopaedic test results) can be considered of greater clinical and 
conceptual relevance (Kromer et al. 2010). 
 
In this respect, clinical presentation suggestive of the target pathology was used as an inclusion 
criterion by Bartolozzi et al. (1994), Morrison et al. (1997) and Ogon et al. (2009). This included 
Engebretsen et al. (2010) and Kromer et al. (2014) requiring dysfunction or pain on shoulder 
abduction and pain on isometric tests of abduction, external and internal rotation and Conroy and 
Hayes (1998) requiring pain in the supero-lateral shoulder region. 
 
From an exclusion perspective, elimination of other discrete pathologies such as instability, adhesive 
capsulitis, acromio-clavicular joint pain and GHJ arthritis was used by Conroy and Hayes (1998), 
Engebretsen et al. (2010) and Kromer et al. (2014); Bartolozzi et al. (1994), Morrison et al. (1997), 
Conroy and Hayes (1998) and Kromer et al. (2014); Morrison et al. (1997), Conroy and Hayes (1998) 
and Engebretsen et al. (2010); Bartolozzi et al. (1994), Conroy and Hayes (1998) and Engebretsen et 
al. (2010), respectively. As such, exclusion of other discrete pathologies is a commonly used 
mechanism.  
  
The above section presents the variety of approaches taken for identifying a patient sample, many of 
which overlap to a greater or lesser extent. However this heterogeneity highlights the challenges of 
prognostic research in SIS/RCTendinopathy patients, in that uncertainty persists as to the relevance 
or otherwise of different pathological characteristics. As such, these factors highlight potential 
challenges in identifying predictors of outcome.   
  
2.4.3 Patient care pathway and clinical setting 
This thesis is focused on physiotherapy, but it is of note that various treatment approaches for 
patients with SIS/RCTendinopathy may be offered and that physiotherapy treatment can occur at 
one or more of a variety of points within the care pathway.  
 
Typically, most patients will initially present in primary care, usually to their GP (Ostor et al. 2005; 
Dorrestijn et al. 2011). Treatment options here include advice, rest, oral medication (analgesia 
and/or anti-inflammatories), injection of the shoulder (typically with a combination of analgesia and 
anti-inflammatories) (Gruson et al. 2008) and referral on (Mitchell et al. 2005). 
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Other specialities involved include Orthopaedic surgery and Rheumatology where available 
treatment modalities include surgery such as subacromial decompression with or without rotator 
cuff repair (Neer 1972; Henkus et al. 2009; Butt et al. 2015; Carr et al. 2015), shoulder injections 
(image guided or unguided) (Dogu et al. 2012; Min et al. 2013; Haghighat et al. 2016; Messina et al. 
2016) and referral on. 
 
As noted above, where patients are referred for rehabilitation, typically in the form of physiotherapy 
in the NHS, this can be directly from their GP or from other care providers based in secondary care 
(Dorrestijn et al. 2011; Kooijman et al. 2013). However the care pathway for shoulder pain and 
SIS/RCTendinopathy is typically poorly defined and may be more influenced by clinical availability, 
patient preference and symptom persistence, rather than a definitive, optimal patient management 
pathway.  
 
In the studies under consideration, patients were recruited from a variety of setting. Studies such as 
Kennedy et al. (2006) recruited patients who were beginning treatment at a large number of 
different physiotherapy practices. Mintken et al. (2010) also recruited from outpatient 
physiotherapy clinics whilst Hung et al. (2010) and Engebretsen et al. (2010) recruited from 
orthopaedic clinics and university hospital outpatient departments; respectively. Others such as 
Kromer et al. (2014) recruited their sample from outpatient physiotherapy clinics, GPs and 
orthopaedic surgeons. The above details are evidence of patient recruitment heterogeneity in 
relation to care pathway. 
 
In addition to this, Virta et al. (2009) recruited patients who were on a waiting list for orthopaedic 
surgery but had been referred for physiotherapy prior to surgery. Similarly Ogon et al. (2009) only 
included patients who had been referred following failed conservative treatment, which comprised 
physiotherapy, manual therapy, electrotherapy, oral analgesics or NSAIDs and up to three 
subacromial corticosteroid injections. It could therefore be argued that both studies were concerned 
with patients at a relatively late stage in the care pathway and where patient expectations of 
physiotherapy may have been low. 
 
Such methodological elements have obvious implications in terms of likelihood of success as well as 
transferability of the findings. In order to optimise the usefulness of study findings, clearly defined 
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care pathways would increase the likelihood of meaningful results and also the ability to apply any 
findings in a more targeted way for clinical implementation.   
  
2.4.4 Sample size and nature of those who did and did not consent 
As in other types of research, sample size is an important consideration particularly in relation to the 
statistical power to accurately detect factors that are or are not predictive of outcome. However the 
challenges around sample size calculations are manifold (Moons et al. 2009a; Riley et al. 2013) and 
this is reflected by the lack of sample size justification in the majority of prognostic studies in this 
area.  
 
Typically where sample size calculations were presented these related to determining the sample 
required for differences to be identified in RCTs, such as by Engebretsen et al. (2010) and Kromer et 
al. (2014). However with cohort studies a commonly used approach is the guide of 10 cases per 
prognostic factor (Peduzzi et al. 1996). One challenge here is that prior to the onset of a study it is 
not possible to identify the number of variables that will be retained for entering into the prognostic 
model (depending on how the model is populated). This might help to explain the predominance of 
seemingly pragmatic sample sizes. As such these are likely influenced by the use of retrospective 
electronic databases which facilitate collection of large samples (e.g. Deutscher et al. 2009 with 
n=5,000) through to complex three-dimensional motion analysis requiring lengthy data collection 
phases where smaller sample sizes are seen (e.g. Hung et al. 2010 with n=33).  
 
An alternative, pragmatic approach is to use a combination of statistical and conceptual methods to 
align the number of potential predictor variables with the size of the sample. This has the advantage 
of reducing the risk of overfitting, whereby the inclusion of too many potential predictors for the 
sample size makes it unlikely that when model validation is undertaken in a new sample that the 
original results will be reproduced (Kent et al. 2010). Indeed this has been cited as one of the 
greatest threats to the robustness of prognostic research, particularly in smaller sample sizes 
(Babyak 2004).  
  
Alongside the sample size, the characteristics of those who did and did not consent should be 
considered, so as to avoid potential selection bias. A comparison of characteristics between groups 
was not performed by the majority of studies and so any potential bias is unknown. However the 
studies by Kennedy et al. (2006) and Chester et al. (2016) did undertake statistical analysis and 
identified no difference in gender or age between the groups.  
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2.5 Potential prognostic factors and how they were measured 
 
The potential prognostic factors selected and the methods by which they are derived, processed and 
utilised in prognostic modelling have substantial implications for study findings and interpretation 
(Hemingway et al. 2009). Typically, potential predictors are assessed at baseline such that the 
subsequent results can inform how baseline characteristics can influence outcome (Moons et al. 
2009b). The variables to be considered can be across a spectrum of elements either identified as 
being predictive in previous studies or conceptually associated with the condition, management or 
outcome.  
  
In the case of the identified prognostic studies for review, a wide range and number of variables 
have been considered. In order to allow for meaningful comparison within categories, the potential 
prognostic factors considered in the relevant published literature have been collated according to 
(A) demographics, (B) clinical history, (C) patient reported measures, (D) clinical measures and (E) 
structural pathology.  
 
In the following section the strengths and weaknesses of the approaches used in previous studies 
will be considered. Later in this chapter the actual variables which were and were not identified as 
being predictive in individual studies will be presented.  
 
2.5.1 A. Demographics 
Age and gender were the demographic variables most commonly explored as prognostic factors by 
studies in this topic area. Indeed all studies that explored demographic factors as potential 
predictors considered age, while only Conroy and Hayes (1998) and Hung et al. (2010) omitted 
gender from their analysis. For the later study this was due to their use of a male only sample. 
Kromer et al. (2014) recognised a potential role for these variables but chose to control for both age 
and gender when constructing their prognostic model.  
 
Along with the potential association of increasing age with poorer tissue healing, age could be 
rationalised as a predictor due to theorised associations with pre-existing activity levels, greater 
functional reserves and enhanced ability to modify lifestyle amongst the young (Cecchi et al. 2014). 
Analysis of age as a continuous variable facilitates retention of maximal statistical power and is 
advocated for robust prognostic analysis (Hingorani et al. 2013). The decision by studies such as 
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Bartolozzi et al. (1994), Morrison et al. (1997) and Kennedy et al. (2006) to convert their continuous 
variable of age into an ordinal variable is therefore controversial due to a subsequent reduction in 
statistical power.  
 
A potential role for gender as a predictor for outcome comes from evidence of differences between 
the sexes for pain sensitivity (Horn et al. 2014) including in the shoulder (Kindler et al. 2011). The 
evidence generally points to a higher incidence of pain conditions and sensitivity in women 
compared to men, although conflicting evidence predominates in response to differences between 
the genders for pain treatment (Fillingim et al. 2009). Evidence of a gender effect in the low back 
pain prognostic literature (George et al. 2006) supports the potential cross-condition and generic 
relevance of this variable.  
 
A less commonly explored generic demographic variable was smoker status which was only 
considered by those studies that investigated general shoulder pathology (Deutscher et al. 2009; 
Chester et al. 2016). The potential impact on tissue healing provides a rationale for considering this 
variable although uncertainty regarding the direction of cause and effect with regards to smoking 
and pain confounds establishing a consensus in this area (Ditre et al. 2011).  
 
The study by Chester et al. (2016) was the only one to consider the variables of body mass index 
(BMI) and social deprivation. Associations between elevated BMI and both a higher incidence of and 
poorer recovery from musculoskeletal disorders (Viester et al. 2013) provides a rationale for 
considering this variable. Socioeconomic status has been identified as impacting upon morbidity 
arising from musculoskeletal disorders (Brekke et al. 2002), thereby providing a rationale for 
exploring it as a predictor. However the use by Chester et al. (2016) of the index of multiple 
deprivation as a representative variable can be considered of limited accuracy as it is postcode based 
rather than individualised to the patient. Another representative variable (educational attainment) 
was only explored by Engebretsen et al. (2010) who defined this as whether the patient had 
attended college or university. An association of educational attainment with musculoskeletal pain 
and disability (Katz 2006) provides a rationale for considering this variable.   
 
One or more of work, recreational or functional task related variables were included by 8 studies, 
with occupation and/or work status recorded by Bartolozzi et al. (1994), Kennedy et al. (2006), Ogon 
et al. (2009), Engebretsen et al. (2010), Mintken et al. (2010) and Chester et al. (2016). Physical 
activity levels were recorded by Deutscher et al. (2009) and Chester et al. (2016) whilst functional 
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tasks were considered by Engebretsen et al. (2010) and Chester et al. (2016). However studies such 
as Ogon et al. (2009) provided no details of how such variables were collected or defined. Conversely 
Chester et al. (2016) used a robust measure to quantify activity levels, namely the Godin leisure time 
exercise questionnaire (Godin and Shephard 1985). Deutscher et al. (2009) on the other hand simply 
recorded the number of times per week patients said they were active, thereby providing less robust 
data.  
 
There was also inconsistency with how occupation and/or work status was derived. Kennedy et al. 
(2006) looked at whether the patient was unable to work due to their shoulder pain whilst 
Engebretsen et al. (2010) and Chester et al. (2016) looked at the type of work, the intensity and 
likely symptom aggravating nature of their work or recreational activities. Such inconsistencies in the 
methods of data collection inevitably present a potential barrier to deriving a consensus from the 
literature in this area.  
 
It can therefore be concluded that a wide variety of demographic related variables have been 
considered in previous prognostic studies. There is merit is collecting such data in order to 
adequately describe the sample. However a judicious choice should be made as to the demographic 
variable or variables to be entered into a subsequent prognostic model so as to avoid potential over-
fitting.  
 
2.5.2 B. Clinical history 
Symptom duration was the most commonly investigated ‘current condition related variable’ and can 
be justified by evidence of more established conditions being more stubborn to treatment (Collins et 
al. 2010). In addition the inter-relationship of chronicity, depression and pain levels (Sullivan et al. 
2008); and identification of symptom duration as a predictor across various musculoskeletal 
disorders (Rihn et al. 2011; McClinton et al. 2015) provide further rationale for considering it.  
 
However the handling of this patient reported variable was a source of less consistency, including 
dichotomising to acute versus chronic (as per Deutscher et al. 2009), the use of categories of time 
and retention of it as a continuous variable. In justifying the use of soft-tissue healing timescales, 
Kennedy et al. (2006) converted their duration data into less than 4 weeks, 4 to 12 weeks and longer 
than 12 weeks. However controversy regarding tissue-healing timescales (Broughton et al. 2006) and 
the complex mechanisms underpinning SIS/RCTendinopathy symptoms make such arbitrary 
timescales arguably of limited utility. Conversely, retaining such data as a continuous variable has 
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the advantage of preserving optimal statistical power (Hingorani et al. 2013). However absolute 
numerical data is potentially subject to recall error, particularly where onset is not attributed to a 
single, discrete event. As such, the use of an ordinal category as per Engebretsen et al. (2010) and 
Virta et al. (2009) provides a reasonable compromise.   
 
Side-related symptoms were also commonly investigated, with five studies reporting data in relation 
to arm dominance. Conversely Chester et al. (2016) explored bi-laterality and the side of the 
symptoms relative to the non-involved side, making it difficult to compare results directly between 
studies. A similar number of publications (n=5) explored the reason for symptom onset although as 
this was patient reported it is inherently subject to potential recall bias or inaccuracy. Recurrence of 
the shoulder symptoms was explored as a potential predictor by four studies although again as 
patient reported data this comes with the caveats previously mentioned. Associated symptoms of 
neck pain and paraesthesia in the arm were explored by Engebretsen et al. (2010) and Chester et al. 
(2016); respectively. The Engebretsen et al. (2010) data was patient reported, again raising the 
spectre of recall error whilst Chester et al. (2016) failed to clarify whether paraesthesia was 
determined by the patient or clinician.  
 
In regard to treatment related variables, the variable of previously receiving treatment (including 
physiotherapy) might indicate that treatment again will be successful or unsuccessful, depending on 
the previous therapeutic response. As such, Engebretsen et al. (2010), Mintken et al. (2010) and 
Chester et al. (2016) explored this variable. Taking medication for pain or psychological state might 
also reflect either a more complex clinical presentation or conversely that other condition related 
symptoms are being actively managed (Ndlovu et al. 2014). As such, Kennedy et al. (2006), 
Deutscher et al. (2009), Engebretsen et al. (2010), Mintken et al. (2010) and Chester et al. (2016) all 
considered this variable. Finally, the presence of co-morbidities might conceivably represent a 
further level of clinical complexity and as such were explored by five studies.  
 
As with the demographic variables, it can be concluded that a wide variety of clinical history related 
variables have been considered in previous prognostic studies. Recognising this and in relation to the 
use of this variable type in a prognostic study, a judicious choice should be made as to the variable 
or variables to be entered into a prognostic model so as to avoid potential over-fitting. 
Notwithstanding this, recording of clinical history related variables are also of value in adequately 
describing the sample.  
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2.5.3 C1. Patient reported measures: Pain 
Alongside functional restrictions, pain is typically the major symptom that patients with 
SIS/RCTendinopathy report. Consequently the management and/or resolution of pain are major 
aims in the healthcare management of SIS/RCTendinopathy (Baring et al. 2007). In the context of 
prognosis, substantial pain levels at baseline could be theorised to be associated with worse 
outcome due to high pain levels potentially representing severity of the condition along with the 
potential impact of high pain levels on other aspects such as function, strength and wellbeing 
(Kooijman et al. 2015).  
 
The studies by Kennedy et al. (2006), Engebretsen et al. (2010), Mintken et al. (2010), Kromer et al. 
(2014) and Chester et al. (2016) considered pain as a potential predictor and all measured pain levels 
via patient self-reported scores. However the complexities of how painful stimuli are generated, 
transmitted and received are only partly established (Chien et al. 2013). Furthermore, pain is 
recognised as a largely subjective experience which can be impacted upon by aspects such as 
personal belief mechanisms, societal conditioning and mental health, all of which add to the 
complexity of the measurement and treatment of pain (Hjermstad et al. 2011). As such, measuring 
pain is a challenging area (Ferreira-Valente et al. 2011).  
 
One commonly used clinical approach is to ask patients to rate their symptoms using a scale which 
can be Likert, numerical rating or visual analogue in nature (Hjermstad et al. 2011), such as the 
Visual Analogue Scale (VAS). These have the advantage of being quick to perform but can be subject 
to recall bias and subjective interpretation. Whilst recognising these caveats, the VAS has been 
widely tested for acceptability (Joyce et al. 1975), reliability (Ferraz et al. 1990), construct validity 
when compared to verbal descriptive and numeric rating scales (Downie et al. 1978). A further 
advantage of this approach is that minimum clinically important difference data has been reported 
for patients with rotator cuff disease managed non-operatively (Tashjian et al. 2009) making it a 
relevant approach to use.  
 
Engebretsen et al. (2010) asked patients to rate their pain according to the levels ‘at rest’ and ‘during 
activity’ in the previous week. However they failed to stipulate whether the ‘during activity’ rating 
given by the patient was to refer to pain levels during generalised shoulder activity or in relation to a 
pain reproducing shoulder activity. Such a variation in potential interpretations makes the ‘during 
activity’ pain data in this study of questionable value. Chester et al. (2016) recorded only pain levels 
at rest, although whether this was momentary or over a time period was not stipulated.  
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Conversely Kennedy et al. (2006) and Kromer et al. (2014) made no attempt to stipulate what aspect 
of rest or activity their patients should report their pain levels in relation to, asking instead that 
subjects simply gave the rating that best described their average pain level. Such an approach is non-
specific considering the potential for substantial symptom variability.  
 
The use by Kennedy et al. (2006), Engebretsen et al. (2010) and Kromer et al. (2014) of 1 week as the 
period over which patients were asked to rate their pain has the advantage of potentially 
accommodating day to day variation in pain levels. However the use of such a time period might 
introduce recall error because accurately recalling pain levels across a 7-day period could be prone 
to inaccuracy. Furthermore, in the case of Engebretsen et al. (2010) it also raises the question of 
whether patients reported their lowest, greatest or average pain levels across the time period.    
 
The data processing and presentation of the pain variables for potential inclusion in the final 
prognostic model also varied across different studies. Most studies simply reported their individual 
pain variables whilst Mintken et al. (2010) reported only the mean of their three variables (current 
pain along with their worst and least amount of pain in the previous 24 hours). This approach has 
the advantage of accommodating likely variation in pain across time periods and activities, and 
therefore arguably being more globally representative.  
 
It can be concluded that whilst there is consistency in the choice of patient self-reporting as the 
mechanism for measuring pain, the specifics of how this has been carried out varies widely across 
previously published prognostic studies. In relation to the measuring of this variable in a prognostic 
study, the accurate stipulating of the aspect of pain (e.g. lowest, greatest, average) and what it is in 
relation to (e.g. rest, activity, a test movement, etc.) is advocated. Similarly, recognition of potential 
recall error when considering the time period over which to rate pain and the segregating of rest, 
activity and night pain is of merit. The use of a combination or mean score as a mechanism for 
accommodating the wide variation across such segregations also has merit.   
 
2.5.4 C2. Patient reported measures: Psychological symptoms 
A patient’s state of mind has the potential to impact upon their perception of subjective experiences 
such as pain and their self-identification of impairment levels. It can also influence the willingness of 
patients to use their shoulder and their willingness to participate in work, recreational activities and 
even treatment (Vargas-Prada and Coggon 2015). As such, psychological symptoms such as elevated 
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levels of anxiety, depression, somatisation or distress can potentially have a widespread impact 
(Vranceanu et al. 2009) and where elevated at baseline could be theorised to be associated with 
worse outcome. In the context of musculoskeletal pain, psychological symptoms might be pre-
existing or might be precipitated or worsened by ongoing pain and impairment.   
 
The studies by Kennedy et al. (2006), Engebretsen et al. (2010), Mintken et al. (2010) and Chester et 
al. (2016) used outcome measures of elements which are linked to state of mind but are not 
themselves psychological symptoms. Specifically these were self-efficacy for pain (Engebretsen et al. 
2010; Chester et al. 2016), expectation (Kennedy et al. 2006; Mintken et al. 2010; Chester et al. 
2016) and perceived general health status (Engebretsen et al. 2010).    
 
Engebretsen et al. (2010) reported perceived self-efficacy data for pain comprising a mean score 
from four items rated from 1 (easy) to 7 (impossible) concerning self-judgments of performance 
capability. However they provided no further detail of the tool other than referring to the paper by 
(Lorig et al. 1989) who described a tool validated for patients with arthritis comprising 20 questions 
across 3 subscales, each scored on a scale from 10 (very uncertain) to 100 (very certain). The 
uncertainty as to the nature of the tool used by Engebretsen et al. (2010) and how it was derived 
means that such data cannot be relied upon. Conversely Chester et al. (2016) cited the thoroughly 
evaluated version reported by Nicholas (2007).  
 
Kennedy et al. (2006) asked patients to rate their expectations for recovery under the domains of (i) 
how much they would recover and (ii) how quickly they would return to usual activities. The 
inclusion of patient expectation has merit in that expectation could be theorised to influence the 
level of participation in non-invasive, multimodal physiotherapy and the potential for high or low 
expectation of outcome to be a self-fulfilling prophecy (Vargas-Prada and Coggon 2015). However 
Kennedy et al. (2006) provided no evidence as to the specific question wording used nor the 
psychometrics of their tool and so it is difficult to gauge the value of the evidence provided in 
relation to this variable. Similarly Chester et al. (2016) stated their wording “how much do you 
expect your shoulder problem to change as a result of physiotherapy treatment?” but provided no 
reference for it. Mintken et al. (2010) also included expectation although they provided no further 
details beyond “The historical examination included ….. expectations for treatment …..” (page 29) 
and so it is not possible to gauge how this was collected or the subsequent nature of the data 
relating to this potential prognostic variable.  
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The study by Engebretsen et al. (2010) used an outcome measure that looked at other global 
elements which arguably incorporate state of mind. Specifically they evaluated general health status 
by using the EuroQol-visual analogue scale (EQ-VAS), a self-rated score for health on a vertical, visual 
analogue scale where the endpoints are labelled ‘Best imaginable health state’ and ‘Worst 
imaginable health state’ with higher scores indicating better perceived health (Brooks 1996). This 
internationally used outcome score has been demonstrated to be valid and reliable, including in 
musculoskeletal pain (Hurst et al. 1997). However it is an inherently generalist measure of self-
perceived general health and so provides limited insight into or quantification of psychological 
symptoms. This is relevant because poor mental health can have a wide-reaching impact on, and 
association with, musculoskeletal pain and disability (Bair et al. 2003; Pincus et al. 2002; Phyomaung 
et al. 2014).  
 
The more direct measures of state of mind or psychological symptoms included in the studies by 
Kennedy et al. (2006), Engebretsen et al. (2010), Mintken et al. (2010), Sindhu et al. (2012), Kromer 
et al. (2014) and Chester et al. (2016) can therefore be considered of greater relevance. 
Psychological symptoms in relation to fear of pain and consequent avoidance of physical activity 
because of fear were measured by Mintken et al. (2010), Kromer et al. (2014) and Sindhu et al. 
(2012) who used the Fear Avoidance Beliefs Questionnaire (FABQ) (Waddell et al. 1993). However 
there was wide variation in how this tool was described and applied.  
 
The FABQ examines high pain avoidance behaviour and generates ‘general, physical activity and 
work’ subscales (representing beliefs about how work and physical activity impact upon their pain) 
from which a total score is calculated (Waddell et al. 1993). Its potential relevance as a predictor of 
outcome in patients with low back pain receiving physiotherapy has been previously demonstrated 
by George et al. (2008). However Mintken et al. (2010) and Kromer et al. (2014) modified the FABQ 
by changing the word “back” to “shoulder” on the questionnaire. It is unclear whether the validity of 
the questionnaire in a different anatomical region has been established and so the robustness of the 
data for this potential prognostic variable is uncertain. Furthermore Kromer et al. (2014) only chose 
to use a component of it, namely the physical activity subscale.  
 
Sindhu et al. (2012) took this further and chose to only use a single item from the physical activities 
scale of the FABQ, namely “I should not do physical activities that (might) make my pain worse”.  The 
use of a single item was justified by the study by Hart et al. (2009) whose data supported this item as 
accurately identifying subjects with elevated levels of fear. This was appropriate for the unusual 
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study design used by Sindhu et al. (2012) as the authors were interested in exploring fear avoidance 
as a potential predictor of functional outcome across different patient groups but whilst controlling 
for other potential predictors. However the use of a dichotomised, single item greatly limits the 
breadth and sensitivity of the original FABQ, thereby providing very limited consideration of 
psychological symptoms of subjects in this study.  
 
Alongside the FABQ, Mintken et al. (2010) also used an 11-item, shortened version of the Tampa 
Scale for Kinesiophobia (TSK) which is similar to the FABQ in that it assesses fear of both movement 
and pain. It has been previously used as a potential predictor of outcome in shoulder pain patients 
(Bot et al. 2005) and high test-retest reliability, good internal consistency and concurrent validity has 
been reported (Woby et al. 2005). Along with the FABQ, the relevance of the TSK to a patient 
population undergoing physiotherapy for shoulder pain is evident as it assesses fear of movement 
and pain. However it could be argued that this is also the major weakness of measures such as the 
FABQ and TSK in that complex, multi-faceted aspects of psychological symptoms will potentially be 
missed by such specific screening tools.  
 
An alternative approach to quantifying psychological symptoms was used in the study by Kennedy et 
al. (2006) as the authors used subsections of another outcome measure to derive state of mind 
measures. Specifically Kennedy et al. (2006) used the Mental Component Score (MCS) from the 36-
Item Short-Form Health Survey (SF-36). The SF-36 is a widely used health-related outcome measure 
and reliability of the component scales and summary measures have been demonstrated (McHorney 
et al. 1994), including the validity of the MCS (Ware et al. 1995). However the MCS comprises a 
broad range of subsections from the SF-36, i.e. Vitality, Mental Health, Emotional Role, and Social 
Functioning and so the MCS by its very nature can be considered a very general assessment of a 
respondents’ state of mind but with limited specificity in relation to psychological symptoms per se.    
 
Chester et al. (2016) reported data pertaining to anxiety and depression over the last 7 days but 
failed to detail how their rating of ‘No, moderately and extremely’ were determined. Considering the 
complex and sensitive nature of such elements the limited ability for a single question to capture 
this, raises doubts as to the value of their data. Conversely Kromer et al. (2014) took a more robust 
approach in using a multi-faceted, formal measure, namely the Pain Catastrophizing Scale (Sullivan 
et al. 1995).   
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Engebretsen et al. (2010) included a specific measure of psychological symptoms, which was the 25-
items Hopkins Symptoms Checklist to assess emotional distress with a high score indicating more 
distress. However there is a lack of clarity as to which elements the measurement tool actually 
measured because they referenced Derogatis et al. (1974) which is the original 58-item tool for 
scoring somatisation, obsessive-compulsive, interpersonal sensitivity, anxiety and depression. This 
contrasts with the 25-item scale which comprises 10 anxiety items, 13 depression items and 2 
somatisation (Winokur et al. 1984).  
 
The inclusion of an outcome measure specific to psychological symptoms is a notable strength of the 
study by Engebretsen et al. (2010). However distress is only one of the mental health symptoms that 
patients may present with, alongside depression, anxiety and somatisation (den Boeft et al. 2016). 
The use of a measure of psychological symptoms such as via the four-dimensional symptom 
questionnaire (4DSQ) therefore provides a mechanism for measuring the broad range of 
psychological symptoms. The 4DSQ is specifically designed to measure psychological symptoms and 
sub-categorise the nature of them according to levels of anxiety, depression, distress and 
somatisation. Cut-off points have been published for the 4DSQ to guide the clinical interpretation of 
levels of psychological symptoms (Terluin et al. 2006). Collapsing of the moderately and strongly 
elevated categories into a single score to illustrate prevalence has also been published (Koorevaar et 
al. 2016). Alongside evidence of its validity (Tebbe et al. 2013), the appropriateness of its use in 
orthopaedic shoulder patients has also been demonstrated (Koorevaar et al. 2016).   
 
It can be concluded that the inclusion of a specific assessment of psychological symptoms as a 
potential prognostic factor has merit so that the potential to impact upon prognosis and outcome 
can be explored. In relation to study design, it is proposed that diffuse aspects of state of mind such 
as perception, expectation and general well-being may be relevant but can be considered to be of 
limited specificity in relation to psychological symptoms. Movement or pain specific elements can be 
considered relevant to MSK conditions but limited in their ability to capture the full range of 
psychological symptoms that patients may present with. The use therefore of a measurement tool 
where the full breadth of psychological symptoms can be assessed is therefore advocated.  
 
2.5.5 C3. Patient reported measures: Function / Disability 
The level of shoulder function that a patient demonstrates is a composite of their physical ability (i.e. 
shoulder strength and range of movement) and how much they are able or willing to use that 
physical ability due to pain, perception and state of mind (Roe et al. 2013). Function and disability 
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are therefore wide ranging aspects of the patient experience and consequently encompass many of 
the elements that prompt patients to seek treatment for their shoulder (Payne and Michener 2014). 
As such, the optimising of function and addressing of disability are major aims in the healthcare 
management of shoulder pain, including SIS/RCTendinopathy. 
 
In the context of prognosis, substantial impairment of function at baseline could be theorised to be 
associated with worse outcome due to the need to address substantial impairment, making for a 
more challenging rehabilitative process (Schmidt et al. 2014).  
 
Many shoulder prognostic studies have utilised function as their primary outcome measure, i.e. the 
mechanism by which improvement or otherwise is determined. Where studies have considered 
function in that capacity, these will be considered later in the literature review. However the 
prognostic studies by Bartolozzi et al. (1994), Kennedy et al. (2006), Deutscher et al. (2009), 
Engebretsen et al. (2010), Hung et al. (2010), Mintken et al. (2010), Kromer et al. (2014) and Chester 
et al. (2016) included assessment of function as a potential prognostic factor and so these will be 
considered here. 
 
The study by Kennedy et al. (2006) used a single item, global rating of disability score. The authors 
provided no details beyond stating that the variable was ‘Patient global rating of shoulder 
injury/problem’ scored as ‘very mild, mild, moderate, severe or serious, very severe or serious’ (page 
1,018) and so the nature, reliability and validity of this variable cannot be determined. Kennedy et al. 
(2006) also used a derivation of another outcome measure to derive function measures. Specifically 
they used the Physical Component Score (PCS) from the 36-Item SF-36. It was noted in the section 
concerning psychological symptoms that the SF-36, its derivations and components have been 
widely tested. However the use of generic, quality of life scores means that whilst function related 
symptoms per se can be assessed, the measurement approach provides very limited shoulder-
specific function information. 
 
In contrast to a generic measure, Bartolozzi et al. (1994) used a shoulder specific functional outcome 
score, the University of California Los Angeles (UCLA) score. This 5-section questionnaire considers 
pain, function, active range of movement (ROM), strength and patient satisfaction (Amstutz et al. 
1981) but Bartolozzi et al. (1994) chose to only use the function sub-section, which has not been 
separately tested for reliability or validity.  
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Conversely Hung et al. (2010) used the Flexilevel Scale of Shoulder Function (FLEXSF) whereby 
respondents answer a single question that grossly classifies their level of function as low, medium or 
high; respondents are then directed to only the items that target their level of function. Evidence of 
good reliability, validity, and responsiveness to clinical change has been reported (Cook et al. 2003). 
Similarly Deutscher et al. (2009) used the shoulder Computerized Adaptive Test (CAT) (Hart et al. 
2006) which also adapts to the functional level of the individual patient. A notable strength of the 
FLEXSF and CAT are their ability to tailor the mechanism for assessing patients according to their 
different baseline levels, therefore potentially addressing concerns regarding using the same 
measure with different target populations such as high level sports people versus the frail (Schmidt 
et al. 2014).   
 
Engebretsen et al. (2010), Mintken et al. (2010), Kromer et al. (2014), and Chester et al. (2016) also 
used a shoulder specific functional outcome score, namely the Shoulder Pain and Disability Index 
(SPADI) which comprises 5 pain related questions and 8 disability related questions. The SPADI 
provides three scores: the total pain score, the total disability score and the total SPADI score of 
which Kromer et al. (2014) chose only to use the disability sub-score. The high reliability, validity, 
and responsiveness of the SPADI have been previously documented (Roach et al. 1991; Heald et al. 
1997) making this a robust measure of shoulder specific function. Indeed the SPADI has been widely 
tested for internal reliability (Roddey et al. 2000) and test-retest reliability (Beaton and Richards 
1998). Its construct validity in relation to other shoulder function scores has been identified as being 
high (Angst et al. 2004; Cloke et al. 2005). Furthermore, effect sizes in relation to shoulder pain 
managed with physiotherapy have been reported (Heald et al. 1997). Alongside the SPADI, Chester 
et al. (2016) also used the Quick-DASH (Disabilities of the Arm, Shoulder and Hand Score) and 
Kennedy et al. (2006) used the DASH which are both robust measures of upper limb specific function 
(Desai et al. 2010) although less specific to the shoulder.  
 
The baseline scores for the above outcome measures were explored as prognostic factors but 
Chester et al. (2016) and Kennedy et al. (2006) also used the final scores as the dependent variables 
for determining outcome. A similar approach was taken by Engebretsen et al. (2010), Kromer et al. 
(2014) and Chester et al. (2016) with the SPADI, Bartolozzi et al. (1994) with the UCLA and Deutscher 
et al. (2009) with the CAT. It can be considered that where the same tool is used as both a potential 
predictor and also as a determinant of outcome this is methodologically questionable due to the 
measurement overlap between one of the independent variables and the dependent variable.  
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It is therefore concluded that the assessment of function as a potential prognostic factor has merit 
so that the potentially wide-ranging impact on outcome can be considered. It is advocated that a fit 
for purpose, shoulder specific assessment of function is used and applied in its entirety rather than 
only a component thereof. However the large variation in outcome measures used underlines both 
uncertainty as to which outcome measure is best suited and the wider issue of lack of consensus 
regarding shoulder pain and specifically SIS/RCTendinopathy. Furthermore, the shoulder specific 
assessment of function should not be the same measure that is also used to determine patient 
outcome.  
 
2.5.6 D1. Clinical measures: Strength  
The amount by which a patient with SIS/RCTendinopathy is able to generate force using their 
shoulder is relevant because strength impairment +/- ROM impairment can result in functional 
limitation (Payne and Michener 2014). Furthermore strengthening the muscles of the shoulder, 
particularly the rotator cuff, are major components of non-invasive, multimodal physiotherapy 
(Holmgren et al. 2012).   
 
In the context of prognosis, it could be postulated that substantial impairment of strength at 
baseline could be associated with worse outcome due to the high pain levels and/or pathology-
related deconditioning that might underpin it (Cook and Purdam 2009). Such patients might be 
theorised to require substantial correction of their strength impairment for them to be classified or 
self-identify as having improved. Indeed where the rotator cuff is torn, it might be perceived that 
any associated weakness might not be correctable via non-invasive, multimodal physiotherapy 
alone.   
 
The study by Bartolozzi et al. (1994) used manual muscle testing via a grading system to quantify 
their subjects’ strength. Despite grading out of five, they chose to categorise the scores according to 
(i) no weakness, (ii) mild weakness if 4/5, (iii) moderate weakness if 3/5 and (iv) severe weakness if 
the patient was unable to actively elevate the arm against gravity. However they failed to provide 
evidence of the reproducibility of the measure and so confidence in the strength-related evidence 
from this study is therefore low.   
 
In the study by Kennedy et al. (2006) a combination of muscle wasting and decreased muscle 
strength were recorded as being mild, moderate, or severe. However for analysis purposes the 
authors chose to collapse down these ratings to ‘some degree of decreased strength’ versus 
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‘normal’. As with the other grading system, such an approach has the advantage of incorporating 
dynamic, through-range movements, thereby ensuring clinical and functional relevance. However 
whilst the authors’ rationale was that dichotomising the data might address potential issues around 
inter-rater reliability, they failed to provide operational definitions for the ratings or assess the 
reliability of how the ratings were applied. The robustness of the strength-related evidence from this 
study is therefore limited.   
 
Mintken et al. (2010) reported muscle strength as ‘weakness’ or ‘no weakness’, using the definition 
for specific muscles from the textbook by Kendall et al. (1993). The reporting by Mintken et al. 
(2010) of moderate to substantial agreement between testers for most of the muscles they tested 
provides evidence for the reliable application of this tool. However the use of binary measures by 
Kennedy et al. (2006) (‘some degree of decreased strength’ versus ‘normal’) and Mintken et al. 
(2010) (‘weakness’ versus ‘no weakness’) mean that their measurement tools arguably have limited 
discriminative capacity.  
 
In contrast to the above studies, Hung et al. (2010) and Chester et al. (2016) took quantitative 
measures of muscle force using hand-held dynamometers. Hung et al. (2010) used a ‘make test’ 
whereby an isometric contraction is generated by the subject against a fixed point, namely the 
assessor holding the dynamometer (Conable and Rosner 2011). However as with the manual muscle 
testing, the accuracy of this approach is dependent upon the assessor being able to fully resist the 
subject’s force. Nonetheless hand-held dynamometry offers an accurate measure of the force 
generated with units such as the one used by Hung et al. (2010) having manufacturer reported 
accuracy levels of 1% of the 0-300 lbs range and the ability to record in 0.1 lbs increments 
(http://www.hogganhealth.net/pdfs/microfet2.pdf; last accessed 24/04/2017).  
 
However for research applications to be meaningful the tool must be applied in a reproducible 
manner. Chester et al. (2016) provided no details of any reliability assessment. This is particularly 
relevant because the clinical measures in the study by Chester et al. (2016) were collected by 
treating clinicians across 11 NHS trusts and social enterprises. However no details of individual or 
collective reliability for the measures were presented. Uncertainty as to the inter- and intra-rater 
reliability of the strength measures therefore raises questions as to the accuracy of the reported 
strength measures. Hung et al. (2010) cited the intra-rater reliability data from a paper by McClure 
et al. (2006). However the McClure et al. (2006) intra-rater reliability data actually referred to a 
different type of muscle test, the ‘break test’ whereby the subject was resisted until they are able to 
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‘break’ the resistance offered by the tester. This raises the spectre of lower confidence in the 
strength data reported by Hung et al. (2010).  
 
The specific muscles and movements assessed in prognostic studies varied considerably. Where 
grading systems were used some authors stated the specific muscles and physiological movements 
(Serratus Anterior, Middle trapezius, Lower trapezius, Rhomboid, Deltoid, External and internal 
shoulder rotator muscle strength by Mintken et al. 2010), others assessed only specific muscles 
(supraspinatus, infraspinatus, serratus anterior by Kennedy et al. 2006) and some failed to describe 
either the specific muscles or physiological movements (Bartolozzi et al. 1994). Deriving a consensus 
from such disparate approaches is therefore challenging.  
 
Conversely where studies used hand-held dynamometry there was a degree of consistency, with 
Hung et al. (2010) assessing shoulder abduction, internal rotation (IR), external rotation (ER) force 
and scapular protraction force and Chester et al. (2016) measuring abduction and ER. The consistent 
use of ER mirrors the concept of posterior rotator cuff strength (Reinold et al. 2004). However both 
Hung et al. (2010) and Chester et al. (2016) failed to describe their testing positions which is of 
relevance because it can be postulated that strength measures will be highly influenced by which 
part of the muscle range the testing is performed in and also whether the test is performed in a 
position where pain is present due to potential pain inhibition. In addition the use of composite 
planes of movement such as scaption are frequently used in the literature due to the functional 
nature of the plane and the ability for it to partially represent both abduction and flexion, whilst 
avoiding excessive burden of testing (Hsu et al. 2009).  
 
It can be concluded that a variety of approaches including different measurement tools and aspects 
of strength including different shoulder muscles and movements have been assessed in previously 
published prognostic studies. Whilst grading systems offer arguably greater clinical and functional 
relevance than measures of static muscle strength via dynamometry, isometric force measures offer 
greater sensitivity to change and reproducibility, thereby providing more robust research data. 
However the reporting of application-specific reproducibility data should be a pre-requisite along 
with standardisation of the limb position during testing.   
 
2.5.7 D2. Clinical measures: ROM  
The amount by which a patient with SIS/RCTendinopathy is able to move their shoulder is relevant 
because ROM impairment can result in functional limitation and so restoration of ROM is both a 
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major component of non-invasive, multimodal physiotherapy and a key variable used to assess 
outcome (Holmgren et al. 2012; Payne and Michener 2014). In the context of prognosis it could be 
postulated that substantial impairment of ROM at baseline could be associated with worse outcome 
due to the high pain levels, deconditioning or structural / functional deficits that might underpin it 
(Koester et al. 2005)). Such patients might be theorised to require substantial correction of the ROM 
impairment for them to be classified or self-identify as having improved.  
 
Hung et al. (2010) and Tyler et al. (2010) both measured passive GHJ IR and ER ROM in supine with 
the arm in 90° abduction using a goniometer and inclinometer; respectively. Measuring passive GHJ 
ER ROM can be used as an exclusion criterion for patients with adhesive capsulitis (Vermeulen et al. 
2006). However Tyler et al. (2010) assessed passive GHJ IR and ER ROM as a potential contributing 
factor to posterior shoulder tightness which has been theorised to be linked to internal impingement 
(Spiegl et al. 2014). As part of this Tyler et al. (2010) and Hung et al. (2010) also measured posterior 
shoulder tightness (PST) and glenohumeral internal rotation deficit (GIRD) again via an inclinometer. 
Mintken et al. (2010) quantified PST by measuring cross-chest adduction in supine along with passive 
ROM of the shoulder in respect to shoulder abduction and both IR and ER at 90° abduction. Chester 
et al. (2016) measured passive flexion, abduction and ER but gave no details as to the testing 
positions.  
 
Compared to passive ROM, active ROM is arguably more relevant to SIS/RCTendinopathy due to the 
movement-related nature of the pathology (Koester et al. 2005). It is therefore unsurprising that the 
majority of studies assessed active ROM, including those that assessed composite or functional 
movements. Engebretsen et al. (2010) assessed hand behind back ROM whilst Mintken et al. (2010) 
used a battery of three functional tests. For Mintken et al. (2010) these were hand to neck, hand to 
scapula and hand to opposite shoulder. Engebretsen et al. (2010) quantified the ROM by recording 
the maximal position of the patient’s thumb to the corresponding vertebral level. Whilst such 
approaches have the advantage of being quick to perform, potential errors around spinal level 
palpation threaten the robustness of this measure. In contrast, the approach used by Mintken et al. 
(2010) involved grading each movement on a scale of 0-4 using descriptors relating to the gross 
amount and quality of movement (Yang and Lin 2006). Such a composite assessment is highly 
clinically relevant; however the authors failed to assess the reproducibility of how this measure was 
applied. This is particularly relevant given that they had nine different assessors and so the accuracy 
of their data could be questioned.  
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Confidence in the data reported by Kennedy et al. (2006) was even more questionable as they failed 
to provide operational definitions for their criteria ‘mild, moderate or severe’ impairment of ROM. 
This was particularly relevant given the potential for variation in interpretation between the 81 
assessors who participated in the project. Furthermore they failed to state which movements (e.g. 
planar or functional movements) the ROM data related to, thus severely undermining the value of 
their data.  
 
Other studies which assessed active ROM considered planar movements such as flexion (Bartolozzi 
et al. 1994; Engebretsen et al. 2010; Mintken et al. 2010; Chester et al. 2016) and abduction 
(Bartolozzi et al. 1994; Chester et al. 2016). In terms of symptomatic movements, active flexion and 
abduction can be considered relevant movements to assess in SIS/RCTendinopathy due to the 
frequency with which patients report symptoms during shoulder elevation (Koester et al. 2005). 
However scaption can be considered a preferred movement to asses as it is a composite planar 
movement, occurring at 30-40° anterior to the frontal plane (Hsu et al. 2009). Thus it has the 
advantage of assessing GHJ ROM where the scapula lies in its natural position on the thoracic wall, 
thereby replicating a more typically functional movement plane (McClure et al. 2006).   
 
The accuracy of both the tool and its application by an assessor influence the reliability of the 
subsequent ROM findings. In measuring bilateral flexion, Engebretsen et al. (2010) used an 
inclinometer and cited an accuracy of 5°, although no reference for this figure (neither 
manufacturer’s data nor their own reproducibility study) could be located. Mintken et al. (2010) 
reported shoulder flexion measured in degrees via goniometry but provided no detail of its accuracy. 
Bartolozzi et al. (1994) failed to state what measurement tool was used. Chester et al. (2016) 
provided no evidence of inter or intra rater reliability for the clinicians who collected the ROM 
measures in their multi-centre investigation. This was of particular concern considering the poor 
inter-observer agreement in measuring ROM in shoulder pain patients reported by de Winter et al. 
(2004). There are therefore uncertainties about the accuracy of the ROM data from such studies. 
One mechanism to address this might be the use of Magneto-Inertial Measurement Unit sensors 
(MIMU) with high levels of precision reported, although substantial operator training is necessary to 
attain such accuracy (Bouvier et al 2015).  
 
The issue of ROM relative to pain is of clear relevance in SIS/RCTendinopathy because pain is a 
frequent reason why patients will report functional restriction (Johansson et al. 2002). Engebretsen 
et al. (2010) stated that they allowed their patients to decide at which point pain restricted further 
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movement occurring. This is in contrast to Mintken et al. (2010) who reported the measurement of 
pain-free active shoulder flexion. Both pain-free and limit of ROM can be considered relevant in 
SIS/RCTendinopathy because improvement in function related pain is a common therapeutic aim, 
whilst maximal ROM is often of greatest functional relevance (Johansson et al. 2002).  
 
It can therefore be concluded that a broad range of approaches to measuring ROM have been used 
in previous prognostic studies. However it is proposed that the measurement of active ROM is more 
relevant in SIS/RCTendinopathy than passive ROM. The reliability of the tool in the context within 
which it is used should be assessed and the influence of pain upon the movement should be 
included.    
 
2.5.8 D3. Clinical measures: Scapular movement and control 
The way in which the scapula moves in patients with SIS/RCTendinopathy is potentially relevant 
because the scapula plays a key role in the control of the shoulder (Lopes et al. 2015). This includes 
the model of SIS/RCTendinopathy where tissue compression under the acromion is theorised to 
occur (Atalar et al. 2009). In the context of prognosis, substantial impairment of scapular movement 
at baseline might be associated with worse outcome due to the theorised correction of scapular 
control required for a patient to improve. The studies by Hung et al. (2010), Mintken et al. (2010) 
and Chester et al. (2016) considered scapular movement and control variables as potential 
predictors.   
 
Chester et al. (2016) used a novel approach, which involved noting the symptomatic response to 
manual facilitation of the scapula during shoulder elevation (Lewis 2009). This technique could be 
considered to be a symptom modification test but directly associated with the scapula, which can 
provide valuable information in guiding clinicians as to the likely benefit of targeting the scapula 
during treatment.  
 
The prognostic studies by Hung et al. (2010) and Mintken et al. (2010) used a variety of tools. 
Mintken et al. (2010) used two types of static measures, namely the lateral slide test and scapular 
index. The lateral scapular slide test (Kibler 1998) is used to identify asymmetrical scapular 
positioning relative to the thoracic spine. In reporting high inter-rater reliability Intra-class 
correlations (ICCs) (0.67 to 0.71), Mintken et al. (2010) demonstrated the notable strength of these 
static measures, namely their high reproducibility. However the lateral scapular slide test can be 
considered of limited clinical and pathological relevance because it is based upon the assumption 
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that asymmetry is pathological, when clinical experience and published evidence (Koslow et al. 2003) 
indicate this to commonly be a normal finding.   
 
The scapular index is a unilateral ratio of sternal notch to coracoid process distance and 
posterolateral angle of scapula to thoracic spine distance (Borstad 2006). This static measure can be 
considered by its very nature to be of limited relevance to dynamic shoulder pathology. However 
Borstad (2006) provided evidence of correlation of the scapular index with both scapular internal 
rotation and pectoralis minor length – both of which are theorised as contributors to shoulder 
pathology, thereby providing a degree of clinical relevance.  
 
Alongside quantitative measures, Mintken et al. (2010) assessed scapular function qualitatively as 
per Kibler et al. (2002). This involved categorising a patient’s movement pattern into one of four 
categories: type I = prominence of inferior scapular angle (excessive anterior tilt), type II = 
prominence of medial scapular border (excessive internal rotation), type III = prominence of superior 
scapular border (excessive elevation) and type IV = ‘normal’, symmetrical scapular motion. 
Assessment of dynamic, through-range scapular function is a notable strength of such an approach. 
However this classification approach could be considered to be conceptually flawed because it is 
based upon mutual exclusivity of movement patterns when in fact scapular function is a composite 
of planar (elevation and protraction) and rotational (upward rotation, anterior tilt and internal 
rotation) movements (McClure et al. 2006).  
 
One alternative approach is the scapular dyskinesis test (SDT) which is a qualitative assessment of 
scapular position and movement based upon descriptive criteria and subsequently rating patients 
according to normal, subtle or obvious dyskinesis (McClure et al. 2009). Notable strengths include 
non-mutual exclusivity of movement patterns and validation (albeit using binary dyskinesis ratings) 
against a three-dimensional movement analysis system (Tate et al. 2009). However it is noted that 
development and testing was undertaken with high-level athletes and so the transferability of this 
approach to typical NHS patient populations may be questionable.  
 
Hung et al. (2010) used a different approach via a three-dimensional movement analysis system 
(‘FASTRAK’) to quantify scapular kinematics (upward rotation, anterior tilt and internal rotation) at 
30°, 60°, 90°, and 120° of humeral elevation in the scapular plane. The objective, through-range 
measurement of all 3 scapular rotations is a notable strength. Furthermore the inclusion of a 
weighted trial where subjects held a 2Kg load during humeral elevation enhanced the likelihood of 
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identifying differences by making use of the observation that scapular dysfunction is more 
prominent when fatigue or loading is present (Tate et al. 2004). However the substantial time and 
equipment burden associated with using a three-dimensional movement analysis system makes it 
prohibitive to use such a tool in clinical practice, thereby limiting the clinical transferability of the 
findings.  
 
It can therefore be concluded that whilst scapular function as a potential prognostic factor has been 
assessed in a variety of ways, there are both strengths and limitations with each of the tools 
previously used. It is proposed that where scapular function is included in prognostic research as 
part of informing clinical care pathways, any tool used should ideally be reliable, dynamic, 
conceptually acceptable and clinically applicable in nature.     
 
2.5.9 E1. Structural pathology via imaging  
Where a patho-anatomical model of SIS/RCTendinopathy is favoured then the presence and nature 
of structural pathology in the shoulder is considered highly relevant (Tempelaere et al. 2016). In the 
context of prognosis, substantial structural pathology at baseline could be theorised to be associated 
with worse outcome due to the severity of the condition and the assumed inability of non-invasive, 
multimodal physiotherapy to directly address structural pathology, such as a hooked acromion or 
rotator cuff calcific deposits or tears. Consequently, such patients might be theorised to be much 
more likely to fail conservative management. The prognostic studies by Bartolozzi et al. (1994), 
Morrison et al. (1997) and Ogon et al. (2009) included assessment of structural pathology as a 
potential prognostic factor.  
 
The study by Morrison et al. (1997) examined acromion morphology using plain X-rays and 
categorised their subjects’ acromions according to being flat, curved, or hooked. Whilst an 
established categorisation approach was used, the observation of a hooked acromion does not 
indicate structural pathology per se; rather it is a theorised contributor to rotator cuff damage in a 
compression / impingement model of pathology (Balke et al. 2013). Therefore the absolute 
relevance to a patient of having a particular acromion type is debatable.  
 
Bartolozzi et al. (1994) used magnetic resonance imaging (MRI) to identify rotator cuff pathology, 
using the categories of (i) impingement, tendinitis; (ii) partial or a small full thickness tear(<1cm2) 
and (iii) tears > 1cm2. It is unclear how impingement was defined as it is an inherently dynamic 
concept yet MRI is taken in static postures. Furthermore, ‘tendinitis’ infers inflammation of the 
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tendon but it is widely accepted that tendon inflammation is rare and that tendinosis is more 
commonly observed (Joseph and Denegar 2015). Bartolozzi et al. (1994) provided no further details 
or reference for their categorising system and so it is not possible to answer these questions.  
 
Ogon et al. (2009) used plain X-rays to identify the presence and nature of any calcific deposits. X-ray 
has the advantage of being quick and inexpensive. The authors employed two different classification 
systems (Mole et al. 1993; Gartner and Heyer 1995) for the observed deposits as well as their own 
system for localising the position of the calcium. They then went on to use diagnostic ultrasound as 
an additional modality to detail the sonographic appearance of the deposits. Whilst the bi-modality 
approach used by Ogon et al. (2009) for assessing calcific deposits was thorough, they chose not to 
report concurrent structural pathology such as rotator cuff tears and subacromial bursitis, thereby 
prohibiting the inclusion of these potentially important structural pathology findings (Micheroli et al. 
2015).    
 
Diagnostic ultrasound can be considered an ideal clinical modality for identifying or excluding rotator 
cuff tears; whilst for rotator cuff tendinosis and subacromial bursitis it can provide tissue-specific 
imaging information (Jacobson 2011). When considering SIS/RCTendinopathy then from a patho-
anatomical perspective such data could be considered highly relevant (Micheroli et al. 2015). The 
advantages of ultrasound include the ability to deliver it in the clinical environment, the ability for 
the sonographer to interact with the patient and for movement of the limb to be incorporated into 
the assessment (Corazza et al. 2015). However whilst ultrasound is recognised as having comparable 
sensitivity and specificity as MRI, the highly operator dependent nature of the modality means that 
extensive training is essential (Ottenheijm et al. 2010). Furthermore, the reproducibility of the 
operator should be quantified and the uncertain link between structural pathology and symptoms 
must be acknowledged (Girish et al. 2011).   
 
It can be concluded that a variety of assessment approaches on a range of target tissues and 
pathologies have been used in previously published prognostic studies. It is proposed that when 
considering structural pathology, the pathological tissue is imaged rather than theorised through 
associated structures, such as acromion morphology. Furthermore the imaging of multiple tissues 
that are potentially involved in SIS/RCTendinopathy is advocated rather than a single element, e.g. 
calcium deposits. Finally the subjective nature of imaging interpretation means that reproducibility 
data should be provided for the combination of operator and imaging tool.  
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2.5.10 E2. Structural pathology via orthopaedic tests  
Where a patho-anatomical model of SIS/RCTendinopathy is favoured then, as with diagnostic 
ultrasound, the presence and nature of structural pathology in the shoulder is considered highly 
relevant (Calis et al. 2000). In relation to outcome for patients managed with non-invasive, 
multimodal physiotherapy, the presence of symptomatic “structural pathology” (such as a positive 
Neer's sign or Hawkins-Kennedy test) could conceptually be used as an identifier of the nature of the 
pathology (Kromer et al. 2014) and/or used as an objective marker to indicate severity of the 
condition. As such, it could be theorised to influence and therefore predict outcome.  
 
The studies by Mintken et al. (2010) and Chester et al. (2016) were the only ones to include 
orthopaedic tests as potential prognostic factors whilst many of the other studies under 
consideration used them solely as an inclusion criterion.  
 
Mintken et al. (2010) used 13 tests to explore GHJ instability, symptom reproduction from the ACJ 
and subacromial region along with tests of rotator cuff integrity. This wide-ranging approach reflects 
the generalised shoulder pain population that the authors investigated. Chester et al. (2016) also 
investigated a non-specific shoulder pain population but conversely only used a test of rotator cuff 
integrity, namely the external lag sign. However the combination of tests designed for testing 
symptom reproduction and structural integrity used by Mintken et al. (2010) did overlap with that of 
Chester et al. (2016) as Chester et al. (2016) also included the testing of symptomatic response to 
manual facilitation of the scapula during shoulder elevation. As this later technique is scapular 
orientated, it was considered earlier in this literature review.   
 
The use of a battery of tests by Mintken et al. (2010) reflects the opinion that singular tests in 
isolation are of limited value due to issues of poor specificity or sensitivity (Calis et al. 2000). 
Conversely, in looking to explore structural integrity, the robustness of the single test approach by 
Chester et al. (2016) would be enhanced by the use of diagnostic imaging.  
 
It can therefore be seen that orthopaedic tests have only been used in a limited capacity in previous 
prognostic studies considered in this literature review. Where they are applied for the purposes of 
identifying the symptom reproducing structures then a battery of tests should be used. 
Recommendations here include standardised performance and interpretation of the findings 
(Hanchard et al. 2013). A combination of tests with high sensitivity (e.g. Neer's sign, Empty can and 
Hawkins-Kennedy test) (Alqunaee et al. 2012) and high specificity (e.g. painful arc) (Calis et al. 2000) 
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are advocated. Furthermore, signs that are commonly used to identify SIS/RCTendinopathy patients 
such as pain on active abduction (Diercks et al. 2014) have a potential role. A frequently advocated 
approach is three or more positive tests as a cut-off point, albeit typically for identifying pathology 
(Michener et al. 2009) rather than prognosis.   
 
It can be concluded that orthopaedic tests are typically used in an attempt to identify pathology and 
therefore define a sample. However, due to widely identified issues with the sensitivity, specificity 
and conceptual value of these tests, using them instead as a potential prognostic factor has merit. Of 
relevance here is the use of a battery of tests and a threshold of three or more positive tests as a 
cut-off point is advocated.  
  
2.5.11 Conclusion 
It can therefore be concluded that a large number of categories of variables have been explored in 
previous studies and that each of these categories has included often very different mechanisms to 
quantify the variable of interest. This belies a persistent uncertainty and lack of consensus in this 
subject area as to the relevant signs and symptoms of SIS/RCTendinopathy in terms of the aetiology, 
treatment and prognosis of this patient group.  
   
2.6 Treatment / intervention 
The wide range of care pathway variants and the treatment approaches available via other 
professions was briefly described earlier. As noted previously, physiotherapy for SIS/RCTendinopathy 
includes education and advice, exercise based therapy and hands-on techniques such as manual 
therapy, taping and electrotherapy. The rationale behind education and advice includes empowering 
patients, addressing unhelpful belief mechanisms and avoidance of unnecessary symptom 
exacerbation (Dragesund and Kvale 2016). Exercise therapy (Holmgren et al. 2012; Lewis 2012; 
Littlewood et al. 2015) may include strengthening of weak muscles due to disuse or pain, including 
those muscles that stabilise the GHJ, scapula or trunk; also the regaining of ROM and stretching of 
muscles theorised to place the shoulder into symptom producing positions. Taping (Kalter et al. 
2011) is theorised to influence similar mechanisms as well as muscle recruitment (Smith et al. 2009), 
whilst manual mobilising of the GHJ, cervical or thoracic spine region (Senbursa et al. 2007; Cook et 
al. 2014) is theorised to facilitate optimal joint glide and local pain inhibition. Electrotherapeutic 
modalities may be used for pain relief or the theorised addressing of structural pathology via 
shockwave therapy (Schmitz et al. 2015) although evidence for this modality is lacking.    
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Additional interventions (Littlewood et al. 2016) may include use of heat or cold, acupuncture and 
hydrotherapy; whereby pain and muscle spasm relief, ROM and strengthening may be enhanced. To 
maximise treatment carry over and patient independence and empowerment, home exercise 
programmes may also be prescribed which may mirror or complement approaches taken in the 
clinic-based interactions (Bennell et al. 2010). The nature of the treatment approaches used in 
previous prognostic studies will now be considered.  
 
2.6.1 Types of treatment 
The studies by Kennedy et al. (2006) and Sindhu et al. (2012) provided no details of the component 
elements of the intervention received by the patients in their studies. Ogon et al. (2009) stated they 
applied a physiotherapy treatment algorithm including heat or cold and manual therapy but 
provided no further details. It is therefore not possible to determine how representative of 
physiotherapy the treatments were and so transferability of the prognostic findings is limited. 
 
The studies by Conroy and Hayes (1998), Engebretsen et al. (2010) and Kromer et al. (2014) all used 
standardised interventions due to their prognostic findings being derived from secondary analyses of 
RCT data. The use of standardised interventions has the methodological and statistical benefit of 
controlling for the potential confounding factor of treatment variability thereby providing evidence 
regarding people who respond differently to specific treatments, i.e. treatment effect modifiers 
(Kent et al. 2010). However this standardisation places inherent limitations upon the transferability 
to routine practice of the subsequent prognostic findings. 
 
Subjects in the study by Engebretsen et al. (2010) were treated with either supervised exercises or 
radial extracorporeal shockwave therapy, where the electrotherapeutic modality used shockwaves 
to theoretically stimulate pain relief and optimise tissue healing (Harniman et al. 2004). However, 
such a modality requires specialist equipment which is not routinely used, so the transferability of 
prognosis when treated with this modality is inherently limited. The other patients in the study by 
Engebretsen et al. (2010) received supervised exercises which emphasised relearning of normal 
movement patterns with an initial focus on unloading the rotator cuff via postural correction and 
manual techniques. Combined with the progression to endurance and control exercises, these are 
more typical of standard non-invasive, multimodal physiotherapy. 
 
Exercise therapy was a common theme amongst the RCT derived data, with Conroy and Hayes 
(1998) incorporating muscle strengthening, whilst Kromer et al. (2014) included shoulder girdle and 
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thoracic spine stretching and strengthening exercises. Manual therapy techniques were also 
included by these RCTs, with Conroy and Hayes (1998) incorporating joint mobilisation, and Kromer 
et al. (2014) using manual mobilisation techniques for the shoulder complex and cervical spine. 
Exercise therapy and manual techniques are considered a main stay of physiotherapy (Bennell et al. 
2010) and so their frequent use in these RCTs ensures their findings are broadly representative. 
However patient education (Dragesund and Kvale 2016), also a mainstay of physiotherapy, was only 
included by Engebretsen et al. (2010) and Kromer et al. (2014) and only in their intervention arms. 
The comparability of prognostic findings across each of these studies is therefore potentially limited 
by the absence for some patients of this critical component of non-invasive, multimodal 
physiotherapy. 
 
Some studies were not RCTs in nature but nonetheless chose to standardise the interventions 
received. Mintken et al. (2010) explored prognosis following treatment with only thrust 
manipulations of the cervicothoracic spine and specifically detailed the prohibiting of clinicians 
adjusting the intervention, regardless of their clinical findings. A broader approach was taken by 
Hung et al. (2010) whose standardised regimen comprised stretching, strengthening and ROM 
exercises along with manual therapy. This ensured a more representative delivery of non-invasive, 
multimodal physiotherapy, although their standardising of the exercises and even stretch hold times 
potentially limits the transferability to routine practice. 
 
As with Mintken et al. (2010), Tyler et al. (2010) limited their intervention to components that 
mirrored their conceptual framework, namely GIRD and PST. As such, they emphasised 
glenohumeral joint glides, sleeper stretches and cross-chest adduction. Such approaches strengthen 
the patho-anatomic specificity of the prognostic results and limits the inherent variability introduced 
by using various treatment approaches. However again this approach limits the transferability to the 
wider treatment of SIS/RCTendinopathy patients. 
 
A pseudo-controlled approach (where a structured approach was utilised but included elements of 
adaptability, for example timescales of how long certain treatment components were continued) 
was taken by Morrison et al. (1997) who used a physiotherapy programme consisting of stretching 
and then strengthening, whilst Bartolozzi et al. (1994) simply stated they included rotator cuff 
strengthening and ROM exercises. Virta et al. (2009) similarly detailed the component treatments 
including ROM and strengthening exercises along with how they were delivered. However in basing 
the delivery of the regimen upon assessment of the individual patient’s dysfunction, they mirrored 
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routine clinical practice. Kromer et al. (2014) used the novel approach of including an arm in their 
RCT where alongside a standardised exercise protocol they also incorporated individualised 
physiotherapy based on clinical examination results. This reflects the complex nature of 
physiotherapy intervention, tailored to the individual patient. However capturing the specific nature 
of the treatment can be challenging, as can defining the nature and dose of the intervention. As 
such, deriving evidence as to the key ingredients of the intervention and its efficacy in different 
pathologies, settings and patient groups is challenging. 
 
An entirely clinician directed approach was used by Deutscher et al. (2009) and Chester et al. (2016). 
Such an approach is truly representative of clinical practice where physiotherapists assess and treat 
their patients using an individualised approach (Kromer et al. 2013). However the challenge posed 
by this pragmatic approach is the introduction of between-subject treatment variability. 
 
The large-scale study conducted by Deutscher et al. (2009) categorised treatment using an electronic 
database system (Deutscher et al. 2008). However the clinical utility of this is limited by the 
requirement to purchase and integrate this electronic system. Chester et al. (2016) on the other 
hand did not publish details of how the delivered intervention was recorded nor of treatment 
duration or frequency and so it is not possible to identify the representativeness or otherwise of the 
treatment received by patients in their study. 
 
2.6.2 Duration and frequency of treatment  
Wide variation in the duration and frequency of treatment was seen in the previously published 
prognostic studies considered in this review. Where studies used a standardised approach and 
provided details of treatment duration this ranged from a matter of days (Mintken et al. 2010) to 3 
weeks (Conroy and Hayes 1998), 5 weeks of clinician directed non-invasive, multimodal 
physiotherapy followed by 7 weeks of home based exercises (Kromer et al. 2014), 6 weeks (Hung et 
al. 2010), 8 weeks (Virta et al. 2009), a maximum of 12 weeks (Engebretsen et al. 2010) and a 
minimum of 3 months (Ogon et al. 2009). In terms of frequency of treatment, those who reported 
data ranged from once a week (Engebretsen et al. 2010), twice a week (Virta et al. 2009; Hung et al. 
2010; Kromer et al. 2014) to 3 times per week (Conroy and Hayes 1998; Tyler et al. 2010). 
 
The inherent variability in the subsequent intensity and dose of non-invasive, multimodal 
physiotherapy received in these different studies is a limiting factor in pooling prognostic findings 
across them. Although Kennedy et al. (2006) provided no details of content, they reported a mean of 
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15 sessions (SD=9) over a mean of 65 days (SD=26), whilst Deutscher et al. (2009) reported a mean 
of 9 sessions (SD=6) over a mean of 56 days (SD=40). The broadly comparable number of sessions 
and duration in these studies could be viewed as a providing a benchmark for studies such as 
Chester et al. (2016) who also used a pragmatic approach. However location of the clinical setting 
(Israel, Canada and UK for Deutscher et al. (2009), Kennedy et al. (2006) and Chester et al. 2016; 
respectively) along with local funding pressures (private versus public health) may also influence the 
availability of healthcare resources including the number and timing of physiotherapy appointments. 
 
In conclusion, to optimise the reproducibility and accurate interpretation of prognostic study 
findings, details of the intervention delivered, including duration and frequency should be recorded. 
Clinician led treatment is arguably the most representative but brings challenges in terms of 
capturing the nature of the intervention delivered and it potentially introduces additional variability 
into a study.  
 
2.7 Response to intervention 
The proportion of subjects in previous prognostic studies who did and did not get better is of 
relevance both from the perspective of prognostic statistical analysis and also as a reflection of the 
uncertainty as to which patients do and do not respond to particular treatment approaches. The 
non-RCT studies which reported rates of successful outcome ranged from 61% (Mintken et al. 2010), 
67% (Morrison et al. 1997), 70% (Hung et al. 2010), 73% (Ogon et al. 2009) to 87% (Virta et al. 2009). 
Ironically, the highest successful outcome rate (Virta et al. 2009) was for those patients on a surgical 
waiting list.  
 
In terms of patients worsening with physiotherapy, these rates were typically low. Where reported, 
these ranged from 3% (Engebretsen et al. 2010), 4% (Mintken et al. 2010) to 7% (Kennedy et al. 
2006).  
 
2.8 How outcome is defined and measured  
The mechanism by which outcome is measured and defined are key considerations in the design of a 
prognostic study. The outcome might be mortality or survival across a specific time period; 
escalation of treatment or failure with a particular treatment approach; through to levels of 
symptoms and function or returning to work (Altman et al. 2009). The choice of outcome will 
therefore have a substantial impact on the subsequent findings and how they are interpreted. 
Similarly, the time scale over which outcome is measured and whether the final state or the change 
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in state from baseline is the dependent variable, all will have similar importance. In the area of 
shoulder prognosis, areas of variation include mechanisms such as clinical judgements of symptom 
change or treatment escalation, measurement of an outcome as a continuous variable or collapsing 
down to a categorical or binary variable.  
 
In considering prognostic studies relevant to this thesis, authors such as Ogon et al. (2009) used 
treatment-related outcomes. Ogon et al. (2009) defined a negative outcome by progression to 
advanced therapeutic measures, which included extracorporeal shock wave therapy or surgery. A 
strength of this approach is that it reflects an escalation along the clinical pathway, including a likely 
increased cost to the healthcare provider (Carr et al. 2015). However a limitation is that a decision to 
escalate the intervention may be influenced by clinician preference and so may be subject to bias or 
it may not be aligned to the patient’s perception of outcome. Furthermore as a binary decision, it 
arguably lacks sensitivity. Alternatively Engebretsen et al. (2010) included working status as an 
outcome measure. This has limitations regarding those who are studying, unemployed or retired. 
However this choice of outcome measure means that the study findings can provide valuable 
information for the patient (in terms of financial and job security), their employers and wider society 
when considering taxation and productivity, sickness or unemployment benefit costs (Linaker and 
Walker-Bone 2015).  
 
The other studies under consideration all used patient based measures. The study by Conroy and 
Hayes (1998) simply used a VAS pain score as its determinant of outcome. However the breadth of 
the patient experience and impact of shoulder pain is typically multifactorial where pain is only one 
component (Gartsman et al. 1998). In order to address this, the majority of prognostic studies in this 
area have used validated, patient-reported outcome measures to determine outcome. Hung et al. 
(2010) and Mintken et al. (2010) both used the GROC (Jaeschke et al. 1989) which is a 15-point 
global rating scale ranging from -7 (‘a very great deal worse’) to 0 (‘about the same’) to +7 (‘a very 
great deal better’). Both authors chose to use a score of +4 or greater (i.e. ‘moderately better’ and 
above) to define in a binary form a positive outcome. However such an approach is inherently 
subjective to recall bias, as it requires patients to rate how much they perceive they have changed 
relative to baseline.  
 
An alternative approach is the use of outcome measures completed both at baseline and at the 
follow up time point(s). Kennedy et al. (2006) chose to use the DASH to measure disability whilst 
Chester et al. (2016) used the QuickDASH. There is evidence in the literature (Turchin et al. 1998; 
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Beaton et al. 2001) that this measure is reliable and valid. However a shoulder-specific outcome was 
used by the majority of other authors. Bartolozzi et al. (1994), Morrison et al. (1997) and Virta et al. 
(2009) all used the UCLA, which covers pain, function and overall satisfaction alongside physical 
measures of active ROM and strength. In contrast Deutscher et al. (2009) and Sindhu et al. (2012) 
used purely patient reported outcomes via the shoulder CAT (Hart et al. 2006). This robust outcome 
measure (Crane et al. 2006; Hart et al. 2010; Wang et al. 2010) has the advantage of adapting to the 
functional level of the individual patient in assessing their functional status in terms of ability to 
perform daily tasks. 
 
Tyler et al. (2010) used the Simple Shoulder Test (SST) which comprises 12 questions regarding 
shoulder function. Whilst robustness of the tool has been reported in the literature (Beaton and 
Richards 1998; Roddey et al. 2000; Godfrey et al. 2007) the timescale over which the questions 
relate to (i.e. at the moment of assessment) limits the ability to representatively capture the 
sometimes fluctuating nature of symptoms. 
 
The SPADI was used by Engebretsen et al. (2010), Kromer et al. (2014) and Chester et al. (2016) to 
determine outcome. As noted in the section on function / disability, the SPADI can be considered a 
robust measure of shoulder specific function. However the methodological concerns regarding the 
use of the same tool as a potential prognostic factor and as a determinant of outcome have been 
discussed earlier. One mechanism to partially overcome this is to use a different functional outcome 
score for the dependent variable compared to that explored as a potential prognostic factor. One 
such tool is the Oxford Shoulder Score (OSS) (Dawson et al. 1996) which is highly rated for its 
psychometric properties and has the advantage of being developed on a cohort of shoulder patients 
largely comprising those with impingement symptoms (Desai et al. 2010; Ekeberg et al. 2008). There 
is published evidence of the internal consistency and test-retest reliability of the OSS (Huber et al. 
2004). Minimal clinically important change data specific to patients with rotator cuff disease has 
been published (Ekeberg et al. 2010b). As the OSS has been widely used in the surgical literature 
then given the potential for patients with SIS/RCTendinopathy who receive physiotherapy to 
potentially escalate their treatment to surgery (Butt et al. 2015), the use of such an outcome could 
enhance the transferability of the findings between different professional and clinical elements of 
the care pathway.  
 
Where authors have used outcome scores, their handling of the variable is highly relevant. In this 
respect Bartolozzi et al. (1994), Morrison et al. (1997), Kennedy et al. (2006), Deutscher et al. (2009), 
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Engebretsen et al. (2010) and Chester et al. (2016) used the final scores as their dependent variable 
irrespective of baseline. Tyler et al. (2010) took this one step further and dichotomised their patients 
(based upon their SST scores) into those with and those without residual symptoms. However the 
use of only final scores fails to reflect any actual change that has occurred over the treatment and 
follow up period and so can be considered of limited relevance beyond reflecting final state. 
Conversely Kennedy et al. (2006), Sindhu et al. (2012) and Kromer et al. (2014) calculated a change 
score (including direction) from baseline, which has the advantage of incorporating baseline state.  
 
2.8.1 Timing 
The time scale over which outcome is measured plays a role in determining the applicability of the 
subsequent prognostic information. The studies by Conroy and Hayes (1998), Deutscher et al. 
(2009), Virta et al. (2009), Hung et al. (2010), Mintken et al. (2010), Tyler et al. (2010) and Sindhu et 
al. (2012) all collected their outcome scores upon completion of treatment. This provides meaningful 
information with regards to whether a patient will respond by the end of treatment. However if only 
this time point is used it provides very limited information regarding the stability of any change over 
time. The study by Kennedy et al. (2006) used a broadly comparable approach except that discharge 
data collection occurred whichever happened first: (i) when the patient was discharged or (ii) after a 
12-week period of treatment, thereby introducing inherent variability regarding the timescale of 
data collection relative to the completion of face-to-face treatment.  
 
The studies by Morrison et al. (1997) and Bartolozzi et al. (1994) used longer but again non-
standardised follow up time points, with means of 27 months (range 6 to 81 months) and 20 months 
(range 6 to 41 months); respectively. Whilst such timescales provide valuable information regarding 
stability of change over time, the range of follow up time points introduces inherent variability as a 
potential confounding factor. Conversely, the study by Engebretsen et al. (2010) used a standardised 
time point of 1 year. However as treatment in this RCT was 4-6 weeks and up to 12 weeks depending 
on the treatment arm then there was inherent variability within the cohort in terms of the time 
between discharge and follow up. Kromer et al. (2014) used a 3 month follow up time point and 
Chester et al. (2016) used a combination of short (6 weeks) and longer (6 months) term follow up. 
However, their use of these time points from the start of physiotherapy means that conceivably a 
large number of patients at particularly the 6-week and 3-months time points were still under 
treatment, thereby introducing this as a potential confounding factor. Nonetheless the use of a 3-
month post-discharge time point has the potential to provide meaningful information regarding 
maintenance of any change over time. However it is proposed that anchoring the follow up periods 
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to the completion of face-to-face treatment or discharge from physiotherapy will ensure maximum 
clinical relevance of the subsequent findings.  
 
2.8.2 Loss to follow up 
The studies by Bartolozzi et al. (1994), Morrison et al. (1997), Kennedy et al. (2006), Ogon et al. 
(2009), Virta et al. (2009) and Hung et al. (2010) stated their loss to follow up rates which varied 
from 3% (Hung et al. 2010) to 26% (Virta et al. 2009). However the above studies failed to compare 
the baseline characteristics of those who were and those who were not followed up. Analysis of 
baseline differences between these two groups is essential in order to identify any bias within the 
final analysis group. Consequently the potential for such bias in the results from these studies 
cannot be discounted.  
 
Deutscher et al (2009), Engebretsen et al (2010), Sindhu et al (2012) and Chester et al (2016) 
reported loss to follow up rates between 10% (Engebretsen et al. 2010) through to 43% (Sindhu et 
al. 2012) and 60% (Deutscher et al 2009). All of these authors undertook an analysis of any 
differences between groups, with Engebretsen et al. (2010) reporting their missing subjects as being 
older and with a higher level of functional impairment at baseline compared to those for whom 
follow up at 1 year was possible. Sindhu et al. (2012) also identified differences between those 
available for and lost to follow up in terms of age, pain levels and function but the authors failed to 
provide details on the direction of difference. Conversely Chester et al. (2016) reported younger 
patients as being lost to follow up as well as those not partaking in leisure time physical activity. 
Deutscher et al. (2009) reported their missing cohort subjects as comprising a higher percentage of 
patients with a chronic condition at intake and a higher number of comorbidities. As each of the 
variables reported by these authors might conceptually impact on prognosis then the reporting of 
such baseline differences is essential so that any potential bias can be acknowledged.   
 
2.8.3 Blinding and potential bias 
Few studies reported whether sources of potential bias were addressed and the nature of how 
blinding was achieved. Where the researcher was also the person delivering treatment (as in Conroy 
and Hayes 1998) then the potential for conscious or unconscious bias must be acknowledged. 
Conversely Hung et al. (2010) explicitly stated that the assessor was blinded to treatment.  
 
The approach used by Chester et al. (2016) had the benefit of the investigator not being involved 
with the face-to-face collection of any of the variables and so intentional or unintentional bias was 
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removed. However the dependent variable in the study by Chester et al. (2016) was the absolute 
outcome scores at 6-weeks and 6-months. As such, blinding of the assessor to the dependent 
variable may not have been possible.   
 
In conclusion, there was wide variation in the type of outcome measures used and the timescales 
over which they have been applied in the shoulder prognostic studies considered in this chapter. 
However the use of a shoulder specific, functional outcome score has the advantage of being 
condition specific and providing robust, meaningful information to inform prognosis. The use of a 
change score as the outcome measure has the advantage of reflecting change from baseline state. 
The timescale over which it is applied should be anchored to the actual end of treatment, but also be 
long enough to capture any sustained change beyond cessation of treatment.   
 
Loss to follow up should be reported along with statistical analysis of any differences between those 
who were followed up and those who were not. Furthermore the assessor should not be involved 
with the treatment of the patients and should be blinded to the individual patient’s outcome until all 
other data collection and processing is completed.  
 
2.9 Analysis approach 
As noted in the introduction chapter, prognostic research involves the analysis of multiple and 
potentially disparate factors to explore their individual and collective influence on outcome (Royston 
et al. 2009). This approach aligns well with the likely multifactorial nature of SIS/RCTendinopathy 
(Hanchard et al. 2013). 
 
2.9.1 How candidate variables are selected, including the number of cases per variable 
As demonstrated earlier in this chapter, a large number of candidate variables across a broad range 
of categories have been used in previous prognostic studies. However a critical element is the threat 
of over-fitting in prognostic models where too many candidate variables are explored in a given 
sample size (Moons et al. 2009b).   
 
The studies by Bartolozzi et al. (1994), Morrison et al. (1997), Conroy and Hayes (1998), Ogon et al. 
(2009), Virta et al. (2009), Tyler et al. (2010) and Chester et al. (2016) made no attempt to trim the 
number of candidate variables. However other studies reduced the number of candidate variables 
via statistical methods by looking at univariate relationships between variables. The studies by 
Kennedy et al. (2006), Engebretsen et al. (2010), Hung et al. (2010) and Mintken et al. (2010) tested 
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any relationship between potential prognostic factors and the dependent variable using a liberal 
significance level (p<.10) so as to avoid excluding potential predictive variables (Cohen et al. 2013). 
However such an approach is widely cautioned against due to the failure to consider confounder 
interaction (Sun et al. 1996), particularly with small data sets (Steyerberg et al. 2001).  
 
Collapsing of variables within a category was performed by Kennedy et al. (2006) if distributions 
were too low in any one variable. A similar approach was taken by Deutscher et al. (2009) who chose 
to exclude variables where the incidence was too low. Collinearity amongst independent variables 
was assessed by Kennedy et al. (2006), Deutscher et al. (2009), Engebretsen et al. (2010) and Kromer 
et al. (2014). Where sufficient correlation was identified in these studies, the variable with the 
greatest clinical relevance was retained.  
 
The combining of a statistical and conceptual approach to variable selection was particularly evident 
in the study by Kromer et al. (2014) who applied a priori a targeted approach to the selection of 
potential prognostic factors relative to their final sample size. Specifically they collected a full range 
of demographic and clinical-related variables but only entered into their prognostic model those that 
they were interested in from a theoretical perspective. This allowed them to comprehensively define 
their sample but select only an appropriate number of key variables relative to their sample size for 
the subsequent prognostic statistical analysis.  
 
The resulting number of cases per variable in the studies was highly variable. These ranged from 0.5 
(Hung et al. 2010) to 5.5 (Engebretsen et al. 2010), 6 (Mintken et al. 2010), 7 (Tyler et al. 2010), 10 
(Bartolozzi et al. 1994; Kennedy et al. 2006), 11.8 (Chester et al. 2016), 18 (Virta et al. 2009), 25 
(Ogon et al. 2009) and 123 (Morrison et al. 1997). Where a minimum of 10 cases per prognostic 
factor is advocated (Peduzzi et al. 1996) then the findings from several of these studies are unlikely 
to be replicated in a new sample due to the high risk of overfitting. 
 
2.9.2 Multivariate regression analysis approach, including logistic versus linear regression 
Multivariate regression techniques are typically employed in prognostic research to examine the 
interaction of multiple variables in predicting a particular outcome (Hemingway et al. 2009). 
However there is a lack of consensus as to the most appropriate approach for prognostic model 
building (Royston et al. 2009).  
 
70 
 
One method is a hierarchical regression model as used by Kromer et al. (2014) whereby following 
their first step (which concerned variables they were controlling for) their second step explored 
clinical variables and their third step explored psychological variables. A benefit of this approach is 
the ability to investigate the contribution of multiple variables within a category before moving onto 
the next category. However the selection and ordering of the specific categories introduces potential 
bias into the subsequent model (Field 2009).  
 
Another source of potential bias is demonstrated by the decision by both Engebretsen et al. (2010) 
and Kromer et al. (2014) to retain numerous variables in their model, irrespective of their 
contribution or level of significance, thereby adjusting their model for these factors. For both 
studies, age and gender were controlled for whilst Engebretsen et al. (2010) also included treatment 
group. As the Engebretsen et al. (2010) study was examining data from a two arm RCT then 
controlling for treatment group has merit. However the use of other variables has the potential to 
undermine confidence in the final prognostic model due to the arbitrary retention of candidate 
variables whose interaction with other factors may or may not be of relevance. A stepwise but non-
hierarchical strategy was employed by the majority of other studies, whereby all permutations of 
variables can be considered, irrespective of the category to which they belong (Royston et al. 2009).  
 
In terms of constructing the most parsimonious model, studies such as Kennedy et al. (2006), Ogon 
et al. (2009), Engebretsen et al. (2010) and Kromer et al. (2014) used a simple approach whereby 
variables with p ≥ 0.05 were removed. However a combined forward selection and backward 
elimination approach as used by Deutscher et al. (2009), Hung et al. (2010) and Chester et al. (2016) 
has the advantage of ensuring that statistically justified removal and retention of variables are 
performed so as to derive the most accurate model (Royston et al. 2009). An example of the 
approach used comes from Hung et al. (2010) where a significance of p ≤ 0.05 was required to enter 
a variable into the model and a significance of p ≥ 0.10 was required to remove it. 
 
The use by studies of either logistic or linear regression was determined by the nature of their 
dependent variables as binary or continuous; respectively. As noted previously, the nature of the 
outcome variable has substantial implications for the interpretation of the subsequent prognostic 
findings.  
 
Where studies have used outcomes which are inherently binary in nature such as yes/no progression 
to advanced therapeutic measures by Ogon et al. (2009) or yes/no in work by Engebretsen et al. 
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(2010) then logistic regression was undertaken. Other studies chose to convert actual or potentially 
continuous variables into binary outcomes, such as Hung et al. (2010) and Mintken et al. (2010) who 
both used the GROC to define in a binary form a positive outcome. However such an approach 
inevitably leads to a loss of statistical sensitivity (Altman and Royston 2006) and so where possible 
the use of a continuous variable is preferred.  
 
The subsequent reporting of R2 values indicate the amount of variation in the outcome variable 
explained by each model. Depending on the reference outcome these ranged from 23% (Kennedy et 
al. 2006) to 30% (Deutscher et al. 2009; Engebretsen et al. 2010; Chester et al. 2016), 34% (Chester 
et al. 2016), 36% (Deutscher et al. 2009), 43% (Chester et al. 2016) and 48% (Kromer et al. 2014; 
Chester et al. 2016).  
 
However some studies such as Bartolozzi et al. (1994), Ogon et al. (2009), Virta et al. (2009) and 
Hung et al. (2010) failed to present their R2 values or regression equation coefficients (β).  β are used 
to identify the direction of any relationships between predictor variables and the dependent variable 
and the significance of the β values are used to identify the magnitude of the contribution of the 
variable. As such, consideration of the contribution from each variable to the overall model was not 
possible to establish from these studies nor the overall percentage of variability explained by the 
combination of factors. These highlight serious flaws in the standard of reporting in prognostic 
research (Hemingway et al. 2009).   
 
In conclusion therefore, when examining predictors of outcome in SIS/RCTendinopathy a 
multivariate analysis approach is advocated where the number of candidate variables is aligned to 
the sample size in order to address the threat of over-fitting. An a priori approach to variable 
selection should be used incorporating one or more of: exclusion of low incidence variables, 
collapsing of variables within a category and assessment of correlations to select the variable with 
the greatest clinical or conceptual relevance. Where possible, the outcome variable should be 
retained as a continuous variable and a stepwise multiple regression approach using forward 
selection and backward elimination should be used. Subsequent β and R2 values should be reported.  
 
2.10 Overall quality of the studies 
There is merit in attempting to identify a hierarchy of studies from those considered in this literature 
review. However there is a limited consensus on mechanisms by which to assess the quality of 
prognostic study evidence (Altman 2001; Hayden et al. 2006). Previous systematic reviews (Kuijpers 
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et al. 2004; Hayden et al. 2006; Chester et al. 2013) have used bespoke checklists. Alongside the 
formal assessment of risk of bias and applicability via the PROBAST process, an overall judgment on 
the type of study design was undertaken to complement the project specific critique already 
undertaken. In this respect the hierarchy of: (i) prospective cohort study, (ii) RCT derived data, (iii) 
retrospective cohort study, was applied (NHMRC 2000) where Phillips et al. (2016) specify >80% 
follow up as an additional criterion for a prospective cohort study.  
 
Applying the above criteria, the studies by Ogon et al. (2009), Hung et al. (2010), Mintken et al. 
(2010), Tyler et al. (2010) and Chester et al. (2016) (for their 6 week follow up dataset) were 
identified as being of the highest level of quality as they were prospective cohort studies with >80% 
follow up. Next were the studies by Deutscher et al. (2009), Kennedy et al. (2006), Virta et al. (2009) 
and Chester et al. (2016) (for their 6 month follow up dataset) as they were prospective cohort 
studies but with <80% follow up. The RCT derived data studies by Conroy and Hayes (1998), 
Engebretsen et al. (2010) and Kromer et al. (2014) were the next lowest. Finally the lowest level of 
quality were the retrospective cohort studies by Bartolozzi et al. (1994), Morrison et al. (1997) and 
Sindhu et al. (2012).   
 
 
2.11 Prognostic findings from previously published papers 
The factors identified from previously published papers as being prognostic or not, and the direction 
of prediction, will now be presented. As with section 1.5 where potential prognostic factors and how 
they were measured was considered, the gross categories of (A) demographics, (B) clinical history, 
(C) patient reported measures, (D) clinical measures and (E) structural pathology will be used.  
 
2.11.1 A. Demographics 
 
Table 2-2: A. Demographics factors, segregated according to (i) Generic demographic variables and 
(ii) Work, recreational or functional task related variables 
Paper 
Prognostic factor; direction Not prognostic 
(i) Generic demographic variables  
(ii) Work, recreational or functional 
task related variables 
(i) Generic demographic variables  
(ii) Work, recreational or functional 
task related variables 
Bartolozzi et 
al. (1994) 
 (i) 
 Age 
 Gender 
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(ii) 
 Occupation 
Chester et 
al. (2016) 
(i) 
 Gender: being female rather than 
male; worse disability via absolute 
Quick DASH score at 6 weeks post 
baseline  
(ii) 
 Work status: employment: not 
being in employment due to 
redundancy, unemployment or 
disability, compared with being in 
employment or education; worse 
pain and disability via absolute 
SPADI score at 6 weeks and both 
worse pain and disability via 
absolute SPADI score and worse 
disability via absolute Quick DASH 
score at 6 months post baseline  
 Physical activity levels: most 
strenuous weekly exercise classified 
as ‘none’ compared to ‘moderate’; 
worse pain and disability via 
absolute SPADI score at 6 months 
post baseline  
(i) 
 Age 
 Social deprivation: index of multiple 
deprivation 
 BMI 
 Smoker status 
(ii) 
 Work status: currently off work due 
to shoulder pain 
 Occupation: nature of employment 
 Occupation: type of work or regular 
activity 
Conroy and 
Hayes 
(1998) 
 (i) 
 Age 
Deutscher 
et al. (2009) 
(i) 
 Gender: being female; poorer 
functional status via absolute CAT 
score at discharge 
 Age: older age; poorer functional 
status via absolute CAT score at 
discharge 
(i) 
 Smoker status 
(ii) 
 Physical activity levels 
Engebretsen 
et al. (2010) 
(i) 
 Educational attainment: low 
education; worse pain and disability 
via absolute SPADI score and ‘not 
working’ status at 12 months post 
baseline 
(i) 
 Age 
 Gender  
(ii) 
 Work status 
 Occupation: frequency of working 
above shoulder height 
 Occupation: frequency of carrying 
heavy loads at work 
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Hung et al. 
(2010) 
 (i) 
 Age 
Kennedy et 
al. (2006) 
(i) 
 Gender: female; greater disability 
via absolute DASH score at 
discharge / 12 weeks 
 Age: older age; greater disability via 
absolute DASH score at discharge / 
12 weeks 
 Age: younger age; greater 
improvement in disability via 
change from DASH score at baseline 
to discharge / 12 weeks 
(ii) 
 Work status: workers compensation 
claim; greater disability via absolute 
DASH score at discharge / 12 weeks 
(ii) 
 Work status 
Kromer et 
al. (2014) 
 (i) 
*Age and gender were controlled for in 
the regression model 
Mintken et 
al. (2010) 
 (i) 
 Age 
 Gender 
(ii) 
 Work status 
Morrison et 
al. (1997) 
(i) 
 Age: greater age; worse pain, 
function, active ROM, strength and 
overall satisfaction via absolute 
UCLA score at average of 27 months 
(i) 
 Gender 
Ogon et al. 
(2009) 
  (i) 
 Age 
 Gender 
(ii) 
 Occupation 
Virta et al. 
(2009) 
 (i) 
 Age 
 Gender 
 Sindhu et al. (2012) and Tyler et al. (2010) did not explore demographic variables as potential 
prognostic factors.  
 
The published studies in this area provided evidence of age and gender as the demographic factors 
most commonly predictive of outcome. Specifically, older age was associated with poorer absolute 
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outcome status at discharge (Deutscher et al. 2009), discharge / 12 weeks (Kennedy et al. 2006) and 
average of 27 months follow up (Morrison et al. 1997). In addition, younger age was predictive of 
greater improvement in disability via change in DASH score from baseline to discharge / 12 weeks 
(Kennedy et al. 2006). The direction of prediction from these studies is consistent and could be 
viewed as aligning with the theories of increasing age being associated with poorer tissue healing 
and/or enhanced ability to modify lifestyle and greater functional reserves amongst the young 
(Cecchi et al. 2014).  
 
However it must be noted that a larger number of studies (n=8) did not identify age as a predictor. 
Of those studies identified as being of the highest level of quality (prospective cohort studies with 
>80% follow up), all that included age in their regression analysis found it to not be a predictor. 
Consequently the strength of evidence for age being a predictor is weakened.  
 
Three studies (Kennedy et al. 2006; Deutscher et al. 2009; Chester et al. 2016) identified gender as a 
predictor of outcome and were consistent with female gender predicting poorer outcome. However 
these studies all measured absolute outcome at discharge rather than change from baseline. A 
larger number of studies (n=6) found gender not to be predictive of outcome, of which n=4 were 
prospective cohort studies and so in the higher end of the quality of prognostic study evidence 
hierarchy. Therefore, whilst age and gender were the most commonly identified demographic 
predictors of outcome, the strength of evidence is moderate.   
 
The other generic demographic factors investigated were smoker status for which both studies that 
explored it (Deutscher et al. 2009; Chester et al. 2016) reported it to not be predictive of outcome. 
Chester et al. (2016) also considered BMI and the index of multiple deprivation but again neither 
were predictive of outcome. Finally Engebretsen et al. (2010) was the only study to consider 
educational attainment and identified low (defined as not having attending college or university) as 
predicting both worse pain and disability via absolute SPADI score and ‘not working’ status at 12 
months post baseline.   
 
With regards to work, recreational or functional task related variables, only three were identified as 
being predictive of outcome and none in more than one study. Work related variables were 
identified by Chester et al. (2016) as predicting worse absolute pain and disability follow up scores at 
6 weeks and 6 months for those subjects not in employment due to redundancy, unemployment or 
disability, compared with being in employment or education. Kennedy et al. (2006) identified 
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presence of a workers compensation claim as predicting greater absolute disability at discharge / 12 
weeks. Chester et al. (2016) was the only study to identify weekly exercise levels as predictive whilst 
no study identified functional tasks as being predictive. Indeed six studies did not find one or all of 
their work related variables as being predictors. Evidence of a consensus on work, recreational or 
functional task related variables predicting outcome in this topic area is therefore lacking.   
 
In conclusion, a large number of different demographic related variables have been considered as 
potential prognostic factors in previous studies. However evidence for a consensus is lacking and 
there is only weak evidence for age and gender as predictors.  
 
2.11.2 B. Clinical history 
 
Table 2-3: B. Clinical history factors, segregated according to (i) Current condition related variables 
and (ii) Treatment related variables 
Paper 
Prognostic factor; direction Not prognostic 
(i) Current condition related variables;  
(ii) Treatment related variables 
(i) Current condition related variables;  
(ii) Treatment related variables 
Bartolozzi et 
al. (1994) 
(i) 
 Symptom duration: longer duration 
symptoms; worse outcome via 
combination of UCLA score at 
discharge and perceived 
improvement at average of 20 
months 
(i) 
 Side-related symptoms: dominant 
arm involvement 
 Reason for symptom onset 
Chester et 
al. (2016) 
(i) 
 Side-related symptoms: presence of 
pain in the opposite upper 
quadrant; worse pain and disability 
via absolute SPADI score and worse 
disability via absolute Quick DASH 
score at 6 weeks post baseline  
 Side-related symptoms: both 
shoulder affected or patient stated 
‘ambidextrous’; worse disability via 
absolute Quick DASH score at 6 
months post baseline  
 Symptom duration: longer duration 
of symptoms; worse pain and 
disability via absolute SPADI score 
(i) 
 Reason for symptom onset  
 Timing of onset of symptoms 
 History of previous shoulder pain 
 Paraesthesia in arm 
 (ii) 
 Taking pain medication 
 Previously receiving treatment: 
physiotherapy helpful for previous 
shoulder problems  
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and worse disability via absolute 
Quick DASH score at 6 months post 
baseline 
(ii) 
 Co-morbidities: additional health 
problems; worse pain and disability 
via absolute SPADI score and worse 
disability via absolute Quick DASH 
score at 6 months post baseline 
Conroy and 
Hayes 
(1998) 
 (i) 
 Side-related symptoms: dominant 
arm involvement 
 Symptom duration 
Deutscher 
et al. (2009) 
(i) 
 Symptom duration: chronic 
symptoms; poorer functional status 
via absolute CAT score at discharge 
(ii) 
 Taking antidepressant medication; 
poorer functional status via 
absolute CAT score at discharge 
(ii) 
 Taking pain medication 
 Co-morbidities: number of co-
morbidities 
Engebretsen 
et al. (2010) 
(i) 
 Recurrent shoulder pain: previous 
shoulder pain; worse pain and 
disability via absolute SPADI score 
at 12 months post baseline 
(i) 
 Symptom duration 
 Associated neck pain 
 Side-related symptoms: dominant 
arm involvement 
(ii) 
 Previously receiving treatment: 
previous physiotherapy 
 Taking medication 
Kennedy et 
al. (2006) 
(i) 
 Symptom duration: shorter duration 
in symptoms; greater improvement 
in disability via change from DASH 
score at baseline to discharge / 12 
weeks  
 Post-surgical case; greater 
improvement in disability via 
change from DASH score at baseline 
to discharge / 12 weeks 
(i) 
 Recurrent shoulder pain 
 Reason for symptom onset  
(ii) 
 Co-morbidities: number of co-
morbidities and number that limit 
activity 
 Taking pain medication 
Kromer et 
al. (2014) 
(i) 
 Symptom duration: longer duration 
of complaints; less improvement in 
functional status via change in 
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functional subscale of SPADI (SPADI-
F) between baseline and 3 months 
post baseline 
Mintken et 
al. (2010) 
(i) 
 Symptom duration: shorter duration 
of symptoms; ‘improvement’ via 
GROC score => 4 at discharge 
(ii) 
 Taking pain medication: not taking 
pain medication; ‘improvement’ via 
GROC score => 4 at discharge 
(i) 
 Reason for symptom onset  
 Recurrent shoulder pain: number of 
previous episodes 
(ii) 
 Previously receiving treatment: 
treatment for previous episodes 
 Past medical history 
Morrison et 
al. (1997) 
(i) 
 Symptom duration: longer duration 
in symptoms; worse score at 
average of 27 months 
(i) 
 Side-related symptoms: dominant 
arm involvement 
Ogon et al. 
(2009) 
 (i) 
 Periods of professional disability 
 Reason for symptom onset  
 Symptom duration 
 Side-related symptoms: dominant 
arm involvement  
(ii) 
 Past medical history 
Virta et al. 
(2009) 
 (i) 
 Symptom duration 
 Hung et al. (2010), Sindhu et al. (2012) and Tyler et al. (2010) did not explore clinical history 
variables as potential prognostic factors. 
 
The clinical history variable most commonly identified as a predictor was duration of symptoms, 
whereby longer duration was associated with a worse outcome state (Morrison et al. 1997; 
Deutscher et al. 2009; Chester et al. 2016) and with worse change in status (Bartolozzi et al. 1994; 
Kromer et al. 2014). Similarly, shorter duration was predictive of greater improvement (Kennedy et 
al. 2006; Mintken et al. 2010) which together align with the concept that more established 
conditions are more stubborn to treatment (Collins et al. 2010). Four studies did not find it to be a 
predictor but only two of these were prospective cohort studies and so in the higher end of the 
quality of prognostic study evidence hierarchy. Therefore there is stronger evidence for duration of 
symptoms being a predictor than not; and where identified, the direction of prediction is consistent.  
 
In relation to the other ‘Current condition related variables’, there was greater variability in findings. 
Chester et al. (2016) identified side related symptoms as being predictive of a worse outcome state, 
namely where patients had pain in the opposite upper quadrant and both shoulders affected or 
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patient stated ‘ambidextrous’. However, five studies found that symptoms defined relative to the 
limb side was not predictive, including high level of evidence studies (i.e. prospective cohort studies 
with >80% follow up). Similarly, previous shoulder pain episodes was found by Engebretsen et al. 
(2010) to be predictive of a worse outcome state but 3 other studies found it not to be predictive, 
including the larger and higher quality study by Chester et al. (2016). Of less ambiguity was the 
reason for onset of symptoms which was consistently identified as not being predictive in all five 
studies that investigated it. Similarly, the studies that considered neck pain or paraesthesia found 
them to not be predictive.  
 
Treatment related variables included not taking pain medication or taking anti-depressant 
medication which Mintken et al. (2010) reported as predicting greater improvement and the larger 
study by Deutscher et al. (2009) reported as predicting a worse outcome state; respectively. 
However three studies found taking pain medication as not being predictive whilst Engebretsen et 
al. (2010) looked only at ‘use of medication’ and again found it to not be predictive. Similarly whilst 
Chester et al. (2016) found co-morbidities to predict a worse outcome state, four other studies 
found it to not be predictive. The three studies that looked at previous treatment for shoulder 
problems all found this variable to not be predictive.  
 
It can therefore be concluded that a large range of clinical history related variables have been 
explored as potential prognostic factors in previous studies. For duration of symptoms there is 
moderate evidence for it predicting outcome and the direction of prediction is consistent. However 
for the remaining clinical history variables there is weak evidence of their predictive capacity.  
 
2.11.3 C1. Patient reported measures: Pain 
  
Table 2-4: C1. Patient reported measures: Pain 
Paper Prognostic factor; direction Not prognostic 
Chester et 
al. (2016) 
 Pain intensity: higher pain severity 
at rest; worse pain and disability via 
absolute SPADI score and worse 
disability via absolute Quick DASH 
score at 6 weeks and 6 months post 
baseline 
 
Engebretsen 
et al. (2010) 
  Pain intensity  
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Kennedy et 
al. (2006) 
 Pain intensity: higher pain intensity 
at baseline; less improvement in 
disability via change from DASH 
score at baseline to discharge / 12 
weeks 
 
Kromer et 
al. (2014) 
  Pain intensity 
Mintken et 
al. (2010) 
  Pain intensity 
  
Bartolozzi et al. (1994), Conroy and Hayes (1998), Deutscher et al. (2009), Hung et al. (2010), 
Morrison et al. (1997),  Ogon et al. (2009),  Sindhu et al. (2012), Tyler et al. (2010) and  Virta et al. 
(2009) did not explore pain variables as potential prognostic factors. 
 
Three of the studies that explored pain as a potential prognostic factor found it not to be a predictor. 
However two of these were low in the hierarchy of prognostic evidence as they were RCT derived 
data and were at risk of over-fitting due to having less than 10 cases per variable. In contrast, the 
studies that found pain to be a predictor (Chester et al. 2016; Kennedy et al. 2006) were both 
prospective cohort studies and had 10 or more cases per variable, thereby providing higher quality 
evidence that was more likely to be replicated in a new sample. Specifically, Chester et al. (2016) 
identified higher pain at baseline as predicting a worse outcome state whilst the multiple regression 
equation coefficient reported by Kennedy et al. (2006) identified higher pain intensity predicting less 
improvement in status. Therefore there is moderate evidence of baseline pain levels being a 
predictor, with higher pain levels predicting worse outcome.  
 
2.11.4 C2. Patient reported measures: Psychological symptoms 
 
Table 2-5: C2. Patient reported measures: Psychological symptoms 
Paper Prognostic factor; direction Not prognostic 
Chester et 
al. (2016) 
 Self-efficacy for pain: lower pain self-
efficacy; worse pain and disability via 
absolute SPADI score and worse 
disability via absolute Quick DASH 
score at 6 weeks and 6 months post 
baseline 
 Patient expectation of ‘slight 
improvement’ rather than ‘complete 
 Anxiety and depression in the 
previous 7 days 
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recovery’ as ‘a result of physiotherapy 
treatment; worse pain and disability 
via absolute SPADI score and worse 
disability via absolute Quick DASH 
score at 6 weeks and 6 months post 
baseline 
 Patient expectation of ‘much 
improvement’ rather than ‘complete 
recovery’ as ‘a result of physiotherapy 
treatment’; worse pain and disability 
via absolute SPADI score and worse 
disability via absolute Quick DASH 
score at 6 months post baseline 
 Patient expectation of ‘no change’ 
rather than ‘complete recovery’ as ‘a 
result of physiotherapy treatment’; 
worse pain and disability via absolute 
SPADI score at 6 weeks post baseline 
Engebretsen 
et al. (2010) 
 General health status: poor, via 
baseline EQ-VAS; ‘not working’ status 
at 12 months post baseline 
 Emotional distress: Hopkins 
Symptom checklist 
 Self-efficacy for pain 
Kennedy et 
al. (2006) 
  Patient expectation 
 Mental Component Score (MCS) 
from the 36-Item Short-Form 
Health Survey (SF-36) 
Kromer et 
al. (2014) 
  Fear Avoidance Beliefs 
Questionnaire (physical activity 
subscale)  
 Pain catastrophising scale 
Mintken et 
al. (2010) 
  Patient expectation 
 Fear Avoidance Beliefs 
Questionnaire 
 Tampa Scale for Kinesiophobia 
Sindhu et al. 
(2012) 
 Fear Avoidance Beliefs Questionnaire: 
lower fear-avoidance beliefs; greater 
functional improvement via change in 
CAT score between baseline and 
discharge 
 
 
Bartolozzi et al. (1994), Conroy and Hayes (1998), Deutscher et al. (2009), Hung et al. (2010), 
Morrison et al. (1997), Ogon et al. (2009), Tyler et al. (2010) and Virta et al. (2009) did not explore 
psychological symptoms variables as potential prognostic factors. 
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Three of the six studies that explored state of mind or psychological symptoms as potential 
prognostic factors found one or more of them to be predictive of outcome. However there was 
substantial variation between studies in which variables were found to be predictive. Chester et al. 
(2016) reported three elements of patient expectation to be predictive of outcome, whilst neither 
Kennedy et al. (2006) nor Mintken et al. (2010) found patient expectation to be predictive. Chester 
et al. (2016) also found self-efficacy for pain to be a predictor whilst Engebretsen et al. (2010) did 
not.  
 
Where more direct measures of state of mind or psychological symptoms were considered these 
were generally not found to be predictive of outcome. Indeed only Sindhu et al. (2012) found their 
state of mind variable of fear avoidance beliefs to be predictive of outcome and this was where only 
a single, dichotomised question was posed. However where fear avoidance beliefs were explored 
more fully as per Mintken et al. (2010) and Kromer et al. (2014) then this variable was not found to 
be predictive. Furthermore where informal (as per Chester et al. 2016) or formalised assessment (as 
per Engebretsen et al. 2010) of mental health was undertaken these were not found to be 
predictive. The strength of evidence pointing to state of mind or psychological symptoms being a 
predictor is therefore weak, although the wide variation in approaches used in previous studies 
compounds this further.  
 
 
2.11.5 C3. Patient reported measures: Function / Disability 
 
Table 2-6: C3. Patient reported measures: Function / Disability 
Paper Prognostic factor; direction Not prognostic 
Bartolozzi et 
al. (1994) 
 Function / disability: more severe 
functional impairment as measured 
by the function element of the 
UCLA; worse outcome via 
combination of UCLA score at 
discharge and perceived 
improvement at average of 20 
months 
 
Chester et 
al. (2016) 
 Function / disability: higher baseline 
disability on SPADI; worse pain and 
disability via absolute SPADI score 
at 6 weeks and 6 months post 
baseline 
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 Function / disability: higher baseline 
disability on Quick DASH; worse 
disability via absolute Quick DASH 
score at 6 weeks and 6 months post 
baseline 
Deutscher 
et al. (2009) 
 Function / disability: higher 
functional status via CAT at 
baseline; better functional status via 
absolute CAT score at discharge  
 
Engebretsen 
et al. (2010) 
 Function / disability: higher pain 
and disability levels via baseline 
SPADI; worse pain and disability via 
absolute SPADI score at 12 months 
post baseline 
 
Hung et al. 
(2010) 
 Function / disability: FLEX-SF score 
<41 (higher baseline disability); 
‘improvement’ via GROC score => 4 
at discharge 
 
Kennedy et 
al. (2006) 
 Function / disability: higher DASH 
(more disabled) at baseline; greater 
disability via absolute DASH score at 
discharge / 12 weeks 
 Physical Component Score (PCS) 
from the 36-Item Short-Form Health 
Survey (SF-36): worse physical 
health (SF-36: PCS) at baseline; 
greater improvement in disability 
via change from DASH score at 
baseline to discharge / 12 weeks 
 Global rating of disability score 
Kromer et 
al. (2014) 
 Function / disability: higher 
disability levels as measured by the 
function element of the SPADI; 
greater improvement in functional 
status via change in functional 
subscale of SPADI (SPADI-F) 
between baseline and 3 months 
post baseline 
 
Mintken et 
al. (2010) 
  Function / disability: SPADI 
Conroy and Hayes (1998), Morrison et al. (1997), Ogon et al. (2009), Sindhu et al. (2012), Tyler et al. 
(2010), Virta et al. (2009) did not explore function / disability variables as potential prognostic 
factors. 
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Seven of the eight studies that explored function / disability found this variable category to be 
predictive of outcome and where outcome was defined in terms of absolute state, the direction of 
prediction was consistent. Specifically greater functional impairment / disability at baseline 
predicted a worse outcome state (Bartolozzi et al. 1994; Kennedy et al. 2006; Engebretsen et al. 
2010; Chester et al. 2016) and higher functional status predicted better functional status at 
discharge (Deutscher et al. 2009).  
 
Where the outcome was change of status, three studies (Kennedy et al. 2006; Hung et al. 2010; 
Kromer et al. 2014) found baseline function / disability to be predictive whilst only Mintken et al. 
(2010) did not. Both Hung et al. (2010) and Mintken et al. (2010) used the GROC although the very 
short study duration from Mintken et al. (2010) of approximately 1 week (from baseline to follow 
up) makes it difficult to meaningfully compare findings with the other studies in this area. With 
Kennedy et al. (2006), Hung et al. (2010) and Kromer et al. (2014) the direction of prediction was 
consistent, namely higher baseline disability was predictive of greater improvement.  
 
Given the consistent finding that function / disability has been identified as a predictor, including in 
4 prospective cohort studies, then the evidence to support this variable is strong. However the 
direction of prediction appears to be linked to how outcome is defined.  
 
2.11.6 D1. Clinical measures: Strength  
 
Table 2-7: D1. Clinical measures: Strength 
Paper Prognostic factor; direction Not prognostic 
Bartolozzi 
et al. 
(1994) 
  Strength: shoulder girdle weakness 
Chester 
et al. 
(2016) 
  Strength: shoulder force (abduction, 
ER) 
Hung et 
al. (2010) 
 Strength: <27.4% body weight 
scapular protractor force; 
‘improvement’ via GROC score => 4 at 
discharge 
 Strength: ER, IR and abduction  
Kennedy 
et al. 
(2006) 
  Strength: muscle wasting and muscle 
weakness 
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Mintken 
et al. 
(2010) 
  Strength: Serratus Anterior, Middle 
trapezius, Lower trapezius, 
Rhomboid, Deltoid, External and 
internal shoulder rotator muscle 
strength 
Conroy and Hayes (1998), Deutscher et al. (2009), Engebretsen et al. (2010), Kromer et al (2014), 
Morrison et al. (1997), Ogon et al. (2009), Sindhu et al. (2012), Tyler et al. (2010) and Virta et al. 
(2009) did not explore strength variables as potential prognostic factors. 
 
The majority of studies (4 out of 5) found strength to not be predictive of outcome. In addition, a 
large number of individual strength variables were also not found to be predictive. It is noted that 
Hung et al. (2010) found scapular protractor force was predictive of improvement at discharge; 
however the sample size in this study was the smallest of those that considered strength as a 
potential predictor. As such the weight of evidence is that strength is not predictive of outcome.  
 
2.11.7 D2. Clinical measures: ROM  
 
Table 2-8: D2. Clinical measures: ROM 
Paper Prognostic factor; direction Not prognostic 
Bartolozzi et 
al. (1994) 
  ROM: active abduction and flexion 
ROM 
Chester et 
al. (2016) 
 ROM: reduced range of active 
shoulder abduction; worse pain and 
disability via absolute SPADI score 
at 6 weeks post baseline 
 ROM: increasing difference 
between the range of active and 
passive shoulder abduction; worse 
pain and disability via absolute 
SPADI score at 6 months post 
baseline 
 ROM: AROM (flexion) 
 ROM: PROM (flexion, abduction, ER) 
Engebretsen 
et al. (2010) 
  ROM: AROM – HBB 
 ROM: flexion on the affected side 
Hung et al. 
(2010) 
  ROM: PROM IR, ER  
 ROM: posterior shoulder tightness 
(PST) 
Kennedy et 
al. (2006) 
  ROM: active and passive ROM 
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Mintken et 
al. (2010) 
 ROM: <127° of pain-free shoulder 
flexion; ‘improvement’ via GROC 
score => 4 at discharge  
 ROM: <53° passive shoulder IR at 
90° abduction; ‘improvement’ via 
GROC score => 4 at discharge 
 ROM: Passive shoulder abduction 
 ROM: Passive shoulder ER at 90° 
abduction 
 ROM: Battery of 3 functional tests 
Tyler et al. 
(2010) 
 ROM: Improvement in PST at 
discharge; symptom free via Simple 
Shoulder Test at discharge 
 
 ROM: Improvement in passive ER 
ROM 
 ROM: Improvement in GIRD 
Conroy and Hayes (1998), Deutscher et al. (2009), Kromer et al (2014), Morrison et al. (1997), Ogon 
et al. (2009), Sindhu et al. (2012) and Virta et al. (2009) did not explore ROM variables as potential 
prognostic factors.  
 
ROM variables were found to be predictive of outcome in three of the seven studies that explored 
this variable. However of these 3 studies the ROM variables were relatively disparate, ranging from 
static measures of soft tissue tightness (Tyler et al. 2010) to passive ROM and pain free active ROM 
(Mintken et al. 2010) to the difference between active and passive ROM (Chester et al. 2016). This 
makes it difficult to establish a consensus as to what aspects of ROM might be predictive. The large 
number of ROM variables not found to be predictive in all seven studies makes any such consensus 
even more tenuous.  
 
2.11.8 D3. Clinical measures: Scapular movement and control 
 
Table 2-9: D3. Clinical measures: Scapular movement and control 
Paper Prognostic factor; direction Not prognostic 
Chester 
et al. 
(2016) 
 Scapular movement and control: No 
change compared to change in 
shoulder pain/ range  during manual 
facilitation of the scapula around the 
chest wall during arm elevation; 
worse pain and disability via absolute 
SPADI score and worse disability via 
absolute Quick DASH score at 6 
months post baseline 
 
Hung et 
al. (2010) 
 Scapular movement and control: 
<0.7° scapular IR at 30° elevation 
during descending phase in the 
unloaded condition; ‘improvement’ 
via GROC score => 4 at discharge 
 Scapular movement and control: 
Scapular kinematics (UR, IR and 
scapular tilt) at 30°, 60°, 90°, 120° 
elevation during both the ascending 
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and descending phases in loaded and 
unloaded conditions 
Mintken 
et al. 
(2010) 
  Scapular movement and control: 
Lateral slide test and scapula index 
 Scapular movement and control: 
Qualitative assessment of scapular 
function  
Bartolozzi et al. (1994), Conroy and Hayes (1998), Deutscher et al. (2009), Engebretsen et al. (2010), 
Kennedy et al. (2006), Kromer et al (2014), Morrison et al. (1997), Ogon et al. (2009), Sindhu et al. 
(2012), Tyler et al. (2010) and Virta et al. (2009) did not explore scapular movement and control 
variables as potential prognostic factors. 
 
The potential for scapular movement and control variables to predict outcome was only explored in 
three previous studies, two of whom identified it as being a predictor. However whilst Chester et al. 
(2016) explored this variable using essentially a symptom modification test, Hung et al. (2010) was 
measuring detailed movements using a 3-dimensional movement analysis system. Of note here is 
that in the Hung et al. (2010) study only one of the three movements at one of the four positions, 
during one of the two phases and under one of the two loaded trials provided a predictive variable. 
Along with the absence of prediction from the static measures and qualitative assessment used by 
Mintken et al. (2010), a lack of consensus is seen in the previous literature.  
 
2.11.9 E1. Structural pathology via imaging  
 
Table 2-10: E1. Structural pathology via imaging 
Paper Prognostic factor; direction Not prognostic 
Bartolozzi 
et al. 
(1994) 
 Rotator cuff pathology: (moderate or 
large rotator cuff tears) on MRI; 
worse outcome via combination of 
UCLA score at discharge and 
perceived improvement at average of 
20 months 
 
Morrison 
et al. 
(1997) 
 Acromion morphology: (type 1) on X-
ray; better outcome at average of 27 
months 
 
Ogon et 
al. (2009) 
 Calcific deposits: Radiographic 
classification of the calcific deposits 
and the sonographic penetration of 
the deposits; ‘success of non-
operative therapy’ via no progression 
to advanced therapeutic measures 
 Calcific deposits: Multifocal 
distribution of calcific deposits 
 Calcific deposits: French Society of 
Arthroscopy classification of calcific 
deposits 
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after a minimum of 6 months non-
operative treatment (including 
minimum of 3 months treatment at 
the study location) 
 Calcific deposits: Bilateral calcific 
deposits, location and volume of the 
deposits on X-ray; ‘failure of non-
operative therapy’ via progression to 
advanced therapeutic measures due 
to persistence of symptomatic calcific 
tendonitis after a minimum of 6 
months non-operative treatment 
(including minimum of 3 months 
treatment at the study location) 
Chester et al (2016), Conroy and Hayes (1998), Deutscher et al. (2009), Engebretsen et al. (2010), 
Hung et al. (2010), Kennedy et al. (2006), Kromer et al (2014), Mintken et al. (2010), Sindhu et al. 
(2012), Tyler et al. (2010) and Virta et al. (2009) did not explore structural pathology via imaging 
variables as potential prognostic factors. 
 
The potential for structural pathology via imaging variables to predict outcome was only explored in 
three previous studies (Bartolozzi et al. 1994; Morrison et al. 1997; Ogon et al. 2009), all of whom 
identified it as being a predictor. Each study used a different measurement tool and identified 
different structures or tissues as being predictive. The presence of these different structures or 
tissues was predictive of both improved outcome (Morrison et al. 1997; Ogon et al. 2009) and worse 
outcome (Bartolozzi et al. 1994; Ogon et al. 2009). In addition, Ogon et al. (2009) found multiple 
structural pathology via imaging variables to not be predictive. It should also be noted that two 
(Bartolozzi et al. 1994; Morrison et al. 1997) of the studies were retrospective cohort studies and so 
provide the lowest quality of prognostic evidence. It can therefore be concluded that there is only 
moderate evidence for structural pathology via imaging variables to be predictive. There is also a 
lack of consensus as to what tools and structures / tissues generate predictive variables or in what 
direction they predict.  
 
2.11.10 E2. Structural pathology via orthopaedic tests  
 
Table 2-11: E2. Structural pathology via orthopaedic tests 
Paper Prognostic factor; direction Not prognostic 
Chester 
et al. 
(2016) 
  Orthopaedic tests: External lag sign 
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Mintken 
et al. 
(2010) 
 Orthopaedic tests: Negative Neer's 
sign; ‘improvement’ via GROC score 
=> 4 at discharge 
 Orthopaedic tests: 12 other 
orthopaedic tests, including the 
Hawkins-Kennedy impingement test, 
the empty can and full can test and 
the drop sign 
Bartolozzi et al. (1994), Conroy and Hayes (1998), Deutscher et al. (2009), Engebretsen et al. (2010), 
Hung et al. (2010), Kennedy et al. (2006), Kromer et al (2014), Morrison et al. (1997), Ogon et al. 
(2009), Sindhu et al. (2012), Tyler et al. (2010) and Virta et al. (2009) did not explore orthopaedic 
tests variables as potential prognostic factors. 
 
Only two previous studies investigated the potential of structural pathology via orthopaedic tests to 
predict outcome. Of these only Mintken et al. (2010) found them to be predictive and this was only 
the Neer's sign out of a battery of 13 tests. However, as the Mintken et al. (2010) study undertook 
treatment and follow up over a time period of only a few days, the clinical utility of their findings is 
very weak. As such there is weak evidence for orthopaedic tests being predictive of outcome.  
 
2.11.11 Summary of individual prognostic variables 
Using a Cochrane style ‘traffic light’ summary, the evidence for the variables being predictive from 
the previous literature can be coded as follows: 
Age & gender  
Duration of symptoms  
Pain  
Psychological state  
Function  
Strength  
ROM  
Scapula movement control  
Structural pathology via imaging  
Structural pathology via orthopaedic tests  
Where green denotes moderate or strong evidence, yellow denotes weak evidence or lacking in 
consensus and red denotes evidence that it is not predictive. However the utility of these 
judgements in informing the objectives of this study (including how to identify the potential 
prognostic factors to investigate) is limited by (i) the short-comings of attempting to synthesise 
evidence regarding individual prognostic factors rather than actual prognostic models (Braun et al. 
2016), (ii) the PROBAST guided quality appraisal which identified all studies as being at high risk of 
bias, the majority where there was high level concern regarding applicability to the research 
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question and no studies identified as being useable in the context of the intended context and target 
population which in turn limits the ability to synthesise the evidence. 
 
It can however be concluded that potential prognostic factors from a wide range of categories have 
been identified in each of the 10 categories (A, B, C1, C2, C3, D1, D2, D3, E1 and E2) – and these each 
have conceptual relevance – around which the literature review on prognostic factors was 
structured. As such this provides a rationale and a context for examining these variables in this 
thesis. 
 
2.11.12 Multivariate predictors  
As noted previously, multivariate regression techniques enable examination of the interaction of 
multiple variables in predicting a particular outcome (Hemingway et al. 2009). Where studies used 
end state as their outcome variable then the number of variables comprising their predictive model 
ranged from three (Engebretsen et al. 2010) to four (Kennedy et al. 2006) and five (Deutscher et al. 
2009). Where multiple outcome variables and time points were used, then between three (for Quick 
DASH at 6 weeks) and six (for SPADI at 6 months) comprised the model (Chester et al. 2016). Where 
change in state was the outcome variable then the number of variables comprising predictive 
models ranged from two (Kromer et al. 2014) to three (Hung et al. 2010) and five (Kennedy et al. 
2006). In the previously published literature, wide variation was therefore seen in the number of 
variables comprising the final predictive models.  
 
2.12 Overall summary 
This review of the literature has highlighted the wide range of potential prognostic categories and 
variables that have collectively been explored by previous studies in this area. This is perhaps 
unsurprising given the uncertain nature of SIS/RCTendinopathy in regard to its aetiology, signs and 
symptoms, how best to define it and the conceptual frameworks within which it can be 
contextualised. In light of this persistent uncertainty then there is merit in incorporating the full 
range of potential prognostic categories within a single study. Such an approach aligns well with the 
complex, multi-factorial intervention of physiotherapy. Recognising the historically poor standard of 
prognostic studies in both musculoskeletal and non-musculoskeletal research areas, an emphasis on 
high quality study design is imperative.  
 
Identification of the patient population was explored early on in this literature review, including the 
limitations of relying on orthopaedic tests for diagnosis due to their limited sensitivity and 
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specificity. Yet as the most commonly diagnosed shoulder pathology, a clinically and conceptually 
meaningful approach to identifying an SIS/RCTendinopathy patient sample is essential. As such, the 
exclusion of discrete shoulder pathologies provides one mechanism to identify a patient sample, 
combined with a clinical presentation suggestive of the target pathology. Another aspect of 
identifying a patient sample is to identify where in the patient care pathway should subjects be 
recruited from. Ideally this should be based upon an established, evidence-based, optimum care 
pathway. However this is currently lacking for patients with SIS/RCTendinopathy and so the use of a 
meaningful and well-defined section of the care pathway provides a constructive compromise.  
 
This literature review has highlighted a number of study design limitations with previous studies in 
this area. Given the emphasis in the prognostic methodology literature on high standards, the use of 
a prospective cohort study with >80% follow up is essential. Further failings in the previous literature 
include not examining the characteristics of those who did and did not consent as a potential source 
of selection bias. Comparison of baseline characteristics between those who were available for 
follow up and those lost to follow up was also rarely performed. As a potential source of bias within 
the final analysis groups it is essential that such analysis is performed, as is blinding of assessors to 
the individual patient’s outcome until all other data collection and processing is completed.  
 
By including the full range of potential prognostic categories within a single study, there is merit in 
collecting (A) demographics and (B) clinical history data. However, given the large number of 
potential variables within these categories, a judicious decision should be made as to which to 
include in the prognostic model. For (A) demographics, age and gender are two likely candidates 
whilst for (B) clinical history data, duration of symptoms is the variable which the literature indicates 
has the most predictive potential. Nonetheless the collecting of a wide range of (A) demographics 
and (B) clinical history variables provides a mechanism for comprehensively defining the sample and 
is therefore advocated.  
 
In relation to (C) patient reported measures, there is moderate evidence of (C1) pain measured by 
the VAS as predicting outcome. However the wide range of references for quantifying it (e.g. at rest, 
on movement, etc) and timescales for recall of pain levels that have been used in the previous 
literature undermine any such consensus. As such the use of a well reasoned approach to identifying 
the pain variable to be included in the final prognostic model should be made.  
 
92 
 
In relation to (C2) psychological symptoms, the wider musculoskeletal literature provides a strong 
rationale for including this variable type. However the prognostic literature provides a less 
unanimous picture of its predictive ability and this is compounded by both the complexity of 
psychological symptoms and the myriad measurement tools that have previously been used to 
measure it. As such, the use of an established tool for capturing the wide range of psychological 
symptoms in a clinically interpretable manner is advocated.  
 
When considering patient reported measures of (C3) function and disability, the previous literature 
provides unanimous evidence of the predictive value of this variable type. However of greater 
challenge is which tool to use given the wide range of outcome scores available in the published 
literature. The frequent use in previous studies of the same outcome score as both a candidate 
variable and the definer of outcome is a notable limitation of such studies and must be addressed in 
any future study.  
 
The conceptual relevance of (D) clinical measures such as (D1) strength, (D2) ROM and (D3) scapular 
movement and control are represented in both the path-anatomical and the International 
Classification of Functioning, Disability and Health derived models of SIS/RCTendinopathy. However 
this contrasts with limited evidence from previous studies that strength is predictive of outcome; 
whilst establishing a consensus as to which aspects of ROM might be predictive is challenging given 
the wide range of approaches previously used. The use therefore of well reasoned measures of 
strength and ROM along with formal testing of the reliability of the tools in the context within which 
they are used should be undertaken. In the case of (D1) strength, consideration of this as a potential 
prognostic variable – in spite of the weight of evidence being that strength is not predictive of 
outcome – is rationalised by such evidence being only one factor in determining which variables to 
consider, combined with the clear conceptual relevance of this variable.  
 
Given the clearly recognised challenges of measuring scapular movement and control in the clinical 
setting, issues around reproducibility of any tool pose a particular issue given the emphasis within 
the prognostic methodology literature on using robust measurement approaches. Therefore 
alongside a judicious choice of measurement tool, the formal testing of the reproducibility of any 
tool should be undertaken.  
 
The exploration of (E) structural pathology is a less commonly used approach in the previous 
literature, including the use of (E1) imaging modalities. The ability for diagnostic ultrasound to 
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provide high resolution, clinic-based imaging of a wide range of potentially relevant shoulder 
structures makes it an attractive option. However given the highly technical nature of performing 
and interpreting diagnostic ultrasound, any such inclusion of the modality must be premised upon 
the use of an appropriately trained operator. Furthermore, given the subjective nature of imaging 
interpretation, formal reproducibility data should be provided. The exploration of (E2) orthopaedic 
test results as a potential predictor variable has rarely been undertaken in the literature. Given their 
limited diagnostic value, inclusion of orthopaedic tests in a prognostic model reflects one of the 
notable advantages of prognostic research, namely that it is not constrained by diagnosis per se.  
 
Due to the complex, multi-factorial nature of physiotherapy, the use by many previous studies of a 
narrowly defined approach to treatment makes their findings of limited clinical relevance. As such 
there is a strong case for using a pragmatic approach to treatment. However the challenges of 
recording and quantifying the intervention are substantial. When considering what factors at the 
outset can predict outcome then the omitting of treatment related data from prognostic modelling 
is appropriate. However awareness of the content, duration and frequency of treatment – along 
with response to the intervention and levels of non-completion of treatment – allow a study to be 
set in the context of routine care.  
 
Alongside the process by which a prognostic model is constructed, the mechanism by which 
outcome is defined and measured has a substantial impact on the subsequent findings. The 
consistent use in recent studies of patient reported measures enables the capturing of the wide 
impact of SIS/RCTendinopathy and is therefore advocated. As however is the importance of ensuring 
no absolute overlap with any measurement tools used for capturing potential prognostic factors. In 
the published literature there has been wide variation in the timescales used for follow up and this 
limits both the clinical relevance of their results and the ability to pool findings. An optimal approach 
is to align follow up with the actual completion of active treatment alongside use of a standardised 
follow up period post-discharge. Changes in patient reported measures from baseline provides a 
highly clinically relevant mechanism for processing the dependent variable.  
 
In considering the full range of potential prognostic categories within a single study, one notable 
issue is how to address the risk of over-fitting due to the inclusion of too many variables relative to 
the sample size. Several of the previously published studies in this area were identified as being at 
risk of this, thereby undermining the potential value of their evidence. One mechanism to overcome 
this is the defining a priori of a reasoned mechanism to select variables to be considered in a 
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prognostic model and to align the number of these to the actual recruited sample size. Due to the 
inevitable compromises that such an approach requires, placing a prognostic research study within a 
method framework whereby the nature and interpretation of studies sits within stages of prognostic 
research development (Hemingway et al. 2013) has merit. As such the emphasis on methodological 
rigour and exploration of factors across a range of types of variables would allow a study of this type 
to sit at the exploratory end of the prognostic framework (Kent et al. 2010), thereby providing a 
foundation for informing hypothesis-testing in a new sample.  
 
This review of the literature will therefore inform the design and interpretation of data from a 
prospective study to explore prognostic indicators of successful rehabilitation outcome in patients 
with SIS/RCTendinopathy.  
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3 AIMS, OBJECTIVES AND HYPOTHESES 
3.1 Aim 
The aim of this study is to identify baseline factors that predict outcome in SIS/RCTendinopathy 
patients following physiotherapy treatment.  
 
3.2 Research question 
Which baseline variable or combination of baseline variables predict outcome following 
physiotherapy treatment in a cohort of SIS/RCTendinopathy patients?    
 
3.3 Null Hypotheses 
A.(i) Demographics  
In a multivariate analysis, demographics will not be a predictor of outcome between baseline and 
discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
B.(i) Clinical history related  
In a multivariate analysis, clinical history related variable will not be a predictor of outcome between 
baseline and discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
C.(i) Patient reported measures 
In a multivariate analysis, baseline patient reported measures will not be a predictor of outcome 
between baseline and discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
D.(i) Clinical measures  
In a multivariate analysis, baseline clinical measures will not be a predictor of outcome between 
baseline and discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
E.(i) Structural pathology  
In a multivariate analysis, baseline structural pathology will not be a predictor of outcome between 
baseline and discharge in SIS/RCTendinopathy patients treated with physiotherapy.  
 
F.(i) Multivariate prognosis 
In a multivariate analysis, a combination of 2 or more of A.(i) demographics, B.(i) clinical history 
related, C.(i) baseline patient reported measures, D.(i) baseline clinical measures and E.(i) baseline 
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structural pathology will not predict outcome between baseline and discharge in 
SIS/RCTendinopathy patients treated with physiotherapy. 
 
A.(ii) Demographics  
In a multivariate analysis, demographics will not be a predictor of outcome between baseline and 3 
months post-discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
B.(ii) Clinical history related  
In a multivariate analysis, clinical history related variable will not be a predictor of outcome between 
baseline and 3 months post-discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
C.(ii) Patient reported measures 
In a multivariate analysis, baseline patient reported measures will not be a predictor of outcome 
between baseline and 3 months post-discharge in SIS/RCTendinopathy patients treated with 
physiotherapy.  
 
D.(ii) Clinical measures  
In a multivariate analysis, baseline clinical measures will not be a predictor of outcome between 
baseline and 3 months post-discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
E.(ii) Structural pathology   
In a multivariate analysis, baseline structural pathology will not be a predictor of outcome between 
baseline and 3 months post-discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
F.(ii) Multivariate prognosis 
In a multivariate analysis, a combination of 2 or more of A.(i) demographics, B.(i) clinical history 
related, C.(i) baseline patient reported measures, D.(i) baseline clinical measures and E.(i) baseline 
structural pathology will not predict outcome between baseline and 3 months post-discharge in 
SIS/RCTendinopathy patients treated with physiotherapy. 
 
3.4 Experimental Hypotheses 
A.(i) Demographics  
In a multivariate analysis, demographics will be a predictor of outcome between baseline and 
discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
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B.(i) Clinical history related  
In a multivariate analysis, clinical history related will be a predictor of outcome between baseline 
and discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
C.(i) Patient reported measures 
In a multivariate analysis, baseline patient reported measures will be a predictor of outcome 
between baseline and discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
D.(i) Clinical measures  
In a multivariate analysis, baseline clinical measures will be a predictor of outcome between baseline 
and discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
E.(i) Structural pathology  
In a multivariate analysis, baseline structural pathology will be a predictor of outcome between 
baseline and discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
F.(i) Multivariate prognosis 
In a multivariate analysis, a combination of 2 or more of A.(i) demographics, B.(i) clinical history 
related, C.(i) baseline patient reported measures, D.(i) baseline clinical measures and E.(i) baseline 
structural pathology will predict outcome between baseline and discharge in SIS/RCTendinopathy 
patients treated with physiotherapy. 
 
A.(ii) Demographics  
In a multivariate analysis, demographics will be a predictor of outcome between baseline and 3 
months post-discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
B.(ii) Clinical history related  
In a multivariate analysis, clinical history related will be a predictor of outcome between baseline 
and 3 months post-discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
C.(ii) Patient reported measures 
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In a multivariate analysis, baseline patient reported measures will be a predictor of outcome 
between baseline and 3 months post-discharge in SIS/RCTendinopathy patients treated with 
physiotherapy. 
 
D.(ii) Clinical measures  
In a multivariate analysis, baseline clinical measures will be a predictor of outcome between baseline 
and 3 months post-discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
E.(ii) Structural pathology  
In a multivariate analysis, baseline structural pathology will be a predictor of outcome between 
baseline and 3 months post-discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
F.(ii) Multivariate prognosis 
In a multivariate analysis, a combination of 2 or more of A.(i) demographics, B.(i) clinical history 
related, C.(i) baseline patient reported measures, D.(i) baseline clinical measures and E.(i) baseline 
structural pathology will predict outcome between baseline and 3 months post-discharge in 
SIS/RCTendinopathy patients treated with physiotherapy. 
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4 PRE-METHODS 
The primary focus of this thesis is a prospective cohort study of SIS/RCTendinopathy patients to 
identify what variable or combination of variables predict outcome. Specifically these variables will 
be A. demographics, B. clinical history related, C. patient reported measures (C1. pain; C2. 
psychological symptoms; C3. function/disability), D. clinical measures (D1. strength; D2. ROM; D3. 
scapular movement and control) and E. structural pathology (via E1. imaging; E2. orthopaedic tests). 
For reasons of consistency, all methods by which the cohort study was undertaken will be detailed in 
the methods chapter.  
 
However numerous preliminary studies were performed to inform the methods and analysis of the 
prognostic cohort study data and these comprise the current chapter. As per the GRRAS checklist 
(Kottner et al. 2011) they are summarised in appendix IV. Specifically, intra-rater reliability was 
required to be assessed for clinical measures: D1. strength and D2. ROM. Inter-rater reliability was 
assessed for D3. clinical measures: scapular movement and control and E1. structural pathology via 
imaging. Furthermore, formal post-graduate clinical training was undertaken for E1. structural 
pathology via ultrasound imaging. In addition a bespoke tool was developed for recording the 
physiotherapy delivered which comprised the pragmatic treatment.  
 
4.1 D Clinical measures  
4.1.1 D1. Clinical measures: Strength  
In this prognostic cohort study, isometric strength (‘make’ test) was measured as a potential 
prognostic variable. A handheld dynamometer (Commander Muscle Tester, JTech Medical, USA) was 
used by Michael Smith (MS) to quantify the force generated by each subject. Full details of how 
strength was measured will be provided in the method section (page 126). However an intra-rater 
reliability study was conducted to determine how reliable the data collection method was in the 
prognostic cohort study.  
 
4.1.1.1 Strength intra-rater reliability study 
The handheld dynamometer has high levels of force accuracy as reported by the manufacturer (99% 
force accuracy over the entire test pad area; 
http://www.jtechmedical.com/phocadownload/manuals/MN084-
CommanderMuscleTesterManual.pdf; accessed 31/10/2016); however this was not independently 
tested. As a single rater (MS) performed the prognostic cohort study strength measurements, it was 
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deemed necessary to assess the absolute accuracy of the strength measures taken in the same test 
positions using the same measurement tool as for the prognostic cohort study (Schrama et al. 2014).    
 
In order to minimise the within subject, within-side variability of the force generated by the 
shoulders to be tested, the reproducibility study was undertaken on healthy subjects as they were 
deemed more able to repeatedly generate a consistent force (Awatani et al. 2016). The 
reproducibility study was undertaken on a convenience sample of 12 healthy subjects (4 male, 8 
female; 1 left handed, 11 right handed). The demographics and OSS scores for these subjects are 
shown in the table below and the raw data is in appendix 4. The corresponding data collection form 
can also be seen in appendix 4.   
 
Table 4-1: Demographics of strength intra-rater reliability study subjects 
Variable 
Measure of variability 
Mean SD Minimum Maximum 
Age (years)  38.6 12.7 21.0 67.0 
Height (m)  1.73 0.11 1.57 1.91 
Weight (kg)  75.0 10.8 63.3 93.6 
BMI (kg/m2)  25.2 2.8 21.9 31.8 
OSS  47.5 1.0 45 48 
Key: Kg = kilograms, m = metres, BMI = body mass index, OSS = Oxford shoulder score, SD = standard deviation 
 
It can be seen from the above table that the mean OSS for the reproducibility subjects was 47.5 with 
a range of 45 to 48. This is well within the range reported in the literature for asymptomatic subjects 
(Younis et al. 2011).  
 
4.1.1.1.1 Procedure 
The strength measurements in the reproducibility study were performed in the same test positions, 
with the same instructions to the subject and in the same order as in the prognostic cohort study. 
The distance from the axis of rotation to the point of force application was measured in metres using 
a measuring tape (Awatani et al. 2016). Three strength measures were taken on each limb side for 
each contraction type. The order was internal rotation (IR; right then left), external rotation (ER; 
right then left) and finally elevation in the scapular plane (Scaption; right then left). No shoulder pain 
was reported by any reproducibility study subjects during testing. 
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4.1.1.1.2 Data processing 
The rotational moments (Newton metres) were calculated by multiplying the force generated 
(Newtons) during IR, ER and Scaption multiplied by the relevant moment arm (metres) (Schrama et 
al. 2014).  
 
4.1.1.1.3 Data analysis 
The intra-rater reliability study was concerned with the absolute agreement between measures 
taken by the same, single rater (MS) who took all the measures both in the intra-rater reliability 
study and in the prognostic cohort study. Thus, intraclass correlation coefficient (ICC(3,1)) (Shrout and 
Fleiss 1979) was calculated in Statistical Package for the Social Sciences (SPSS version 20; IBM) where 
the model was ‘two way mixed’, type was ‘absolute agreement’ and the ‘single measures’ variable 
reported (Portney and Watkins 2007).  
 
4.1.1.1.4 Results  
The raw data of the strength readings for each trial, each contraction type and each limb side (IR, ER, 
Scaption; left, right) is in appendix 4 and the measures of variability for the contraction type and 
limb side combination is shown in the below table.   
 
 
Table 4-2: Descriptive data of strength readings (Nm) for the strength measures and limb side 
combination trials from the intra-rater reliability study 
Variable 
Measure of variability 
Mean SD Minimum Maximum 
IR Left  21.3 7.7 9.7 35.0 
IR Right  20.8 8.5 8.7 37.3 
ER Left  17.4 5.8 9.7 31.9 
ER Right  18.0 6.3 9.7 29.4 
Scaption Left  25.0 7.0 11.9 36.6 
Scaption Right  25.1 7.9 11.9 37.3 
Key: Nm = Newton metres, SD = standard deviation 
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Table 4-3: Intraclass Correlation Coefficient (ICC(3,1)) results for strength intra-rater reliability 
study 
Variable 
Intraclass Correlation Coefficient 
ICC(3,1) 95% CI (Lower bound) 95% CI (Upper bound) 
IR Left   0.978 0.944 0.993 
IR Right   0.973 0.932 0.992 
ER Left   0.896 0.753 0.966 
ER Right   0.966 0.915 0.989 
Scaption Left   0.863 0.680 0.955 
Scaption Right   0.881 0.685 0.962 
Key: CI = confidence interval 
 
4.1.1.1.5 Interpretation 
The intra-rater reliability findings for the left and right side for IR, ER and Scaption are all in the very 
good range (Landis and Koch 1977; Altman 1991). Therefore the data collection method can be 
considered to be reliable and so the tool could be used in the same format in the prognostic cohort 
study.  
 
4.1.2 D2. Clinical measures: ROM  
In this prognostic cohort study, active planar ROM was assessed as a potential prognostic variable. A 
digital inclinometer (DigiPas DWL-180s, JSB Tech Pte Ltd, Singapore) was used to quantify the 
angular ROM achieved by each patient. Full details of how ROM was measured will be provided in 
the method section (page 128). However an intra-rater reliability study was conducted to determine 
how reliable the data collection method was in the prognostic cohort study. 
 
4.1.2.1 ROM intra-rater reliability study 
The digital inclinometer has high levels of angular accuracy as reported by the manufacturer (±0.05° 
at 0° and 90°; and ±0.2° at 1° to 89° (http://www.digipas.co.uk/products/digital-level-module/dwl-
180.php; accessed 02/11/2016); however this was not independently tested. A single rater (MS) 
performed the prognostic cohort study ROM measurement and so it was deemed necessary to 
assess the intra-rater reliability of this tool in the context within which it was to be used in the 
prognostic cohort study. This involved assessing the absolute accuracy of the procedure of placing 
the inclinometer on the subject’s arm and taking a reading.   
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The reproducibility study was undertaken on the same convenience sample of 12 healthy subjects as 
the strength reproducibility study. In order to remove the potential variable of the subjects moving 
their arm between measures, the reproducibility study was undertaken on healthy subjects as they 
were more likely to be able to maintain a consistent arm position.  
 
4.1.2.1.1 Procedure 
In order to replicate the likely ROM positions which the prognostic cohort study subjects would 
achieve, the ROM intra-rater reliability study subjects were measured in various sections of the 
available range. Vertical poles were used to standardise the plane of movement and a marker was 
placed on each pole (left and right) to which the subjects moved their arms. One was at a point that 
was <90° elevation and the other at >90° elevation. The order of this in relation to arm side (left / 
right) was counterbalanced within the sample.   
 
The subjects were instructed to elevate their arms bilaterally to the respective markers. MS placed 
the digital inclinometer on the mid-point of the lateral aspect of the subject’s upper arm, parallel to 
the humerus. A reading was taken, the digital inclinometer was removed from the subject’s upper 
arm and the reading recorded on a sheet of paper. This procedure was repeated a further 2 times. 
The above procedure was then repeated for the other arm and recorded on the data collection form 
in appendix 4. 
 
4.1.2.1.2 Data processing 
ROM readings were converted from the reading on the unit (where 0° represents horizontal) to the 
absolute ROM attained by adding the reading to 90 (for above horizontal positions) and subtracting 
the reading from 90 (for below horizontal positions). 
 
4.1.2.1.3 Data analysis 
The intra-rater reliability study was concerned with the absolute agreement between measures 
taken by the same, single rater (MS) who took all the measures both in the intra-rater reliability 
study and in the prognostic cohort study. Thus, intraclass correlation coefficient (ICC(3,1)) (Shrout and 
Fleiss 1979) was calculated in SPSS where the model was ‘two way mixed’, type was ‘absolute 
agreement’ and the ‘single measures’ variable reported (Portney and Watkins 2007). 
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4.1.2.1.4 Results 
The raw data of the ROM readings for each trial and position (<90° elevation and >90° elevation) is in 
appendix 4 and the measures of variability for the <90° and >90° elevation trials is shown in the 
below table.  
 
 
Table 4-4: Descriptive data of ROM readings (/°) for the <90° and >90° elevation trials from the 
intra-rater reliability study 
Variable 
Measure of variability 
Mean SD Minimum Maximum 
<90° elevation  43.7 9.6 26.6 62.3 
>90° elevation  135.7 7.2 119.5 151 
Key: SD = standard deviation 
 
 
Table 4-5: Intraclass Correlation Coefficient (ICC(3,1)) results for ROM intra-rater reliability study 
Variable 
Intraclass Correlation Coefficient 
ICC(3,1) 95% CI (Lower bound) 95% CI (Upper bound) 
<90° elevation  0.980 0.949 0.994 
>90° elevation  0.922 0.813 0.975 
Key: CI = confidence interval 
 
4.1.2.1.5 Interpretation 
The intra-rater reliability findings for both <90° elevation and >90° elevation are both in the very 
good range (Landis and Koch 1977; Altman 1991). Therefore the data collection method can be 
considered to be reliable and so the tool could be used in the same format in the prognostic cohort 
study.  
 
4.1.3 D3. Clinical measures: Scapular movement and control 
In this prognostic cohort study, scapular movement and control was assessed as a potential 
prognostic variable. The scapular dyskinesis test (SDT) described by McClure et al. (2009) was used 
to categorise the presence and extent of any altered scapular movement and control. Full details of 
how scapular movement and control was measured will be provided in the method section (pg 129). 
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However as a subjective rating system it was deemed necessary for MS to undertake an inter-rater 
reliability study.  
 
4.1.3.1 Scapular dyskinesis test inter-rater reliability study 
Details of the validity (Tate et al. 2009) and inter-rater reliability of the SDT (McClure et al. 2009) 
have been published previously. However the SDT was developed on overhead athletes whilst the 
current study is concerned with NHS patients who were a non-athletic population. The likely greater 
heterogeneity of NHS patients in terms of body habitus and range of movement at the shoulder 
complex meant that establishing the level of agreement between the MS and another experienced 
musculoskeletal clinician using a sample of such patients was necessary.  
  
As with the main cohort data, rating of scapular movement and control was performed on video 
recordings of the patients’ movement patterns. To ensure direct transferability of the inter-rater 
reliability findings to the main cohort, the reliability study was undertaken on a subset of patients 
from the main cohort and level of agreement in rating the symptomatic side was established with 
one of the treating musculoskeletal clinicians in the study. This was Kevin Nicholas (KN) who worked 
at the Whitchurch hospital (WHI) site and had 10 years’ experience working in musculoskeletal 
outpatients. In order to remove the potential confounding factor of being involved with the 
treatment of a subject, the sub-set of patients were ones that were treated at a different clinical site 
to where KN worked.   
 
As with the published SDT reproducibility study (McClure et al. 2009), KN and MS undertook 
standardised training, which comprised the operational definitions, rating scale and photographic 
examples provided in the original publication. As the SDT is based upon interpretation of descriptive 
terminology, it was considered essential that the training and familiarisation process included 
applying the SDT to footage of scapular movement. Twenty videos of scapular movement patterns 
from patients with SIS/RCTendinopathy from both loaded (i.e. holding a weight in each hand) and 
un-loaded (i.e. not holding a weight) trials which demonstrated a spectrum of scapular movement 
patterns were therefore selected from the prognostic cohort. KN and MS viewed these videos and 
had the opportunity to discuss the interpretation and application of the descriptive terminology and 
recording process. This mirrored a typical, peer-supported clinical training environment (Baertschi et 
al. 2013).   
 
106 
 
Following the training period, KN and MS each had a copy of the inter-rater reliability study videos 
and data collection forms. These inter-rater reliability study videos were of a different 30 subjects 
which were not used in the training phase. Each assessor independently graded each of the videos 
with blinding to the other assessor’s grading ensured by undertaking the grading when the other 
rater was not present. 
 
The raw demographics data of the sub-set of patients is shown in appendix 4. The sample comprised 
13 male and 17 female subjects whose symptoms were on the left side in 12 cases and right side in 
18 cases. The type of trial were counterbalanced to give 15 loaded and 15 non-loaded trials. To allow 
for a degree of comparability with the inter-rater reliability sample examined by McClure et al. 
(2009), BMI and maximum range of movement on the symptomatic side from the goniometric data 
for each subject is presented below.  
 
 
Table 4-6: Demographics of scapular dyskinesis test intra-rater reliability study subjects 
Variable 
Measure of variability 
Mean SD Minimum Maximum 
BMI (kgm-2) 29.0 6.3 18.2 50.5 
Maximum range of 
movement on 
symptomatic side (°) 
138 25 74 174 
Key: Kg = kilograms, m = metres, BMI = body mass index, ° = degrees, SD = standard deviation 
 
It can be seen from the above table that the average BMI was 29.0 kgm-2 and from the raw data that 
13 of the 30 subjects (43%) had a BMI of greater than or equal to 30.0 kgm-2. There was wide 
variation in the maximum range of movement on the symptomatic side around a mean of 138.0°.  
 
The raw data of the scapular dyskinesis gradings for each rater is in appendix 4 and the frequency of 
the gradings shown in the below table.   
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Table 4-7: Frequency of the Scapular gradings from the inter-rater reliability study (n=30) 
 Scapular Dyskinesis Grading  
Rater Normal Subtle abnormality Obvious abnormality 
MS 8 13 9 
KN 5 10 15 
 
 
Table 4-8: Cross-tabulation table of Scapular gradings from the inter-rater reliability study (n=30) 
 Rater is KN 
Normal Subtle abnormality Obvious abnormality 
Rater is 
MS 
Normal 3 1 4 
Subtle abnormality 1 8 4 
Obvious abnormality 1 1 7 
 
Assessment of agreement between MS and KN was performed using Cohen’s Kappa (McHugh 2012)  
 
Table 4-9: Inter-rater reliability of Scapular gradings 
n= Kappa  p value  
30 0.395 0.002 
 
For the Scapular gradings the Kappa value showed fair agreement (Kappa 0.21 to 0.40) (Viera and 
Garrett 2005), borderline moderate (Kappa 0.41 to 0.60) (Sim and Wright 2005) between MS and 
KN. Based upon the Kappa value it can therefore be concluded that when compared to an 
experienced musculoskeletal outpatient physiotherapist involved with the study, MS demonstrated 
a fair level of agreement for scapular dyskinesis test gradings.  
 
To allow for more direct comparability with the original publication by McClure et al. (2009), a linear 
weighted Kappa was also performed. Although McClure et al. (2009) didn’t state the scaling of their 
weightings, it was assumed that it was 0, 1, 2 for same grade, one grade disparity and two grades 
disparity; respectively.  
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Table 4-10: Inter-rater reliability of Scapular gradings; linear weighted Kappa 
n= Kappa  p value  
30 0.329 0.002 
 
 
4.1.3.1.1 Interpretation 
The linear weighted Kappa results confirm fair agreement (Kappa 0.21 to 0.40) (Viera and Garrett 
2005) for inter-rater reliability of Scapular grading. Therefore the SDT must be applied with caution 
in the main cohort study.  
 
 
4.2 E Structural pathology 
4.2.1 E1. Structural pathology via imaging  
In this prognostic cohort study, structural pathology was assessed as a potential prognostic variable. 
Specifically, diagnostic ultrasound was used to image the rotator cuff tendons and subacromial 
bursa. Full details of how the imaging was performed and the diagnoses determined are provided in 
the method section (page 131). However as a highly operator dependent modality with variable 
levels of agreement in the published literature (Ottenheijm et al. 2010) it was deemed necessary for 
the MS to undergo formal training in diagnostic ultrasound and to undertake an inter-rater reliability 
study.  
 
4.2.1.1 Clinical training in diagnostic ultrasound 
MS is a physiotherapist by clinical training and prior to commencement of the study had no 
diagnostic imaging experience. Through the School of Medicine in Cardiff University a 2 year 
Postgraduate Certificate (PgC) in Medical ultrasound was undertaken as part of the training 
component of his PhD. The training was extensive and included formal assessments of theoretical 
knowledge, image optimisation and sonographic diagnosis (http://www.case-uk.org/; accessed 
24/04/2017). Further details of the course requirements are provided in appendix 4. MS successfully 
completed the PgC (Distinction grade) and is on the voluntary register of Sonographers operated by 
the Society of Radiography (http://www.sor.org/practice/ultrasound/register-sonographers ; 
accessed 24/04/2017).  
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4.2.1.2 Shoulder ultrasound reproducibility study 
For the purposes of the PhD it was essential that the ability of MS to accurately diagnose structural 
pathology was assessed. To do this, comparison with directly observed pathology on arthroscopy 
would have provided a gold standard comparator (Jeyam et al. 2008). However this would lack 
transferability to the target sample because the prognostic cohort study sample was drawn from a 
non-surgical population. Alternatively, comparison could have been undertaken against another 
imaging modality such as MRI (Vahlensieck 2000) but for cost reasons the inclusion of additional MRI 
scanning would have been prohibitive.   
 
A reproducibility study was therefore undertaken comparing scans performed by MS against an 
experienced musculoskeletal ultrasound practitioner, Dr Peter Mullaney (PM). PM has been a 
Consultant Radiologist since 2007 and is a level 3 ultrasound practitioner (The Royal College of 
Radiologists 2012). Scanning was undertaken on a convenience sample of patients referred for 
ultrasound scans of their shoulder in the Radiology department at the University Hospital of Wales 
(UHW). For pragmatic reasons no restriction was placed upon the pathology the patient was 
referred with. Radiology department scanning was performed on a Toshiba Aplio 500 unit (Toshiba 
Medical Europe B.V.) using high frequency linear musculoskeletal probes, depending on body 
habitus.    
 
Potential subjects were sent a patient information sheet (appendix 4) along with their Radiology 
appointment letter. The option to include a particular subject in the study was dependent upon 
clinical service demands during that particular clinical session. Where service demands allowed, MS 
approached potential subjects in the waiting area to answer any questions they had and as 
appropriate took consent using the consent form in appendix 4.  
 
4.2.1.3 Performance of ultrasound scan for reproducibility study 
All shoulder ultrasound scans were based upon the internationally recognised protocol published by 
the European Society of Skeletal Radiology (Beggs et al. 2010; appendix 4) to ensure that each scan 
was performed in a standardised manner. This included all structures around the shoulder and 
reflects routine sonographic practice for the shoulder (Corazza et al. 2015). However for the 
purposes of this study, only those structures directly implicated in the theorised pathological models 
of SIS/RCTendinopathy were compared for sonographic reproducibility. These were cuff tears and 
subacromial bursal involvement along with tendinopathic findings and calcific deposits (Read and 
Perko 1998). 
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Each patient was first scanned by MS who wrote down the sonographic findings, specifically in 
relation to the components of the rotator cuff (Subscapularis, Supraspinatus, Infraspinatus/Teres 
Minor) and the subacromial bursae (Smith et al. 2015). For the sonographic diagnostic criteria, these 
were based upon the clinical practice of PM and the work of McNally (2014). The same patient was 
then immediately scanned by PM who was the senior clinician with overall responsibility for the 
sonographic diagnosis. Differential sonographic diagnoses and proforma for data collection were 
based upon section 1b and section 1c of the ultrasound differential diagnoses and record scan 
findings in appendix 4 (Smith et al. 2015). 
 
4.2.1.4 Analysis and interpretation of ultrasound reproducibility study data 
Findings for each component of the rotator cuff (Subscapularis, Supraspinatus, Infraspinatus/Teres 
Minor) were collapsed to provide a single sonographic diagnosis judgement in relation to the 
presence of each of tendinopathic change, calcific deposits, bursitis, partial and full thickness tears. 
Where one or more components of pathology was identified in the cuff (independent of bursal 
findings) then a ‘cuff pathology’ diagnosis was assigned.  
 
4.2.1.4.1 Demographics of ultrasound inter-rater reliability study subjects 
The ultrasound inter-rater reliability study was undertaken between 21/8/2013 and 21/5/2014 and 
the demographic and clinical data can be seen in appendix 4. The sample comprised 15 male and 20 
female subjects with symptoms on the left side (n=12) compared to the right (n=23). Referral source 
was predominantly via GP (n=30) with two from Rheumatology, two from trauma / fracture clinic 
and one not recorded. The patient reported reason for onset of symptoms was insidious (n=22), 
trauma (n=5), combination of trauma and insidious (n=4), Rheumatoid Arthritis (n=2), overuse (n=1) 
and not recorded (n=1). Data on specific shoulder pathology was not recorded.  
 
 
Table 4-11: Demographics of US inter-rater reliability study subjects 
Variable 
Measure of variability 
Mean SD Minimum Maximum 
Age (years)  54.0 15.9 21.0 82.0 
Chronicity  
(months)  
23.9 38.2 1.0 216.0 
Key: SD = standard deviation 
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The raw data and measures of variability demonstrate that there was wide variation in the age and 
chronicity of the subjects in the ultrasound inter-rater reliability study. This mirrors the non-specific 
nature of the shoulder patients seen in the Radiology department, which were predominantly from 
GP referrals, with a predominance of insidious onset.  
 
4.2.1.4.2 Inter-rater reliability of sonographic diagnosis 
The raw structural pathology data from the ultrasound inter-rater reliability study are shown in 
appendix 4 and the incidence of each diagnostic category per rater is shown in table 1-12: 
 
 
Table 4-12: Incidence of each diagnostic category per rater 
Sonographic 
diagnosis 
Rater = MS Rater = PM 
Finding 
recorded? 
Yes 
n= 
Incidence of pathology 
identified 
n= ;  (% of Finding 
recorded) 
Finding 
recorded? 
Yes 
n= 
Incidence of pathology 
identified 
n= ;  (% of Finding 
recorded) 
Cuff pathology 34 23 (68%) 35 22 (63%) 
Tendinopathy 34 20 (59%) 35 21 (60%) 
Calcific deposits 33 5 (15%) 35 2 (6%) 
Bursitis 33 19 (58%) 19 6 (32%) 
PTT 34 1 (3%) 35 3 (9%) 
FTT 34 4 (12%) 35 3 (9%) 
Key: PTT = Partial Thickness Tear; FTT = Full Thickness Tear  
 
As per the raw data in appendix 4, one or more pairs of data in each sonographic diagnosis category 
was missing which is why although the number of inter-rater reliability subjects was 35, the number 
of recorded sonographic diagnosis pairs was 34 or less in each category.   
 
The data in the above table demonstrate that tendinopathy and bursitis were the most frequently 
assigned individual pathologies by each rater whilst the composite grading of ‘cuff pathology’ had 
the highest overall incidence.   
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Assessment of agreement between MS and PM was performed using Cohen’s Kappa (McHugh 2012) 
where the diagnosis provided by PM was defined as the gold standard. In addition sensitivity and 
specificity values were calculated where sensitivity = true positive / (true positive + false negative) 
and specificity = true negative / (true negative + false positive) (Lalkhen and McCluskey 2008).  
 
 
Table 4-13: Inter-rater reliability of sonographic diagnosis 
Sonographic 
diagnosis 
n= Kappa  
Kappa 
95% C.I. 
p value  
Sensitivity 
(%)  
Specificity 
(%)  
Cuff pathology 34 0.358 0.032 to 
0.647 
0.035 53.8 81.0 
Tendinopathy 34 0.150 -0.174 to 
0.481 
0.382 65.0 50.0 
Calcific 
deposits 
33 0.298 0.000 to 
0.784 
0.016 100.0 87.5 
Bursitis 19 0.503 0.191 to 
0.791 
0.012 100.0 61.5 
PTT 34 0.477 0.000 to 
1.000 
0.001 33.3 100.0 
FTT 34 0.841 0.000 to 
1.000 
0.000 100.0 96.8 
Key: PTT = Partial Thickness Tear; FTT = Full Thickness Tear  
 
The data in the above table demonstrate a non-significant Kappa value for tendinopathy. For the 
sonographic diagnoses of cuff pathology and calcific deposits the Kappa values showed fair 
agreement (Kappa 0.21 to 0.40) (Viera and Garrett 2005) with high specificity for both cuff pathology 
and calcific deposits. Maximum sensitivity was demonstrated for calcific deposits.   
 
For bursitis, agreement was in the moderate range (Kappa 0.41 to 0.60) (Viera and Garrett 2005), 
although as almost half of the data set pairs had no bursal findings recorded by one of the raters, 
caution must be applied when interpreting the Kappa value (Adejumo 2005). Maximum sensitivity 
was demonstrated but lower specificity.   
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For PTT and FTT an almost complete data set was available with Kappa in the moderate range 
(Kappa 0.41 to 0.60) and almost perfect agreement range (0.81 to 0.99) (Viera and Garrett 2005); 
respectively. For PTT the low sensitivity indicates that MS’s ability to identify PTT tears that were 
present was low. However the ability to correctly exclude pathology was absolute. With FTT MS’s 
ability to identify PTT tears that were present was perfect and the ability to correctly exclude 
pathology was very high. However the low incidence of PTT (n=3) and FTT (n=3) in the Inter-rater 
reliability sample means that such values must be viewed with caution.  
 
Based upon the Kappa values it can therefore be concluded that when compared to an experienced 
musculoskeletal radiologist, MS demonstrated acceptable agreement for all categories except for 
the sonographic diagnosis of tendinopathy.  
 
4.3 Treatment 
4.3.1 Development of treatment recording tool 
One potential approach to recording the nature of the clinician-directed intervention received by 
patients was for MS to transcribe from the treatment notes onto a standardised form. However, this 
risked potential incorrect interpretation of clinician notes and subsequent errors with recording the 
treatment.  
 
Instead, a bespoke treatment-recording tool was developed in collaboration with the treating 
clinicians. The preliminary version in appendix 4 was developed by MS following identification of 
common categories of treatment from the literature. However feedback from the treating clinicians 
identified the following problems: 
 Some of the gross categories had more emphasis, e.g. three entries for exercise therapy, two 
for stretching and one for the other categories. This carried a potential risk for biasing 
clinicians in the modalities they delivered.  
 Recording the time spent on the modality during treatment session was considered to be 
too time consuming for clinicians to complete and prone to error in estimating. 
 The option for all modalities to be given as a home exercise programme was of limited 
relevance for some options, e.g. manual therapy, electrotherapy and taping.  
 
Following feedback the final version in appendix 4 was developed. The cover page provided a brief 
context for the study and emphasised the non-judgmental, anonymous nature of the treatment data 
collection and analysis. 
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Key elements of the final version were: 
 Use of circling pre-completed boxes so as to make it more user friendly and quicker.  
 Similar categories used as in the preliminary version but with an equal weighting for each 
type.  
 Prompts given to encompass the main sub-elements and use of highlighting to differentiate 
the different exercise therapy elements.  
 Separate section for home exercise programme. 
 An ‘Additional details’ section to capture any modalities not included on the form. 
 
All methods by which the cohort study was undertaken will be detailed in the following Methods 
chapter.  
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5 METHODS 
This chapter presents the methods by which the prospective cohort study was undertaken. This will 
comprise the study design, ethical approval and aspects of the pathology, patient care pathway, 
clinical setting and sample size. The procedures by which the patient sample was identified and 
recruited will be presented followed by each of the potential prognostic factors and how they were 
measured. The method by which the pragmatic treatment was captured will be explained along with 
the defining and measurement of the outcome. The prognostic variable trimming approach will then 
be presented along with the prognostic data analysis approach. Aligning with the STROBE statement 
(http://www.strobe-statement.org. ; accessed 25th January 2018) regarding the reporting of 
observational studies, these map to the sections of this chapter as per the below table.  
 
Table 5-1: Alignment of methods chapter with components of STROBE 
Component of STROBE Section in methods chapter 
Study design 5.1 Study design 
Setting 5.3.3 Patient care pathway and clinical setting 
Participants 5.3.1 Clinical presentation of SIS/RCTendinopathy 
5.4 Identification and recruitment of patient sample 
Variables 5.5 Potential prognostic factors and how they were measured 
5.6 Treatment / intervention 
5.7 How outcome is defined and measured 
Data sources/ 
measurement 
5.5 Potential prognostic factors and how they were measured 
5.6 Treatment / intervention 
5.7 How outcome is defined and measured 
Bias 5.7 How outcome is defined and measured 
Study size 5.3.4 Sample size 
Quantitative variables 5.8 Prognostic variable trimming approach 
Statistical methods 5.9 Prognostic data analysis approach 
 
 
 
5.1 Study design 
This was a prospective cohort study investigating potential prognostic factors in patients with 
SIS/RCTendinopathy undergoing physiotherapy with outcome defined by change in a functional 
outcome score (OSS).  
 
The potential prognostic factors will be selected across a range of categories as presented in the 
literature review (A. to E2.). Treatment was pragmatic but was not included within the prognostic 
model as only baseline potential prognostic factors were considered. Blinding of MS to the OSS was 
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ensured by placing each outcome score in a sealed envelope and retaining it thus until all other 
variables were processed and analysed.  
 
5.2 Ethical approval 
Ethical approval for the study was via an amendment to a pre-existing umbrella ethical approval 
(REC reference: 10/MRE09/28) and NHS R&D approval was secured under C&V UHB reference: 
12/OAE54/48. 
 
5.3 Pathology, patient care pathway and clinical setting 
Subjects were required to have a clinical diagnosis of SIS/RCTendinopathy and been referred for 
outpatient physiotherapy in C&V UHB. No restrictions were placed upon the clinical source of the 
referral.    
 
5.3.1 Clinical presentation of SIS/RCTendinopathy 
As noted previously the commonly used clinical tests for SIS/RCTendinopathy have poor sensitivity 
or specificity (Calis et al. 2000). Furthermore, there is controversy as to the signs and symptoms of 
SIS/RCTendinopathy (Lewis 2009). Due to the poorly differentiated nature of the pathology, patients 
were identified via a process of elimination of pathologies discrete from SIS/RCTendinopathy. This 
was supplemented by the treating clinician identifying any subject who was subsequently found to 
have a non-SIS/RCTendinopathy pathology.  
 
5.3.2 Inclusion and exclusion criteria 
 
Table 5-2: Inclusion and exclusion criteria 
Inclusion criteria for SIS/RCTendinopathy 
sample 
Exclusion criteria for SIS/RCTendinopathy sample 
 18 years of age or older 
 Referred for out-patient physiotherapy 
in C&V UHB 
 Ability to provide informed, written 
consent 
 Clinical presentation of local shoulder 
pain: 
 Shoulder surgery on the involved side in the 
previous year 
 Trauma leading to a sudden onset of 
symptoms within the last 4 weeks 
 Referred following a fracture of the shoulder 
girdle or upper limb 
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o Pain in the GHJ region or 
proximal segments of the arm 
o Reproduction or worsening of 
symptoms upon use of the arm.  
 Reproduction of shoulder symptoms from the 
cervical spine 
 Rheumatoid arthritis or similar inflammatory 
joint disorder  
 Imaging confirmed massive rotator cuff tear 
 Clinical presentation of shoulder pathology 
discrete from SIS/RCTendinopathy; 
specifically: 
o Shoulder instability 
o Adhesive capsulitis 
o ACJ pain 
o Radiologically confirmed osteo-
arthritis 
 Multi-area symptoms 
  
Patients were excluded if they were referred following shoulder surgery because the study was 
concerned with identifying the characteristics of those patients who are treated conservatively (i.e. 
with physiotherapy) as oppose to a composite of surgery and post-operative non-invasive, 
multimodal physiotherapy.  
 
Trauma leading to a sudden onset of symptoms was an exclusion criterion, as this was considered 
potentially indicative of a massive rotator cuff tear (Turman et al. 2010). However an exclusion 
timescale was capped at it occurring within the last 4 weeks. This was applied so that where trauma 
was an incidental or contributing factor to the development of overuse / impingement related 
symptoms then such patients could still be included in the study.   
 
Patients were excluded if they were referred following a fracture of the shoulder girdle or upper 
limb because the study was concerned with the soft-tissue pathology of SIS/RCTendinopathy as 
oppose to bony fractures. Whilst it is acknowledged that SIS/RCTendinopathy could still be present 
in a patient with a recent fracture there are differences in clinical management and treatment 
timescales for post-fracture patients (Rangan et al. 2015).  
 
Where the cervical spine was identified as the source of the symptoms experienced in the shoulder 
then such patients were excluded as this was considered to be discrete from SIS/RCTendinopathy 
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(Gorski and Schwartz 2003). However, patients with concomitant cervical spine symptoms were not 
excluded. Similarly, where a systemic pathology such as rheumatoid arthritis was identified as the 
source of the symptoms experienced in the shoulder then such patients were excluded as this was 
considered to be discrete from SIS/RCTendinopathy (Smith et al. 2005). Imaging confirmed massive 
rotator cuff tears were excluded as conceptually this was deemed a substantial progression from the 
target population of SIS/RCTendinopathy with a discrete conservative management approach 
(Ainsworth 2009).  
 
Patients were excluded if they were referred following shoulder subluxation or dislocation because 
the study was concerned with the overuse / impingement related pathology of SIS/RCTendinopathy. 
Evident disruption of the GHJ was considered a separate clinical entity with clear differences in 
clinical management and treatment timescales (Hayes et al. 2002).   
 
Adhesive capsulitis was defined as being a substantial restriction in shoulder range of movement 
(particularly external rotation) with or without the presence of shoulder pain (Struyf and Meeus 
2014). Although there is uncertainty as to its aetiology and a degree of overlap is noted with 
SIS/RCTendinopathy, it can be regarded as being a separate clinical entity from SIS/RCTendinopathy 
(Zuckerman and Rokito 2011).  
 
An isolated ACJ problem was defined as instability of the ACJ following trauma and/or pain locally 
reproduced at the ACJ (Armstrong 2014). Severe osteoarthritis confirmed radiographically typically 
presents from the 6th decade onwards with associated restricted ROM and pain (Armstrong 2014). 
 
Patients were excluded if the referral included multiple anatomical regions of musculoskeletal 
symptoms because for service delivery reasons the shoulder-specific treatment for such patients 
would inevitably need to be balanced with the treatment for the other anatomical regions. This 
could lead to skewing of the treatment duration and total number of appointments data for such 
patients. 
 
Where baseline function (as measured by the primary outcome measure of OSS) was within the 
minimally clinically important change (MCIC) of 5 (Ekeberg et al. 2010b) of maximum then such 
patients were excluded from the final analysis because conceptually no ‘improvement’ could occur. 
However as MS was blinded to the OSS scores, this exclusion criteria could not be applied until all 
data collection was completed.  
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5.3.3 Patient care pathway and clinical setting 
The inclusion criterion of patients being referred for out-patient physiotherapy in C&V UHB meant 
that they were recruited at the same place within the SIS/RCTendinopathy care pathway, namely 
upon referral to secondary care based physiotherapy. However as no restriction was placed upon 
who or how patients were referred in, the specific component of the patient management pathway 
this represented (i.e. following consultation and/or treatment by General Practitioner, Orthopaedics, 
Rheumatologist or other speciality) was not pre-defined. However all patients were recruited and 
baseline data collected immediately prior to their first clinical contact. As such, the cohort can be 
considered in a limited capacity to be an inception cohort.  
 
Data collection occurred at two different sites (University Hospital Wales (UHW) and Whitchurch 
hospital (WHI)) which were a major, regional centre and a district general hospital type (DGH) 
setting; respectively. This was to address the potential limitation of data collection only occurring at 
a specific type of setting, thereby limiting transferability of the findings.  
 
5.3.4 Sample size 
As noted in the literature review, sample size calculation procedures are an area of controversy 
within the prognostic literature (Riley et al. 2013). For the purposes of this exploratory prognostic 
study, the guide of 10 cases per variable was employed (Peduzzi et al. 1996). As per the literature 
review structure of potential prognostic factors, 10 variables were identified (across the five 
categories), giving a sample size requirement of 10 x 10 = 100.   
 
5.4 Identification and recruitment of patient sample 
The mechanism by which the patient sample was identified and recruited is described below.  
 
5.4.1 Stage 1: geographical location 
Potential subjects were required to have been referred for outpatient physiotherapy within C&V 
UHB. This is a large out-patient physiotherapy service covering the capital city of Wales, with 2010 
figures showing that over 23,000 musculoskeletal patients were treated across the 7 C&V UHB out-
patient physiotherapy sites (Cardiff & Vale University Health Board 2015a).    
 
In C&V UHB, referrals are received centrally and assigned to specific clinical sites according to the 
geographical area where the patient lives. Two outpatient physiotherapy sites were selected for data 
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collection, thereby forming the first stage of identifying the patient sample as the geographical area 
where a potential subject lived would determine whether or not they would be screened for 
inclusion in the study.  
 
5.4.2 Stage 2: anatomical location of symptoms 
Identification of potential subjects with shoulder problems was performed by MS searching the 
electronic waiting list database. This database was screened on a weekly basis by site (UHW, WHI) 
and anatomical area (Shoulder) and stratified according to time on the waiting list. This allowed MS 
to recruit from the bottom of the waiting list, thereby minimising the delay between initial contact 
with potential subjects and subsequent data collection.   
 
5.4.3 Stage 3: screening of written referral for SIS/RCTendinopathy 
For each shoulder patient who was identified as a potential subject, MS located the scanned 
electronic copy of their referral for outpatient physiotherapy. MS is an experienced musculoskeletal 
physiotherapist with 15 years’ experience and screened each written referral using the previously 
presented inclusion and exclusion criteria.   
 
5.4.4 Invitation of potential subjects to participate in the study 
Once a shoulder pain patient had been identified as a potential subject, MS sent them a study 
invitation pack on behalf of the strategic lead for physiotherapy. The contents of this postal 
invitation are shown in appendix 5 and comprised: 
 Letter outlining the study, inviting the potential subject to participate and directing the 
potential subject to the self-screening form 
 Self-screening form 
 Sealed envelope containing: 
o Patient information sheets  
o Set of baseline questionnaires 
 
5.4.5 Stage 4: decision by potential subject of whether to participate in study and 
subsequent self-screening  
The self-screening form in appendix 5 was adapted with kind permission from one developed by Dr 
Rachel Chester. At the time of the data collection Dr Chester was also undertaking a study of 
prognostic indicators in patients with shoulder pain receiving physiotherapy.  
 
121 
 
The self-screening form enabled those patients who were considering participating in the study to 
self-identify if they were grossly eligible for the study. This involved using lay terminology to convey 
the inclusion and exclusion criteria of the study. Specifically “Is stiffness in your shoulder much more 
of a problem for you than pain in your shoulder?” was used in an attempt to exclude adhesive 
capsulitis by emphasising the stiffness component of the pathology. “Do your shoulder symptoms 
get worse when you move your neck rather than your shoulder in a particular position?” was used in 
an attempt to exclude the cervical spine as the source of the symptoms experienced in the shoulder. 
However it is noted that the effectiveness of the self-screening process was dependent upon the 
potential subjects (who were often lay individuals) correctly interpreting the descriptors. 
 
The above processes meant that potential subjects would not be recruited if they decided that they 
did not want to be involved in the study or self-identified that they were in-eligible for the study. As 
the postal information did not direct such patients to make further contact with MS then it was not 
possible to differentiate the reason for that potential subject not being recruited. Consequently the 
rate of incorrect self-exclusion could not be determined. 
 
5.4.6 Stage 5: telephone screening of potential subject 
Those potential subjects who were happy to participate in the study and self-identified as being 
eligible contacted MS by phone or email. This enabled MS to use his clinical experience to repeat the 
screening process with a refined level of triage. Where a potential subject was identified as being 
eligible, MS provided additional information on the study and answered any questions that the 
subject had. MS also reminded the subject to bring the questionnaires along when they attended 
and to complete them as close to the time of the appointment as possible. This minimised the 
potential for these inherently subjective potential prognostic factors to be biased by clinician 
interaction and also made for an efficient use of the subject’s time on the day of their first 
appointment. 
 
To ensure accurate but anonymous tracking of patients throughout the study, each was assigned a 
patient specific code which comprised their gender (M for male, F for female), the last 4 digits of 
their hospital number (this was prefixed by TM if this was a temporary hospital number) and then h 
(for UHW) and w for WHI. 
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5.4.7 Logistical challenges associated with recruitment and attrition 
As per the letter outlining the study and inviting the potential subject to participate, potential 
subjects who had decided they were happy to participate in the study and had self-identified as 
being eligible were directed to contact the physiotherapy Department to make an appointment.  
 
Baseline data collection had to occur immediately prior to the patient’s first appointment so that (i) 
capture of the potential prognostic factors truly reflected the status of the patient at the 
commencement of physiotherapy and (ii) the potential prognostic factors were not biased by 
patient-clinician interaction, including the assessment process. However the study had to assimilate 
into routine clinical care and this was ultimately determined by clinical service need, which meant 
that clinical service provision procedures and pressures were the ultimate determinants of if – and 
when – data collection could occur.  
 
In order to maximise efficient recruitment to the study MS took a multi-layered approach to 
interacting with both potential subjects and the receptionist staff: 
(i) potential subjects were contacted via text or telephone call as a follow up to the initial invitation 
letter. Up to two texts or voice messages were used before attempting to recruit a potential subject 
was ceased 
and  
(ii) weekly screening of the electronic clinical records for all potential subjects was performed to 
identify if they had been removed from the waiting list due to no contact OR had already been 
assigned a clinical appointment 
and 
(iii) weekly screening of the physiotherapy clinical appointments for each site to identify if a 
potential subject had been booked in for data collection but MS had not been informed. 
 
The time period over which recruitment occurred and the recruitment numbers will be presented in 
the results section.  
 
5.5 Potential prognostic factors and how they were measured 
The mechanisms by which the potential prognostic factors from categories A. to E2. were collected 
will now be presented. For variables A. demographics and B. clinical history, these were collected 
using the patient data collection form shown in appendix 5.  
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5.5.1 A. Demographics 
As noted in the literature review, a wide variety of demographic related variables have been 
considered in previous prognostic studies. For the purposes of this study, data across these variables 
was collected in order to adequately describe the sample. However, in the data reduction section of 
the results chapter the choice of variable to be entered into the prognostic model will be presented.  
 
Generic demographic variables were: 
 Age at time of first appointment, calculated from date of birth. Retained as a continuous 
variable 
 Gender; taken from clinical records 
 Smoking history; patient reported as (i) current, (ii) previous, (iii) never 
 Education level; identified as (i) College / University, (ii) less than 12 years in education 
(Engebretsen et al. 2010) 
 BMI calculated from height and weight recorded at first appointment  
 
Work, recreational or functional task related variables: 
 Currently working; patient reported as (i) full time, (ii) part time, (iii) retired, (iv) full time 
carer, (v) part time carer, (vi) student or unemployed 
 Paid work type; patient reported as (i) not paid working, (ii) professional / managerial / 
office, (iii) manual / semi-manual / unskilled 
 How often carry 10Kg at work; patient reported as (i) seldom / never, (ii) sometimes, (iii) 
extremely / often, (iv) not applicable as not working (Reilingh et al. 2008) 
 How often work above shoulder height; patient reported as (i) seldom / never, (ii) 
sometimes, (iii) extremely / often, (iv) not applicable as not working (Reilingh et al. 2008) 
 Play overhead sports; patient reported as Yes / No 
 
5.5.2 B. Clinical history 
As with the demographic variables, a wide variety of clinical history related variables have been 
considered in previous prognostic studies and these partially informed the collection of such 
variables in the current study.  
 
For the purposes of this study, data across these variables was collected in order to adequately 
describe the sample. However, in the data reduction section of the results chapter the choice of 
variable to be entered into the prognostic model will be presented.  
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Current condition related variables: 
 Source of referral 
 Duration current episode; patient reported as (i) 0 to <3 months; (ii) 3 to <6 months; (iii) 6 to 
<12 months; (iv) 12 to <24 months; (v) 24 months or longer (Engebretsen et al. 2010) 
 Involvement of dominant side; patient reported as Yes / No 
 Precipitating cause; patient reported as (i) Unknown / insidious / gradual onset; (ii) Injury / 
trauma; (iii) Strain / overuse: unusual activities; (iv) Strain / overuse: usual activities 
 Previous shoulder pain; patient reported as Yes / No 
 Associated neck pain; patient reported as Yes / No 
 Neurological symptoms; patient reported as (i) None; (ii) Pins and needles / tingling; (iii) 
Distal symptoms; (iv) other 
 Course of condition; patient reported as (i) Worse; (ii) Same; (iii) Better 
 
Treatment variables were: 
 Previous rehabilitation; patient reported as (i) None; (ii) Physiotherapy; (iii) Chiropractic; (iv) 
Massage 
 This episode; currently taking analgesia/NSAIDS, patient reported Yes / No  
 This episode; treatment via GP; patient reported as (i) No contact; 2 = Advice only; 3 = oral 
or topical medication (Analgesia / NSAIDs) (+/- advice); 4 = oral medication + injection; 5 = 
injection only; 6 = referral only 
 This episode; patient reported number of GP injections 
 This episode; injection by non GP, patient reported Yes / No 
 This episode; investigations, patient reported (i) None; (ii) U/S; (iii) MRI; (iv) X-ray; (v) U/S 
and X-ray 
 
5.5.3 C1. Patient reported measures: Pain 
As per appendix 5 ‘Order of testing’, patients completed the VAS shown in appendix 5 ‘Visual 
Analogue Scale’ prior to undertaking any physical assessment or testing so as to minimise any 
contamination of this variable by the physical procedures. Pain was assessed at baseline for all 
prognostic cohort study subjects using the 100 mm horizontal line VAS. This was anchored with the 
phrases ‘no pain’ and ‘worst pain imaginable’ (Jensen et al. 1986; Hawker et al. 2011). Written 
instructions as to the context of the measure and how to complete it were provided on the form so 
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as to standardise its completion; MS was present to answer any patient queries. Pain under three 
conditions was recorded: ‘On activity’, ‘At rest’ and ‘At night over the last week’.  
 
‘On activity’ was selected in order to capture the dynamic, functional and movement related 
elements of SIS/RCTendinopathy (Schellingerhout et al. 2008). Patients were directed to consider a 
movement or activity that reproduced their pain as the reference for this pain rating. ‘At rest’ was 
selected in order to capture the pain levels when the arm was not being used, the prompt being “for 
example when you are just resting with your arm by your side”. As with ‘On activity’, for the ‘At rest’ 
score, patients were directed to rate this as a momentary rating rather than one over a period of 
time.   
 
‘At night over the last week’ was selected in order to capture the commonly reported sleep-related 
and night time pain (Factor and Dale 2014). As this was likely to incorporate numerous elements 
such as prolonged periods of non-movement, different sleeping postures and turning in bed then 
patients were directed to rate this over a period of time, i.e. 1 week.   
 
Data processing: VAS readings were recorded for each condition, namely ‘On activity’, ‘At rest’ and 
‘At night over the last week’. A mean score was calculated to provide a fourth pain variable. The 
linear measurement was undertaken by MS and re-checked by a colleague (Steve Hiles; SH) for 
quality control purposes. Where one or more of the individual scores was missing then a mean score 
was not calculated.  
 
5.5.4 C2. Patient reported measures: Psychological symptoms 
As per appendix 5 ‘Order of testing’, the psychological symptoms questionnaire (4DSQ) was posted 
to patients for completion immediately prior to their first appointment.  
 
The 4DSQ (available from www.emgo.nl/researchtools/4DSQ.asp ; appendix 5 ‘4DSQ’) is a self-
contained questionnaire with instructions as to the background to the questionnaire, the timescale 
over which responses should be derived and how to complete it. In addition, MS was available at the 
first appointment to answer any queries that patients had about completing the questionnaire.  
 
At the time of data collection, MS reviewed the scores and where elevated readings were present 
MS encouraged the patient to contact their GP to discuss their psychological well-being. This was 
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separate to the purposes of the research study and was undertaken from the perspective of duty of 
care to the patient.   
 
Data processing: the 4DSQ scores were calculated using the procedures detailed in appendix 5 
‘4DSQ: Scoring and interpretation’ whereby each question relates to a particular subsection 
(Distress, Depression, Anxiety or Somatisation). The responses are scored according to the frequency 
with which the patient reports experiencing those symptoms. Collapsing down the ‘regularly’, ‘often’ 
and ‘very often or constantly’ to the same score means that emphasis is placed on the number of 
symptoms rather than their severity or constancy per se (Terluin et al. 2006). The scores for each 
subsection are then totalled and cut off points used to identify moderately elevated or strongly 
elevated symptoms for that subsection. 
 
For the purposes of this study the originally published cut off points (Terluin et al. 2006) were not 
applied. Instead the adjusted anxiety cut off points subsequently published and advocated by the 
original developers was used. This was based on data from Terluin et al. (2014a) and the higher cut-
off point for anxiety was further adjusted as per (Terluin et al. 2014b) to align with its use in English.  
 
5.5.5 C3. Patient reported measures: Function / Disability 
The Function / Disability questionnaire (SPADI) was posted to patients for completion immediately 
prior to their first appointment. The wording and guidance provided to respondents was 
standardised as per appendix 5 ‘SPADI’, whereby the second page was sent to patients to complete 
and the first page used by MS for data processing.  
 
Data processing: each of the 13 questions is scored out of 10 with 0 being the least and 10 being the 
worst pain or difficulty. The five pain questions give a pain score via the score in points divided by 50 
and multiplied by 100 to give a percentage score. The eight disability questions give a disability score 
via the score in points divided by 80 and multiplied by 100 to give a percentage score. The total 
SPADI score is derived by summing all the scores, dividing by 130 and multiplying by 100 to give a 
percentage score. Guidance is also provided for any missing values although MS was available to 
answer any queries that patients had about completing the questionnaire.  
 
5.5.6 D1. Clinical measures: Strength  
Isometric strength was assessed at baseline for all prognostic cohort study subjects. As with previous 
prognostic studies that used a hand-held dynamometer (Hung et al. 2010; Chester et al. 2016), 
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internal rotation and external rotation were measured. Whilst such studies also measured 
abduction, elevation in the scapular plane was performed in the current study (Hsu et al. 2009).  
 
5.5.6.1 Patient positioning and testing 
All testing was performed with subjects seated as this prevented them from using their body weight 
to generate additional force; it also ensured that subjects were stable during testing. IR and ER 
testing were performed with the arm against the side (i.e. GHJ in 0° flexion and 0° abduction). 
Neutral GHJ rotation was ensured by having the elbow flexed at 90° and the fingers pointing 
forwards (Cools et al. 2014). Forearm pro/supination was standardised by having the palm facing 
upwards. Scaption testing position was standardised by flexing the GHJ to 90° in the scapular plane 
and by having subjects lead with their thumb uppermost (Harrington et al. 2013). For reasons of 
time pressure, testing positions were confirmed visually rather than goniometrically.  
 
5.5.6.2 Testing procedure 
Due to the unfamiliar nature of the isometric testing procedure it was first verbally explained to 
subjects while MS demonstrated the test procedure on himself. For IR and ER the subjects 
performed the physiological movement to familiarise themselves with it. For IR, ER and scaption the 
isometric contraction was then performed with the static nature emphasised but without resistance 
being applied. For IR the verbal cue “keep your elbow tucked into the side and try to move your 
hand across your body” and for ER “keep your elbow tucked into the side and try to move your hand 
away from your body” were used so as to minimise the potential for subjects to attempt to perform 
isometric adduction or abduction; respectively.  
 
Demonstration was performed on the asymptomatic side (where bilateral symptoms were present 
the least symptomatic side was used) and then the symptomatic side so that symptom exacerbation 
due to performance of an unfamiliar test was minimised. Testing was performed in the same order 
of IR then ER then scaption so as to limit pain inhibition affecting the strength readings. This order 
was chosen because clinical experience indicated that symptom exacerbation was likely to be 
greatest with scaption as this closely resembled one of the orthopaedic symptom reproduction test 
positions (Michener et al. 2009; Hegedus et al. 2012). The order of side testing (right then left) was 
the same throughout.  
 
The verbal instructions given to subjects was to push as hard as they could within the limits of their 
pain. Subjects self-determined how hard to push and no attempt was made to quantify the ‘within 
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limits of pain’ instructions (e.g. via a visual analogue score rating) due to the potential for confusion 
if subjects were to be asked to perform the isometric contraction and concurrently rate their pain.  
 
MS took the measures in a stride-standing position with his hand holding the dynamometer in 
contact with his torso. This enabled him to offer maximal, stable resistance to the contraction of the 
subject (Lu et al. 2007). Resistance was applied at the distal ulnar (IR) and distal radius (ER and 
scaption) (see page 413) and three measures recorded (i.e. three trials) for each side at each 
position. The unit recorded the maximal force (Newtons) generated for each trial. The distance from 
elbow to distal radius (IR and ER) and GHJ to distal radius (scaption) was recorded using a tape 
measure so that the force (Newtons) could be converted to a rotational moment (Newton metres).  
 
5.5.6.3 Data processing 
The mean force (Newtons) of the three trials per side at each position was calculated and converted 
to a rotational moment (Newton metres) by multiplying the mean force by the moment arm 
(metres) (Schrama et al. 2014). Even though the protocol included opportunity for the subjects to 
familiarise themselves with the testing procedure, there was still the potential for learning to occur 
and/or symptom exacerbation, either of which had the potential to affect an individual trial. To 
minimise the impact of these factors, the mean of the three trials was selected as the variable of 
interest.  
 
The strength measures in the prognostic cohort study are not presented relative to the dominant 
side but instead relative to the symptomatic side as this is of greater clinical relevance. It is 
acknowledged that the strength intra-rater reliability study data however was presented relative to 
the dominant side. This was deemed a relevant method of analysis because the intra-rater reliability 
study subjects were asymptomatic, i.e. they did not have a symptomatic / asymptomatic side. 
Furthermore, the intra-rater reliability study data (ICC(3,1)) was presented per side as this allowed 
for confirmation that single side measures were robustly recorded.  
 
5.5.7 D2. Clinical measures: ROM  
Active, planar ROM (elevation in the scapular plane, i.e. Scaption) was assessed at baseline for all 
prognostic cohort study subjects.  
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5.5.7.1 Patient positioning and testing 
Scaption ROM was measured with subjects in standing with their knees and hips in a comfortable, 
stable position. Scaption was defined as 30° anterior to the coronal plane (McClure et al. 2006). In 
order to standardise the plane of elevation between subjects, vertical poles were used and a 
template with a 30 degree angle marked on it was used to ensure the vertical poles were at a 30 
degree angle relative to the foot positions. Subjects were instructed to stand on the foot markers 
and elevate their arms bilaterally, keeping their elbows fully extended, thumbs pointed upwards and 
their arms lightly in contact with the vertical bars (McClure et al. 2006).  
 
5.5.7.2 Testing procedure 
Subjects elevated their arms as far as pain allowed, at which point a ROM reading was taken (see 
page 414), defined as ‘limit of ROM’. The contralateral side (for subjects with unilateral symptoms 
this was the non-involved side) was then measured and the subject instructed to return to a neutral 
position. Subjects then performed bilateral elevation again, but this time to inform MS as soon as 
their symptoms started. For those patients with pain at rest they were instructed to inform MS of 
the point in range where their symptoms started to get worse. For all subjects this elevation position 
was recorded and defined as the ‘point of symptom exacerbation by movement’. All measurements 
were taken by the same rater (MS) using a digital inclinometer placed on the mid-point of the lateral 
aspect of the subject’s upper arm, parallel to the humerus (Kolber et al. 2011).  
 
Data processing was as per the pre-methods chapter. However readings were calculated for both 
‘limit of ROM’ (symptomatic side and asymptomatic side) and the ‘point of symptom exacerbation 
by movement’ on the symptomatic side.   
 
5.5.8 D3. Clinical measures: Scapular movement and control measures:   
5.5.8.1 Recording of standardised scapulo-humeral movement  
Subjects were required to expose their scapulae, upper arms and mid/upper back. Female subjects 
retained their brassieres and all subjects were offered a single-use cotton apron to cover their 
anterior chest if preferred. As with the ROM measures, subjects stood to perform scaption.  
 
When performing scaption, subjects looked straight ahead with their elbows extended and their 
thumbs pointing upwards. This was to standardise cervical posture, plane of movement and 
glenohumeral internal and external rotation (Borstad and Ludewig 2002). Speed of movement was 
regulated via a metronome (Puretone Digital Metronome) set at 60 beats per minute (1 per second); 
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4 beats to elevate and 4 to return to resting position i.e. 45 degrees per second. Where subjects had 
less than full range of movement in an arm they were instructed to move that limb at the same 
velocity through their available range. Subjects performed bilateral scaption in order to reduce 
potential compensatory thoracic side flexion (Borstad and Ludewig 2002). Subjects practiced the 
correct plane and velocity of movement with a sufficient rest period provided prior to the data 
collection recording.  
 
A digital video camera (Sony Handycam CMOS) was positioned 2 metres behind the subject and the 
field of view adjusted to capture from waist to above head. It was mounted on a tripod adjusted to 
the vertical height of the subject’s scapulae to ensure a true posterior view with no superior or 
inferior angulation. Recording occurred in a double clinical cubicle with standardised lighting. This 
was ensured by minimising natural light and positioning the subject to ensure symmetrical halogen 
strip lighting was directly above the subject. This allowed subtle shadowing of the scapulae to 
optimise landmark identification.  
 
A piece of paper with the subject’s project code, date and trial type was placed in front of the lens 
when recording commenced so as to ensure both patient anonymity and project-specific 
identification of the recording. Subjects performed four, through range scaption movements and 
then recording was stopped. Subjects were then offered to perform an additional, loaded trial using 
hand-held weights. Patients self-determined whether they were able to perform this, based upon 
pain levels and any symptom exacerbation during the non-loaded trial. Patients also self-determined 
the magnitude of any weight to be used (0.5, 1, 1.5kg), but load symmetry was required.  
 
Subjects who chose to perform a loaded trial practiced the correct plane and velocity of movement 
with a sufficient rest period prior to the data collection recording. Movement performance and 
recording was identical to the non-loaded trial except for the piece of paper placed in front of the 
lens when recording commenced which identified it as a loaded trial. Order of non-loaded versus 
loaded trial was not randomised due to the potential for disruptive symptom exacerbation in 
subjects who could not tolerate a loaded trial.  
 
5.5.8.2 Measurement tools  
The Scapular Dyskinesis test (SDT) (McClure et al. 2009) was used although the original test involved 
bilateral shoulder flexion and abduction holding 1.4kg or 2.3kg weights and subsequent qualitative 
grading. The SDT assessment criteria are recorded in appendix 5.  
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The McClure et al. (2009) ratings involve a judgement across loaded-only trials involving both flexion 
and abduction movements. This contrasts with the current study where a single plane of movement 
was used to make the judgement. However this single composite movement (scaption) was selected 
due to the emphasis on minimising the exacerbation of symptoms that was likely to occur when 
multiple movements were performed. Consequently in the current study there is a fundamental 
deviation from the criteria reported by McClure et al. (2009).  
 
As with the inter-rater reliability study, the analysis of scapular function on the symptomatic side for 
the cohort study was performed on video recordings of patient movement patterns rather than live 
assessment. This had the advantage of limiting within and between-trial variability caused by natural 
variation in patients’ movement patterns.   
 
For each subject the grading of their un-loaded and (if performed) loaded trial was recorded for 
descriptive analysis.  
 
5.5.9 E1. Structural pathology via imaging  
Sonographic evidence of structural pathology was assessed at baseline for all prognostic cohort 
study subjects using the same standardised protocol, differential sonographic diagnoses and 
proforma for data collection as detailed in the pre-methods chapter.  
 
In light of the reproducibility study findings, an additional mechanism was employed with the aim of 
increasing the robustness of the sonographic findings, particularly tendinopathy and bursitis. This 
stemmed from verbal feedback from the experienced musculoskeletal ultrasound practitioner (PM) 
that his judgements on such sonographic diagnoses were often based on experience derived from 
the large number of scans he had previously performed.  
 
To overcome this, MS therefore used a composite approach of (i) performing bilateral scans to 
provide a pseudo comparator and (ii) applied specific criteria relating to the sonographic appearance 
of cuff tendinopathy and bursitis (appendix 5). Whilst formal assessment of the reproducibility of 
this approach was not undertaken, this was deemed a constructive attempt to increase the 
robustness of the sonographic diagnoses in the main cohort (Ingwersen et al. 2016).  
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All scanning was performed on a Philips CX-50 (Koninklijke Philips N.V.) (appendix 5) using a L12-3 
linear array probe with musculoskeletal imaging pre-sets. This portable unit was purchased 
specifically for the cohort data collection with the expert input of PM. It was in part selected due to 
its comparability with the Toshiba Aplio units used in the UHW Radiology department for imaging of 
the shoulder.  
 
As with the ultrasound inter-rater reliability study, findings for each component of the rotator cuff 
were collapsed to provide a single sonographic diagnosis judgement in relation to the presence of 
calcific deposits, tendinopathic change, bursitis, partial and full thickness tears. Where one or more 
components of pathology was identified in the cuff (independent of bursal findings) then a ‘cuff 
pathology’ diagnosis was assigned.  
 
5.5.10 E2. Structural pathology via orthopaedic tests  
Orthopaedic tests were performed by MS in a standardised manner (Hanchard et al. 2013) for all 
subjects at baseline; namely Neer's sign, the Empty can and Hawkins-Kennedy test, painful arc and 
pain on active abduction.   
 
Neer's sign (see page 418) involved MS applying a downward, stabilising force on the subject’s 
scapula whilst simultaneously elevating the arm into full flexion (Michener et al. 2009). Unlike the 
original Neer's sign (Neer 1983) this was performed without a diagnostic injection (Hughes 2011). A 
positive finding was defined as replication or worsening of the subject’s symptoms (Michener et al. 
2009). 
 
The Empty can test (see page 418) involved the subject elevating their arm to 90° flexion in the 
scapular plane. Subjects were then instructed to internally rotate at the GHJ such that their thumb 
pointed to the floor and asked to resist downward pressure applied by MS at the distal ulnar 
(Michener et al. 2009). A positive finding was defined as replication or worsening of the subject’s 
symptoms (Holtby and Razmjou 2004).  
 
The Hawkins-Kennedy test (see page 418) involved MS flexing the shoulder to 90° and internally 
rotating the humerus with gentle overpressure (Park et al. 2005). A positive finding was defined as 
replication or worsening of the subject’s symptoms (Hughes 2011).  
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For a positive painful arc finding to be assigned the subject needed to report replication of their pain 
only between 60° and 120° of active glenohumeral abduction (Kessel and Watson 1977). Pain on 
active abduction was defined as onset or worsening of their pain during or at the end of the 
physiological movement.  
 
5.6 Treatment / intervention 
Although the nature of the intervention was not considered as a potential prognostic factor, it was 
nonetheless necessary to record what treatment was delivered so that comparison with other 
prognostic studies could be meaningfully performed and the clinical transferability established for 
the findings. As treatment was pragmatic and determined by clinical need, the treatment recording 
tool detailed in the pre-methods chapter was used.  
 
A training session was arranged at each clinical site where MS presented the treatment collection 
form to the treating clinicians. In addition, a link clinician was present at each site to provide support 
with any queries. This form included pages printed up to the 8th appointment with the option for 
clinicians to request additional pages if required. The form was inserted into the clinical notes and 
when the patient was discharged, the treatment form was returned to MS. If any missing 
information was identified then the treating clinician was asked to transcribe onto the form the 
relevant missing information.  
 
Data processing: the treatment data was entered onto an excel spreadsheet from which the 
treatment categories delivered per appointment were collated. In addition, details regarding the 
grade of treating clinician and number of weeks from first to last appointment were recorded.  
 
5.7 How outcome is defined and measured  
Outcome was measured using the OSS (Dawson et al. 1996), a validated and reliable, shoulder-
specific self-reported measure of function and pain. The OSS was measured at baseline and at two 
further time points, namely upon discharge from physiotherapy and 3 months post-discharge from 
physiotherapy. Due to the pragmatic nature of the study, no limit was placed upon the treatment 
period or discharge time point; instead these were determined by individual clinical need.  
 
The OSS can be seen in appendix 5 ‘OSS: Questionnaire’ and was posted to patients for completion 
immediately prior to their first appointment. At the first appointment it was placed by MS into a 
sealed envelope and this procedure was repeated for follow up completions of the OSS. Only once 
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all variables within the study had been processed and graded did MS open the OSS envelopes, 
thereby ensuring blinding of MS to the primary outcome measure. The OSS was scored as per 
appendix 5 ‘OSS: Scoring’ whereby scores range from zero to 48 with 48 being the best outcome.  
 
The treating clinician gave each subject their discharge OSS to complete at the end of treatment. 
However where patients failed to attend their last appointment MS posted the OSS with a self-
addressed, stamped envelope for return. This procedure was repeated for the 3-month follow up 
and subjects were prompted to return the OSS if not received by MS.  
 
The OSS MCIC of five (Ekeberg et al. 2010b) was used to calculate whether a patient had improved 
or not at each time point. Specifically an increase in OSS that was greater than or equal to the MCIC 
denoted ‘improved’, an increase in OSS that was less than the MCIC or unchanged or a reduction in 
OSS that was less than the MCIC was denoted ‘same’. A reduction that was greater than or equal to 
the MCIC denoted ‘worsened’. This data provided the opportunity to explore the clinical change over 
the period of treatment and 3 months post completion of treatment.  
 
However as noted in the literature review, outcome defined by a continuous variable retains 
maximal statistical power (Altman and Royston 2006). Therefore a change score was calculated by 
taking the OSS scores at discharge from physiotherapy and OSS scores at 3 months post-discharge 
away from the baseline OSS score for that patient. The dependent variable for the prognostic model 
was therefore a continuous variable reflecting numerical change in OSS from baseline.  
 
5.8 Prognostic variable trimming approach 
The importance of aligning the number of candidate variables with the recruited sample in order to 
avoid over-fitting was previously highlighted. In light of the sample size requirement of 100 and 
identification of five categories comprising a total of 10 variables, a systematic approach to variable 
trimming was required. The following principles were applied: 
 Emphasis on logical, theoretical and statistical procedures for trimming the number of 
candidate variables to align with 10 cases per variable (Peduzzi et al. 1996).  
 Retention of minimum of 1 variable per category 
 Where novel measurement tool or approaches were used (namely the scapular dyskinesis 
test and diagnostic ultrasound) then these variables to be retained for consideration in the 
final regression model.  
In addition: 
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 For prognostic modelling, use of continuous variable to allow for linear regression and 
retention of maximal statistical power (Altman and Royston 2006). 
 
5.8.1 Sequential decision making process 
The approach to trimming the number of candidate variables based upon the principles of logic, 
theoretical and statistical methods (based on Kromer et al. (2014) was as follows: 
  
1. Clinical relevance; a variable was discarded if its clinical relevance was low compared to other 
similar variables 
2. Conceptual relevance: 
a) where a high % of missing data occurred for conceptual rather than measurement error 
reasons; a variable was discarded if for conceptual reasons a large proportion of data were 
likely to be missing which would limit the statistical utility of the variable 
b) Where the incidence of the variable in the cohort was less than 5%; a variable with such low 
incidence was unlikely to contribute to or influence the subsequent regression model.  
c) where multiple variables can be meaningfully collapsed down into a single score; this 
provides a mechanism for reducing the number of candidate variables whilst retaining 
conceptual impact.  
d) where there is high correlation between variables within a category indicating that a single 
measure could be representative; this provides a mechanism for reducing the number of 
candidate variables whilst retaining conceptual and statistical impact  
e) where the above rules are of limited utility but the literature indicates that a particular 
variable is commonly predictive, particularly in relation to alignment with the dependent 
variable in the current study 
 
The above process was performed once the size of the final recruited sample was known and was 
further informed by descriptive and univariate analysis of the data.  
 
5.9 Prognostic data analysis approach 
Once the candidate variables were identified, they were entered into a multivariate stepwise 
regression for each model, namely baseline to discharge; and baseline to 3 months post-discharge. 
SPSS (IBM) version 20 was used. A process of forward selection and backward elimination was 
applied based on entirely statistical methods, whereby for each variable probability of F to enter ≤ 
0.050 and probability of F to remove ≥ 0.100 (Field 2009).  
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In the subsequent, most parsimonious model, R2 values were presented to indicate the amount of 
variation in the change in OSS between the time points explained by each variable and overall model 
(Bowerman and O'Connell 2000). The adjusted R2 value will be reported to indicate how well the 
model generalises from the sample to a population. Analysis of variance (ANOVA) will also be 
performed to test whether the mean or the model is significantly better as a predictor (Bowerman 
and O'Connell 2000).   
 
The multiple regression equation coefficients (β) will be used to identify the direction (+ve or –ve) of 
any relationships between predictor variables and the dependent variable (Miles and Shevlin 2001). 
The significance of the β values will be used to identify the magnitude of the contribution of the 
variable. The p values for the variables not featuring in the final regression models will also be 
stated.  
 
Two fundamental requirements of multiple regression are (a) the dependent variable is continuous 
and (b) there are two or more independent variables, which can be either continuous (i.e. an interval 
or ratio variable) or categorical (i.e. an ordinal or nominal variable) (Bowerman and O'Connell 2000). 
These were met, as per the previous description of the dependent variable (change in OSS score) 
and the number and nature of the potential prognostic variables.  
 
In addition, appropriate tests of the fit of the model and diagnostics will be performed (Miles and 
Shevlin 2001; Field 2009): 
 Independence of observations will be checked using the Durbin-Watson statistic 
 Linearity and homoscedasticity of the residuals will be visually checked by means of a 
scatterplot of the standardised residuals (errors) against the standardised predicted values 
 Absence of collinearity in the data will be checked via the collinearity statistics of the 
Variance inflation factor (VIF) and Tolerance 
 Normal distribution of the residuals will be checked by histogram and PP plots 
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6 RESULTS 
This chapter presents the results pertaining to the prognostic cohort study. The nature of the 
patients recruited to the study will be presented, along with consideration of any statistical 
differences between those who did and did not consent to participate in the study. The baseline 
characteristics of those eligible and consented to the study will then be presented and analysed 
descriptively. The nature of the pragmatic treatment delivered and the clinical outcome as defined 
by the OSS MCIC will then be considered along with descriptive analysis of the OSS change score 
between each of the time points. In light of the data characteristics, the data reduction procedures 
employed for each prognostic variable will be detailed, leading onto an analysis of any difference 
between those lost to follow up and those for whom follow up was data was available. Finally the 
regression analysis for each prognostic model will be presented. 
 
6.1 Flow chart of patient recruitment and follow up 
Between 19/9/2013 and 23/1/2015 patient recruitment and follow up was as follows: 
 
Figure 6-1: Patient recruitment and follow up 
 
 
 
Key: d/c = discharge; f/u = follow up 
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* Excluded via exclusion criteria (n=): 
Post-surgical referral = 5; Trauma leading to a sudden onset of symptoms within the last 4 weeks = 7; 
Imaging confirmed massive tear = 13; Post-fracture = 20; Cervical spine as the source of the 
symptoms = 46; Rheumatoid arthritis = 2; Shoulder instability presentation = 26; Adhesive Capsulitis 
presentation = 49; ACJ as source of symptoms = 13; GHJ osteoarthritis = 18; multi-area symptoms = 
16.  
 
** Not recruited to study because (n=):  
Declined OR had already made appointment when received study invitation OR couldn't attend on 
days when study occurring = 77  
Patient didn’t contact clinical department for treatment and so discharged = 30  
Following contact with patient, they did not match the inclusion criteria: (i) underwent surgery 
between referral and study contact = 2, (ii) symptoms characteristic of cervical referral = 5  
Following contact with patient symptoms had resolved so declined appointment = 2  
 
*** Excluded due to exclusion criteria (n=): 
Baseline function (as measured by the primary outcome measure of OSS) was within the MCIC of 
maximum = 4 
Treating clinician identified recruited subject as having non-SIS/RCTendinopathy pathology = 2 
(adhesive capsulitis), 2 (Cervical spine as the source of the symptoms) 
 
6.2 Sample size 
As per the above flow chart, 215 of the 415 patient referrals screened (stage 3 of identification and 
recruitment of patient sample; methods chapter) were excluded as they met the exclusion criteria. 
Of these, adhesive capsulitis, cervical referral of the symptoms and shoulder instability were the 
most common reasons for exclusion. Of the remaining 200 patients, 116 were not recruited to the 
study. In the majority of cases this was either because of being unable to participate in the study or 
they declined to participate. However a large number of patients did not contact the department for 
their clinical appointment and so were directly discharged from physiotherapy. Eighty-four subjects 
were subsequently recruited to the study. This was less than the 100 subjects stipulated in the 
sample size, but for time pressures reasons, recruitment had to cease in January 2015.  
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6.2.1 Characteristics of those who did and who did not consent to participate in the study 
Differences between the two groups were assessed to look for any systematic bias. As a continuous 
variable, age was found to be non-parametrically distributed and so analysed via the Mann-Whitney 
U test (Altman 1991).   
 
6.2.2 Age  
 
Table 6-1: Age 
 
Variable Mean Standard deviation 
Range (minimum – 
maximum) 
Consented (n=84) 49.6 13.4 18 - 71 
Not Consented (n=116) 51.5 14.7 20 - 83 
 
Table 6-2: Mann-Whitney U result 
 
Mann-Whitney U Wilcoxon W Z Significance 
3886.5 6812.5 - 0.912 0.362 
 
As shown in the above table, there was no statistically significant difference between those that 
consented and those that did not in regard to age.  
 
6.2.3 Gender 
As a dichotomous variable, differences in gender was analysed via the chi-square test (Altman 1991).   
 
Table 6-3: Gender 
 
Variable Male Female 
Consented (n=84) n=35; 41.7% n=49; 58.3% 
Not Consented (n=116) n=63; 54.3% n=53; 45.6% 
 
Chi-square value of 3.117 with p=0.077 indicated no statistically significant difference in gender 
between those that consented and those that did not.  
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6.2.4 Source of referral 
 
Table 6-4: Source of referral 
 
Variable 
Not 
recorded 
GP Orthopaedics Rheumatology Other 
Consented 
(n=84) 
0 n=75; 89.2% n=6; 7.1% n=2; 2.4% n=1; 1.2%* 
Not Consented 
(n=116) 
25 n=86; 94.5%^ n=3; 3.3%^ n=0; 0%^ n=2; 2.2%^** 
Key: ^ = % calculated relative to the total number recorded for that group, * = 1 x Extended nurse practitioner 
via A&E, ** = 2 x GP with specialist interest 
 
In both groups the overwhelming majority of patients were referred by their GP. However the large 
number of patients for whom a referral source was not recorded in those who did not consent 
introduces uncertainty as to how accurate the percentage values are.  
 
Of the remaining 84 subjects, four were subsequently deemed by their treating clinician, during their 
treatment phase, as having non-SIS/RCTendinopathy pathology. Specifically two were deemed to 
have cervical referral of their symptoms and for two the dominant pathology was adhesive 
capsulitis. A further four patients were subsequently excluded because once all data collection was 
completed they were identified as having a baseline OSS of 44 or higher. Specifically their baseline 
OSS were 44 (TM5024h, M0668w) and 48 (M1586h, F8145w). This left n=76 patients as being 
eligible and consented.  
 
6.3 Characteristics of those eligible and consented to the study (n=76)   
6.3.1 A. Demographics 
Raw demographic data for the prognostic cohort at baseline is shown in appendix 6 ‘Demographics’ 
and summarised below.  
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6.3.1.1 Generic demographic variables: continuous data 
 
Table 6-5: Generic demographic variables: continuous data 
 
Variable Mean Standard deviation Range (min – max) 
Age (years) 49.3 13.6 18 - 71 
BMI (kgm-2) 29.0 6.2 17.3 - 50.5 
Key: kgm-2 = mass in kilogrammes divided by height in meters squared 
 
6.3.1.2 Generic demographic variables: categorical data 
 
Table 6-6: Generic demographic variables: categorical data 
 
Variable   
Gender Male: n=31; 40.8% Female: n=45; 59.2% 
Education level Educated to college or university 
level: n=62; 81.6% 
Less than 12 years in education: 
n=14; 18.4% 
 
6.3.1.3 Generic demographic variables: ordinal data 
 
Table 6-7: Generic demographic variables: ordinal data 
 
Smoking history n= % of cohort at baseline 
Current 7 9.2 
Previous 19 25.0 
Never 48 63.2 
Not recorded 2 2.6 
 
The above tables demonstrate a wide range of age and BMI amongst the cohort. They also show a 
greater proportion of females and a very high incidence of college or university level education 
amongst the prognostic study cohort. In addition, the majority of subjects had never smoked and 
less than 10% of the cohort were current smokers.   
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6.3.2 Work, recreational or functional task related variables 
6.3.2.1 Currently working; patient reported 
 
Table 6-8: Currently working; patient reported 
 
Currently working status n= % of cohort at baseline 
Full time 36 47.4 
Part time 13 17.1 
Retired 13 17.1 
Full time carer 2 2.6 
Part time carer 0 0 
Student or unemployed 9 11.8 
Combination 2 2.6 
Not recorded 1 1.3 
 
The above table shows that almost half of subjects were working full time with equal numbers of 
subjects working part-time as retired. The next largest group were not in paid employment as they 
were unemployed or were a student. The two subjects with a combination were both working part-
time and also studying.  
 
6.3.2.2 Paid work type; patient reported 
 
Table 6-9: Paid work type; patient reported 
 
Paid work type n= % of cohort at baseline 
Not paid working 23 30.3 
Professional / managerial / office 42 55.3 
Manual / semi-manual / unskilled 8 10.5 
Combination 2 2.6 
Not recorded 1 1.3 
 
The above table shows that of those patients who were working, the majority reported they worked 
in jobs considered professional, managerial or office based. A much smaller number reported they 
worked in jobs considered manual, semi-manual or unskilled. 
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6.3.2.3 How often carry 10Kg at work; patient reported 
 
Table 6-10: How often carry 10Kg at work; patient reported 
 
How often carry 10Kg at work? n= % of cohort at baseline 
Seldom / never 36 47.4 
Sometimes 13 17.1 
Extremely / often 8 10.5 
Not applicable 19 25.0 
 
The above table shows that almost half of the patients identified as seldom or never carrying 10kg at 
work whilst a smaller number identified as sometimes and only 10% of the cohort identified as 
extremely or often carrying 10kg. The number of ‘not applicable’ subjects in the above table was less 
than the number of subjects who were not in paid working because responses to the question “How 
often carry 10Kg at work?” also applied to those who were carers.  
 
6.3.2.4 How often work above shoulder height; patient reported 
 
Table 6-11: How often work above shoulder height; patient reported 
 
How often work above shoulder height? n= % of cohort at baseline 
Seldom / never 35 46.1 
Sometimes 13 17.1 
Extremely / often 9 11.8 
Not applicable 19 25.0 
 
The above table shows an almost identical distribution of those who self-identified as working above 
shoulder height as those who self-identified as carrying 10kg at work.  
 
6.3.2.5 Play overhead sports? 
Forty-seven subjects (61.8%) reported that they did play overhead sports whilst the remaining 29 
subjects (38.2%) said they did not.  
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6.3.3 B. Clinical history 
Raw clinical history data for the prognostic cohort at baseline is shown in appendix 6 ‘Clinical history’ 
and summarised below.  
 
6.3.3.1 Current condition related variables 
6.3.3.1.1 Source of referral  
 
Table 6-12: Source of referral 
 
GP Orthopaedics Rheumatology Other 
n=69; 90.8% n=5; 6.6% n=1; 1.3% n=1; 1.3%* 
Key: * = Extended nurse practitioner via A&E 
 
As per the above table, the overwhelming majority of patients were referred by their GP. A much 
smaller number came from orthopaedics referrals with only one from each of Rheumatology and 
A&E.  
 
6.3.3.1.2 Duration of current episode 
 
Table 6-13: Duration of current episode 
 
Duration current episode n= % of cohort at baseline 
0 to <3 months 6 7.9 
3 to <6 months 24 31.6 
6 to <12 months 26 34.2 
12 to <24 months 8 10.5 
24 months or longer 12 15.8 
 
The above table shows that the majority of subjects reported that they had experienced symptoms 
from the current episode for between 3 and 12 months although 12 subjects reported symptoms for 
more than 2 years.  
 
  
145 
 
6.3.3.1.3 Current condition related variables: categorical data 
 
Table 6-14: Current condition related variables: categorical data 
 
Variable   
Involvement of 
dominant side* 
Symptomatic side = dominant arm: 
n=35; 46.1% 
Symptomatic side = non-dominant 
arm: n=40; 52.6% 
Previous shoulder 
pain 
Previous shoulder pain: n=15; 19.7% First episode: n=61; 80.3% 
Associated neck 
pain^ 
Associated neck pain: n=21; 27.6% No associated neck pain: n=54; 71.1% 
Key: * = 1 subject was ambidextrous, ^ = not recorded from 1 subject 
 
The above table illustrates that there was a fairly even split between those whose symptomatic side 
was also their dominant arm, versus those for whom it was their non-dominant arm. In the majority 
of cases it was the patient’s first episode of shoulder pain that they were presenting with. For almost 
¾ of subjects they reported no associated neck pain.  
 
6.3.3.1.4 Precipitating cause 
 
Table 6-15: Precipitating cause 
 
Precipitating cause n= % of cohort at baseline 
Unknown / insidious / gradual onset 48 63.2 
Injury / trauma 11 14.5 
Strain / overuse: unusual activities 6 7.9 
Strain / overuse: usual activities 9 11.8 
Combination  1 1.3 
Not recorded  1 1.3 
 
The above table shows that the majority of subjects reported that the precipitating cause of their 
symptoms was unknown or insidious / gradual onset. Injury or trauma was the next most frequently 
identified reason for onset although pooled incidence of strain / overuse was higher. The 
combination was Injury / trauma with Strain / overuse: unusual activities.  
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6.3.3.1.5 Neurological symptoms 
 
Table 6-16: Neurological symptoms 
 
Neurological symptoms n= % of cohort at baseline 
None  48 63.2 
Pins and needles / tingling 15 19.7 
Distal symptoms 9 11.8 
Other 1 1.3 
Not recorded 2 2.6 
 
The above table shows that the majority of subjects reported no neurological symptoms. Pins and 
needles / tingling and distal symptoms accounted for the majority of the remaining subjects with 
one patient reporting ‘cold fingers’.  
 
6.3.3.1.6 Course of condition 
 
Table 6-17: Course of condition 
 
Course of condition n= % of cohort at baseline 
Worse  21 27.6 
Same 40 52.6 
Better 14 18.4 
Not recorded 1 1.3 
 
The above table shows that just over half of subjects reported their symptoms as being static whilst 
more reported their symptoms worsening than improving.  
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6.3.3.2 Treatment related variables 
6.3.3.2.1 Previous rehabilitation 
 
Table 6-18: Previous rehabilitation 
 
Previous rehabilitation n= % of cohort at baseline 
None  58 76.3 
Physiotherapy 14 18.4 
Chiropractic 2 2.6 
Private massage 2 2.6 
 
The above table shows that the majority of subjects reported no previous rehabilitation. Of those 
that had, most received physiotherapy.  
 
6.3.3.2.2 Current condition related variables: categorical data 
 
Table 6-19: Current condition related variables: categorical data 
 
Variable   
Currently taking 
analgesia/NSAIDS* 
Yes: n=26; 34.2% No: n=49; 64.5% 
This episode; number 
of GP injections^ 
1 injection: n=9; 11.8% 2 injections: n=3; 3.9% 
Key: * = not recorded for 1 patient, ^ = 64 subjects did not receive an injection from their GP 
 
Just over a third of patients were currently taking oral medication for their pain. Just over 15% of 
subjects had received an injection via their GP, of whom most had received one injection.  
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6.3.3.2.3 This episode; treatment via GP  
 
Table 6-20: This episode; treatment via GP 
 
This episode; treatment via GP n= % of cohort at baseline 
No contact 3 3.9 
Advice only 2 2.6 
Oral or topical medication (analgesia / NSAIDs) (+/- advice) 27 35.5 
Oral medication + injection 6 7.9 
Injection only 6 7.9 
Referral only 32 42.1 
 
The above table shows that the majority of subjects saw their GP and were either directly referred 
on to physiotherapy or received analgesia / NSAIDs before being referred on. The same number of 
subjects had an injection via their GP as those who received oral medication and an injection. Note 
that the above dataset is for n=76 even though only n=69 were referred to physiotherapy via their 
GP. This was because all except three patients had contact with their GP at some point in the care 
pathway for this current episode.  
 
6.3.3.2.4 This episode; injection by non GP 
Seventy-four subjects (97.4%) reported that they had not received an injection from someone other 
than their GP. Of those that did, in both cases it was an orthopaedic surgeon who had administered 
the shoulder injection. Of these two subjects, one also received two injections via their GP; whilst 
the other subject was simply referred on by their GP.   
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6.3.3.2.5 This episode; investigations  
 
Table 6-21: This episode; investigations 
 
This episode; investigations n= % of cohort at baseline 
None 38 50.0 
U/S only 10 13.2 
MRI only 0 0 
X-ray only 17 22.4 
X-ray + U/S  7 9.2 
Other combination 3 3.9 
Not recorded 1 1.3 
Key: U/S = Ultrasound, MRI = Magnetic resonance imaging 
 
The above table shows that exactly half of subjects had no investigations performed. X-ray only 
followed by ultrasound only and then X-ray + ultrasound were the most undertaken investigations. 
Other combinations were MRI + X-ray (n=2) and ultrasound + MRI + X-ray (n=1).  
 
6.3.4 C1. Patient reported measures: Pain  
Raw pain data for the prognostic cohort at baseline is shown in appendix 6 and summarised below.  
 
Table 6-22: Descriptive analysis of pain data (cm) for the prognostic cohort study subjects 
 
Variable n = 
Measure of variability 
Mean SD Min Max 
‘On activity’ 74 5.9 2.2 0.2 9.1 
‘At rest’ 74 2.0 2.0 0.0 8.7 
‘At night over the last week’ 76 4.4 2.9 0.0 9.4 
Mean of 3 pain scores 74 4.1 1.9 0.5 8.7 
Key: SD = standard deviation, Min = minimum, Max = maximum 
 
The above table shows a higher mean pain reading for ‘On activity’ than ‘At night over the last 
week’, with ‘At rest’ having the lowest mean score. Whilst the SD demonstrate comparable spread 
of data across all 4 variables, greatest absolute variability is seen with the ‘At night over the last 
week’ pain score and greatest variability relative to the mean is seen with the ‘At rest’ pain score. 
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The large range from minimum (0.0 to 0.5 across all 4 variables) to maximum (8.7 to 9.4 across all 4 
variables) again highlights the large variability within the cohort.   
 
The heterogeneous nature of the cohort is highlighted by subjects such as M2747w with high ‘On 
activity’ scores but zero for ‘At rest’ and ‘At night over the last week’; subjects such as M1662h with 
very high pain scores across all parameters; and subjects such as M8695h with very low pain scores 
across all parameters.  
 
6.3.5 C2. Patient reported measures: Psychological symptoms 
Raw 4DSQ data for the prognostic cohort at baseline is shown in appendix 6 and summarised below.  
 
Table 6-23: Descriptive analysis of 4DSQ data for the prognostic cohort study subjects 
 
Variable n = 
Not elevated 
(n= ; % of respondents) 
Moderately elevated 
(n= ; % of respondents) 
Strongly elevated 
(n= ; % of respondents) 
Distress 74 n=56 ; 75.7% n=13 ; 17.6% n=5 ; 6.8% 
Depression 74 n=65 ; 87.8% n=5 ; 6.8% n=4 ; 5.4% 
Anxiety 74 n=63 ; 85.1% n=8 ; 10.8% n=3 ; 4.1% 
Somatisation 74 n=58 ; 78.4% n=15 ; 20.3% n=1 ; 1.4% 
 
4DSQ data was not available for subjects F6847h and M2146h due to non-completion of the 
questionnaire and there being insufficient time for its completion during the face-to-face 
assessment period. This gave 4DSQ cohort data for 74 subjects.   
 
The above table shows that there was a low incidence of ‘strongly elevated’ psychological symptoms 
in the cohort. However ‘moderately elevated’ psychological symptoms were more prevalent, 
particularly those categorised as signifying symptoms of ‘distress’ and ‘somatisation’.   
 
As shown in the raw 4DSQ data (appendix 6 ‘4DSQ: absolute score’) there was wide variation in the 
levels and pattern of psychological symptoms reported. For example, subjects such as F4417h and 
M8305w were classified as being below ‘moderately elevated’ across all categories. Conversely 
subjects such as M7524w were rated as ‘moderately elevated’ in the majority of categories whilst 
other subjects such as F9240h were rated as ‘strongly elevated’ in the majority of categories. Finally 
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some subjects such as M0035w were rated as ‘strongly elevated’ in a single category (distress) but 
below ‘moderately elevated’ across all other categories.  
 
6.3.6 C3. Patient reported measures: Function / Disability 
Raw SPADI data for the prognostic cohort at baseline is shown in appendix 6 and summarised below.  
 
Table 6-24: Descriptive analysis of SPADI data (%) for the prognostic cohort study subjects 
 
Variable n = 
Measure of variability 
Mean SD Min Max 
Total pain score 76 53.3 21.9 6.0 100.0 
Total disability score 76 36.7 23.3 0.0 95.0 
Total SPADI score 76 43.2 21.6 2.3 96.9 
Key: SD = standard deviation, Min = minimum, Max = maximum 
 
The above table shows the total pain score had the highest mean value (53.3%) of the three 
variables with total disability score the lowest mean value (36.7%). The SD for each variable was very 
comparable (21.6% to 23.3%) and reflected a large variation in ‘total score’ data for each variable. In 
relation to the mean, this variability was largest for the total disability score variable.    
  
As shown in the raw SPADI data in appendix 6 there was wide variation in individual scores and 
patterns of response. For example, subjects such as M1662h and F9240h had very high scores across 
all three variables, subjects such as M8695h had very low scores across all three variables and some 
subjects such as F6847h had high total pain scores but much lower total disability scores.  
 
6.3.7 D1. Clinical measures: Strength  
The raw strength data for the prognostic cohort study subjects is shown in appendix 6 and the 
descriptive analysis of the strength variables are shown in the below table.  
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Table 6-25: Descriptive analysis of strength (Nm) data for the prognostic cohort study subjects 
 
Variable n = 
Measure of variability 
Mean SD Min Max 
In
te
rn
al
 
R
o
ta
ti
o
n
 
Symptomatic side 
Mean moment  
75 11.5 8.2 2.1 52.7 
Asymptomatic side 
Mean moment  
75 14.3 8.8 4.8 58.0 
Ex
te
rn
al
 
R
o
ta
ti
o
n
 
Symptomatic side 
Mean moment  
75 10.6 6.7 2.1 35.5 
Asymptomatic side 
Mean moment  
75 13.6 7.1 2.2 36.3 
Sc
ap
ti
o
n
 
Symptomatic side 
Mean moment  
75 11.7 9.9 0.0 60.8 
Asymptomatic side 
Mean moment  
75 17.7 10.7 4.1 57.2 
Key: SD = standard deviation, Min = minimum, Max = maximum 
 
The above table shows that for each contraction type (IR, ER and scaption) the mean moment on the 
symptomatic side was less than on the asymptomatic side and this difference was greatest for 
scaption. Furthermore for each contraction type and side there was substantial variability in the data 
as demonstrated by the large SD values relative to the respective means.  
 
Strength data were available for 75 subjects because of an error with the unit with subject M2279h. 
Subject F4417h had a recorded strength value of zero for scaption on the symptomatic side, as this 
subject was unable to reach the unit’s recording threshold (4.4N) due to pain during the test 
movement. Subject M4091h reported symptoms on the ‘asymptomatic side’ at the time of testing.  
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6.3.8 D2. Clinical measures: ROM  
The raw ROM data for the prognostic cohort study subjects is shown in appendix 6 and the 
descriptive analysis of the ROM variables are shown in the below table.  
 
Table 6-26: Descriptive analysis of ROM (°) data for the prognostic cohort study subjects 
 
Variable n = 
Measure of variability 
Mean SD Min Max 
Symptomatic side 
Limit of ROM  
76 131.2 31.8 59.0 178.0 
Symptomatic side 
Point of symptom exacerbation 
by movement    
66 102.2 29.4 34.0 155.0 
Asymptomatic side 
Limit of ROM    
76 157.7 12.3 110.0 179.0 
Key: SD = standard deviation, Min = minimum, Max = maximum 
 
The above table shows the mean ‘limit of ROM’ on the symptomatic side (131.2°) with a large SD of 
31.8° and range of 59.0° to 178.0°. This reflects a large variation in ‘limit of ROM’ data on the 
symptomatic side in the prognostic cohort.   
  
Compared to the ‘limit of ROM’ data, the table shows the lower mean ‘point of symptom 
exacerbation by movement’ ROM on the symptomatic side (102.2°) with again a large SD of 29.4° 
and range of 34.0° to 155.0°. As with ‘limit of ROM’, this reflects the large variation in ‘point of 
symptom exacerbation by movement’ in the prognostic cohort. However as shown in the raw ROM 
data (appendix 6), 8 subjects reported no symptoms during movement whilst 2 subjects reported 
pain which remained the same throughout the ROM that they performed. As such, no ‘point of 
symptom exacerbation by movement’ ROM data was entered for these subjects. Of the remaining 
66 subjects, 10 reported the ‘point of symptom exacerbation by movement’ to also be their ‘limit of 
ROM’ whilst 56 reported their ‘point of symptom exacerbation by movement’ as being during their 
movement towards their ‘limit of ROM’, i.e. lower in their range than their ‘limit of ROM’. 
 
Unsurprisingly the mean ‘limit of ROM’ on the asymptomatic side (157.7°) was greater than on the 
symptomatic side; and the spread of data (SD = 12.3°) was less than either ROM variable on the 
symptomatic side. However the minimum was 110° and the raw ROM data reveals that 40 subjects 
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had a ‘limit of ROM’ of less than or equal to 160° on their asymptomatic side. This included the two 
subjects (M3288h, M4091h) who reported bilateral symptoms at the time of testing. Of the subjects 
with unilateral symptoms, 50 had a lower ‘limit of ROM’ on the symptomatic side than the 
asymptomatic side. However, 18 subjects with unilateral symptoms had the same ‘limit of ROM’ 
bilaterally whilst six actually demonstrated a higher ‘limit of ROM’ on their symptomatic side 
compared to their asymptomatic side.   
 
6.3.9 D3. Clinical measures: Scapular movement and control  
The raw scapular dyskinesis data (SDT) for the prognostic cohort study subjects is shown in appendix 
6 and the descriptive analysis of the SDT grading variables are shown in the below table.   
 
Table 6-27: Descriptive analysis of SDT data for the prognostic cohort study subjects 
 
Trial type (n= ) 
SDT Grading (n=; %) 
Normal Subtle abnormality Obvious abnormality 
Un-loaded (76) 26; 34% 31; 41% 19; 25% 
Loaded (45) 9; 20% 28; 62% 8; 18% 
 
The above table shows that all subjects completed an un-loaded trial and there was a fairly even 
spread in the grading of normal, subtle and obvious abnormality across the cohort. Thirty-one 
subjects (42% of cohort at baseline) did not perform a loaded trial. Where a loaded trial was 
performed, subtle abnormality was the most commonly applied grading. From the raw scapular 
dyskinesis data it can be seen that 0.5kg was the most commonly used weight (n=32), then 1.0kg 
(n=13) with no subjects using 1.5kg. Of those who performed a loaded trial (n=45) the grading was 
unchanged between the un-loaded and loaded trial in the majority (n=36) of subjects. For seven 
subjects the grading increased by one grade whilst for two subjects it decreased by one grade.     
 
6.3.10 E1. Structural pathology via imaging  
The raw US data for the prognostic cohort study subjects are shown in appendix 6 along with 
examples of how bilateral scanning was used as a mechanism to assist with tendinopathic 
differential diagnoses. Descriptive analysis of the sonographic diagnosis variables are shown in the 
below table. 
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Table 6-28: Descriptive analysis of US data for the prognostic cohort study subjects 
 
Variable n = Yes No 
Cuff pathology 76 n=46 ; 60.5% n=30 ; 39.5% 
Tendinopathy 76 n=44 ; 57.9% n=32 ; 42.1% 
Calcific deposits 76 n=6 ; 7.9% n=70 ; 92.1% 
Bursitis 75 n=38 ; 50.7% n=37 ; 49.3% 
PTT 76 n=2 ; 2.6% n=74 ; 97.4% 
FTT 76 n=3 ; 3.9% n=73 ; 96.1% 
Key: PTT = partial thickness tear; FTT = full thickness tear 
 
The above table shows that approximately half of subjects had sonographic evidence of bursitis and 
almost two-thirds had sonographic evidence of cuff pathology. There was a low incidence of subjects 
with sonographic evidence of calcific deposits (n=6), PTT (n=2) and FTT (n=3). Sonographic evidence 
of tendinopathy was a common finding (n=44).  
 
6.3.11 E2. Structural pathology via orthopaedic tests  
Data on five orthopaedic test findings (Neer's sign, the Empty can and Hawkins-Kennedy test, painful 
arc and pain on active abduction) was collected.  
 
However in relation to the painful arc data, 2 subjects (M9231w and M3960h) reported pain that 
remained the same throughout their range of movement. Furthermore 26 subjects (F4417h, F4583h, 
F2520h, F1005w, F4764h, F0809h, F8774w, F2387h, F8396w, F4674w, M1243h, F8966w, M1662h, 
F4142w, F9240h, F9830h, M2279h, M1543h, F1188h, F5706h, F9261h, M7524w, F3795w, F8809w, 
F6914w and M3960h) did not have the ability to reach 120° of active glenohumeral abduction 
(appendix 6 ‘D2. Clinical measures: ROM’) which was the ROM necessary for a painful arc finding to 
be considered (Kessel and Watson 1977). 
  
In addition, the challenge of patients accurately identifying the point in the range of movement 
where symptom onset began and the range of movement where symptoms ceased was complicated 
by the overlap between symptom onset or worsening and symptoms ceasing or easing. These 
conceptual and measurement issues threatened the robustness of the variable and so the painful arc 
data was not analysed. Consequently, the raw structural pathology via orthopaedic tests data for 
four tests recorded from the prognostic cohort study subjects is shown appendix 6. 
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Table 6-29: Descriptive analysis of orthopaedic test data for the prognostic cohort study subjects 
 
Variable n = +ve -ve 
Hawkins-Kennedy 74 n=50 ; 65.8% n=26 ; 34.2% 
Neer's sign 74 n=59 ; 77.6% n=17 ; 22.4% 
Empty Can 73 n=55 ; 73.3% n=20 ; 26.7% 
Pain on active shoulder elevation 74 n=68 ; 89.5% n=8 ; 10.5% 
 
As can be seen from the above table there was a high incidence of positive test findings ranging from 
66% of the cohort having a positive result with Hawkins-Kennedy test through to 78% for Neer's 
sign. The one subject (F6847h) with no empty can finding was unable to achieve the test position 
due to pain. Only 11% of the cohort did not have pain on active abduction.  
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6.4 Treatment / intervention 
The below table presents the grade of the treating clinician and the treatment delivered to each 
patient per appointment.  
 
Table 6-30: Grade of the treating clinician and the treatment delivered to each patient per 
appointment 
 
P
at
ie
n
t 
co
d
e 
C
lin
ic
ia
n
 
gr
ad
e
 
A
p
p
t 
1
 
A
p
p
t 
2
 
A
p
p
t 
3
 
A
p
p
t 
4
 
A
p
p
t 
5
 
A
p
p
t 
6
 
A
p
p
t 
7
 
A
p
p
t 
8
 
A
p
p
t 
9
 
F6847h 
6 C, G 
 
- - - - - - - - 
F7047h 
7 
A, C, G 
A, B, 
C, G 
A, B, 
C, G 
A, B, 
C, G 
A, C, 
G 
- - - - 
M2146h 
6 
A, C, G 
A, C, 
G 
- - - - - - - 
F5446h 
6 
A, C, G 
A, C, 
G 
A, C, 
G 
A, C, 
G 
A, C, 
G 
A, C, 
G 
C, G A - 
F4417h 
6 A, C, G 
 
C, G C, G C, G F F F F F* 
M0379h 
6 A, B, C, 
F, G 
A, B, 
C, G 
A, B, 
C, G 
A, C, 
G 
C, G - - - - 
F4583h 
6 
A 
A, C, 
E, G 
C, E, 
G 
A, C, 
E, G 
F A 
A, C, 
G 
- - 
F7849h 
6 
A, C, G 
A, C, 
G 
A, C, 
G 
A, C, 
G 
- - - - - 
M0825h 
6 A, B, C, 
G 
A, B, 
C, G 
A, B, 
C, G 
A, C, 
G 
A, G - - - - 
M0061h 
6 
A, B, C 
A, B, 
C, G 
A, B, 
C, G 
A, C, 
G 
A 
A, C, 
G 
A, B, 
C, G 
A, C, 
G 
- 
F2520h 
6 
A, B, C 
A, C, 
G 
A, B, 
C, G 
B, C, 
G 
G - - - - 
F8486h 
7 A, B, C, 
G 
A, B, 
G 
A, B, 
C, G 
B, G 
A, C, 
G 
- - - - 
F1005w 
6 
A, C, G C, G A 
A, C, 
G 
A, C, 
G 
- - - - 
F6416h 
6 A, B, C, 
G 
A, B, 
C, G 
- - - - - - - 
F4764h 
6 A, B, C, 
G 
A, B, 
C, G 
A, C, 
G 
B, C, 
G 
C, G 
A, C, 
G 
- - - 
M4542h 
6 A, B, C, 
G 
A, B, 
C, G 
B, C, 
G 
A, B, 
C, D 
B, C, 
G 
C, G C, G 
A, C, 
G 
A, G 
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M8878h 
6 
A, C, G 
A, B, 
C, G 
C, G A, G - - - - - 
F0165h 
6 
A, C, G 
A, C, 
G 
C, G C, G C, G - - - - 
F5367w 
6 
A, C, G B 
A, B, 
C, G 
A - - - - - 
F7405h 
6 A, B, C, 
G 
B B, G No Rx - - - - - 
M2747w 
7 
A, C, G 
A, C, 
G 
A, C, 
G 
A - - - - - 
F1634w 
6 
A, C, G 
A, C, 
G 
C, G 
C, D, 
G 
A, C, 
G 
A, C, 
G 
C, G A, C - 
F0738w 
6 C, G 
 
- - - - - - - - 
M0035w 
7 A, C, G 
 
C, G - - - - - - - 
F5503w 
6 A, B, C, 
G 
A, C, 
G 
A, C, 
G 
A - - - - - 
M9819h 
8 A, B, C, 
G 
A, B, 
C, G 
- - - - - - - 
M7535w 
6 
A, G 
A, D, 
G 
A, C, 
G 
C, G 
A, C, 
G 
A, C, 
G 
C, G No Rx - 
F0809h 
7 
A, C, G 
A, C, 
G 
A, C, 
G 
A, C, 
G 
- - - - - 
F4113w 
6 
C, G 
B, C, 
G 
C, G 
B, C, 
G 
G C - - - 
F9939h 
7 A, B, C, 
G 
B, C, 
G 
B, G B, G B - - - - 
M5703h 
7 A, B, C, 
G 
B, C, 
G 
A, B, 
C, G 
A, C, 
D, G 
- - - - - 
M1518h 
6 
A, C, G C, G C, G C, G 
A, C, 
G 
C, G C, G - - 
F8774w 
6 A, B, C, 
G 
A, B, 
C, G 
- - - - - - - 
M8695h 
7 
A, C, G 
A, C, 
G 
- - - - - - - 
F7304h 
7 
A, C, G 
A, B, 
C, G 
A, B, 
C, G 
A, B, 
C, G 
- - - - - 
F2387h 
6 
A, C, G 
A, C, 
G 
C, G - - - - - - 
F8396w 
6 A, B, C, 
G 
B, C, 
G 
B, C, 
G 
C, G 
A, C, 
G 
C, G C, G C, G C* 
F4674w 
6 A, B, C, 
G 
A, B, 
C, G 
A, B, 
C, G 
B, C A C, G A, G - - 
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M1243h 
5 
A, B, G G 
A, C, 
G 
B, C, 
G 
A, G - - - - 
M2593 
6 
A, C, G 
A, C, 
G 
- - - - - - - 
M3288h 
6 
A, C, G 
B, C, 
G 
- - - - - - - 
M0519h 
6 A, C, G 
 
A, C - - - - - - - 
M2608w 
6 
A, C, G 
A, C, 
G 
A, C, 
G 
A, C, 
G 
C, G 
C, D, 
G 
- - - 
F8966w 
6 
A, C, G C, G C, G 
A, C, 
G 
A, C, 
G 
- - - - 
F4943h 
7 
A, C, G 
  A, 
C, G 
  A, 
C, G 
- - - - - - 
F5204w 
6 A, B, C, 
G 
C, G C, G C, G C, G C, G - - - 
M1662h 
7 A, C, G 
 
- - - - - - - - 
M5465w 
6 A, B, C, 
G 
C, G A - - - - - - 
M8305w 
6 
A, C, G 
A, B, 
C, G 
B, C, 
G 
B, C, 
G 
B, C, 
G 
B, C, 
G 
C, G 
B, C, 
G 
B, C, 
G* 
F0732w 
7 
A, C, G 
A, B, 
C, G 
B, C, 
G 
C, G C, G - - - - 
F2122w 
6 A, C, G 
 
C, G - - - - - - - 
M2028w 
7 n/r 
 
- - - - - - - - 
F4142w 
6 
A, C, G 
B, C, 
G 
  A, 
C, G 
C, G 
  A, 
C, G 
B, C, 
G 
A, B, 
C, G 
- - 
F9240h 
6 
A, F 
A, C, 
F, G 
  A, 
C, G 
A, B, 
C, G 
A, B, 
C, G 
A, G A, G A - 
F2537h 
5 
A, C, G 
A, C, 
G 
  A, 
C, G 
G - - - - - 
F4735h 
5 
Ax only A 
A, C, 
F, G 
  A, 
C, G 
  A, 
C, G 
- - - - 
F1965w 
7 A, C, G 
 
- - - - - - - - 
M6858w 
6 A, C, G 
 
- - - - - - - - 
F9830h 
6 
A, C, G 
A, B, 
G 
- - - - - - - 
M2279h 
6 A, B, C, 
G 
B, C, 
G 
B, C, 
G 
B, G No Rx - - - - 
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M1543h 
6 A, B, C, 
G 
B, C, 
G 
No Rx - - - - - - 
F1188h 
7 A, C, G 
 
- - - - - - - - 
M4091h 
5 
A, G 
A, C, 
G 
A, C, 
G 
A, C, 
G 
- - - - - 
F5706h 
7 
A, C, G 
B, C, 
G 
A, C, 
D, G 
B, C, 
G 
A, B, 
C, F, G 
A, C, 
G 
A - - 
F1669h 
6 
A, C, G 
A, C, 
G 
A - - - - - - 
F9261h 
6 
A, C, G C, G 
A, B, 
C, G 
B, C, 
G 
C, G 
A, C, 
G 
- - - 
M7524w 
6 
A, C, G 
A, C, 
G 
C, G - - - - - - 
F3795w 
6 A, B, C, 
G 
A, C, 
G 
C, G C, G 
B, C, 
G 
C, G C, G C, G C, G+ 
M9231w 
6 
Ax only 
A, C, 
G 
A, C, 
G 
A, C, 
G 
A, C, 
G 
C, G 
A, C, 
G 
- - 
F5690h 
6 A, B, C 
 
C C, G No Rx - - - - - 
M3609h 
5 A, G 
 
- - - - - - - - 
F8809w 
6 
A, C, G 
B, C, 
G 
A, B, 
C, G 
A, B, 
C, G 
- - - - - 
F6914w 
6 
A, C, G C, G C, G 
B, C, 
G 
B - - - - 
M3960h 
6 
A, C, G 
A, B, 
C, G 
A, C, 
G 
A, C, 
G 
- - - - - 
M9287h 
7 A, B, C, 
G 
B, C, 
G 
- - - - - - - 
F2197w 
5 
A, C, G 
A, C, 
F, G 
C - - - - - - 
Key: Appt = appointment, Ax only = Assessment only, No Rx = No treatment delivered in appointment 
For treatment categories: 
A = Education and advice 
B = Manual therapy 
C = Exercise therapy 
D = Taping 
E = Electrotherapy 
F = Other treatment 
G = Home exercise programme 
 
F4417h; F* denotes 1 further hydrotherapy treatment session and then a further appointment to review and 
discharge 
F8396w; C* denotes 1 further appointment but no treatment delivered in the last appointment 
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M8305w; G* denotes 1 further appointment where home exercise programme was emphasised 
M2028w; n/r denotes not recorded. Patient sustained a cerebral vascular accident independent to treatment 
but during the treatment phase. Treatment notes were not available for inputting.  
F3795w; G+ denotes 4 further appointments comprising A, C, G; C, G; C, G; A 
 
The number of patients treated by each grade of clinician were: n=6 (7.9%) by band 5, n=52 (68.4%) 
by band 6, n=17 (22.4%) by band 7 and n=1 (1.3%) by band 8. Therefore the majority of patients 
were treated by grade 6 and 7 clinicians.  
 
With regards to the treatment delivered in each appointment, there was a predominance of (A) 
education and advice (n=72; 95%), (C) exercise therapy (n=74; 99%) and (G) a home exercise 
programme (HEP) (n=75; 100%). Please note that the percentage of patients is calculated relative to 
the 75 for whom treatment data was available.  Manual therapy was used in the treatment of half 
(n=38) of patients whilst taping (n=6; 8%) and electrotherapy (n=1; 1%) were used on a much smaller 
portion of the sample. For (F) other treatments these were hydrotherapy (F4417h), hot packs 
(M0379h and F9240h), shoulder injection (since physiotherapy treatment commenced) from General 
Practitioner (F4583h and F5706h), cold packs (F4735h) and acupuncture (F2197w).  
 
The raw data for the number of weeks under treatment and discharge situation is seen in appendix 
6. The number of appointments varied widely around a mean of 4.6 and a standard deviation of 2.6. 
Some notable outliers were the seven patients who each only attended one appointment, which 
contrasts with patients such as F4417h, F8396w, M8305w and F3795w who had 11, 10, 10 and 13 
appointments respectively.  
 
The length of time over which treatment occurred also varied widely around a mean of 13 weeks 
and standard deviation of 10 weeks, ranging from zero to 42 weeks. Again, this reflects a high degree 
of heterogeneity within the data and the wide range of treatment circumstances. This included 
patients such as F0738w, M1662h, F1965w, M6858w and F1188h who only attended for their first 
appointment before being discharged from physiotherapy due to failure to attend a subsequent 
appointment. Other patients (F9939h, M5703h, F5690h, and F2197w) attended multiple 
appointments before being discharged from physiotherapy due to failure to attend a subsequent 
appointment.  
 
Typically, those patients with a larger number of appointments were also under treatment for the 
largest period of time. However, notable exceptions are F0732w who attended 5 times over a 32-
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week period and F2197w who only attended 3 times over the same time period. Again this reflects 
the wide variation in treatment circumstances and clinical management.  
 
The majority of patients at discharge (n=57; 75%) had completed physiotherapy treatment and were 
subsequently discharged. However 13 patients (17%) did not attend (DNA) or were unable to attend 
(UTA) and were subsequently discharged from physiotherapy. Five patients (7%) were transferred to 
the care of a different speciality which was orthopaedics for surgery consultation (M9231w and 
F6914w), injection via orthopaedics (F6847h) or GP (M1543h) and specialist psychological treatment 
(F1634w). One patient (M2028w) did not complete treatment for medical reasons unrelated to the 
shoulder.  
 
6.5 Outcome 
6.5.1 Descriptive analysis for OSS at each time point 
Loss to follow up meant that 73 and 62 patients were available for discharge and 3 months post 
discharge follow up; respectively. This represented a 96.1% and 81.6% retention rate at the 2 follow 
up time points relative to those eligible and consented (n=76).  
 
The raw data for the patient reported outcome (OSS) at each time point are shown in appendix 6 
‘Outcome measure’ and summarised below. 
 
Table 6-31: Descriptive analysis of OSS score for the prognostic cohort study subjects 
 
Variable n = 
Measure of variability 
Mean SD Min Max 
Baseline 76 31.6 7.7 8 43 
Discharge 73 39.7 8.0 10 48 
3 months post-discharge 62 41.0 8.3 14 48 
Key: SD = standard deviation, Min = minimum, Max = maximum 
 
The above table illustrates that at baseline, mean OSS was lower than at discharge or at 3 months 
post-discharge. Absolute variability in the data was largely similar at each time point.  
 
6.5.2 Clinical outcome defined by OSS MCIC 
The data for the categorised change in patient reported outcome (OSS) between each time point are 
shown in appendix 6 ‘Outcome measure’ and summarised below.  
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Table 6-32: Categorised change using OSS MCIC from baseline 
 
Categorised 
change 
Baseline to d/c 
(Total n=73) 
Baseline to 3 months post d/c 
(Total n=62) 
‘Improved’ n=51; 69.9% n=47; 75.8% 
‘Same’ n=18; 24.7% n=12; 15.8% 
‘Worse’ n=4; 5.4% n=3; 3.9% 
Key: d/c = discharge 
 
The above table demonstrates that the largest proportion of subjects were ‘improved’ from baseline 
at both the discharge and 3 months post discharge time points. A very small proportion of subjects 
worsened between the same time points with the remaining subjects unchanged.  
 
Discharge OSS data were unavailable for M2028w, F2197w and M9819h. This was because M2028w 
did not complete treatment for medical reasons (stroke) unrelated to the shoulder, whilst the other 
subjects did not return their discharge OSS forms. Three months post-discharge data were 
unavailable for M2146h, F1634w, F9939h, M5703h, F2387h, F0732w, M6858w, F1188h, F1669h, 
F5690h and M3609h as these subjects did not return their 3 months post-discharge OSS forms. 
  
Any systematic differences between those available for follow up at discharge and at 3 months post 
discharge compared to those lost to follow up will be explored. In order that a focused analysis is 
undertaken, this will only be performed once the variables to be considered for the final prognostic 
models have been identified.  
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Table 6-33: Categorised change using OSS MCIC from baseline to discharge to 3 month post-
discharge 
 
Categorised change from Baseline to Discharge to 3 month follow up 
Number (%) 
(Total n=62) 
1a = ‘Improvement’ from baseline to discharge and ‘Improvement’ maintained at 3 
month f/u 
n=34 (54.8%) 
1b = ‘Improvement’ from baseline to discharge and further ‘Improvement’ from 
discharge to 3 month f/u 
n=4 (6.5%) 
1c = ‘Improvement’ from baseline to discharge; ‘worsening’ (according to MCIC) from 
discharge to 3 month f/u, but 3 month f/u level still ‘Improved’ relative to baseline 
n=1 (1.6%) 
2a = ‘Same’ from baseline at any time point  n=5 (8.1%) 
2a* = ‘Same’ from baseline at any time point; note baseline level meant that maximum 
OSS score required to demonstrate ‘Improvement’  
n=1 (1.6%) 
2b = ‘Worse’ from baseline to discharge and ‘Worse’ compared to baseline maintained 
at 3 month f/u  
n=3 (4.8%) 
2c = At discharge was ‘worse’ compared to baseline; at 3 month f/u was within MCIC of 
baseline 
n=1 (1.6%) 
3 = ‘Same’ at discharge but at 3 month f/u had ‘Improved’ from baseline  n=8 (12.9%) 
4 = ‘Improved’ from baseline to discharge but within MCIC of baseline (i.e. Same 
relative to baseline) at 3 month f/u 
n=5 (8.1%) 
 
The above table demonstrates a complex pattern of change across the three time points. The largest 
proportion of subjects improved from baseline to discharge and maintained this relative to baseline 
at 3 months post-discharge. The next largest group were those who were the same at discharge but 
at 3 months post-discharge had improved from baseline. The remaining subjects were fairly evenly 
split amongst the other permutations.  
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Figure 6-2: Representation of change in OSS over time for each subject 
 
The above graph highlights the highly variable nature of the individual changes in OSS over time. A 
small number of very low and dramatic worsening of OSS scores after baseline can be seen. However 
the majority of subjects improve from baseline to discharge and/or 3 months post discharge.  
 
6.5.3 OSS change score as dependent variables for prognostic modelling 
The data for the numerical change score derived from the patient reported outcome (OSS) between 
baseline and each follow up time point is shown in appendix 6 ‘Outcome measure’ and summarised 
below.  
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Table 6-34: Descriptive analysis of OSS change score for the prognostic cohort study subjects 
 
Variable n = 
Measure of variability 
Mean SD Min Max 
Change score from baseline to 
discharge 
73 8.3 8.9 -12.0 29.0 
Change score from baseline to 3 
months post-discharge 
62 9.8 8.6 -13.0 33.0 
 
Key: SD = standard deviation, Min = minimum, Max = maximum 
 
The above table illustrates that the mean change score at each time point was +ve indicating an 
improvement in pain and function. However the large SD relative to each mean along with the wide 
range of scores demonstrates a large spread of data for each variable.  
 
6.6 Data reduction 
The selection of baseline variables for consideration in the final prognostic model was achieved via 
the prognostic variable trimming approach detailed in the method section.  
  
6.6.1 A. Demographics  
1. Clinical relevance – all of the variables were considered to be potentially clinically relevant 
2. Conceptual relevance: 
a) where a high % of missing data occurs for conceptual rather than measurement error reasons –
this was not applicable 
b) where the incidence of the variable in the cohort was less than 5% – this was not applicable 
c) where multiple variables can be meaningfully collapsed down into a single score – this was not 
applicable 
d) where there is high correlation between variables within a category indicating that a single 
measure would be representative – this was not applicable 
e) where the above rules are of limited utility but the literature indicates that a particular variable 
is commonly predictive, particularly in relation to alignment with the dependent variable in the 
current study.   
Age and gender were the two variables most commonly predictive. However age was selected 
over gender because there is evidence of age predicting change in status (as well as outcome 
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state), thereby aligning more closely with the handling of the outcome variable in the current 
study.  
 
6.6.2 B. Clinical history  
1. Clinical relevance – all of the variables were considered to be potentially clinically relevant 
2. Conceptual relevance: 
a) where a high % of missing data occurs for conceptual rather than measurement error reasons – 
this was not applicable 
b) where the incidence of the variable in the cohort was less than 5% – Treatment related variable: 
injection by non-GP was only 2.6% of the cohort, so this variable was excluded 
c) where multiple variables can be meaningfully collapsed down into a single score – this was not 
applicable 
d) where there is high correlation between variables within a category indicating that a single 
measure would be representative – this was not applicable 
e) where the above rules are of limited utility but the literature indicates that a particular variable 
is commonly predictive, particularly in relation to alignment with the dependent variable in the 
current study.  
Symptom duration was selected because it was overwhelmingly the most commonly identified 
clinical history predictor in the literature, including four studies that found it to be predictive of 
change in status. 
 
6.6.3 C1. Patient reported measures: Pain 
1. Clinical relevance – all of the variables were considered to be potentially clinically relevant 
2. Conceptual relevance: 
a) where a high % of missing data occurs for conceptual rather than measurement error reasons –
data were not available for two subjects for ‘On activity’, ‘At rest’ and the mean, but this was for 
logistical and organisational reasons rather than as threats to the conceptual relevance of the 
variable. It was therefore not appropriate to discard a variable on this basis. 
b) where the incidence of the variable in the cohort was less than 5% – this was not applicable  
c) where multiple variables can be meaningfully collapsed down into a single score – this was 
applicable  
d) where there is high correlation between variables within a category indicating that a single 
measure would be representative – this was applicable 
Combination of c) and d): 
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As a continuous variable, pain as measured by VAS was found to be non-normally distributed (see 
appendix 6; although mean of the three scores was normally distributed). Therefore Spearman's rho 
was used to statistically assess for any relationship between the variables (Altman 1991).  
 
Table 6-35: Correlation between VAS variables 
 
VAS variable On activity At rest At night Mean 
On activity 1 0.346 * 0.640 * 0.821 * 
At rest 0.346 * 1 0.475 * 0.678 * 
At night 0.640 * 0.475 * 1 0.891 * 
Mean 0.821 * 0.678 * 0.891 * 1 
Key: Correlation coefficient r, * = significant correlation at p<0.01 
 
Using Spearman's rho a statistically significant relationship between all variables was demonstrated 
and the correlation coefficients were all positive.  
 
The three highest correlations all involved the mean of the three scores and so this was selected to 
be representative of the category. From a conceptual perspective this was advantageous because it 
encompasses all three aspects of pain presentation relative to the patient.  
 
6.6.4 C2. Patient reported measures: Psychological symptoms 
1. Clinical relevance – the gradings for each patient under the individual categories of Distress, 
Depression, Anxiety, and Somatisation all have inherent clinical relevance 
2. Conceptual relevance: 
a) where a high % of missing data occurs for conceptual rather than measurement error reasons –
data were not available for two subjects but this was for logistical and organisational reasons 
rather than as threats to the conceptual relevance of the variable. It was therefore not 
appropriate to discard a variable on this basis. 
b) where the incidence of the variable in the cohort was less than 5% – incidence of ‘strongly 
elevated’ for anxiety and depression; therefore a mechanism was sought to retain this data.  
c) where multiple variables can be meaningfully collapsed down into a single score – this was 
applicable 
d) where there is a high correlation between variables within a category indicating that a single 
measure would be representative – this was applicable 
Combination of b), c) and d): 
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To provide a quantitative estimate of any correlation between variables, Spearman's rho was run. 
However as Spearman's rho can struggle where there are a number of ties in the data, Kendall’s tau 
was run in parallel (Altman 1991).  
 
Table 6-36: Correlation between 4DSQ variables (Spearman's rho) 
 
4DSQ variable Distress Depression Anxiety Somatisation 
Distress 1 0.688 * 0.555 * 0.475 * 
Depression 0.688 * 1 0.569 * 0.507 * 
Anxiety 0.555 * 0.569 * 1 0.417 * 
Somatisation 0.475 * 0.507 * 0.417 * 1 
Key: Correlation coefficient r, * = significant correlation at p<0.001 
 
 
Table 6-37: Correlation between 4DSQ variables (Kendall’s tau) 
 
4DSQ variable Distress Depression Anxiety Somatisation 
Distress 1 0.673 * 0.544 * 0.461 * 
Depression 0.673 * 1 0.556 * 0.496 * 
Anxiety 0.544 * 0.556 * 1 0.409 * 
Somatisation 0.461 * 0.496 * 0.409 * 1 
Key: Correlation coefficient r, * = significant correlation at p<0.001 
 
Both Spearman's rho and Kendal’s Tau demonstrated statistically significant, consistent relationships 
between each of the categories; and the strength of these was largely comparable. 
 
The collapsing of categories into a single score has been previously used in the shoulder literature to 
present psychological symptom prevalence (Koorevaar et al. 2016). It was therefore deemed 
appropriate to collapse the 4DSQ data for the cohort down into a single binary score such that 
where no categories had an elevated reading the patient was coded as 0, but where patients had 
one or more category with an elevated reading they were coded as 1 for psychological symptoms. 
This data can be seen in appendix 6 ‘4DSQ: dichotomised score’, whereby 49 subjects (64.5%) had no 
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categories with an elevated value, 25 subjects (32.9%) had 1 or more category with an elevated 
reading and 2 subjects (2.6%) had no 4DSQ data.  
 
6.6.5 C3. Patient reported measures: Function / Disability 
1. Clinical relevance – the total SPADI score and the two values (total pain score and total disability 
score) that comprise it all have inherent clinical relevance.  
2. Conceptual relevance: 
a) where a high % of missing data occurs for conceptual rather than measurement error reasons – 
this was not applicable.  
b) where the incidence of the variable in the cohort was less than 5% – this was not applicable.  
c) where multiple variables can be meaningfully collapsed down into a single score – whilst the 
total SPADI score is commonly reported, the component parts of the total score are also 
commonly reported, including in the shoulder prognostic study by Kromer et al. (2014). It was 
therefore not appropriate to discard a variable solely on this basis.  
d) where there is high correlation between variables within a category indicating that a single 
measure would be representative – see below 
 
As continuous variables, total pain score, total disability score and total SPADI score were all found 
to be normally distributed (see appendix 6) and so Pearson's correlation coefficient was therefore 
used to statistically assess for any relationship between the variables (Altman 1991).  
 
Table 6-38: Correlation between SPADI variables 
 
SPADI variable Total pain Total disability Total SPADI 
Total pain 1 0.800 * 0.919 * 
Total disability 0.800 * 1 0.970 * 
Total SPADI 0.919 * 0.970 * 1 
Key: Correlation coefficient r, * = significant correlation at p<0.001 
 
Pearson's correlation coefficient demonstrated statistically significant (p<0.001) relationships with 
high correlation coefficients between each of the variables. The high correlations between total 
SPADI score and the total pain and total disability scores are to be expected as each are the 
component parts of the SPADI score. The high correlation between the component scores and the 
total SPADI score indicate that any single measure could be representative of the category. As it 
incorporates both pain and disability, the total SPADI score was selected.  
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6.6.6 D1. Clinical measures: Strength  
1. Clinical relevance – the mean moment data for IR, ER and Scaption on the asymptomatic side 
were discarded as the asymptomatic measures were deemed of limited relevance to the presenting 
condition and were therefore unlikely to provide meaningful prognostic information.  
2. Conceptual relevance: 
a) where a high % of missing data occurs for conceptual rather than measurement error reasons – 
Missing data were present for subject M2279h across all strength measures but this was due to 
technical issues. The only situation where a reading was not possible was subject F4417h who 
was unable to reach the unit’s recording threshold due to pain during the test movement. 
Although this is a conceptual issue in relation to the ability for a cohort patient to have a 
meaningful data point, the low incidence means that it was not deemed appropriate to exclude 
any variables in the strength category due to this criterion. 
b) where the incidence of the variable in the cohort was less than 5% – this was not applicable.  
c) where multiple variables can be meaningfully collapsed down into a single score – this was not 
applicable.   
d) where there is high correlation between variables within a category indicating that a single 
measure would be representative – see below 
 
As continuous variables, all strength variables were found to be non-normally distributed (see 
appendix 6) and so Spearman's rho was therefore used to statistically assess for any relationship 
between the variables (Altman 1991).  
 
Table 6-39: Correlation between strength variables 
 
Strength variable IR mean moment ER mean moment Scap mean moment 
IR mean moment 1 0.899 * 0.772 * 
ER mean moment 0.899 * 1 0.811 * 
Scap mean moment 0.772 * 0.811 * 1 
Key: Correlation coefficient r, * = significant correlation at p<0.001, Scap = scapular 
 
Pearson's correlation coefficient demonstrated statistically significant (p<0.001) relationships with 
high correlation coefficients between each of the variables.  The highly positive correlations across 
all variables indicated that a single measure could be representative of the category. ER was 
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therefore selected due to its clinical relevance as a representation of the posterior rotator cuff 
function (Reinold et al. 2004) and due to the common prescribing of resisted external rotation 
strengthening exercises in SIS/RCTendinopathy non-invasive, multimodal physiotherapy (Holmgren 
et al. 2012).  
 
6.6.7 D2. Clinical measures: ROM  
1. Clinical relevance – the limit of ROM data for the asymptomatic side were discarded as the 
asymptomatic measures were deemed of limited relevance to the presenting condition and were 
therefore unlikely to provide meaningful prognostic information.  
2. Conceptual relevance: 
a) where a high % of missing data occurs for conceptual rather than measurement error reasons – 
Missing data were present for 10 subjects for the variable of ‘point of symptom exacerbation by 
movement’. The reasons for this were either that the subject experienced no symptoms during 
movement (i.e. ceiling effect) or that their symptoms remained the same throughout the 
movement (i.e. floor effect). These were both clinically meaningful threats to the conceptual 
relevance of the variable of point of symptom exacerbation by movement.  
b) where the incidence of the variable in the cohort was less than 5% – this was not applicable.  
c) where multiple variables can be meaningfully collapsed down into a single score – this was not 
applicable.  
d) where there is a high correlation between variables within a category indicating that a single 
measure would be representative – recognising the potential threat posed by the inclusion of 
the variable of ‘point of symptom exacerbation by movement’, potential association with the 
variable ‘limit of ROM’ was explored.  
 
As a continuous variable, limit of ROM was not normally distributed (see appendix 6) and so 
Spearman's rho was used to statistically assess for any relationship between the variables (Altman 
1991).   
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Table 6-40: Correlation between ROM variables 
 
ROM variable 
Symptomatic side: limit of 
ROM 
Symptomatic side: point of 
symptom exacerbation by 
movement 
Symptomatic side: limit of 
ROM 
1 0.611 * 
Symptomatic side: point of 
symptom exacerbation by 
movement 
0.611 * 1 
Key: Correlation coefficient r, * = significant correlation at p<0.001 
 
Spearman's rho demonstrated a statistically significant (p<0.001) relationship between the two 
variables with a correlation coefficients of 0.611. The positive correlation indicated that either 
measure could be representative of the category. Due to the conceptual issues identified with the 
variable ‘point of symptom exacerbation by movement’, the variable ‘limit of ROM’ was selected as 
the candidate variable for the category of strength.  
 
6.6.8 D3. Clinical measures: Scapular movement and control  
1. Clinical relevance – the gradings from both the un-loaded and loaded trials have inherent clinical 
relevance and so it was therefore not appropriate to discard a variable on this basis.  
2. Conceptual relevance: 
a) where a high % of missing data occurs for conceptual rather than measurement error reasons –
42% of the cohort at baseline had no data for the loaded trial, all because of symptom levels or 
exacerbation from the non-loaded trial. This prevented them from performing the loaded trial. 
Such data is evidence of a threat to the conceptual relevance of using the loaded trial as a 
potential prognostic factor.  
b) where the incidence of the variable in the cohort was less than 5% – this was not applicable.  
c) where multiple variables can be meaningfully collapsed down into a single score – this was not 
applicable.   
d) where there is high correlation between variables within a category indicating that a single 
measure would be representative – see below.  
  
To provide a quantitative estimate of any correlation between variables, Spearman's rho was run. 
However as Spearman's rho can become inaccurate where there are a number of ties in the data, 
Kendall’s tau was run in parallel (Altman 1991).  
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Table 6-41: Correlation between scapular variables (Spearman's rho) 
 
Scapular variable Un-loaded SDT Loaded SDT 
Un-loaded SDT 1 0.257 * 
Loaded SDT 0.257 * 1 
Key: Correlation coefficient r, * = significant correlation at p<0.05 
 
Table 6-42: Correlation between scapular variables (Kendall’s tau) 
 
Scapular variable Un-loaded SDT Loaded SDT 
Un-loaded SDT 1 0.259 * 
Loaded SDT 0.259 * 1 
Key: Correlation coefficient r, * = significant correlation at p<0.05 
 
Both Spearman's rho and Kendal’s Tau demonstrated statistically significant relationships in the 
same direction between each of the categories and that the strength of these was largely 
comparable.  
 
Due to the statistically significant relationship between the un-loaded and loaded data and the large 
percentage of missing data from the loaded variable due to conceptual reasons, it was deemed 
appropriate to use the un-loaded SDT data as the representative variable for the category of 
scapular control and movement.  
 
6.6.9 E1. Structural pathology via imaging  
1. Clinical relevance – Whilst acknowledging the non-definitive link between structural pathology 
and symptoms, each of the sonographic diagnosis categories have inherent potential clinical 
relevance. It was therefore not appropriate to discard a variable on this basis.   
2. Conceptual relevance: 
a) where a high % of missing data occurs for conceptual rather than measurement error reasons – 
this was not applicable.  
b) where the incidence of the variable in the cohort was less than 5% – The sonographic diagnosis 
categories of PTT and FTT had an incidence in the main cohort of 2.6% and 3.9% (respectively). 
Applying the above data reduction rule would mean that such findings would be discarded. 
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However from a conceptual and clinical perspective this would be questionable because from 
the perspective of the conceptual framework around structural pathology such sonographic 
findings could be considered highly relevant. To address this, the following data reduction rule 
was applied: 
c) where multiple variables can be meaningfully collapsed down into a single score – in order to 
retain the low frequency variables and partially address concerns regarding the reproducibility of 
the tendinopathy data, conversion of the imaging data into a composite, ordinal variable was 
performed. This was 0 = no pathology, 1 = one of bursal or cuff pathology, 2 = both bursal and 
cuff pathology.  
 
This new variable was generated from the existing imaging data and can be seen in the last column 
of the sonographic diagnosis data in appendix 6. The frequency of these categories was as follows: 
No grading possible (n=1; 1.3%), no pathology (n=13; 17.1%), one of bursal or cuff pathology (n=38; 
50%), both bursal and cuff pathology (n=24; 31.6%).   
 
6.6.10 E1. Structural pathology via orthopaedic tests  
1. Clinical relevance – The individual findings for Neer's sign, the Empty can and Hawkins-Kennedy 
test and pain on active abduction have inherent clinical relevance. However a battery of tests 
approach is commonly advocated as a mechanism to address the sensitivity/specificity issues of the 
individual tests (Park et al. 2005; Hegedus et al. 2012; Diercks et al. 2014).    
2. Conceptual relevance: 
a) where a high % of missing data occurs for conceptual rather than measurement error reasons – 
no further data reduction applicable.  
b) where the incidence of the variable in the cohort was less than 5% – this was not applicable 
c) where multiple variables can be meaningfully collapsed down into a single score – 
acknowledging the battery of tests approach, a cut off point of 3 or more positive tests 
(Michener et al. 2009) was chosen. This provided a meaningful mechanism for reducing the 
number of potential candidate variables from 4 binary variables (Neer's sign, the Empty can and 
Hawkins-Kennedy test and pain on active abduction) to 1 binary variable (yes/no: 3 or more +ve 
test results).     
 
This new variable was generated from the existing orthopaedic test data and can be seen in the last 
column of the orthopaedic test data in appendix 6. The frequency of this category was 
three or more +ve test results: Yes (n=56; 73.7%), No (n=20; 26.3%), demonstrating that just under 
3/4 of subjects had three or more positive findings. 
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6.7 Tapered data reduction aligned with sample size 
As previously noted, 76 patients were eligible and consented to the study, which was less than the 
sample size of 100. Due to the emphasis on 10 cases per variable (Peduzzi et al. 1996) only seven 
variables were permitted to be entered into the prognostic modelling stage. Using the same 
principles, further variable trimming was undertaken, including the retention of a minimum of one 
variable per category.  
 
6.7.1 Patient reported and clinical measures categories  
In the patient reported measures category there was the potential for a conceptual overlap between 
pain (as measured by mean VAS) and function / disability (as measured by total SPADI score). In 
particular the fact that 5/13 of the total SPADI score is derived from questions specific to pain. As 
mean of the three VAS scores and the total SPADI score were both normally distributed, Pearson's 
correlation coefficient was used to statistically assess for any relationship between the variables 
(Altman 1991). 
 
 
Table 6-43: Correlation between patient reported variables 
 
Patient reported variable Mean of the 3 VAS scores Total SPADI score 
Mean of the 3 VAS scores 1 0.800 * 
Total SPADI score 0.800 * 1 
Key: Correlation coefficient r, * = significant correlation at p<0.001 
 
The results show a statistically significant, strong and positive correlation between VAS Mean and 
SPADI Mean. As total SPADI score also measures elements of disability then it was selected over 
mean of the three VAS scores because total SPADI score is more likely to provide broadly 
representative information due to the disability components of the outcome measure. 
 
Between the patient reported and clinical measures categories there was the potential for overlap 
between the total SPADI score and both strength and ROM. This is because 8/13 of the total SPADI 
score is derived from questions specific to physical function, which is in part a composite of shoulder 
strength and ROM. As neither ER mean moment nor limit of ROM were normally distributed, any 
correlation between them was assessed via Spearman's rho (Altman 1991).  
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Table 6-44: Correlation between patient reported and clinical measure variables 
 
Patient reported variable ER mean moment Total SPADI score 
ER mean moment 1 -0.259 * 
Total SPADI score -0.259 * 1 
Key: Correlation coefficient r, * = significant correlation at p<0.05 
 
Patient reported variable Limit of ROM Total SPADI score 
Limit of ROM 1 -0.505 ** 
Total SPADI score -0.505 ** 1 
Key: Correlation coefficient r, ** = significant correlation at p<0.001 
 
The results show that both ER mean moment and limit of ROM had negative correlations with SPADI 
mean. The inverse relationships are explained by a higher SPADI (i.e. more disability and pain) being 
associated with less ROM and strength (i.e. a lower ROM and strength value). The stronger and more 
statistically significant association between limit of ROM and total SPADI score indicated the greater 
correlation. Therefore limit of ROM was selected as the variable to remove.  
 
6.7.2 Structural pathology category  
In the structural pathology category the decision to retain either Ultrasound or Orthopaedic tests 
was informed by evidence in the published literature of correlation between ultrasound findings and 
orthopaedic tests (Naredo et al. 2002; Micheroli et al, 2015) including superior sensitivity and 
specificity of the former over the later (Iagnocco et al. 2003; Kelly et al. 2010). This evidence 
combined with the novel inclusion of ultrasound as a potential prognostic factor in this area of 
research informed the decision to retain the ultrasound findings in the prognostic model but not the 
orthopaedic test findings.  
 
6.8 Variables to be entered into the prognostic modelling stage  
The seven variables were therefore: 
A. Demographics = Age (continuous variable) 
B. Clinical history = Symptom duration (ordinal variable) 
C. Patient reported measures = Psychological symptoms via 4DSQ (dichotomised variable); Function 
/ Disability via total SPADI score (continuous variable) 
D. Clinical measures = Strength via symptomatic side ER mean moment (continuous variable); 
Scapular movement and control via unloaded SDT (ordinal variable) 
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E. Structural pathology = Ultrasound evidence of pathology (ordinal variable) 
 
Noting the conceptual frameworks presented in the introduction chapter, these map as follows: 
 Patho-anatomical model: 
o Intrinsic factors = E. Structural pathology 
o Extrinsic factors = D. Clinical measures; specifically scapular movement and control 
 Psycho-social model = C. Patient reported measures; specifically 4DSQ 
 ICF classification: 
Functioning and disability: 
o Body function: Mental function = C. Patient reported measures; specifically 4DSQ 
o Body function: Sensory function and Pain = C. Patient reported measures; specifically 
pain (represented by total SPADI score) 
o Body function: Neuromusculoskeletal and movement related functions = D. Clinical 
measures; specifically strength, ROM and scapular movement and control (represented 
by strength and scapular movement and control) 
o Body structure: Structure related to movement = E. Structural pathology 
o Activities and participation = C. Patient reported measures; specifically SPADI 
Contextual factors:  
o Personal factors = A. Demographics; specifically age 
Qualifier: 
o Duration = B. Clinical history; specifically duration 
 
6.9 Differences between those lost to follow up and those where follow up data was 
available 
Having identified the seven variables to be entered into the prognostic modelling stage, the 
potential that those lost to follow up may have skewed the subsequent prognostic models was 
explored. Due to the small numbers lost at discharge (n=3: M2028w, F2197w and M9819h) and 3 
months post-discharge (n=11: M2146h, F1634w, F9939h, M5703h, F2387h, F0732w, M6858w, 
F1188h, F1669h, F5690h, M3609h) it was deemed appropriate to use only descriptive statistics to 
explore any systematic bias for the seven variables and absolute baseline OSS.  
 
Below are the descriptive statistics (relative to the data type and distribution) for each of the seven 
variables and absolute baseline OSS. Appendix 6 contains the variable values for the patients lost to 
follow at each of the two time points.  
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6.9.1 Baseline OSS  
 
Table 6-45: Non-normally distributed; continuous data (OSS) 
 
 Median 25th percentile 75th percentile 
Available for follow up at 
discharge (n=73) 
33 26 37 
Available for follow up at 3 
months post-discharge (n=62) 
33 26 37 
 
As per appendix 6, baseline OSS was found to be non-normally distributed. For those patients not 
available at discharge (n=3; appendix 6), one was at the 75th percentile (M2028w = OSS of 37) and 
one was above the 75th percentile (F2197w = OSS of 42). Therefore those recruited to the study but 
unavailable for the baseline to discharge prognostic model had baseline function (as measured by 
the OSS) at the upper end of those who were available for the baseline to discharge prognostic 
model. However the likelihood of this skewing the data is limited by the small sample number who 
were elevated (n=2).  
 
For those patients not available at 3 months post-discharge (n=14, i.e. those lost at discharge plus 
those lost at 3 months post-discharge; appendix 6), four were above the 75th percentile (OSS of 38, 
39, 40 and 42) but two were well below the 25th percentile (OSS of 19 and 21). Therefore the 
likelihood that baseline function as measured by the OSS for those lost to follow up skewed the data 
is small.  
 
6.9.2 Age  
 
Table 6-46: Non-normally distributed; continuous data (Age / years) 
 
 Median 25th percentile 75th percentile 
Available for follow up at 
discharge (n=73) 
50 43 62 
Available for follow up at 3 
months post-discharge (n=62) 
52 47 62 
 
As per appendix 6, age was found to be non-normally distributed. For those patients not available at 
discharge, two were below the 25th percentile (27 and 29 years old) whilst the other subject was 
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above the median age but within the 75th percentile. Again, with the small sample size the likelihood 
of skewing of the data due to age distribution is small.  
 
For those patients not available at 3 months post-discharge, 1 (66 years) was above the 75th 
percentile but 8 (18, 19, 27, 29, 30, 34, 38 and 40 years) were below the 25th percentile. Therefore, 
there is the potential for a systematic bias whereby a disproportionate number of those unavailable 
for the 3 months post-discharge model were younger patients.  
 
6.9.3 Symptom duration 
 
Table 6-47: Ordinal data (Duration of symptoms) 
 
 0 to <3 
months 
3 to <6 
months 
6 to <12 
months 
12 to <24 
months 
24 months 
or longer 
Available for follow up 
at discharge (n=73) 
5 (6.8%) 23 (31.5%) 26 (35.6%) 7 (9.6%) 12 (16.4%) 
Available for follow up 
at 3 months post-
discharge (n=62) 
5 (8.1%) 22 (35.5%) 20 (32.3%) 6 (9.7%) 9 (14.5%) 
 
For those patients not available at discharge, they were spread between 0 to <3 months, 3 to <6 
months and 12 to <24 months. The broad spread and small sample size make it unlikely that any 
skewing of the sample was present due to the duration of symptoms of those not available for the 
baseline to discharge model.  
 
For those patients not available at 3 months post-discharge, they were spread between 0 to <3 
months (n=1), 3 to <6 months (n=2), 6 to <12 months (n=6), 12 to <24 months (n=2) and 24 months 
or longer (n=3). The broad spread across the categories for this variable makes it unlikely that any 
skewing of the sample occurred due to the duration of symptoms of those not available for the 
baseline to 3 months post-discharge model.  
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6.9.4 Psychological symptoms via 4DSQ 
 
Table 6-48: Dichotomised data (4DSQ) 
 
 No categories with elevated 
psychological symptoms 
1 or more category with elevated 
psychological symptoms 
Available for follow up 
at discharge (n=71) 
46 (64.8%) 25 (35.2%) 
Available for follow up 
at 3 months post-
discharge (n=61) 
41 (67.2%) 20 (32.8%) 
 
For those patients not available at discharge (n=3), all of them were classed as having no categories 
with elevated psychological symptoms. Almost 2/3 of subjects available for follow up at discharge 
were also classed as such and so along with the small sample size this is unlikely to represent a 
systematic bias.  
 
For those patients not available at 3 months post-discharge, n=8/13 (61.5%) were classed as having 
no categories with elevated psychological symptoms which is very comparable to those available for 
follow up at 3 months post-discharge (67.2%). As such, skewing of the sample due to the 
psychological symptoms of those not available for the baseline to 3 months post-discharge model is 
unlikely. 
 
6.9.5 Total SPADI score (%)  
 
Table 6-49: Normally distributed; continuous data (Total SPADI / %) 
 
 Mean 95% CI (lower bound) 95% CI (upper bound) 
Available for follow up at 
discharge (n=73) 
43.5 38.5 48.6 
Available for follow up at 3 
months post-discharge 
(n=62) 
44.4 38.6 50.2 
Key: 95% CI = 95% confidence interval of the mean 
 
As per appendix 6, total SPADI was found to be normally distributed. For those patients not available 
at discharge, one had a total SPADI score (54.6%) that was above the upper 95% CI and 1 had a score 
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(8.5%) much lower than the lower 95% CI. Acknowledging the small sample size then this is unlikely 
to represent a systematic bias.  
 
For those patients not available at 3 months post-discharge, 3 (54.6%, 54.6% and 60.0%) were above 
the upper 95% CI and 6 (8.5%, 14.6%, 16.9%, 27.7%, 35.4%, 36.2%) had a score below the lower 95% 
CI. Along with those patients not available at 3 months post-discharge having a mean of 38.1% this 
provides limited evidence of a systematic bias whereby a disproportionate proportion of those 
unavailable for the 3 months post-discharge model had lower total SPADI scores and so had lower 
pain and disability scores at baseline.  
 
 
6.9.6 Symptomatic side ER mean moment (Nm) 
 
Table 6-50: Non-normally distributed; continuous data (Mean moment / Nm) 
 
 Median 25th percentile 75th percentile 
Available for follow up at 
discharge (n=73) 
8.9 7.0 12.6 
Available for follow up at 3 
months post-discharge (n=62) 
8.9 7.1 12.7 
 
As per appendix 6, Symptomatic side ER mean moment was found to be non-normally distributed. 
For those patients not available at discharge, one was below the 25th percentile (2.2Nm) whilst the 
other subjects were above the 75th percentile (13.0Nm and 18.8Nm). With the small sample size, the 
likelihood of skewing of the data due to strength distribution is small.  
 
For those patients not available at 3 months post-discharge, five were above the 75th percentile and 
five were below the 25th percentile. Although this shows a wide spread of data in those not available 
at 3 months post-discharge, a directional bias is unlikely.  
 
  
183 
 
6.9.7 Scapular movement and control via unloaded SDT  
 
Table 6-51: Ordinal data (SDT) 
 
 Normal Subtle abnormality Obvious abnormality 
Available for follow up 
at discharge (n=73) 
26 (35.6%) 28 (38.4%) 19 (26.0%) 
Available for follow up 
at 3 months post-
discharge (n=62) 
21 (33.9%) 25 (40.3%) 16 (25.8%) 
 
For those patients not available at discharge, all were graded as having subtle abnormalities. Along 
with the small sample size, the mid-grading of all three subjects makes it unlikely that any skewing of 
the sample due to scapular movement and control of those not available for the baseline to 
discharge model.  
 
For those patients not available at 3 months post-discharge they were spread between categories of 
normal (n=5), subtle abnormalities (n=6) and obvious abnormalities (n=3). These largely reflect the 
distribution of those available for follow up at 3 months post-discharge, making it unlikely that any 
skewing of the sample due to the scapular movement and control of those not available for the 
baseline to 3 months post-discharge model.  
 
6.9.8 Ultrasound evidence of pathology 
 
Table 6-52: Ordinal data (U/S) 
 
 
No pathology 
1 of bursal or cuff 
pathology 
Both bursal and cuff 
pathology 
Available for follow up 
at discharge (n=72) 
12 (16.7%) 36 (50%) 24 (33.3%) 
Available for follow up 
at 3 months post-
discharge (n=61) 
11 (18.0%) 29 (47.5%) 21 (34.5%) 
 
For those patients not available at discharge, one had 1 of bursal or cuff pathology and two had no 
pathology. Although this represents slight skewing towards less evidence of pathology on ultrasound 
for those not available compared to those available, the small sample size makes it unlikely to 
represent any systematic bias.  
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For those patients not available at 3 months post-discharge they were spread between categories of 
no pathology (n=4), 1 of bursal or cuff pathology (n=6) and both bursal and cuff pathology (n=4). 
These largely reflect the distribution of those available for follow up at 3 months post-discharge, 
making it unlikely that any skewing of the sample due to the evidence of pathology on ultrasound of 
those not available for the baseline to 3 months post-discharge model.  
 
 
6.10 Regression analysis 
The prognostic data analysis approach detailed in the method section was applied to generate two 
separate models: one for baseline to discharge and one for baseline to 3 months post-discharge.  
 
6.10.1 Regression analysis for baseline to discharge 
6.10.1.1 Components of the regression model for OSS change score from baseline to discharge 
Using the criteria and method previously stipulated, the model where the dependent variable was 
the OSS change score from baseline to discharge comprised total SPADI as block 1 and total SPADI 
combined with Age as block 2: 
 
Table 6-53: significant regression analysis findings for baseline to discharge change in OSS 
 
Variable at 
baseline 
R R2 R2 adjusted F-ratio F significance 
Durbin-
Watson 
Total SPADI  0.301 0.090 0.077 6.653 0.012 
2.228 Total SPADI & 
Age 
0.397 0.157 0.132 6.166 0.004 
 
Variable at 
baseline 
β 
β 
significance 
95% CI: 
Lower 
bound 
95% CI: 
Upper 
bound 
Collinearity 
statistic: 
Tolerance 
Collinearity 
statistic: 
VIF 
Total SPADI  0.301 0.012 0.026 0.203 1.000 1.000 
Total SPADI 
& Age 
0.367 0.002 0.051 0.228 0.938 1.066 
-0.268 0.025 -0.310 -0.021 0.938 1.066 
Key: 95% CI = 95% confidence intervals, VIF = Variance inflation factor  
 
6.10.1.2 Explanation of prognostic model parameters 
The R2 value for block 1 (total SPADI) was 0.090 and for block 2 was 0.157. This indicates that total 
SPADI at baseline accounted for 9% of the variation in OSS change. When combined with Age, they 
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collectively accounted for 15.7% of the variance in OSS change. Therefore entering Age into the 
model in block 2 (total SPADI and Age) accounted for an extra 6.7% of the variance in the OSS scores. 
The adjusted R2 value for block 2 is 0.157 – 0.132 = 0.025 or 2.5% and indicates that deriving the 
model from the population rather than a sample would cause it to account for approx. 2.5% less 
variance in the outcome.   
 
The F-ratio from the ANOVA was statistically significant for both block 1 (p=0.012) and block 2 
(p=0.004) at 6.653 and 6.166; respectively. Both F-ratios are greater than 1 demonstrating that there 
is a significant improvement in the final model predicting outcome, calculated by the ratio of the 
improvement in predicting as a consequence of the model to the residual inaccuracy in the model.  
 
The parameters of the model demonstrated via the coefficients (β) for each predictor that for total 
SPADI it is +ve and Age it is –ve. Consequently, there is a positive relationship between total SPADI 
and change in OSS score meaning that a higher total SPADI (greater pain and disability) was 
associated with a greater improvement in OSS. Conversely, the negative relationship between Age 
and change in OSS score means that greater age was associated with less improvement in OSS. The 
significance values of the coefficients (β) were p=0.002 and p=0.025; respectively. These confirm 
that total SPADI contributed more to the model than Age. The 95% CI’s for each variable are 
relatively narrow and do not cross zero, supporting the assumption that the estimates from the 
model are likely to approximate to the true population values (Field 2009).   
 
Where total SPADI was entered into the model (i.e. block 1) each of the variables not included in the 
first stage of the model have p values of greater than 0.05. Specifically these were symptom 
duration p=0.692, psychological symptoms via 4DSQ p=0.709, Symptomatic side ER mean moment 
p=0.961, Scapular movement and control via unloaded SDT p=0.275 and Ultrasound evidence of 
pathology p=0.192. Conversely, Age was significant with p=0.025 and so was entered into the model 
in the next block.  
 
In the final version of the model (i.e. block 2) the excluded variables had p values greater than 0.05. 
Specifically symptom duration p=0.887, psychological symptoms via 4DSQ p=0.267, Symptomatic 
side ER mean moment p=0.896, Scapular movement and control via unloaded SDT p=0.462 and 
Ultrasound evidence of pathology p=0.403.  
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6.10.1.3 Tests of the fit of the model and diagnostics 
The proximity of the Durbin-Watson value to 2 indicates that the residuals are not correlated (Field 
2009).  
 
 
Figure 6-3: Graph of the standardised residuals (errors) against the standardised predicted values 
 
 
The random distribution of the data in the above graph, with an absence of curve indicates that the 
assumptions of linearity and homoscedasticity have been met (Field 2009). 
 
 
The collinearity statistics (VIF <10; average VIF close to 1, tolerance above 0.2) indicate that there is 
no collinearity in the data (Meyers 2000).  
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Figure 6-4: Histogram of the residuals 
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Figure 6-5: PP plot of the residuals 
 
 
 
The close approximation of the histogram plot to a normal distribution, along with the close 
approximation of the PP plot to the reference line confirm the approximately normal distribution of 
the residuals.  
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6.10.2 Regression analysis for baseline to 3 months post-discharge 
6.10.2.1 Components of the regression model for OSS change score from baseline to 3 months post-
discharge 
Using the criteria and method previously stipulated, only total SPADI was retained in the model 
where the dependent variable was the OSS change score from baseline to 3 months post-discharge.  
 
Table 6-54: significant regression analysis findings for baseline to 3 months post-discharge change 
in OSS 
 
Variable at 
baseline 
R R2 R2 adjusted F-ratio F significance 
Durbin-
Watson 
SPADI mean 0.310 0.096 0.081 6.081 0.017 2.607 
 
Variable at 
baseline 
β 
β 
significance 
95% CI: 
Lower 
bound 
95% CI: 
Upper 
bound 
Collinearity 
statistic: 
Tolerance 
Collinearity 
statistic: 
VIF 
SPADI mean 0.310 0.017 0.020 0.196 1.000 1.000 
Key: 95% CI = 95% confidence intervals, VIF = Variance inflation factor 
 
6.10.2.2 Explanation of prognostic model parameters 
The R2 value for the model was 0.096, which indicates that total SPADI at baseline accounts for 9.6% 
of the variation in OSS change. The adjusted R2 value for the model is 0.096 – 0.081 = 0.015 or 1.5% 
and indicates that deriving the model from the population rather than a sample would cause it to 
account for approximately 1.5% less variance in the outcome.  
 
The F-ratio from the ANOVA was statistically significant for the model (p=0.017) at 6.081. As the F-
ratio is greater than 1 then there is a significant improvement in the final model predicting outcome, 
calculated by the ratio of the improvement in predicting as a consequence of the model to the 
residual inaccuracy in the model. 
 
The parameter of the model demonstrates via the coefficient (β) for the predictor that for total 
SPADI it is +ve. Consequently there is a positive relationship between total SPADI and change in OSS 
score meaning that a higher total SPADI (greater pain and disability) was associated with a greater 
improvement in OSS. The 95% CI’s for the variable are relatively narrow and do not cross zero, 
supporting the assumption that the estimates from the model are likely to approximate to the true 
population values (Field 2009).   
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Where total SPADI was entered into the model, each of the variables not included had p values of 
greater than 0.05. Specifically these were Age p=0.199, symptom duration p=0.483, psychological 
symptoms via 4DSQ p=0.682, Symptomatic side ER mean moment p=0.733, Scapular movement and 
control via unloaded SDT p=0.156 and Ultrasound evidence of pathology p=0.186.  
 
6.10.2.3 Tests of the fit of the model and diagnostics 
The proximity of the Durbin-Watson value to 2 indicates that the residuals are not correlated (Field 
2009).  
Figure 6-6: Graph of the standardised residuals (errors) against the standardised predicted values 
 
 
The random distribution of the data in the above graph, with an absence of curve indicates that the 
assumptions of linearity and homoscedasticity have been met (Field 2009). 
 
The collinearity statistics (VIF <10; average VIF close to 1, tolerance above 0.2) indicate that there is 
no collinearity in the data (Meyers 2000). 
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Figure 6-7: Histogram of the residuals 
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Figure 6-8: PP plot of the residuals 
 
 
 
 
 
The close approximation of the histogram plot to a normal distribution, along with the close 
approximation of the PP plot to the reference line confirm the approximately normal distribution of 
the residuals.  
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6.11 Summary of findings 
In considering the results pertaining to the prognostic cohort study, this chapter presented firstly the 
number of patients contacted for the study, those subsequently recruited to the study and those 
excluded or lost to follow up. As part of this, no statistically significant difference was identified 
between those who did and did not consent to participate in the study.   
 
The baseline characteristics of the 76 subjects eligible and consented to the study were then 
presented. Notable descriptive findings included the high mean BMI, the higher proportion of 
females than males and the predominance of those educated to college or university level and 
undertaking professional, managerial or office based work. In addition, referral by GP was the 
predominant referral route, although there was wide variation in the treatment and imaging 
received prior to referral to physiotherapy. For the majority of subjects they reported this episode of 
shoulder pain as being their first and as being either unknown, insidious or gradual onset.  
 
Descriptive analysis of the other candidate categories was then presented, including the high degree 
of variability within the data, alongside the methodological rationale for excluding the ‘painful arc’ 
variable. Descriptive analysis of the treatment delivered, period under treatment and number of 
appointments was detailed, highlighting a high degree of heterogeneity in the intervention.  
 
Descriptive analysis of the outcome (OSS) was then detailed, including the categorised change using 
OSS MCIC from baseline to discharge, baseline to 3 months post-discharge and the more complex 
pattern from baseline to discharge to 3 months post-discharge. The numerical change in OSS data 
demonstrated a mean improvement in pain and function from baseline to discharge and baseline to 
3 months post-discharge.  
 
The logical, theoretical and statistical procedures for trimming the number of candidate variables to 
align with 10 cases per variable was then presented. This included the requirement to perform 
additional data reduction due to the smaller than intended final sample size. For the seven 
candidate variables, descriptive analysis of any difference in potential prognostic variables between 
those lost to follow up and those available for analysis was performed. This identified that a 
disproportionate number of those unavailable for the 3 months post-discharge model were younger 
patients and had lower total SPADI scores (lower pain and disability) at baseline.  
 
The regression analysis for each prognostic model identified that when considering the change in 
OSS from baseline to discharge, total SPADI and Age were the only two variables that predicted 
194 
 
outcome, collectively accounting for 15.7% of the variance in OSS change. Directionally, a higher 
total SPADI (greater pain and disability) was associated with a greater improvement in OSS, whilst 
greater age was associated with less improvement in OSS. For the change in OSS from baseline to 3 
months post-discharge, only total SPADI was predictive of outcome, accounting for 9.6% of the 
variance in OSS change. Directionally, a higher total SPADI (greater pain and disability) was 
associated with a greater improvement in OSS.  
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7 DISCUSSION 
7.1 Overview 
The aim of this study was to identify baseline factors that predicted outcome in SIS/RCTendinopathy 
patients following treatment with physiotherapy. Following a review of the literature in this area, 
five major categories of potential prognostic variables were identified which spanned three 
conceptual frameworks relating to SIS/RCTendinopathy. Seventy-six patients met the inclusion and 
exclusion criteria and received pragmatic physiotherapy treatment as determined by their treating 
clinician.  
 
Data was available from 73 participants at discharge and 62 at 3 months post discharge. Using a 
sequential decision making process of clinical, conceptual and statistical methods, the number of 
potential candidate variables was aligned with the sample size. Two, multivariate regression models 
were constructed where the dependent variable was change in the OSS from baseline to discharge;  
and baseline to 3 months post-discharge.  
 
The major findings of this study was that total SPADI and age were identified as predictors of 
outcome at discharge and together accounted for 15.7% of the variability in the OSS change score at 
discharge. Regarding the change from baseline to 3 months post discharge, only the total SPADI was 
identified as being a predictor and accounted for 9.6% of the variability in the dependent variable.  
 
In discussing these findings, this chapter is structured such that firstly the methodological decisions 
taken and the non-prognostic findings will be explored. The order of this will mirror that of the 
literature review and will cover the study design and sample through to the prognostic variables 
considered, intervention, outcome and statistical analyses. This will lead onto a discussion of the 
hypotheses accepted and rejected by the current study along with the research and clinical 
implications. Limitations and future areas of research will conclude the chapter.  
 
7.2 Methodological elements 
7.2.1 Nature of the study design  
Linking with the assessment criteria applied for prognostic studies (NHMRC 2000), the current study 
was a prospective cohort study. The use of two different types of hospital setting (Regional centre 
and DGH type setting) and a pragmatic, clinician-led approach to treatment enhance the 
representativeness of the findings in respect to routine practice in the NHS. 
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The use of follow up time periods defined according to the point of actual discharge from 
physiotherapy bring further clinical-relevance to the study findings. In spite of the pragmatic and 
highly variable treatment period, retention rates were above 95% at discharge and above the 
threshold of 80% at 3 months post-discharge. These compare favourably with the published 
literature and mean that the current study sits in the highest category of prospective cohort 
prognostic study grading (Phillips et al. 2016). 
 
Embedding the study within routine clinical practice had multiple research benefits such as 
environmental validity and minimal inconvenience for subjects. However it also brought logistical 
challenges including the necessity to avoid contamination of the data by exposure to therapeutic 
elements and data collection being influenced by pressures on clinical service provision. This second 
aspect likely had a negative impact on the size of the final sample.  
 
The posting of subjective questionnaires to patients prior to their first appointment had the 
advantage of capturing their state prior to any therapeutic intervention, including physiotherapy 
assessment. But despite written requests to only complete these questionnaires close to the time of 
their appointment, uniformity in the time between completing the questionnaires and attending 
could not be guaranteed. Conversely, aspects such as VAS were completed face to face and so 
consistency of timing was assured.  
 
As per the methods chapter, sequencing of the physical testing was performed such that activities 
that might be influenced by pain but were of limited likelihood to exacerbate symptoms were 
undertaken first (i.e. ROM assessment) whilst those that were almost certain to exacerbate 
symptoms such as resisted strength testing and orthopaedic symptom reproduction tests were 
undertaken later. The ultrasound scan was performed last because aside from being able to attain 
optimal imaging positions, the imaging findings were highly unlikely to be influenced by acute 
symptom aggravation. As such, the complete battery of subjective, physical and imaging data was 
collected in a single visit, which immediately preceded the patient’s first physiotherapy assessment. 
It was felt that such an approach minimised likely order effects and balanced scientific rigour with 
the demands of an NHS based study undertaken by a single researcher.  
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7.2.2 Nature of the sample  
7.2.2.1 Sample size and nature of those who did and did not consent 
The target sample size (n=100) was determined by the number of potential prognostic variables and 
the guide of 10 cases per variable (Peduzzi et al. 1996). However due to study time-pressures and 
the post-recruitment exclusion of eight subjects from the study, the final sample size of 76 was 
smaller than intended. Trimming of the number of candidate variables was undertaken to reduce 
the likelihood of over-fitting of the subsequent prognostic model. However this inevitably led to a 
narrower range of variables being considered due to the reduction in statistical power, thereby 
limiting the scope of the study. A larger research team would be one mechanism to help address 
this.  
 
In the context of previously published papers in this area it is noted that the current study had a 
higher number of cases per variable than Hung et al. (2010) with 0.5, Engebretsen et al. (2010) with 
5.5, Mintken et al. (2010) with 6 and Tyler et al. (2010) with 7; and comparable to Bartolozzi et al. 
(1994) and Kennedy et al. (2006) with 10 and Chester et al. (2016) with 11.8. As such, the current 
study is able to provide results that likely can be replicated in a new sample. However it is 
acknowledged that some authors (Concato et al. 1993) advocate the number of cases with a positive 
outcome as the mechanism for defining the number of candidate variables. Were this adhered to 
then using the OSS MCIC, only 5 variables would have been included in the current study as those 
subjects that ‘improved’ were n=51 and n=47 at discharge and 3 months post-discharge 
(respectively). This would have further reduced the number of candidate variables. However given 
the anchoring of this study at the exploratory end of the prognostic framework proposed by Kent et 
al. (2010), the use of the total number of cases per variable was deemed permissible.  
 
No statistically significant difference in age or gender was identified between those who consented 
to the study and those who did not. Furthermore although the large number of those not consented 
for whom referral source was not recorded (n=25) does raise questions as to the robustness of this 
data, the source of recorded referral was very similar in both groups. Such findings indicate that 
systematic bias in the recruitment of subjects was unlikely to be present for the variables 
considered.  
 
7.2.2.2 Pathology (including inclusion and exclusion) 
The current study applied a novel approach to identifying an SIS/RCTendinopathy sample whereby 
clinical presentation suggestive of the target pathology, combined with exclusion of discrete non-
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SIS/RCTendinopathy pathologies, plus the clinical opinion of the subsequent treating clinician was 
used. This reflected the limited utility of orthopaedic tests and the poorly defined nature of the 
pathology in terms of both aetiology and signs and symptoms (Calis et al. 2000; Lewis 2009). As such 
there are some fundamental differences between the sample used in the current study and those 
investigations that either considered a general shoulder pain sample or alternatively identified their 
sample using orthopaedic test findings.  
 
Indeed the use in the current study of a battery of orthopaedic tests with a cut-off point of 3 or more 
positive tests (Michener et al. 2009) as an inclusion criterion would have resulted in exclusion of 20 
subjects (26% of the cohort) who were otherwise deemed eligible and consequently recruited to the 
study. This raises the spectre that a percentage of patients with SIS/RCTendinopathy (as identified by 
clinical presentation and confirmed by subsequent treating clinician assessment) are potentially 
being excluded from research where a battery of orthopaedic tests as an inclusion criterion is used.  
 
In the current study, four patients were subsequently excluded as their treating clinicians identified 
them as having non-SIS/RCTendinopathy pathologies. The diagnoses of adhesive capsulitis as the 
dominant pathology (n=2) and cervical referral of the symptoms (n=2) highlights the limitations of 
the clinical application of inclusion and exclusion criteria at baseline. This poses a fundamental 
question in relation to research in this area, namely how can a sufficiently large sample be efficiently 
identified in a reproducible yet clinically meaningful manner. It is also noted that almost 20% of the 
cohort complained of pins and needles which is surprising given the exclusion of cervical referral of 
symptoms; potential explanation for this includes the presence of local neuropathy.  
 
7.2.2.3 Patient care pathway  
In relation to the patient care pathway, all subjects in the current study were recruited at the same 
clinical referral point, namely referral for physiotherapy in a secondary care setting. Whilst a total of 
seven patients were referred via Orthopaedics, Rheumatology and A&E, the overwhelming majority 
were referred by their GP, reflecting a primary into secondary care bias. The largest single route into 
physiotherapy via GP referral was where no treatment was administered (n=32). However in just 
over half of cases (n=41; 53.9%) their GP had applied one or more treatment approach (advice, oral 
or topical analgesia or NSAIDs, injection) before subsequently referring to physiotherapy. This 
introduces inherent variability into the sample because n=32 subjects had received no treatment, 
whilst n=41 had arguably failed conservative treatment via their GP. It also reflects substantial 
differences in care pathway composition, which reflects uncertainty as to the optimal primary care 
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management approach for SIS/RCTendinopathy, despite the publication of guidelines (Diercks et al. 
2014) in this area.  
 
Of further note is that whilst half of the cohort had no imaging prior to their physiotherapy 
appointment, the remaining 38 subjects had one or more of U/S, X-ray and MRI. Such data reflects 
substantial variation in the use of imaging within the same sample of patients, likely reflecting 
uncertainty as to the merit and timing or sequencing of imaging in this condition. As with the 
approach to primary care management, the imaging data highlights heterogeneity in the 
SIS/RCTendinopathy care pathway. This likely represents substantial inefficiencies in the use of 
clinical resources and a potentially negative contribution to chronicity and patient outcomes. The 
improved defining of care pathways is therefore proposed as a priority area. It would allow for 
subsequent prognostic research to be nested within standardised assessment and treatment routes, 
thereby providing more meaningful information amid a reduction in the inherent background noise 
of current care.  
 
7.2.2.4 Non-prognostic variables: patient demographics and clinical history data  
A large number of variables relating to demographics and clinical history were collected. However, in 
order to provide a focused discussion of the non-prognostic patient demographics and clinical 
history information, only data that might potentially influence the methods or findings in this study 
will be considered here.  
 
7.2.2.4.1 BMI 
The mean BMI (29.0 kgm-2) is at the upper end of the ‘Overweight’ banding (25.0 to 29.9 kgm-2) 
(Viester et al. 2013) and includes a large number of patients in the sample who were clinically obese. 
Alongside evidence of an association between BMI and shoulder pain (Vikari-Juntura et al (2008), 
increased adipose tissue will also inevitably impact upon both scapula-humeral assessment and 
ultrasound imaging. Specifically the reduction in ease of bony landmark observation and attenuation 
of the ultrasound signal (respectively) will impair the collection of accurate data. As both 
measurement tools are already noted for their poor reproducibility then elevated BMI levels are a 
likely additional source of error, thereby limiting the prognostic utility of these variables.  
 
7.2.2.4.2 Gender 
A higher proportion of females (59.2%) than males comprised those who were eligible and 
consented to participate in the study. Reasons for this are unclear but evidence from Kennedy et al. 
200 
 
(2006), Deutscher et al. (2009) and Chester et al. (2016) of female gender consistently predicting 
poorer outcome provides limited evidence that the recruited sample may have been biased towards 
a less favourable outcome and by the reported higher pain sensitivity in this gender (Kindler et al. 
2011; Horn et al. 2014). 
 
7.2.2.4.3 Education level and type of paid work 
Over 80% of those recruited to the study had a college or university education. Although education 
level data were not available for those not recruited to the study, census data 
(http://webarchive.nationalarchives.gov.uk/20160105160709/http://www.ons.gov.uk/ons/rel/cens
us/2011-census-analysis/local-area-analysis-of-qualifications-across-england-and-wales/rpt---local-
area-analysis-of-qualifications-across-england-and-wales.html ; last accessed 17/02/2017) for Wales 
indicated 26.5% of the population as having a degree level or above qualification. Whilst direct 
comparison of these data are limited by methodological and geographical differences, they provided 
limited evidence that those recruited to the study were disproportionately well educated compared 
to the general population.  
 
Potential reasons behind this may include those with a higher level of educational qualification 
having greater awareness of the altruistic benefit of contributing to evidence based-healthcare or 
greater background knowledge leading them to recognise the potential advantage of receiving a 
diagnostic ultrasound scan in parallel to their physiotherapy treatment. Were this second aspect the 
case then the inherent ‘treatment effect’ of receiving a diagnostic scan should be noted as a 
potential confounding factor, thereby limiting transferability of the findings to routine NHS care 
where point of care diagnostic ultrasound scanning is not typically available. Research evidence of 
distrust of medical research among certain groups (Cobb et al. 2014) may also help to explain such 
findings. 
 
In parallel to this, Engebretsen et al. (2010) identified that lower education status (as defined by not 
being educated to college or university level) was predictive of worse pain and disability via absolute 
SPADI score and ‘not working’ status at 12 months post baseline. This might indicate a likely 
outcome advantage for the sample in the current study due to the low incidence of lower education 
status.  
 
Partial triangulation with the education level data comes from the ‘type of paid work’ data whereby 
there was a much higher number in professional, managerial or office based work (n=42) compared 
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to manual, semi-manual or unskilled workers (n=8). Although speculative, this might reflect a 
perception by potential subjects that participation in the study was ominous due to the volume of 
paperwork (invitation letter, self-screening and then envelope of questionnaires) sent when inviting 
patients to participate. In spite of the use of lay language, this could indicate that improved 
accessibility of studies to less educated patient groups is warranted. Another aspect of the 
disproportionate mix of workers relates to the potential that unskilled workers may be more likely to 
have zero hour contracts / an unsecure job, aligning with the participation component / 
environmental factor of the ICF. Whilst evidence of this was not collected as part of the study, 
should this be the case then the higher number in professional, managerial or office based work may 
reflect improved opportunities to attend the NHS for the majority of the sample.  
 
In terms of habitual use of the shoulder, demographic data demonstrated low levels of loaded 
and/or above shoulder height working in the cohort. This might be postulated to lead to low levels 
of loading of tissues within the shoulder, linking with the patho-anatomical model. However this 
would potentially be cancelled out by the evidence that the majority of participants played overhead 
sports. Analysis of demographic data to consider the nature of the sample is therefore advocated in 
future studies so as to identify any bias within the sample and areas for emphasis regarding how 
best to ensure future samples are truly representative. 
 
7.2.2.4.4 Previous shoulder pain 
In the majority of cases (80.3%) it was the patient’s first episode of shoulder pain that they were 
presenting with. In light of the highly recurrent nature of shoulder pain (Luime et al. 2004), it is 
conceivable that this is not representative of the wider shoulder pain and SIS/RCTendinopathy 
population. Potential reasons behind this include those who have recurrent symptoms may not 
present to NHS medical services (as they feel the NHS cannot help them further) or are not referred 
onto physiotherapy (for similar reasons) or have already escalated along the care pathway to 
potentially more invasive services such as Orthopaedics. However it is also possible that this 
represents a recruitment bias where those presenting with recurrent symptoms were 
disproportionately less likely to choose to participate in the study. The finding from Engebretsen et 
al. (2010) that previous shoulder pain was predictive of worse pain and disability via absolute SPADI 
score at 12 months post baseline provides limited evidence that the recruited sample may have 
been skewed towards a more favourable outcome.  
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7.3 Exploration of the potential prognostic variables in terms of non-regression 
related findings 
The selection of variables of interest, robustness of data collection procedures, data handling and 
variable trimming along with the descriptive and reliability study findings will now be considered for 
each variable category. Due to the limited methodological elements involved in the collection of the 
demographics and clinical history related variables, these will be considered together.  
 
7.3.1 A. Demographics and B. Clinical history  
In considering demographic and clinical history variables there are a large number of potential but 
disparate variables across a variety of characteristics which could be explored as prognostic factors. 
Where sample sizes are sufficiently large (e.g. Deutscher et al. 2009; Chester et al. 2016), multiple 
such variables can be considered. However where sample size necessitates limiting the number of 
candidate variables then informed trimming of the number of variables is necessary.    
 
Age and duration of symptoms were chosen as the A. demographics and B. clinical history variables 
to be entered into the prognostic model, as detailed previously. Aligning with prognostic research 
best practice, age was retained as a continuous variable so as to retain maximal statistical power 
(Roysten et al. 2009). However duration of symptoms was recorded as an ordinal variable in an 
attempt to address potential recall inaccuracy. This highlights one of the limitations of such variables 
in that they are typically patient reported and so potentially incorrect interpretation or inaccurate 
reporting by patients can be confounding factors. Supporting evidence for this comes from the 
identification by almost 2/3 of the sample in the current study that their symptom onset was 
insidious. As such, accurately identifying duration of symptoms will be inherently challenging where 
onset is gradual.  
  
In this area of research, duration of symptoms was the most consistently identified predictor in the 
published literature thereby providing a degree of confidence in selecting this variable over other 
clinical history variables. With regards to demographic variables, the choice was less clear-cut and 
this highlights the issue of a large amount of potentially relevant demographic and clinical history 
data not being included in the prognostic model. As such, the building of a consensus as to which 
demographic and clinical history variables influence outcome has merit. Similarly, the use of larger 
sample sizes so as to incorporate more candidate variables can be advocated. However mechanisms 
to achieve this in an economically and logistically sustainable manner, whilst preserving clinical 
relevance, need to be developed.  
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7.3.2 C1. Patient reported measures: Pain 
In the current study the request for patients to rate their momentary pain ‘At rest’ using the prompt 
“when you are just resting with your arm by your side” was used to maximise the likelihood that 
scores were provided in a consistent manner across the sample and with minimal impact of recall 
bias. The rating of momentary pain ‘On activity’ using the prompt “your painful movement” sought 
to optimise this patient and condition-specific score. As such this approach can be considered to 
address some of the shortcomings identified in the pain score approaches used by Kennedy et al. 
(2006), Engebretsen et al. (2010), Kromer et al. (2014) and Chester et al. (2016).  
 
The recording of pain ‘At night over the last week’ was a novel element when considering the 
previous studies critiqued in this area of research. The relevance of night time pain has been 
highlighted in those with rotator cuff disease (Minns Lowe et al. 2014) thereby reinforcing the 
relevance of capturing this aspect of symptomatic shoulder disorders. The combining of the three 
pain scores into a mean value mirrored the approach taken by Mintken et al. (2010) and provided a 
mechanism for combining each of these clinically meaningful values. Mintken et al. (2010) arbitrarily 
used only the mean value. However in the current study the identification of weak to strong 
correlations between each of the four pain variables provided a rationale for selecting a single, 
conceptually meaningful value for potential inclusion in the prognostic model as a mechanism for 
minimising over-fitting by reducing the number of candidate variables.  
 
However due to the limited sample size, exploration of options to exclude 3 of the 10 candidate 
variables was undertaken and led to the VAS pain scores being excluded due to their high correlation 
with the total SPADI. This reflects the conceptual overlap between the VAS pain scores and the five 
‘pain scale’ questions on the total SPADI.   
 
For future research in this area the finding from this study that the total SPADI was highly correlated 
with the mean of the three clinically relevant VAS readings – each of which were highly correlated 
with the mean value – provides a (partial) rationale for omitting VAS readings and using only the 
total SPADI. In order to address issues of over-fitting and to reduce the administrative burden upon 
researchers and patients, this finding warrants future implementation.    
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7.3.3 C2. Patient reported measures: Psychological symptoms 
The variety of tools used in previous prognostic studies to explore psychological symptoms reflects 
the complexity of this variable. In order to capture the full breadth of psychological symptoms the 
4DSQ was chosen and published cut-off points used to guide the clinical interpretation of levels of 
different psychological symptoms. These revealed low levels of ‘strongly elevated’ symptoms in the 
sample, from 1.4% for somatisation to 6.8% for distress. These data align with both Kromer et al. 
(2014) and Chester et al. (2016) who also identified low levels of psychological pathology in their 
shoulder pain patient samples. In light of evidence (Pincus et al. 2002) of a high incidence of 
psychological symptoms in people with MSK disorders, there is the potential that the current sample 
and those in other studies were non-representative. Potential reasons for this include those with 
psychological symptoms being less likely to seek help with musculoskeletal disorders or being less 
likely to consider participating in clinical research.  
 
The use of the 4DSQ to identify ‘moderately elevated’ or ‘strongly elevated’ symptoms for each 
subsection provides a guide for treatment. This is a notable strength of the 4DSQ whereby 
‘moderately elevated’ levels indicates possible problems, which should be monitored whilst the 
‘strongly elevated’ category requires further diagnosis and treatment (Koorevaar et al. 2016). In 
dichotomising the 4DSQ data, the subsequent variable entered into the prognostic model 
represented the presence of one or more psychological symptoms at a level requiring monitoring or 
treatment. As such the psychological symptom data can be considered to have been collected in a 
more robust manner than that of previous studies in this area. Nonetheless the potential for 
patients to have incorrectly interpreted the questions or insufficiently self-identified their own 
symptoms are caveats to consider when considering the reported level of psychological symptoms.  
 
7.3.4 C3. Patient reported measures: Function / Disability 
Measures of self-reported function and disability have the potential to capture a wide range of 
shoulder pain related symptoms and impact (Payne and Michener 2014). The use in the current 
study of a robust, region specific measure (i.e. the SPADI) provided a mechanism for capturing this.    
 
As with many patient reported scores, the SPADI comprises sections, each with a different emphasis 
(namely pain and disability) which can be analysed separately. In order to explore options for 
variable trimming, the current study identified high correlations between each of the components 
and the overall score, thereby providing a statistically justified rationale for using the total SPADI 
score. The subsequent identification that this score correlated closely with both the mean of the 
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pain VAS scores and the physical ROM variable likely reflects their close conceptual relationship with 
the component pain and disability SPADI scores (respectively). Such findings provide a rationale for 
considering patient reported measures of function and disability such as the SPADI a high priority 
variable to collect in prognostic studies.   
 
7.3.5 D1. Clinical measures: Strength 
The use in the current study of a HHD for quantifying strength provided a mechanism for bringing 
accuracy to the measuring of strength in the clinical setting whilst still ensuring direct transferability 
of the findings. Conversion of the force readings to a rotatory moment provided a mechanism for 
accommodating individual variation in lever arm length and the pre-methods study results provided 
evidence of excellent intra-rater reliability. These results were highly comparable to those reported 
in the comparable study by Awatani et al. (2016) who reported ICC’s between 0.850 and 0.980. Such 
elements align with prognostic study recommendations (Riley et al. 2013) for inclusion of robustly 
collected variables and methods of recording.  
 
The recording of IR and ER strength aligned with their relevance to rotator cuff strength deficits and 
strengthening (Reinold et al. 2004). However measuring these in neutral shoulder abduction 
positions arguably limits their clinical and functional relevance because symptoms and strength 
deficits typically occur towards mid-range positions (Khan et al. 2013). The use of a composite planar 
movement (scaption) reflected the measurement of strength in a functional plane (Harrington et al. 
2013). However the close overlap of this testing position and the empty/full can test position 
highlights the potential threat to the subsequent strength readings from pain inhibition. Indeed this 
highlights some of the likely contributing factors to strength deficits.    
 
The use in the current study of an absolute strength reading could be considered inferior to a 
reading normalised to the opposite side. However the typical finding of less strength on the non-
dominant side – and therefore arm dominance to be a confounding factor (Westrick et al. 2013) 
where normalisation to the asymptomatic side is used – is illustrated in the finding that n=40 (52.6%) 
of subjects reported that their symptomatic side was their non-dominant arm. As such, this supports 
the decision to use the absolute strength readings on the symptomatic side.  
 
In selecting the variable to be entered into the prognostic modelling, high correlation between each 
of the strength measures provided a justification for choosing a single measure as each can be 
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representative. This provides a rationale for using just a single strength test in future studies, 
thereby reducing burden upon the researcher and patient.  
 
7.3.6 D2. Clinical measures: ROM 
ROM was quantified using a digital inclinometer and a guided but planar movement so as to balance 
reproducibility and clinical relevance (Kolber et al. 2012). The recording of ROM relative to both the 
limit of ROM and the point of symptom exacerbation by movement ensured that any impact of 
these factors were captured. Furthermore, the pre-methods study results provided evidence of 
excellent intra-rater reliability, thereby aligning with prognostic study recommendations (Riley et al. 
2013) for inclusion of robustly collected variables and methods of recording. In addition the intra-
rater reliability results were highly comparable to those reported in the comparable study by 
Mullaney et al. (2010) who reported ICC’s between 0.940 and 0.98. 
 
However the subsequent identification that 10 subjects (13%) had no meaningful reading for the 
variable of ‘point of symptom exacerbation’ because of floor and ceiling effects raised questions 
about the value of this variable. Indeed the high correlation between the readings for limit of ROM 
and the point of symptom exacerbation by movement provides a rationale for recording only the 
limit of ROM data in subsequent studies, thereby reducing the burden upon the researcher and 
patient. However the ROM data also highlights the substantial variability in symptom behaviour in 
this NHS population.   
  
The ROM variable was ultimately excluded from the prognostic modelling stage due to the limited 
sample size. Whilst this may be considered a substantial failing in the current study, the correlation 
between this variable and the total SPADI score provided a statistically justified (partial) rationale for 
omitting the ROM variable. Indeed the disability component of the total SPADI (comprising over 60% 
of the total score) has substantial conceptual overlap with the amount of movement available at the 
shoulder. This provides evidence for the use of total SPADI as a surrogate for the physical measure of 
ROM in future studies, thereby reducing researcher burden and potentially increasing sample size 
within a given timeframe or research budget. As such, the association between the ROM variable 
and the total SPADI also provides evidence to support a theory that patients are accurate in self-
identifying their functional and ROM impairments.   
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7.3.7 D3. Clinical measures: Scapular movement and control 
The choice to use the SDT in the current study was informed by the non-mutual exclusivity of 
movement patterns in this tool and the ability to use it in the clinical setting, thereby maximising 
transferability. However the SDT was developed on high-level athletes using data from loaded trials 
where shoulder flexion and abduction were both assessed.  
 
Data from the current study that 42% (n=32) of the cohort were unable to perform a loaded trial 
provides evidence that in its original form the SDT cannot be uniformly used with NHS populations 
such as in the current study, due to the high levels of symptom provocation from elevating the arm 
whilst holding a load. Furthermore the statistically significant correlation between the gradings from 
the non-loaded and loaded trials provides evidence that the performance of a loaded trial in an NHS 
population could be deemed as not necessary.  
 
The inter-rater reliability study provided evidence of inferior agreement in the current study (Kappa 
= 0.395 and 0.329; un-weighted and linear-weighted Kappa respectively) compared to the original 
study by McClure et al. (2009) (videotape rating: Right side Kappa = 0.61, left side Kappa = 0.48; both 
weighted Kappa). It should be noted that subjects in the study by McClure et al. (2009) were athletes 
from National Collegiate Athletic Association Divisions I and III who participated in sports requiring 
intense overhead arm use. Although no descriptive ROM or BMI data were reported, exclusion 
criteria in their study included a body mass index ≥ 30.0. In addition, the athletes were drawn from 
water polo, swimming, baseball/softball, volleyball and tennis. They were therefore highly likely to 
have much greater ROM than the subjects in the current inter-rater reliability study (mean=138°, 
SD=25°, min=74°). Furthermore the BMI in the current inter-rater reliability study (mean=29 kgm-2, 
SD=6 kgm-2) revealed a much higher BMI than in the study by McClure et al. (2009).  
 
This is of relevance because some of the components of normal scapulohumeral motion and 
scapular dyskinesis detailed in the tool that comprises the SDT are typically seen in the mid to higher 
ranges of shoulder elevation (Ettinger et al. 2014). As such those patients in the current study with 
substantially impaired active ROM may have been unable to attain the range of movement where 
some elements of either normal scapulohumeral motion or scapular dyskinesis occur. Categorising 
of such patients may have been an additional source of disagreement between raters, thereby 
contributing to the lower Kappa.  
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The higher BMI in the current inter-rater reliability study might conceivably make it harder to 
accurately observe the bony landmarks making disagreement between raters more likely. As such 
these data provide evidence that the SDT may not be sufficiently robust to use in NHS populations. 
In light of prognostic research study recommendations regarding robustness of variables (Riley et al. 
2013), it raises the question of whether scapular movement and control are too difficult to 
accurately quantify for them to be considered in a prognostic study. The use of a composite scapular 
variable (Lewis 2009) which emphasises symptom reduction may be an alternative approach.  
 
7.3.8 E1. Structural pathology via imaging 
The recording of a broad spectrum of pathology related features using high-resolution sonography is 
a novel aspect of this study when considering the previous studies critiqued in this area of research. 
Furthermore the undertaking of this by a researcher whose original qualification is that of a treating 
clinician (physiotherapist) mirrors the recent shift towards point of care-based imaging in 
musculoskeletal disorders (Roll et al. 2016). The emphasis here was on gaining a full clinical 
qualification rather than simply project specific training, thereby reflecting the long learning curve 
for shoulder ultrasound (McDonald et al. 2010; Beggs 2011). The subsequent publication (Smith et 
al. 2015) stemmed from the challenges that MS faced during his training and represents an attempt 
to facilitate the high quality training of those undertaking shoulder ultrasound imaging.  
 
The inter-rater reliability findings demonstrated a range of agreement levels from fair (Kappa of 
0.298 and 0.358 for calcific deposits and cuff pathology; respectively) to moderate (Kappa of 0.503 
and 0.477 for bursitis and PTT; respectively) to almost perfect agreement (0.841 for FTT) (Viera and 
Garrett 2005). However the large number of missing datasets for bursitis and the lack of statistically 
significant agreement for tendinopathy findings means that the internal validity and reliability of the 
variable entered into the prognostic model (no pathology; 1 of bursal or cuff pathology; both bursal 
and cuff pathology) must be viewed with caution.  
 
The inter-professional agreement levels in the current study are broadly comparable to those 
reported by Thoomes-de Graaf et al. (2014) who also compared sonography findings of 
Physiotherapists to Radiologists. Specifically they reported a Kappa of 0.54 for bursitis and 0.28 for 
calcific deposits (0.50 and 0.30 in the current study; respectively). However there was wider 
variation between the studies for PTT and FTT with a Kappa of 0.10 and 0.63 (0.48 and 0.84 in the 
current study; respectively).  
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Possible reasons for this include the training of MS under PM and therefore the increased likelihood 
of comparable scanning technique and image interpretation. The use by Thoomes-de Graaf et al. 
(2014) of a general shoulder pain sample mirrored that of the current inter-rater reliability study and 
the percentage incidence of Radiologist reported pathology in the study by Thoomes-de Graaf et al. 
(2014) and the current inter-rater reliability studies were almost identical. Furthermore the primary 
care based Thoomes-de Graaf et al. (2014) study mirrored the largely GP referred sample (n=30; 
86%) in the current inter-rater reliability study, making these unlikely reasons for the observed 
differences in reliability values. Nonetheless, the reproducibility of any diagnostic ultrasound 
variables must be optimised for it to be included in future prognostic studies. Mechanisms to 
achieve this include using experienced Sonographers and employing mechanisms to improve 
diagnostic reproducibility such as standardised terminology.   
 
As noted in the methods section, for the main cohort study MS employed specific mechanisms 
(bilateral scans to provide a pseudo comparator and use of specific criteria relating to the 
sonographic appearance of cuff tendinopathy and bursitis) in an attempt to improve the robustness 
of these sonographic findings which had non-significant agreement and low incidence of PM 
reported findings; respectively. These mechanisms have yet to be formally assessed for reliability or 
acceptability but recent publications in this area (Ingwersen et al. 2016; McCreesh et al. 2016) 
support the use of standardised scanning procedures and definitions in order to improve inter and 
intra-rater reliability for tendinopathy-related findings.    
 
The collapsing of pathology findings in various portions of the rotator cuff into a single binary rating 
(e.g. calcific deposits: yes/no) does not reflect diagnostic ultrasound scanning procedures where 
pathology is identified specifically in relation to the different portions of the rotator cuff (Jacobson 
2011). The subsequent collapsing of all pathology findings into a three level variable (i.e. no 
pathology; one of bursal or cuff pathology; both bursal and cuff pathology) takes this one step 
further. When considering the potential differences in the management of calcific deposits or 
tendinopathy versus PTT or FTT (Baring et al. 2007) then this approach arguably has limited clinical 
transferability. However this compromise in variable trimming approach had the advantage of 
retaining low incidence pathologies (PTT and FTT had an incidence in the main cohort of 2.6% and 
3.9%; respectively) in the final analysis and also reducing the number of variables to be analysed.  
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7.3.9 E2. Structural pathology via orthopaedic tests 
The potential inclusion of orthopaedic test results as a prognostic factor but not as an inclusion 
criterion is a novel aspect of this study. As such it reflects the increasingly held opinion that 
orthopaedic tests are of limited diagnostic utility (Lewis 2009; Kelly et al. 2010; Alqunaee et al. 2012; 
Hanchard et al. 2013) but nonetheless recognise a potential role for predicting outcome. As such, 
this approach aligns with the emphasis within the prognostic methodology literature of overcoming 
the limitations of diagnosis via prognostic research (Hemingway et al. 2013).  
 
The omission of the painful arc variable from the results was in part due to threats to the conceptual 
value of the variable, an element of which was the large portion (n=26; 34%) of the sample whose 
limited active ROM would have precluded them having a meaningful painful arc finding. This 
highlights one of the challenges of assessing a general NHS population where a variety of symptom 
severity and functional limitation can be present. The finding also raises questions regarding the 
merit and clinical utility of the painful arc in such a population.  
 
The collapsing of the remaining four test results into a single variable (yes/no: 3 or more positive test 
results) reflects published evidence regarding the limited diagnostic utility of individual tests and 
simultaneously assisted with reducing the number of candidate variables. As noted earlier in the 
discussion chapter, just over a quarter of subjects had 2 or fewer positive test results and so 
conceivably would have been excluded from the study using a criteria of 3 or more positive tests as a 
cut-off point (Michener et al. 2009) as in the prognostic study by Hung et al. (2010). However the 
approach taken in the current study involved consideration of the clinical presentation and was 
supplemented by the treating clinicians who identified any subjects who as treatment continued 
were identified as being non-SIS/RCTendinopathy. This double-screening procedure is arguably a 
more clinically meaningful, albeit time intensive approach to subject recruitment. However this also 
reflects the challenges of identifying a homogenous SIS/RCTendinopathy patient sample, which 
reflects this difficult to define pathology (Linaker and Walker-Bone 2015). Indeed the necessity for 
larger sample sizes when researching in this area poses significant logistical challenges when 
applying this time intensive, clinically meaningful screening process. The alternative approach of 
recruiting generic shoulder pain samples provides one mechanism to overcome this, as evidenced by 
the larger scale studies by Deutscher et al. (2009), Sindhu et al. (2012) and Chester et al. (2016).  
 
The use of three or more positive tests as a cut-off point (Michener et al. 2009) facilitated the 
reducing of the number of candidate variables but in an evidence informed manner. However due to 
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the limited sample size the orthopaedic test variable was not entered into the prognostic model 
phase. Structural pathology as a variable was still retained for modelling via the diagnostic 
ultrasound data and this reflected published evidence of its superior sensitivity and specificity 
(Iagnocco et al. 2003; Micheroli et al. 2015). Nonetheless, orthopaedic tests are easier to apply in 
routine clinical practice and so the omitting of this variable is a serious consequence of the limited 
sample size. As such it removes the opportunity to consider structural pathology as a potential 
prognostic factor in routine outpatient physiotherapy where immediate access to ultrasound 
imaging would likely be prohibitive. 
 
7.4 Treatment / intervention – contrasted with other shoulder prognostic studies 
7.4.1 Measurement tool  
The bespoke treatment recording tool used in this study was developed in collaboration with the 
treating clinicians at the two data collection sites. In the subsequent prognostic study, clinicians had 
the opportunity to record any interventions they delivered which were not included on the form, but 
in all cases these did not yield additional data. All categories were used at least once indicating that 
there was no redundancy in the tool. Combined with the refinement of the initial version based on 
clinician feedback this provides limited evidence of the content validity of the tool (Mori et al. 2016).  
 
The covering sheet (appendix 4; first page of ‘Final version of proforma for collecting patient 
treatment information’) reminded the treating clinician that treatment data analysis would be 
anonymised and non-judgmental. However it is possible that clinicians may have consciously or 
unconsciously altered their treatment approach or recording of treatments due to being observed. 
The impact of the so-called ‘Hawthorne effect’ (Kohli et al. 2009) must therefore be acknowledged 
as a potential confounding factor.  
 
The treatment approach in the current study contrasts with those papers that used standardised 
interventions including those that were derived from RCTs where treatment was defined a priori. 
However where the intervention involved a degree of examination-based treatment adaptation such 
as with Virta et al. (2009) and Kromer et al. (2014) then comparison with the clinician-determined 
intervention in the current study can be more readily made. 
 
There is potentially greater comparability with the entirely clinician directed approach used by 
Deutscher et al. (2009) although review of their categories demonstrates only a limited overlap with 
those used in the current study. This perhaps reflects differences in clinical approach or professional 
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autonomy between the UK and Israel (where the Deutscher et al. (2009) study was undertaken). 
Furthermore the treatments used by Deutscher et al. (2009) were across all shoulder diagnostic 
categories. Comparability might also be assumed between the work of Chester et al. (2016) and the 
current study as both were UK NHS based and treatment was entirely clinician directed. However 
Chester et al. (2016) did not publish details of the treatments delivered nor of how the delivered 
intervention was recorded. As such, it is not possible to compare the treatment received by patients 
in their study and the current study.  
 
The approach taken in the current study provides a potential foundation for the routine capture of 
what constitutes clinician directed care of patients with SIS/RCTendinopathy. As such, it could form a 
template for prospective testing of whether sub-groups of patients respond to different 
interventions, so called treatment effect modifiers (Kent et al. 2010). However this requires 
prospective testing in a larger cohort alongside formal testing of the inter- and intra-rater reliability, 
inter-departmental reliability and criterion validity of the treatment recording tool.  
 
7.4.2 Treatment delivered  
The treatment was delivered by band 6 and 7 clinicians for the majority of patients (n=69; 91%) 
reflecting the guidance given to the administrative staff to allocate patients in the study to these 
clinician bands. This was to control for the potential confounding factor of the early learning curve of 
newly qualified staff as an additional source of treatment variability (Macznik et al. 2015). Whilst a 
greater consistency of treatment intervention might be expected from using experienced clinicians, 
transferability of the findings to routine practice where there is a wide range of skill mix would be 
limited. In the current study, six patients were subsequently treated by band 5 clinicians and this 
reflects the necessary pragmatic approach with a clinical based prognostic study.  
 
The high frequency with which education and advice, exercise therapy and home exercise 
programmes were used as the treatments delivered mirrors the consistent use of these modalities in 
the literature (Dong et al. 2015) and provides partial evidence that the treatment delivered was 
representative of typical physiotherapy. Despite published evidence of some benefit from combining 
manual mobilisation with exercise (Green et al. 2003; Desjardins-Charbonneau et al. 2015; Steuri et 
al. 2017), hands-on techniques such as manual therapy were only applied in the treatment of half of 
the cohort whilst taping and electrotherapy were rarely utilised. This may reflect the individual 
patient presentations or clinical treatment preferences. However the NHS based nature of the study 
and the likely pressure for patient throughput may influence the predominance of hands-off 
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techniques. Transferability of the findings to a private funded clinical setting where such 
circumstances may be reversed may therefore be limited.  
 
As half of the cohort in the current study were not treated with manual therapy, then comparability 
with the prognostic study by Mintken et al. (2010) will inevitably be limited as those authors used 
only spinal manipulations as their intervention. Conversely the frequent use of exercise therapy in 
the form of stretches, strengthening, stability and ROM exercises in the current study broadly 
mirrors the approaches used by Conroy and Hayes (1998), Deutscher et al. (2009), Virta et al. (2009), 
Engebretsen et al. (2010), Hung et al. (2010) and Kromer et al. (2014), so comparison of outcome 
with these studies can be more readily undertaken.  
 
The high frequency of a home exercise programme mirrors that of Chester et al. (2016) who 
reported its use for 99% of participants. The optimising of treatment carry over and encouragement 
of patient independence and empowerment likely reflects the NHS based treatment investigated in 
the current study and by Chester et al. (2016). However it should be noted that no attempt was 
made in the current study to quantify adherence to HEP and so the reported levels of prescribing 
HEP may be an overestimate of the actual HEP performed by the cohort.  
 
It must also be acknowledged that unlike routine clinical practice, all subjects in the current study 
received a diagnostic ultrasound scan. Patients may conceivably have derived a therapeutic impact 
by implied confirmation or exclusion of structural pathology, which they might have deemed 
relevant to their symptoms. Clinicians may have been similarly influenced in their treatment 
approaches. These potentially confounding or even therapeutic factors merit formalised 
investigation but were beyond the scope of the current study.  
 
7.4.3 Treatment period and discharge status 
A large number of prognostic studies in this area used standardised duration of treatment and 
numbers of appointments, reflecting their RCT or standardised intervention approaches. Typically 
these were much more intensive than the current study, for example with Kromer et al. (2010) 
treatment was twice weekly for 5 weeks. Conversely, the mean of 4.6 appointments over 13 weeks 
in the current study likely reflects the service pressures of routine clinical care and subsequently a 
less intensive but more protracted treatment phase. Such differences have the potential to impact 
on the subsequent outcomes and the timescales for assessing change.  
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The number of appointments in the current study (mean = 4.6, SD = 2.6) was less than those in the 
pragmatic studies of Deutscher et al. (2009) (mean = 9, SD = 6) and the Canada based study by 
Kennedy et al. (2006) (mean = 15, SD = 9) but largely comparable to that of Chester et al. (2016) 
(mean = 5.0, SD = 2.7). This may reflect international differences in the location of the clinical 
settings along with local funding pressures (private versus public health). As such the NHS based 
collection by Chester et al. (2016) and the current study likely reflect the availability of healthcare 
resources in the NHS and illustrate the caution that must be applied when comparing findings from 
different healthcare systems. It should also be noted that the quoted figures for Chester et al. (2016) 
were those who provided follow up data and so may be skewed by loss to follow up, whilst in the 
current study the number of appointments data was for all subjects.  
 
The treatment period is also of relevance, but not only from the perspective of treatment ‘dose’. In 
this respect Kennedy et al. (2006) and Deutscher et al. (2009) reported treatment lasting a mean of 
65 days (SD=26) and 56 days (SD=40); respectively. These were shorter and less variable then the 
mean of 13 weeks (91 days) and SD of 10 weeks (70 days) in the current study. The high degree of 
variability in the treatment duration in the current study indicates a highly heterogeneous 
intervention. However it also highlights that where studies such as Kromer et al. (2014) undertook 
their follow up at 3 months, many subjects (were they receiving a pragmatic intervention) would 
theoretically still be under treatment; specifically 47% (n=36) in the current study. For the study 
most comparable to the current NHS based study – Chester et al. (2016) where their follow up 
occurred at 6 weeks and 6 months after the initial appointment – many subjects would theoretically 
still be under treatment. Specifically 77% (n=58) of subjects in the current study were still under 
treatment after 6 weeks, and 16% (n=12) were still under treatment after 6 months. Assuming 
greater comparability across these two NHS based studies, the conceptual relevance of follow up 
based on arbitrary time points is questionable. The use of ‘discharge from physiotherapy’ as the 
reference time point in the current study brings the benefit of clinical relevance but in so doing 
introduces further variability (i.e. background statistical noise) into the study and might provide a 
partial explanation for the limited power of the final models to predict outcome. From a logistical 
perspective, protracted treatment phases also led to delays in the final data collection and analysis.  
 
The patient status at discharge in the current study provided evidence that the majority (n=57; 75%) 
of those recruited to the study completed physiotherapy treatment and were subsequently 
discharged. This is broadly comparable to the segregated findings of the most comparable study 
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(Chester et al. 2016) who reported 61% and 87% of their cohort completing physiotherapy (those 
who didn’t provide follow up outcome data and those that did; respectively).  
 
In the current study, the 13 patients (17%) who were discharged subsequent to DNA or UTA 
represent wasted clinical resources. Given the pressures on valuable NHS resources the predicting of 
discharge secondary to DNA or UTA could be considered a high priority area of research and one 
where prognostic modelling might be able to play a valuable role.  
 
The discharge for referral onto orthopaedics for surgery consultation (n=2), injection via 
orthopaedics (n=1) or GP (n=1) and specialist psychological treatment (n=1) is evidence of variability 
in the SIS/RCTendinopathy care pathway. The rate (7%) of referral-on to other specialities is likely to 
be artificially low as such data was only collected at discharge and so will not capture post-discharge 
utilisation of other portions of the SIS/RCTendinopathy care pathway. An extended longitudinal 
follow up of this data type is therefore advocated. Along with two patients who received a shoulder 
injection from their GP whilst still under physiotherapy treatment, the referral-on numbers reveal a 
complex web of patient care pathways that likely comprise routine practice. This is both an 
additional source of inherent variability in the study of SIS/RCTendinopathy and potentially a 
contributing factor to patient care inefficiencies.   
 
7.5 Exploration of outcome variable   
7.5.1 Outcome variable and data handling (OSS) 
As noted previously, several prognostic studies (Bartolozzi et al. (1994), Kennedy et al. (2006), 
Deutscher et al. (2009), Engebretsen et al. (2010), Kromer et al. (2014) and Chester et al. (2016)) 
used the same patient reported score as their dependent variable and as a potential prognostic 
factor. In order to partially address the methodological issues posed by this, the current study used a 
different self-reported function and disability score (SPADI) as the determinant of outcome (via the 
OSS).  
 
The published close correlation of the OSS with the SPADI and DASH (Dawson et al. 2001; Cloke et al. 
2005; van der Linde et al. 2015) indicates that the OSS measures similar constructs to those studies 
that used the SPADI (Engebretsen et al. 2010; Kromer et al. 2014; Chester et al. 2016), DASH 
(Kennedy et al. 2006) and QuickDASH (Chester et al. 2016). Consequently a degree of direct 
comparability between the current study and those that used similar outcome measures is 
permissible. However the published close correlation of the OSS with the SPADI indicates that the 
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use in the current study of the SPADI as a potential prognostic factor and the OSS as the determinant 
of outcome is unlikely to substantially address the above concerns regarding overlap between 
patient reported scores as the dependent variable and as a potential prognostic factor.  
 
This highlights a challenge for future prognostic research in this area, namely how best to retain 
patient reported outcome of disability / function as a potential prognostic variable (given the 
overwhelming evidence in the literature of its consistent prognostic relevance) and use a clinically 
relevant measure of outcome (essentially patient reported outcome of disability / function) but 
whilst avoiding the methodological overlap.  
 
7.5.2 Data handling using the OSS MCIC  
The MCIC from Ekeberg et al. (2010b) was used to identify change in status and this provided a 
mechanism for establishing the clinical response of the cohort. However it must be acknowledged 
that the Ekeberg et al. (2010b) MCIC data was derived from a 1-week recall period rather than the 
prescribed 4 week period described by the OSS developers (Dawson et al. 1996) and used in the 
current study. As such, the change in status data in the current study must be viewed with caution.   
 
The OSS MCIC scores demonstrated for those subjects from whom follow up data were available 
that from baseline to discharge 51 subjects (69.9%) improved, four subjects (5.4%) worsened and 18 
subjects (24.7%) remained the same. For the period baseline to 3 months post-discharge 47 subjects 
(75.8%) improved, three subjects (3.9%) worsened and 12 subjects (15.8%) remained the same.   
 
The multi-stage baseline to discharge to 3-month post-discharge data demonstrated that the largest 
group were those who improved from baseline to discharge and maintained this relative to baseline 
at 3 months post-discharge. However there was a complex pattern of change across the three time 
points as illustrated by Figure 6.2: “Representation of change in OSS over time for each subject”. This 
included those who improved and then further improved (n=4; 6.5%), remained the same from 
baseline at each time point (n=5; 8.1%), were the same at discharge but at 3 month post-discharge 
had improved from baseline (n=8; 12.9%) and those that improved from baseline to discharge but 
were within the MCIC of baseline (i.e. same relative to baseline) at 3 month post-discharge (n=5; 
8.1%). Such data highlights the complexities of multiple time points and the individualised pattern of 
change demonstrated across the cohort.  
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As no control group was used it is not possible to specify cause and effect or to differentiate out 
natural course of the condition. Nonetheless the rates of ‘improvement’ (69.9% for baseline to 
discharge and 75.8% for baseline to 3 months post-discharge) in the current study are comparable to 
the non-RCT studies which reported rates of successful outcome, namely Mintken et al. (2010) 
(61%), Morrison et al. (1997) (67%), Hung et al. (2010) (70%) and (Ogon et al. 2009) (73%). This 
provides limited evidence that a high proportion of patients with SIS/RCTendinopathy demonstrate 
improvement following physiotherapy and that this is maintained at 3 months post discharge.  
 
Furthermore only a small proportion of patients worsened over this period (5.4% for baseline to 
discharge and 3.9% for baseline to 3 months post-discharge) in the current study which are 
comparable to those previously reported of 3% (Engebretsen et al. 2010), 4% (Mintken et al. 2010) 
and 7% (Kennedy et al. 2006). No data was specifically collected in the current study regarding 
adverse effects, although from the treatment collection forms and discussion with clinicians no 
reporting of adverse effects occurred. As such, the study provides additional, if limited, data of the 
benefit – with low levels of negative impact – of physiotherapy in patients with SIS/RCTendinopathy.  
 
7.5.3 Differences between those lost to follow up and those where follow up data was 
available 
Any systematic differences in the baseline characteristics (considered in the prognostic modelling 
stage) of those who were lost to follow up might have the potential to influence the prognostic 
models calculated on those who were available for follow up. Although only analysed descriptively, 
no clear evidence of a systematic bias was evident in relation to baseline OSS, symptom duration, 
psychological symptoms, strength, scapular movement and control or ultrasound evidence of 
pathology.  
 
However there was the potential for a systematic bias whereby a disproportionate number of those 
unavailable for the 3 months post-discharge model were younger patients. Evidence from Deutscher 
et al. (2009), Kennedy et al. (2006) and Morrison et al. (1997) of older age being associated with 
poorer absolute outcome status can be combined with evidence from Kennedy et al. (2006) of 
younger age being predictive of greater improvement in disability via change in DASH score from 
baseline to discharge / 12 weeks. As such there is some evidence that the sample available for the 
discharge to 3 month post-discharge modelling phase were less likely to improve due to a loss of 
younger patients. However any conclusions as to an impact on the constructed models is limited by 
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the multi-variate statistical interactions in prognostic modelling and also the absence of age as a 
predictor in the discharge to 3 month post-discharge model.  
 
In relation to total SPADI score there was limited evidence of a systematic bias whereby a 
disproportionate number of those unavailable for the 3 months post-discharge model had lower 
total SPADI scores and so had lower pain and disability scores at baseline. Evidence of greater 
functional impairment / disability at baseline predicting a worse outcome state (Bartolozzi et al. 
1994; Kennedy et al. 2006; Engebretsen et al. 2010; Chester et al. 2016) supports a viewpoint that 
those available for the 3 months post-discharge follow up point may have been less likely to 
improve. Evidence from Kennedy et al. (2006), Hung et al. (2010) and Kromer et al. (2014) of higher 
baseline disability predicting greater improvement in status suggests that those lost to follow up at 3 
months may have influenced the subsequent 3 month model which total SPADI was retained in.  
 
It is interesting to note that the 2 variables (age and total SPADI) where a systematic bias was 
identified in those unavailable for the 3 months post-discharge model were the same variables that 
comprised the baseline to discharge prognostic model (age and total SPADI) and the baseline to 3 
months post-discharge prognostic model (total SPADI). A statistical explanation for this is unclear, 
but it highlights the importance of analysing loss to follow up datasets.  
 
7.5.4 Timing 
The collection of the OSS relative to discharge from physiotherapy arguably optimises the clinical 
meaningfulness of the resulting prognostic findings. However due to the pragmatic nature of the 
study this time point was highly variable relative to when physiotherapy commenced. This had the 
effect of increasing the timescales for completion of the study and also introduced an additional 
source of variability into the study design. However it provides some evidence that studies such as 
Kromer et al. (2014) and Chester et al. (2016) which collected outcome data at arbitrary time points 
may have been pooling data from those who had already completed treatment with those who 
would be under treatment for a considerably longer period. Thus the prognostic data reported by 
Kromer et al. (2014) and Chester et al. (2016) arguably comprises an uncertain mix of patients at 
very different points in their clinical care.  
 
The use of meaningfully spaced follow up time points has merit in providing evidence regarding 
stability of change and prognostic value beyond the point of discharge. However the use by Mintken 
et al. (2010) of follow up occurring a matter of days after baseline data collection makes their data of 
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very limited clinical value. One merit though of the approach of Mintken et al. (2010) is that 
potential confounding factors such as the natural course of the condition, variability in adherence to 
home exercise programmes and exposure to potentially aggravating work, recreational or functional 
tasks is minimised. As such, the current study and those who included longer follow up time periods 
have this as both potential confounding factors and potential sources of inherent background noise 
within their study designs. However as these factors all represent inevitable real world elements 
they are inherent within longitudinal study designs and can either be quantified by attempting to 
measure their occurrence, or sufficiently large sample sizes used to ensure a sufficiently powered 
study to accommodate them. One mechanism by which some of the inherent variability (regarding 
timescales) could be managed would be to use a framework that applies a maximum duration of 
treatment.  
 
7.6 Statistical analysis: Analysis approach and data reduction procedures 
7.6.1 Data handling: prognostic modelling  
The use of a pre-defined, stratified approach to trimming the number of candidate variables 
provided a mechanism for aligning the number of variables with the sample size. This approach to 
avoiding over-fitting and potential under powering of the study aligns with prognostic methodology 
recommendations (Riley et al. 2013) regarding statistical analysis. However as noted earlier, basing 
the number of variables on the number of cases with a positive outcome is recommended by some 
authors.  
 
The use of clinical and logical methods for trimming the number of variables could be argued to 
potentially introduce bias into the analysis approach. However such an approach ensures maximal 
clinical relevance of the subsequent findings. Furthermore, an over-reliance on purely statistical 
criteria can have the disadvantage of producing spurious results. The subsequent use of a 
combination of clinical, logical and statistical methods in the current study is therefore a 
constructive attempt to address the shortcomings of both polarised approaches. It is acknowledged 
that the subsequent removal of the VAS, ROM and Orthopaedic test data from the final analysis 
could be considered un-ethical given the patient and researcher time and cost required to collect 
these variables. However it is argued that the importance of avoiding over-fitting – and the potential 
for inaccurate clinical prediction rules to be generated from such data – would be a more un-ethical 
and harmful outcome.  
 
220 
 
The retention of the OSS as a continuous variable had the advantage of maximising statistical power 
in the study. The subsequent regression model was constructed using an automated, statistically 
determined procedure of forward selection and backward elimination with pre-assigned statistical 
cut off points. The use of a stepwise but non-hierarchical approach allowed all permutations of 
variables to be considered irrespective of their category, which ensured that no single category or 
variable was prioritised. However, it must be acknowledged that the retention a minimum of one 
variable per category and of both the diagnostic ultrasound and scapular movement and control 
variables (irrespective of issues with their reproducibility) could be construed as use of a pseudo-
hierarchical approach.  
 
The subsequent application of thorough testing of fit of the model and diagnostics ensured that the 
model for each time point could be viewed with a degree of confidence. As part of this the thorough 
reporting of R2 values (indicating the amount of variation in the outcome variable explained by each 
model) and regression equation coefficients (β) (used to identify the direction of any relationships 
between predictor variables and the dependent variable) enables the reader to ascertain the 
magnitude and nature of the relationships identified by the analysis.  
 
7.7 Summary of methodological considerations 
It can therefore be seen that the current study with its prospective cohort design and greater than 
80% follow up at each time point makes it of the highest level of prognostic study (NHMRC 2000; 
Phillips et al. 2016). The combination of logical, theoretical and statistical procedures for aligning the 
number of candidate variables to the sample size provides a multi-factorial mechanism for 
addressing potential threats of over-fitting. The subsequent use of a quantified, pragmatic treatment 
and follow up points defined by the actual point when face-to-face treatment finished all ensure 
maximal clinical relevance of the study.  
 
The inclusion of the SDT and diagnostic ultrasound are note-worthy novel elements. Although their 
reproducibility were both lower than preferred for inclusion in a prognostic model, the analysis of 
their robustness provides a mechanism for considering this when interpreting the overall study 
findings. Alongside these the inherent variability in the nature and dose of the intervention 
(physiotherapy) combined with heterogeneity in the care pathway within which the study was 
located are all identifiable sources of background noise which may contribute to the low level of 
predictive ability.  
 
221 
 
7.8 Hypotheses accepted / rejected  
The following null hypotheses were accepted and the corresponding experimental hypotheses 
rejected: 
 
B.(i) Clinical history  
In a multivariate analysis, clinical history related variable will not be a predictor of outcome between 
baseline and discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
D.(i) Clinical measures  
In a multivariate analysis, baseline clinical measures will not be a predictor of outcome between 
baseline and discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
E.(i) Structural pathology  
In a multivariate analysis, baseline structural pathology will not be a predictor of outcome between 
baseline and discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
A.(ii) Demographics  
In a multivariate analysis, demographics will not be a predictor of outcome between baseline and 3 
months post-discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
B.(ii) Clinical history  
In a multivariate analysis, clinical history related will not be a predictor of outcome between baseline 
and 3 months post-discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
D.(ii) Clinical measures  
In a multivariate analysis, baseline clinical measures will not be a predictor of outcome between 
baseline and 3 months post-discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
E.(ii) Structural pathology  
In a multivariate analysis, baseline structural pathology will not be a predictor of outcome between 
baseline and 3 months post-discharge in SIS/RCTendinopathy patients treated with physiotherapy. 
 
F.(ii) Multivariate prognosis 
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In a multivariate analysis, a combination of 2 or more of A. Demographics, B. Clinical history, C. 
Patient reported measures, D. Clinical measures and E. Structural pathology will not predict outcome 
between baseline and 3 months post-discharge in SIS/RCTendinopathy patients treated with 
physiotherapy. 
 
The following null hypotheses were rejected and the corresponding experimental hypotheses 
accepted: 
 
A.(i) Demographics  
In a multivariate analysis, demographics will not be a predictor of outcome between baseline and 
discharge in SIS/RCTendinopathy patients treated with physiotherapy; specifically Age (when 
combined with mean SPADI) was identified as accounting for 6.7% of the variability in the dependent 
variable. The negative coefficient meant that greater age was associated with less improvement in 
OSS. 
 
C.(i) Patient reported measures 
In a multivariate analysis, baseline patient reported measures will not be a predictor of outcome 
between baseline and discharge in SIS/RCTendinopathy patients treated with physiotherapy; 
specifically mean SPADI was identified as accounting for 9% of the variability in the dependent 
variable. The positive coefficient meant that a higher SPADI mean (greater pain and disability) was 
associated with a greater improvement in OSS.  
 
F.(i) Multivariate prognosis 
In a multivariate analysis, a combination of 2 or more of A. Demographics, B. Clinical history, C. 
Patient reported measures, D. Clinical measures and E. Structural pathology will not predict outcome 
between baseline and discharge in SIS/RCTendinopathy patients treated with physiotherapy; 
specifically mean SPADI and Age were identified as accounting for 15.7% of the variability in the 
dependent variable.  
 
C.(ii) Patient reported measures 
In a multivariate analysis, baseline patient reported measures will not be a predictor of outcome 
between baseline and 3 months post-discharge in SIS/RCTendinopathy patients treated with 
physiotherapy; specifically mean SPADI was identified as accounting for 9.6% of the variability in the 
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dependent variable. The positive coefficient meant that a higher SPADI mean (greater pain and 
disability) was associated with a greater improvement in OSS. 
 
7.9 Exploration of prognostic findings in relation to previously published prognostic 
studies 
In this section the prognostic findings from the current study will be considered in the context of 
other studies in this area and in the realm of prognostic research more broadly.  
 
7.9.1 Hypotheses A.(i) and A.(ii) Demographics  
In rejecting the null hypothesis and accepting the experimental hypothesis, the current study found 
in multivariate analysis that the demographics factor of age was a predictor of change in OSS 
between baseline and discharge but not between baseline and 3 months post-discharge. 
Directionally, the current study identified that greater age was associated with less improvement in 
OSS.  
 
Morrison et al. (1997), Kennedy et al. (2006) and Deutscher et al. (2009) all reported greater age to 
be predictive of poorer outcome although their findings referred to absolute score at discharge. Of 
greater comparability to the current study was the finding from Kennedy et al. (2006) that younger 
age was predictive of greater improvement in disability via change in DASH score from baseline to 
discharge / 12 weeks. From these results it could be concluded that greater age predicts both 
greater impairment at follow up and less improvement in impairment at follow up. Such findings 
mirror those from the low back pain literature with respect to improved pain (Verkerk et al. 2015) 
and greater gains in perceived function (Gregg et al. 2014) for younger patients and poorer change 
in disability in older patients (Cecchi et al. 2014).   
 
Whilst the current study and Morrison et al. (1997) dealt specifically with SIS/RCTendinopathy 
patients, both Deutscher et al. (2009) and Kennedy et al. (2006) considered less well defined 
shoulder patient populations, namely shoulder pain and soft tissue disorders of the shoulder; 
respectively. Along with the findings from the low back pain rehabilitation literature, this provides 
evidence that the conceptually generic variable of age may be of relevance in predicting outcome 
across different, albeit overlapping patient populations.   
 
It is acknowledged that eight other shoulder prognostic studies failed to identify age as a predictor 
and that many of these were of a high quality. However in the case of Hung et al. (2010), the age of 
224 
 
their subjects (20-33 years) provides a very narrow range of age data for any association to be 
identified and thus could explain the lack of age being a predictor. Where studies dichotomised the 
age variable (Bartolozzi et al. 1994; Mintken et al. 2010) or used very small sample sizes (Conroy and 
Hayes 1998) the greatly reduced statistical power might also explain the lack of significant findings.  
 
Timescale might also be another explanatory factor because the current study only identified age as 
a predictor of change at the discharge time point but not at 3 months post discharge. This would 
align with those who had null findings for age at a longer time period, namely 6 months (Ogon et al. 
2009), 12 months (Engebretsen et al. 2010) and 20 months (Bartolozzi et al. 1994). Such findings 
indicate that whilst increasing age may influence outcome in the short term, any influence is lost at 
longer follow up time points. Speculative reasons for this include an initial delay in response to 
intervention in those who are older, perhaps due to delayed tissue healing (where a patho-
anatomical model is favoured) or a reduced ability to accept and integrate adaptive activities into 
their lives where a psychosocial model is favoured (Bjorck-van Dijken et al. 2008) or both, where an 
ICF model is favoured.  
 
In terms of an emerging consensus on predicting outcome, the current study adds to the evidence 
base that age is a predictor whereby older age is associated with worse outcome. However the large 
number of studies which did not find age to be predictive, together with the wide variety of 
demographic variables which were found by a small number of studies to be predictive, means that 
a definitive consensus cannot currently be established. However it is recommended that future 
prognostic studies in this area retain age as a continuous variable for consideration in their 
prognostic model.   
 
7.9.2 Hypotheses B.(i) and B.(ii) Clinical history measures 
In accepting the null hypotheses, the current study did not find in multivariate analysis that clinical 
history related measures were a predictor of change in OSS between baseline and discharge nor 
between baseline and 3 months post-discharge. Specifically the duration of symptoms prior to 
baseline data collection was not a predictor of outcome.  
 
This finding is in agreement with that of Conroy and Hayes (1998), Ogon et al. (2009), Virta et al. 
(2009) and Engebretsen et al. (2010). However these previously published studies were generally of 
inferior quality compared to the three studies that found duration of symptoms to be predictive of 
outcome state and four studies that found it predictive of greater change.  
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A potential explanation for these differing results (non-predictive versus predictive) lies in how the 
duration variable was treated. In this respect some of those who found this variable to be predictive 
(Deutscher et al. 2009; Mintken et al. 2010; Bartolozzi et al. 1994) dichotomised chronicity to acute 
versus chronic, greater versus less than 90 days and greater versus less than 12 months; respectively. 
This is in contrast to the use of ordinal duration of symptom data in the current study. However 
Kennedy et al. (2006) also used ordinal data for this variable and did find it to be predictive of 
change in disability from baseline to discharge. Therefore differences in the processing of this 
variable are unlikely to explain the conflicting findings.   
 
Given that a majority of studies in this research area and also many from other musculoskeletal 
disorders have found duration of symptoms to be predictive (Rihn et al. 2011; McClinton et al. 2015) 
then specific elements pertaining to the current study may provide an explanation. In this respect 
the frequency of patients reporting this as being their first episode of shoulder pain (80.3%) is 
unusually high given the high recurrence rate of shoulder pain (Winters et al. 1999). This may 
therefore reflect a skewed sample in terms of those being referred to physiotherapy and/or being 
recruited to the study.   
 
The clinical history data also provide detail on the context of the current study, which may again 
present challenges when comparing findings with those studies considered in the literature review, 
and also those studies excluded.  The literature reviewed in this thesis was limited whereby those 
studies where the intervention was steroid injection +/- non-invasive, multimodal physiotherapy and 
where results were not segregated for those patients who were treated solely with non-invasive, 
multimodal physiotherapy were not considered. Yet for pragmatic reasons 16% of the cohort in the 
current study had received one or more injections via their GP as part of their episode of care, 
thereby potentially tainting the sample with this additional modality. It is therefore possible that 
studies excluded because they did not present segregated results for non-invasive, multimodal 
physiotherapy separate from injection and non-invasive, multimodal physiotherapy would actually 
have provided highly relevant findings.  
 
It can therefore be concluded that the current study does not add to the emerging consensus of 
duration of symptoms being predictive of outcome. However the clinical history data provides some 
differences in patient sample, which may limit comparability of the current study findings with 
previous work in this area. The lack of consensus regarding the other clinical history variables 
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explored in this area of research indicates that further work is required to establish the predictive 
value of other variables.  
 
7.9.3 Hypotheses C.(i) and C.(ii) Patient reported measures 
In rejecting the null hypothesis and accepting the experimental hypothesis, the current study found 
in multivariate analysis that patient reported measures were a predictor of change in OSS between 
baseline and discharge and between baseline and 3 months post-discharge. Specifically function as 
defined by the total SPADI predicted outcome at both time points. However the patient reported 
measure of pain as measured by VAS was excluded from the final prognostic analysis due to the 
limited sample size and the emphasis upon avoiding over-fitting of the model. Psychological 
symptoms as measured by the 4DSQ were not found to be predictive at either time point.  
 
7.9.3.1 Pain 
The previous literature in this area provided moderate evidence of baseline pain levels being a 
predictor, with higher pain levels predicting worse outcome. The current study is unable to directly 
contribute to this debate due to the omission of the pain variable from the prognostic modelling 
stage. As noted previously this was permissible due to the high correlation with the patient-reported 
functional outcome score (total SPADI).  
 
7.9.3.2 Psychological 
The finding from the current study that psychological symptoms as measured by the 4DSQ were not 
predictive contrasts with that of Engebretsen et al. (2010), Sindhu et al. (2012) and Chester et al. 
(2016). However unlike the 4DSQ, the patient expectation predictors (Chester et al. 2016) and 
general health status via EQ-VAS (Engebretsen et al. 2010) provide limited evidence regarding actual 
psychological symptoms.  
 
Where the more relevant measures of fear-avoidance beliefs (Sindhu et al. 2012) and pain self-
efficacy (Chester et al. 2016) were identified as predictive of outcome this was in studies with 
sample sizes greater than 1,000. Conversely, the same factors were not predictive in the studies by 
Mintken et al. (2010) and Kromer et al. (2014); Engebretsen et al. (2010), who had sample sizes of 
80, 90 and 104 (respectively). Where more formal assessments of psychological symptoms were 
collected as in the study by Engebretsen et al. (2010) and the current study, these were not found to 
be predictive. Of note is that they also had sample sizes a factor of 10 smaller than those of Sindhu 
et al. (2012) and Chester et al. (2016).  
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These elements provide a potential explanation regarding the apparently conflicting psychological 
symptoms findings, which is that whilst the psychosocial model is advocated in musculoskeletal 
disorders and non-invasive, multimodal physiotherapy, its actual impact is small. A lack of impact 
from treatments targeting psychosocial factors in similar conditions like low back pain (Jellema et al. 
2005) provides a degree of support for this viewpoint, as does evidence of a lack of association 
between distress and rotator cuff tendinopathy (Mallows et al. 2017). As such the findings raise the 
possibility that the complex nature of psychological symptoms make them inherently difficult to 
identify as predictors, thereby requiring large scale, sufficiently powered studies in order to identify 
a predictive effect.  
 
Furthermore, the limited incidence of clinical levels of psychological distress in the current cohort 
provides partial triangulation for this, as does the low psychological scores in the cohort of Kromer 
et al. (2014) and Chester et al. (2016). One mechanism to explore this would be the inclusion of a 
category within the treatment measurement asking for specific psychological interventions, e.g. 
counselling and exposure therapy. However the addressing of psychological elements that is argued 
to be inherent within the patient-therapist interaction (Dragesund and Kvale 2016) make this a 
challenging aspect of treatment to capture.   
 
7.9.3.3 Function 
In the current study, baseline function / disability as measured by the total SPADI score was 
predictive of change in OSS from baseline to both discharge and 3 months post-discharge. The 
identification of this variable as a predictor agrees with the majority of studies (7 out of 8) that 
explored it as a potential predictor. As such, there is strong evidence from the literature that 
baseline function / disability predicts outcome and this aligns with published systematic reviews 
(Littlewood et al. 2013).   
 
This consensus might be explained by the generic importance of function, i.e. an aspect that is 
consistently of relevance to patients. This theory would be supported by the broad range of 
components that comprise patient reported function scores (e.g. pain, mobility, ability to 
participate) and this fitting with the multi-factorial nature of musculoskeletal conditions, including 
SIS/RCTendinopathy (Walker-Bone et al. 2003). It could also be perceived as reflecting the complex 
intervention nature of non-invasive, multimodal physiotherapy (as demonstrated by the multi-
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faceted treatment intervention data in the current study) and the capacity to potentially influence 
multiple facets of the condition (Littlewood et al. 2016).  
 
However there is also a potential methodological explanation for these findings in that the aspects 
of function / disability measured at baseline will likely have substantial overlap with the aspects of 
function / disability measured at follow up, including the derivation of change scores. Such a 
scenario is highlighted by the use of the same measurement tool in both capacities in the studies by 
Kennedy et al. (2006) with the DASH; Chester et al. (2016) with the Quick DASH; Engebretsen et al. 
(2010), Kromer et al. (2014) and Chester et al (2016) with the SPADI; Bartolozzi et al. (1994) with the 
UCLA; Deutscher et al. (2009) with the CAT. This situation could be termed ‘outcome alignment’, 
whereby the consideration of a potential predictor which is conceptually (or in the above cases 
actually) the same as the dependent variable will more likely give rise to statistically significant 
findings. As such, the use in the current study of two different but conceptually overlapping 
measures (SPADI and OSS) partially mirrors this methodological explanation.  
 
Of further note is that the total SPADI score was the only variable in the current study to be 
predictive at both time points. This finding mirrors that of Chester et al. (2016) who found both the 
SPADI and Quick DASH to be predictive at both the 6 week and 6 month time points. As such, these 
pooled findings can be viewed as providing further evidence of the consistent predictive ability of 
this variable type.  
 
Directionally, a higher SPADI mean score (greater pain and disability) in the current study was 
associated with a greater improvement in OSS. This concurs with the result from Hung et al. (2010) 
whereby higher baseline disability as measured by the FLEX-SF was predictive of improvement which 
was a binary classification based upon the GROC score. These also concur with the reporting by 
Kromer et al. (2014) of higher baseline disability levels as measured by the function element of the 
SPADI as being predictive of a greater change score at 3 months post baseline. Furthermore Kennedy 
et al. (2006) found worse physical health (via the Physical Component Score (PCS) of the SF-36) at 
baseline to be predictive of greater improvement in disability via change from DASH score at 
baseline to discharge / 12 weeks.  
 
Indeed, of the studies that explored function / disability as potential predictors and where change in 
status was the dependent variable, only Mintken et al. (2010) did not find the variable to be 
predictive. However the very short study duration from Mintken et al. (2010) of approximately 1 
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week (from baseline to follow up) makes it possible that such established elements of pathology as 
measured by the SPADI would be unlikely to change. In support of this is the weighting of the SPADI 
whereby eight of the 13 questions pertain to disability.  
 
However the predictive direction in the current study appears to be opposite to that reported by 
Bartolozzi et al. (1994), Kennedy et al. (2006), Deutscher et al. (2009), Engebretsen et al. (2010) and 
Chester et al. (2016), whereby greater functional impairment / disability at baseline predicted a 
worse outcome state. The seemingly opposite findings between the studies (including the current 
one) whose dependent variable was change in state versus those whose dependent variable was 
absolute state might be explained by the way in which outcome was defined.  
 
The explanation here could be that Bartolozzi et al. (1994), Kennedy et al. (2006), Deutscher et al. 
(2009), Engebretsen et al. (2010) and Chester et al. (2016) identified that those with high levels of 
disability at baseline were those who still had high levels of disability (relative to the cohort) at the 
follow up time point. Such a finding need not be incompatible with the findings of the current study, 
Kennedy et al. (2006), Hung et al. (2010) and Kromer et al. (2014), where those with higher baseline 
disability demonstrated the most change, potentially because they had the most scope to improve. 
From a statistical perspective, the regression modelling in the current study and similar 
investigations would have been strongly influenced by those with very large changes in function / 
disability outcome measure and would have differentiated clearly between subjects with worsening 
of score and improvement of score. However with Bartolozzi et al. (1994), Kennedy et al. (2006), 
Deutscher et al. (2009), Engebretsen et al. (2010) and Chester et al. (2016), the magnitude of change 
from baseline would have no impact on the regression modelling as only end state was used.   
 
In essence it is possible for subjects to change the most in a cohort and yet still be poorer 
functioning / more disabled than others in the cohort. Such findings highlight the critical role played 
by the methods used to define the dependent variable, the challenge of pooling results from studies 
using different approaches to measuring outcome and consequently the challenges of establishing a 
consensus on prognosis in this area.   
 
7.9.4 Hypotheses D.(i) and D.(ii) Clinical measures  
In accepting the null hypothesis, the current study did not find in multivariate analysis that clinical 
measures were predictors of change in OSS between baseline and discharge nor between baseline 
and 3 months post-discharge. Specifically neither of strength (as represented by the mean moment 
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of external rotation on the symptomatic side) nor scapular movement and control as represented by 
the scapular dyskinesis test were predictors of outcome. ROM represented by the limit of ROM on 
the symptomatic side was excluded from the final prognostic analysis due to the limited sample size 
and the emphasis upon avoiding over-fitting of the model.  
 
7.9.4.1 Strength 
Hung et al. (2010) identified reduced serratus anterior strength as being predictive of improved 
outcome although in their study IR, ER and abduction strength were not predictive. Bartolozzi et al. 
(1994), Kennedy et al. (2006), Mintken et al. (2010) and Chester et al. (2016) considered various 
aspects of strength but none found it to be a predictor of outcome. The weight of evidence is that 
strength is not predictive of outcome and this is supported by the findings from the current study.  
 
Use in the current study of an accurate and reproducible strength measurement tool addresses 
measurement error as a potential source of statistical background noise. Nonetheless, one possible 
explanation for the null finding are other sources of between-subject variability. Possible 
explanations include the wide variation in duration of symptoms (39.5% < 6 months duration; 15.8% 
>24 months duration) and thus theoretically wide variation in levels of disuse muscle atrophy 
(Vlaeyen and Linton 2000). Wide variation in pain levels at the time of first assessment (VAS of 0.0 to 
9.4) could potentially introduce variability in pain inhibition levels (Verbunt et al. 2005). Similarly, the 
wide variation in baseline upper limb activity levels across the cohort (represented by demographic 
data of recreational and work-related activities) was another potential source of inherent strength 
data variation. The subsequent interaction between these factors provides an additional layer of 
potential complexity within this variable. Indeed these reflect the inherent complexity in the 
manifestation of musculoskeletal pain, including in SIS/RCTendinopathy.  
 
One mechanism by which such sources of variability might be accommodated is by assessing 
subgroups of patients according to their symptom duration, symptom intensity or background levels 
of shoulder activity. However the generalisability of such findings would be limited.  
 
7.9.4.2 ROM 
As noted previously, the disparate nature of those ROM variables that were found to be predictive in 
previous studies (Mintken et al. 2010; Tyler et al. 2010; Chester et al. 2016) – along with the much 
larger number of ROM variables which were not found to be predictive – makes establishing a 
consensus on the predictive value of ROM very challenging.  
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In considering the current study, comparison would have been limited by the following factors: 
 In reporting posterior shoulder tightness as predictive, Tyler et al. (2010) were actually 
investigating the change in ROM across the treatment period as the variable of interest, whilst 
the current study was concerned with baseline ROM as a predictor. As such, fundamentally 
different uses of ROM-related data were employed in the current study and that of Tyler et al. 
(2010).  
 Mintken et al. (2010) on the other hand identified baseline ROM variables as being predictive of 
a better outcome. It should be noted that the sample size available for prognostic analysis in the 
current study at discharge (n=73) was comparable to that of Mintken et al. (2010) (n=80). 
However whilst the current study used a stepwise procedure to enter seven variables into the 
regression model, Mintken et al. (2010) entered double this number. The less conservative 
approach taken by Mintken et al. (2010) raises the potential for over-fitting of their model.  
 The baseline active ROM variable identified by Chester et al. (2016) as being a predictor was only 
predictive for their end state SPADI score at 6 weeks. In the current study a pragmatic, clinician-
led treatment approach was used, as was the case with Chester et al. (2016). However at 6 
weeks, 77% of subjects in the current study were still under treatment. Therefore the timing of 
the 6-week finding by Chester et al. (2016) is likely to reflect a heterogeneous mix of patients 
who have completed and who are still under treatment.   
 
Nonetheless, ROM was not entered into the prognostic model in the current study for the statistical 
reasons previously presented. In light of the wide-ranging aspects of ROM that have been 
investigated in previous prognostic studies – and predominantly found not to be predictive – there is 
a lack of clarity as to the predictive merit of ROM and what manifestation of it might be meaningful 
in predicting outcome.   
 
7.9.4.3 Scapular movement and control 
Mintken et al. (2010) considered scapular position, movement and control related variables but 
found them to not be a predictor of outcome and this concurs with the findings of the current study. 
Although there are noteworthy differences such as the use of static measures applied in the Mintken 
et al. (2010) study compared to the current study, the parallel use by Mintken et al. (2010) of a 
dynamic, qualitative approach (Kibler et al. 2002) is broadly comparable with the method used in the 
current study. Such findings provide a degree of triangulation with uncertainty as to the clinical 
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relevance of scapular movement / dyskinesis and whether people with and without shoulder pain 
have differences in scapular function (Timmons et al. 2012). 
 
However Hung et al. (2010) identified less IR of the scapula as a predictor of better outcome. 
Specifically this was at 30° shoulder elevation during the descending phase in the unloaded 
condition. This reflects a key measurement difference, which was the use of a motion analysis 
system allowing for highly detailed measurement of 3 dimensional scapular kinematics. It should be 
noted however that the 60°, 90°, and 120° humeral elevation positions, the ascending phase and the 
other kinematic variables (upward rotation and anterior tilt) did not yield predictors. This might 
provide an explanation for the seemingly disparate results between the current study and that of 
Hung et al. (2010) in that the scapular dyskinesis test incorporates both ascending and descending 
phases, across all shoulder elevation ranges and provides a composite rating from all component 
kinematic elements. It might therefore be postulated that any such predictive scapular elements in 
the current study might have been dwarfed by the majority of non-predictive scapular elements.  
 
However this potential explanation does highlight one of the key limitations of including scapular 
variables in a predictive study design, in that scapular movement is inherently difficult to quantify in 
a meaningful, comprehensive and reliable manner. It might be argued that with existing clinical tools 
the complexity is such that their inclusion as candidate variables in a predictive study is unlikely to 
yield useful results. Conversely, the use of more treatment-orientated approaches such as the 
symptom modification test (Lewis 2009) might yield more promising prognostic results. In addition, 
Hung et al. (2010) entered 48 scapular variables into their prognostic model. With a sample size of 
only 32 and the consideration of a further 12 other potential prognostic variables, the threat of over-
fitting is particularly likely in this study, with only 0.5 cases per variable.    
 
The use by Chester et al. (2016) of just such a symptom modification approach was novel and was 
identified by the authors as a predictive variable at the 6 months time point for both their end state 
SPADI and QuickDASH scores. Fundamental differences between this symptom adjustment approach 
and the movement and control approach used in the current study limits direct comparison. 
However the arguably more direct clinical relevance of the approach used by Chester et al. (2016) 
provides some limited support for the use of this scapula-related characteristic in future studies. Of 
further note here is that Chester et al. (2016) examined a general shoulder pain sample and so their 
study provides evidence of the relevance of symptom modification with scapular facilitation 
techniques to be independent of the type of shoulder pain pathology.   
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The absence of clinical measures being identified as predictors in the current study is noted. Due to 
the time consuming nature of collecting clinical measures then this provides one mechanism by 
which the requisite increasing of prognostic study sample sizes might be achieved whilst 
accommodating logistical and financial constraints. The conceptual overlap and statistical 
correlations between the total SPADI score and both ER mean moment and limit of ROM provide a 
rationale for selecting patient reported measures rather than clinical measures. As such they also 
highlight the ability for patients to fairly accurately self-identify their own levels of physical 
impairment.  
 
7.9.5 Hypothesis E.(i) and E.(ii) Structural pathology  
In accepting the null hypothesis, the current study did not find in multivariate analysis that structural 
pathology was a predictor of change in OSS between baseline and discharge nor between baseline 
and 3 months post-discharge. Specifically U/S findings as characterised by (i) no sonographic 
evidence of pathology, (ii) sonographic evidence of either bursal or rotator cuff pathology and (iii) 
sonographic evidence of bursal and rotator cuff pathology, were not predictors of outcome. 
Orthopaedic test findings were excluded from the final prognostic analysis due to the limited sample 
size and the emphasis upon avoiding over-fitting of the model.  
 
The finding in the current study that structural pathology via imaging were not predictive contrasts 
with all of those previous studies (Bartolozzi et al. 1994; Morrison et al. 1997; Ogon et al. 2009) that 
have considered this variable type and subsequently found it to be predictive. However 
comparability with the results from Morrison et al. (1997) are very limited as the retrospective 
cohort study by Morrison et al. (1997) only considered acromion morphology which is of limited 
direct relevance to the sonographic variables considered in the current study.  
 
The study by Bartolozzi et al. (1994) identified rotator cuff pathology in the form of moderate or 
large rotator cuff tears as being predictive of outcome. However it is noted that all patients in the 
Bartolozzi et al. (1994) study received a diagnosis of pathology ((i) impingement, tendinitis, (ii) PTT or 
small FTT, (iii) tears >1cm2). This contrasts with the current study whereby n= 14 (18%) of patients 
were identified as having no sonographic evidence of pathology and this rose to n= 28 (37%) with a 
criteria of no sonographic evidence of rotator cuff pathology. Fundamental differences in the nature 
of the samples and/or the potential that Bartolozzi et al. (1994) inappropriately assigned an imaging 
rotator cuff pathology diagnosis to all their participants means that comparability of the different 
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prognostic findings in relation to structural pathology cannot be made between the current study 
and that of the retrospective cohort study by Bartolozzi et al. (1994).  
 
The higher quality prospective cohort study with >80% follow up by Ogon et al. (2009) identified 
multiple sonographic factors as predictive of positive outcome (i.e. radiographic classification of the 
calcific deposits and the sonographic penetration of the deposits) and negative outcome (i.e. 
bilateral calcific deposits, location and volume of the deposits). Multiple fundamental differences in 
study design may account for these differences. Specifically the current study was concerned with 
SIS/RCTendinopathy whereby only n=6 (7.9%) of the cohort had sonographic evidence of calcific 
deposits, compared to the study by Ogon et al. (2009) where imaging confirmed presence of calcific 
deposits was their primary inclusion criterion. Therefore there is very limited comparability of the 
current cohort with that of Ogon et al. (2009) in relation to the structural pathology characteristics 
they explored.  
 
Further key differences include their entering of four radiographic and three sonographic calcific 
variables into their regression model whilst the current study entered only one sonographic variable 
into the regression model whereby calcific deposits comprised only one element (cuff pathology) of 
one grading of the variable. This reflects the different emphases of the two studies with Ogon et al. 
(2009) concerned primarily with radiographic and sonographic variables whilst the current study 
explored variables across structural pathology, clinical measures, patient reported measures, 
demographics and clinical history domains. Indeed this highlights one of the quandaries of 
prognostic research: with Ogon et al. (2009) narrowly aligning the nature of the sample with the 
candidate prognostic factors to explore, this will arguably be more likely to produce prognostic 
models where multiple predictors are retained in the final model. Conversely the use of a more 
loosely defined sample with candidate prognostic factors from a broad range of aspects (as in the 
current study) makes it potentially more challenging to identify multiple predictors in the final 
model. The limited sample size upon which the prognostic models were run in the current study 
(n=73 and n=62 at the discharge and 3 months’ time points) and subsequent limited statistical 
power will arguably compound this further.  
 
Although the non-prognostic findings in relation to structural pathology align with published 
systematic review findings (Littlewood et al. 2013), it nonetheless can be concluded that the current 
study is the first prognostic study of its kind which included imaging of structural pathology but did 
not identify it as a predictor of outcome. The above section provides various possible explanations 
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for this difference, in relation to the published literature. However of note is the highly subjective 
nature of imaging and particularly sonographic diagnoses, which has led some authors (Moons et al. 
2009) to caution against the inclusion of such variables in prognostic research. The preliminary use 
by the candidate of mechanisms such as bilateral scanning and criteria for the identification of 
tendinopathic change might be one such mechanism to improve repeatability but this remains an 
area for future work.  
 
7.9.6 Orthopaedic test evidence 
In the literature review it was concluded that there was weak evidence for orthopaedic tests being 
predictive of outcome. In the current study the exclusion of orthopaedic test findings from the final 
prognostic analysis means that the evidence base around this variable type is not contributed to.  
 
To further compound this lack of clarity, the identification by Mintken et al. (2010) of a single test 
(negative Neer's sign) as being predictive of a positive outcome, conflicts with research opinion 
(Hegedus et al. 2012) that a battery of tests should be used in order to overcome issues of sensitivity 
and specificity with individual tests. Chester et al. (2016) did not identify the external rotation lag 
sign as a predictor but this test concerns rotator cuff tears (Castoldi et al. 2009).  
 
The approach by Chester et al. (2016) of using a singular, structural integrity test is conceivably 
inferior to the use of diagnostic imaging in the current study. However the incumbent time and cost 
requirement of scanning placed inevitable limits on the sample size in the current study thereby 
reducing the overall power to detect prognostic factors. Furthermore, transferability to routine 
clinical practice is arguably better with the approach taken by Chester et al. (2016) for the same 
reasons.   
  
7.9.7 Hypotheses F.(i) and F.(ii) Multivariate prognosis 
In rejecting the null hypothesis and accepting the experimental hypothesis, the current study found 
in multivariate analysis that a combination of variables were predictors of change in OSS between 
baseline and discharge but not between baseline and 3 months post-discharge. Specifically total 
SPADI and age combined to explain 15.7% of the variance in OSS change between baseline and 
discharge. In the baseline to 3 months post-discharge model, total SPADI explained 9.6% of the 
variance in OSS.  
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The inclusion of only two predictor variables in the final baseline to discharge OSS model and one 
variable in the final baseline to 3 months post-discharge OSS model are at the lower end of the 
number of variables comprising multi-variate models in the previously published literature. Where 
studies used change of state as the outcome variable their final models comprised 2 (Kromer et al. 
2014), 3 (Hung et al. 2010), 4 (Mintken et al. 2010) or 5 (Kennedy et al. 2006; Ogon et al. (2009)) 
variables. As with the current study these were prospective cohort studies with >80% follow up 
(except for Kennedy et al. (2006) and Kromer et al. (2014)) and so considered of the highest level of 
study quality. Study quality is therefore unlikely to explain the broad range in the number of 
variables comprising the final multivariate models.  
 
Wide variation in the methods used to construct the final prognostic models provides one potential 
explanation for such variation. This included Kromer et al (2014) who was the only one of the above 
studies to retain numerous variables in their model, irrespective of the contribution or level of 
significance, thereby adjusting their model for these factors. The studies by Kennedy et al. (2006), 
Ogon et al. (2009) and Kromer et al. (2014) used an approach whereby variables with p ≥ 0.05 were 
removed. Conversely Mintken et al. (2010) required variables with a p<0.10 so as to be retained. A 
combination approach was used in the current study and also by Hung et al. (2010) whereby a 
significance of p≤0.05 was required to enter a variable into the model and a significance of p≥ 0.10 
was required to remove it. Evidence to support this comes from Bekkering et al. (2005) who 
analysed the same dataset using different regression modelling techniques and generated differing 
numbers of predictive variables.  
 
The amount of variation (15.7%) explained by the baseline to discharge OSS model and for the 
baseline to 3 months post-discharge model (9.6%) in the current study are the lowest of any of the 
previously reported studies in this area. Potential explanations include the use of larger samples and 
therefore more highly powered studies by Chester et al. (2016) and Deutscher et al. (2009) whose 
final models explained 31% and 30% of the variance in their outcome variables. However studies 
with sample sizes that were very comparable to the current study such as Engebretsen et al. (2010) 
(n=104) and Kromer et al. (2014) (n=90) were able to explain 30% and 48% of the variation in their 
outcome variables; respectively. Such findings make it unlikely that sample size alone explains the 
differences in amount of variation predicted by the regression models.  
 
Looking beyond shoulder pain, the low back pain literature provides some limited evidence of 
comparatively low predictive values. For example the investigation of chronic low back pain patients 
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by Steffens et al. (2014) was only able to predict 10 % of the variance in the 1-year pain outcome via 
baseline pain intensity. For their dependent variable of disability at 12 months, a combination of 
duration of current episode, baseline disability and educational level accounted for 15% of the 
variation. Interestingly the authors speculated that the partial absence in their cohort of previously 
identified predictors (due to the intentional skewing towards high educational and socioeconomic 
status patients accessing a private paying exercise program incorporating cognitive behavioural 
therapy) was a potential explanation for their low levels of prediction. Comparatively low levels of 
predictive ability in the low back pain literature were reported by Bekkering et al. (2005) where a 
disproportionately high number of positive responses by patients may have made discriminative 
prediction challenging.   
 
However an alternative explanation for the low level of prediction in the current study may come 
from the multi-factorial variability within the overall study. This variability would conceivably create 
a large amount of statistical background noise, thereby making it much harder to statistically identify 
predictive factors which (collectively) would account for a higher percentage of variability in the 
outcome measure. The most notable source of variability in the current study is the use of pragmatic 
treatment which varied substantially between patients, including the duration, ‘dose’ and nature of 
physiotherapy. As such, a potential explanation for the even lower percentage of predictive capacity 
in the baseline to 3 months post-discharge model might be further variability introduced by the 
nature and level of shoulder activities that different patients may have undertaken once discharged 
from physiotherapy.   
 
An additional source of inherent variability is the time between baseline data collection and 
discharge data collection. The studies critiqued in this thesis used either standardised treatment 
and/or standardised post-baseline data collection time points. The use in the current study therefore 
of individualised baseline to discharge durations means that such variability introduces further 
background noise into the overall study. Picking through this background noise in order to predict an 
adequate level of variation in the outcome variable will inevitably be more challenging and may 
explain the low level of variability predicted in the current study.  
 
Potential mechanisms to address this include limiting variation within the system by partially 
standardising the intervention and also the follow up time. Other alternatives include aligning the 
nature of the population with the predictor variables as with Ogon et al. (2009) who recruited 
patients with calcific tendonitis and entered characteristics of the calcific deposits into their model. 
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From a generalisability perspective, increasing the sample size might allow for an improved capacity 
to predict a higher percentage of variation whilst also maximising generalisability.  
 
7.10 Implications of findings from the current study 
In the above sections an array of research and clinical implications were highlighted. In the following 
section, some key aspects of these will be further explored.  
 
7.10.1 Implications in relation to SIS/RCTendinopathy conceptual frameworks  
A number of conceptual frameworks within which SIS/RCTendinopathy can be viewed were 
presented in the literature review chapter. The prognostic findings from the current study will now 
be considered in relation to these frameworks.  
 
The first of these was the patho-anatomical model, incorporating both intrinsic and extrinsic factors. 
The failure of the current study to identify either E. Structural pathology (intrinsic factors) or D. 
Clinical measures; specifically scapular movement and control (extrinsic factors) as predictors of 
outcome provides evidence that this model does not assist with modelling prediction of outcome in 
SIS/RCTendinopathy patients treated with physiotherapy.  
 
The psychosocial model was represented by C. Patient reported measures; specifically 4DSQ which 
was also found to not be predictive. A role of this model in predicting outcome in this context is 
therefore not supported by the study findings.   
 
Finally, the ICF classification incorporated both factors which were not found to be predictive and 
those that were. Specifically: 
Not predictive: 
Functioning and disability: 
o Body function: Mental function = C. Patient reported measures; specifically 4DSQ 
o Body function: Neuromusculoskeletal and movement related functions = D. Clinical 
measures; specifically strength and scapular movement and control   
o Body structure: Structure related to movement = E. Structural pathology 
Qualifier: 
o Duration = B. Clinical history; specifically duration 
Predictive: 
Functioning and disability: 
239 
 
o Body function: Sensory function and Pain = C. Patient reported measures; specifically 
pain (represented by total SPADI score) 
o Activities and participation = C. Patient reported measures; specifically SPADI 
Contextual factors:  
o Personal factors = A. Demographics; specifically age 
 
Data from this study therefore provides evidence of a limited ability for conceptual frameworks to 
contribute to predicting outcome in SIS/RCTendinopathy patients treated with physiotherapy. 
Specifically only some elements of the ICF classification contributed to predicting outcome. The lack 
of contribution from the more narrowly focused patho-anatomical and psychosocial models can be 
seen as partial triangulation with the concept of SIS/RCTendinopathy being a complex, multifactorial 
condition. Indeed even the prediction of outcome in SIS/RCTendinopathy by the multi-faceted ICF 
model was only achieved by a limited portion of the framework.  
 
This raises questions as to whether the current models of disease have utility when exploring 
prognosis; and whether predicting outcome in SIS/RCTendinopathy is too complex to be adequately 
modelled. However it has been highlighted in the prognostic methodology literature that predicting 
outcome is not the same as explaining cause (Moons et al. 2009). This provides an alternative 
explanation; namely that bespoke predictive frameworks need to be constructed. Whilst these can 
be informed by models of disease, they should neither be constrained by them, nor their utility 
judged by them.  
 
7.10.2 Research implication 
Noting the points highlighted earlier in this chapter, research implications from the current study 
findings include consideration of how SIS/RCTendinopathy subjects are identified. In terms of 
prognostic studies, the novel method of identifying the sample partly via exclusion of discrete other 
shoulder pathologies provided a high rate of correct pathology identification where treating clinician 
opinion was used as a determinant of pathology type. Specifically of the 84 patients recruited to the 
study, only four were subsequently deemed to be of a different primary pathology, equating to 
95.2% (80/84) accuracy. This provides a novel mechanism for identifying patients in subsequent 
studies of SIS/RCTendinopathy cohorts. The prospective testing of the inter-rater reliability of this 
approach is therefore advocated. 
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The statistically significant correlation between the mean VAS score and the 3 constituent scores 
provides a rationale for using only the mean score in future studies, therefore providing a 
mechanism for data reduction. However the limited strength of some of these correlations must also 
be recognised. The same applies with the strength readings whereby the highly significant 
correlations between each of the strength variables supports the use of a single strength measure. 
However the finding that the total SPADI score was highly statistically significantly correlated with 
both the mean VAS score and limit of ROM variables provides a mechanism for substantially 
reducing both researcher and patient burden whereby the more readily collected tool of SPADI can 
be used instead.  
 
The inter-rater reliability studies provided evidence that ROM and strength measures as undertaken 
were highly reproducible by a single rater and thereby future use in research settings can be 
advocated. However the same cannot be said for the SDT which in the current study was found to be 
conceptually flawed (regarding the use of loaded trials) and with poor levels of inter-rater 
agreement. An important caveat here is that these relate to NHS patients and specifically to the 
patients and raters involved with the current study. However they highlight the necessity of 
undertaking reliability studies and conceptual testing when a measurement tool is to be used in a 
substantially different setting to the one where it was originally developed and tested. Regardless, 
the conclusion from the current study is that the SDT should not be used in its current form with 
NHS patient populations.  
 
Alongside the elements highlighted elsewhere in this chapter, the use of bilateral scanning as a 
pseudo comparator combined with a descriptive terminology to quantify the very subjective 
category of tendinopathy provide potential routes for the improvement of ultrasound as a 
measurement tool in future research. Mechanisms by which these could be investigated include 
testing this for reliability (within and between raters when looking at similar sonographic 
conclusions) and validity (outcome following treatment; also tissue biopsy for histology).  
 
The treatment measurement tool developed for the current study provides a potential template for 
quantifying the component parts of physiotherapy for patients with SIS/RCTendinopathy. This could 
contribute to the subsequent describing and stratifying of the intervention as a mechanism for 
aligning treatment approaches with particular patient groups or exploring more homogenous 
intervention types.  
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The identification of patient reported outcome scores as a consistent predictor of outcome provides 
a rationale for making this a high priority variable to include in future research. However the risk of 
excessive prognostic alignment between potential prognostic factor and outcome variable must be 
acknowledged and as such the use of alternative or parallel determinants of outcome should be 
noted, e.g. patient satisfaction.  
 
The identification of patient reported measures of function / disability along with age as predictors 
of outcome, provide evidence to support their inclusion in future prognostic research. When 
considering a method framework of prognostic research, confirmatory hypothesis-testing in an 
independent sample is advocated. However, due to the low percentage of variance explained by the 
current study it is recommended that a move from the exploratory end of study design approach 
cannot be advocated at this time. Further work on refining the tools to be used, or mechanisms to 
increase sample size, or nesting of future work within a section of the care pathway are advocated 
first.  
 
7.10.2.1 ‘Background noise’ and potential mechanisms to address this  
The predictive capacity of the current study was low. In the context of this study, where potential 
prognostic factors across a wide range of categories were explored, where treatment was pragmatic 
and the timescale for follow up defined by the individualised cessation of treatment, then predictive 
ability was limited.  
 
One potential explanation for this is the multi-level variability within the system. Specifically the 
complex, multifactorial nature of shoulder pain (including SIS/RCTendinopathy) will itself be a source 
of ‘background noise’ in terms of presentation and manifestation of the condition. Coupled with this 
is the inherent variability in the intervention (physiotherapy), including the component treatments, 
duration and dose received by each patient.  
 
Mechanisms to overcome this include to closely align the nature of the sample with the predictive 
variables explored, as with the study by Ogon et al. (2009) where patients were recruited with 
calcific tendinopathy and the majority of potential prognostic variables related to calcific deposits. 
An alternative approach is to substantially increase the sample size as a mechanism to increase the 
power of the study, as in the samples of 5,000 (Deutscher et al. 2009) and 1,030 (Chester et al. 
2016). A different alternative is the use of a self-management programme based around a single 
exercise, with data from Littlewood et al. (2016) providing evidence in support of using a single 
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exercise which in turn would arguably address some of the issues around ‘background noise’ in the 
study. 
 
Regardless of the approach taken, any potential prognostic variable must have acceptable levels of 
repeatability. Tools with low reliability (such as the SDT and ultrasound diagnoses in the current 
study) themselves introduce additional ‘background noise’, in parallel to limiting the confidence with 
which statistical conclusions can be viewed. Mechanisms by which the repeatability of any such tools 
can be improved is therefore a requisite stage for their use in future prognostic studies.  
 
Given the wide-ranging nature of the physiotherapy intervention then it could be argued that there 
is merit in attempting to more closely define or constrain the content and dose of physiotherapy 
and/or the clinical pathway in which it sits. Whilst these approaches could be criticised for having 
limited clinical transferability, it could be argued that shaping the clinical environment in this manner 
could improve consistency in care as well as allowing more direct and constructive informing of 
future care by more relevant prognostic research.  
 
One mechanism by which the above factors could be addressed is by designing clinical care with 
routine data collection embedded within it. This could occur in a defined component of the care 
pathway such as secondary care, whereby all patients who are referred in are routinely offered the 
opportunity to have routine data collection performed. This would allow for a much larger sample 
size with a potential reduction in potential biasing of those recruited. By analysing the baseline 
referral in, treatment and referral on patterns, then an informed mechanism for stratifying both care 
pathway and treatment could be undertaken.  
 
As a next stage, prognostic factors at well-defined parts of the care pathway and/or where 
treatment is more narrowly defined could be undertaken. Such prognostic research would allow for 
both direct exploration of the utility of the prognostic models in a new sample (a key part of the 
prognostic framework; Kent et al. 2010) and also the subsequent refining of the care pathway 
whereby prognostic factors could be used to select specific patient cohorts for treatment. This 
cyclical mechanism would allow for maximal utility of the prognostic findings leading to a continual 
refinement of patient care alongside the opportunity for large scale, longitudinal cohort research.   
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7.10.3 Clinical implications 
Regarding the potential prognostic factor of pain as measured by VAS, the study provided evidence 
that although some individuals in the cohort demonstrated substantial variation across their 3 VAS 
readings, the overall cohort VAS data demonstrated statistically significant correlations between the 
3 measures taken, namely ‘On activity’, ‘At rest’ and ‘At night’. As such these pain measures can be 
viewed as being inter-related, thereby providing insight into commonalities between the 
manifestation of pain in SIS/RCTendinopathy across different circumstances.  
 
The comparatively low incidence of psychological symptoms at a level requiring monitoring or 
potential treatment in the SIS/RCTendinopathy cohort could be interpreted as evidence that 
clinicians need not be overly vigilant for indicators of poor mental health when managing such 
patients. However whilst the current study did not find psychological symptoms as being predictive 
this does not preclude the potential that sub-clinical levels of psychological symptoms might be 
present which the multi-factorial nature of physiotherapy intervention might be able to address.  
 
The treatment measured in the current study provides a descriptive representation of physiotherapy 
delivered in an NHS setting for patients with SIS/RCTendinopathy. In highlighting the highly 
heterogeneous nature of the intervention, it could provide a foundation for stimulating debate as to 
whether the inherent variation is reflective of personalising treatment to the patient or simply 
inherent variability in the approaches of different clinicians. This should be balanced with the low 
predictive percentage from the current study as support for the opinion that SIS/RCTendinopathy is 
itself a highly complex, multi-factorial condition. This leads onto the main prognostic study findings 
which are that predicting outcome in patients with SIS/RCTendinopathy treated with physiotherapy 
is very difficult.  
 
7.10.3.1 Prognosis 
The clinical implications of this study are that there is value in clinicians considering baseline 
function and age of subjects for informing the likely change in patient reported pain and disability 
across the period of treatment and up to 3 months post discharge. Specifically those with greater 
impairment of function and disability at baseline are more likely to demonstrate greater 
improvement both at the point of discharge and for 3 months afterwards. Conversely the older the 
subject, the less likely they are to improve at the point of discharge. This can provide a context for 
discussions with patients regarding likely outcome and associated timescales. It can also provide a 
mechanism for patient triage where resources are limited.  
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However the findings also provide evidence that the ability to predict outcome in 
SIS/RCTendinopathy patients is limited and that where definitive answers are sought regarding 
absolute likelihood of improvement, current evidence is not able to guide this. One speculative 
explanation is that outcome may be independent of physiotherapy and at least partially reflect the 
natural course of the condition. If recovery is partially down to the natural course of the condition, 
then identifying the key ingredients of non-invasive, multimodal physiotherapy that optimise such 
recovery would be a noteworthy mechanism for optimising the use of limited clinical resources.  
 
The identification of subjects that did not improve with physiotherapy reinforces the concept that 
some patients will not respond to this treatment approach. Identifying the nature of these patients 
is an equally important aspect of prognostic research so that such patients can be directed to other 
services or counselled on the limited therapeutic benefit of being referred for physiotherapy.  
 
From the current study findings, the use of routine diagnostic ultrasound imaging to inform 
prognosis cannot be advocated. This provides partial triangulation with published guidelines 
recommending the use of diagnostic ultrasound if a first period of conservative management fails 
(Diercks et al. 2014). However multiple patients informally told MS that one of the reasons for them 
participating in the study was so that they could receive a scan. This highlights the issue of patient 
beliefs and the importance of managing expectations around imaging and care pathway. 
Nonetheless the potential for imaging to provide a mechanism for patients to derive a therapeutic 
benefit is worthy of future investigation.  
 
7.11 Limitations 
Numerous limitations must be acknowledged when considering the findings of this study. Firstly, the 
study was modest in size and undertaken by a single researcher. Consequently the timescale over 
which the study was undertaken and the consequent sample size were both limited. In light of the 
likely inherent ‘background noise’ within the study, the complex multi-factorial nature of the 
condition, poorly defined clinical care pathways and the highly heterogeneous nature of the 
intervention, the limited sample size and study duration limit the ability to accommodate such 
variation.  
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Due to the absence of a control group, any predictive capacity cannot be assigned to the 
intervention. Any improvements seen could be due instead to the natural course of the condition or 
interaction between the two.  
 
Other categories that might be predictive of outcome such as patient or clinician expectation were 
not included in the study. Similarly it is possible that the particular variables and/or measurement 
tools used were not the ones likely to provide a predictive capacity. Therefore, whilst the majority of 
variables in the study were not found to be predictive, this does not mean that other aspects of 
these variable types would not be.  
 
There is evidence in the literature that increasing experience as a Sonographer equates to improved 
consistency (Jeyam et al. 2008). As such it is possible that MS was improving in experience during the 
cohort data collection phase, thereby introducing additional inherent variability in diagnostic 
accuracy within the data. As such the use of a more established operator is advocated. Furthermore 
the specific shoulder pathology of patients comprising the ultrasound reproducibility study data 
were not recorded and so comparability with the cohort sample is limited.  
 
In recording the treatment delivered it must be acknowledged that what was recorded was the 
treatment issued by the physiotherapist and not necessarily that received by the patient, particularly 
with regards to HEP where levels of adherence were not recorded.  
 
7.12 Summary of discussion chapter 
This study investigated factors across a wide range of categories as potential baseline predictors of 
change in functional status in patients with SIS/RCTendinopathy treated with physiotherapy in an 
NHS setting. Following a process of data reduction, seven variables were entered into a multivariate 
regression analysis for two different models, namely change in function from baseline to discharge 
and from baseline to 3 months post-discharge.  
 
In the first model, total SPADI and age combined to explain 15.7% of the variance in OSS change 
between baseline and discharge and only total SPADI was retained in the second model, explaining 
9.6% of the variance in OSS between baseline and 3 months post-discharge. Demographic (age), 
clinical history (duration of symptoms), patient reported measures (psychological symptoms), clinical 
measures (strength and scapular movement and control) and structural pathology via ultrasound 
imaging were not predictive in multi-variate analysis at any time point.  
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The low number of predictor variables and small amount of overall variation that was predicted by 
the models may be explained by the highly variable nature of (i) the pragmatic intervention and (ii) 
time from baseline to discharge. However the complex, multi-faceted nature of SIS/RCTendinopathy 
and the subjective experience of shoulder pain and disability highlight the challenge of predicting 
outcome, particularly where a relatively small sample size is used. Furthermore, the inclusion of two 
novel variables (SDT and diagnostic ultrasound) both with relatively poor reproducibility may also 
explain the low level of prediction.  
 
The study findings provide some preliminary recommendations for future work in this area. These 
include an emphasis on including patient reported measures of function and disability in preference 
to physical measures. Alongside the likely predictive impact, parallel benefits of this include the 
reduced time and patient burden of testing thereby allowing for potentially greater sample sizes. 
Recognising the importance of statistical power and the threat of over-fitting, larger sample size and 
a focus on robustly measured variables is paramount.  
 
In addition, the segmenting of groups of patients whose characteristics mean they are likely to 
receive particular treatment approaches may allow for a pragmatic reduction in variability within 
such studies. Furthermore, consideration of the length of time that patients are under treatment 
may also provide a similar focusing of future studies.  
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8 CONCLUSION 
Currently available evidence to inform the prognosis of patients with SIS/RCTendinopathy who are 
treated with physiotherapy is of variable quality and provides limited consensus. However 
prognostic research has the potential to provide valuable information to inform patient expectation 
and guide clinicians with patient triage and counselling.  
 
This study sought to contribute to the evidence base regarding predicting outcome in this patient 
group by undertaking analysis of a broad range of baseline variables collected in the clinical setting. 
These included the novel use of the scapular dyskinesis test and diagnostic ultrasound. A sequential 
process of data reduction was performed in order to tailor the number of candidate variables to the 
number of subjects recruited, so as to avoid the threat of overfitting.  
 
The subsequent, most parsimonious model comprised baseline function and disability as measured 
by total SPADI and age as predictors of the change in the OSS between baseline and discharge. 
Specifically greater impairment of function and disability at baseline was predictive of greater 
improvement, whilst greater age was predictive of less improvement. For the change in the OSS 
between baseline and 3 months post-discharge, only baseline function and disability as measured by 
the total SPADI was predictive and in the same direction as for the baseline to discharge model. The 
percentage variance in the dependent variable explained by each model was low at 15.7% and 9.6% 
for the discharge and 3 months post-discharge models; respectively.  
 
In light of the complex, multi-factorial nature of SIS/RCTendinopathy, the use of a pragmatic 
approach to treatment content and duration was a source of additional heterogeneity in the overall 
study. Furthermore the low levels of reproducibility of the 2 novel variables (scapular dyskinesis test 
and diagnostic ultrasound) retained for consideration in the prognostic models reduced their 
capacity to act as meaningful prognostic factors. These elements inevitably combined with the 
smaller than planned sample size to bring a reduction in overall statistical power to the study.  
 
Along with the likely difficulty of predicting outcome in this patient group, the above methodological 
factors mean that the low predictive value of the models in this study are perhaps unsurprising. 
Mechanisms to optimise predictive ability in future studies include the use of prognostic research 
embedded within routine clinical care, so that minimally biased, large samples can be recruited. 
Development of mechanisms to optimise the reproducibility of any measurement tools used is also 
advocated.  
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As part of this, a more meaningful condensing of the current care pathways would provide a 
mechanism to address some additional sources of variability and also allow for more meaningful 
implementation of subsequent findings. Furthermore the quantifying and perhaps streamlining of 
the treatment ‘ingredients’ of physiotherapy would serve to similarly improve the research and 
subsequent clinical implementation environments.  
 
Nonetheless, it is recommended that clinicians are made aware that baseline function and disability 
along with age may serve to partially predict outcome and that awareness of these aspects when 
triaging, assessing and treating patients will enable clinicians to tailor the management and 
communication with such patients, accordingly.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
249 
 
9 REFERENCE LIST 
Adejumo, A. O. 2005. Effect of missing values on the Cohen's Kappa statistic for raters agreement 
measurement. Int J Pure App Math 22(1), pp. 13-31.  
 
Ainsworth, R. et al. 2009. A prospective randomised placebo controlled clinical trial of a 
rehabilitation programme for patients with a diagnosis of massive rotator cuff tears of the shoulder. 
Shoulder and Elbow 1(1), pp. 55-60.  
 
Alqunaee, M. et al. 2012. Diagnostic accuracy of clinical tests for subacromial impingement 
syndrome: a systematic review and meta-analysis. Arch Phys Med Rehabil 93(2), pp. 229-236.   
 
Altman, D. 1991. Practical statistics for medical research. London: Chapman and Hall. 
 
Altman, D. G. 2001. Systematic reviews of evaluations of prognostic variables. BMJ 323(7306), pp. 
224-228.  
 
Altman, D. G. and Royston, P. 2006. The cost of dichotomising continuous variables. BMJ 332(7549), 
p. 1080.   
 
Altman, D. G. et al. 2009. Prognosis and prognostic research: validating a prognostic model. BMJ 338, 
p. b605.   
 
Amstutz, H. C. et al. 1981. UCLA anatomic total shoulder arthroplasty. Clin Orthop Relat Res (155), 
pp. 7-20.  
 
Ando, A. et al. 2013. Identification of prognostic factors for the nonoperative treatment of stiff 
shoulder. Int Orthop 37(5), pp. 859-864.   
 
Angst, F. et al. 2004. Comprehensive assessment of clinical outcome and quality of life after total 
shoulder arthroplasty: usefulness and validity of subjective outcome measures. Arthritis Rheum 
51(5), pp. 819-828.   
 
Armstrong, A. 2014. Evaluation and management of adult shoulder pain: a focus on rotator cuff 
disorders, acromioclavicular joint arthritis, and glenohumeral arthritis. Med Clin North Am 98(4), pp. 
755-775, xii.   
 
Atalar, H. et al. 2009. Restricted scapular mobility during arm abduction: implications for 
impingement syndrome. Acta Orthop Belg 75(1), pp. 19-24.  
 
Awatani, T. et al. 2016. Same-session and between-day intra-rater reliability of hand-held 
dynamometer measurements of isometric shoulder extensor strength. J Phys Ther Sci 28(3), pp. 936-
939.   
 
Aydogan, A. et al. 2003. Factors affecting therapeutic response of adhesive capsulitis in type II 
diabetes mellitus. J Back Musc Rehab 17, pp. 3-7.  
 
Babyak, M. A. 2004. What you see may not be what you get: a brief, nontechnical introduction to 
overfitting in regression-type models. Psychosom Med 66(3), pp. 411-421.  
 
Baertschi, E. et al. 2013. Interrater reliability of clinical tests to evaluate scapulothoracic motion. 
BMC Musculoskelet Disord 14, p. 315.   
250 
 
 
Bair, M. J. et al. 2003. Depression and pain comorbidity: a literature review. Arch Intern Med 
163(20), pp. 2433-2445.   
 
Balke, M. et al. 2013. Correlation of acromial morphology with impingement syndrome and rotator 
cuff tears. Acta Orthop 84(2), pp. 178-183.   
 
Baring, T. et al. 2007. Management of rotator cuff disease: specific treatment for specific disorders. 
B Prac Res Clin Rheum 21(2), pp. 279-294.  
 
Bartolozzi, A. et al. 1994. Determinants of outcome in the treatment of rotator cuff disease. Clin 
Orthop Relat Res (308), pp. 90-97.  
 
Beaton, D. and Richards, R. R. 1998. Assessing the reliability and responsiveness of 5 shoulder 
questionnaires. J Shoulder Elbow Surg 7(6), pp. 565-572.  
 
Beaton, D. E. et al. 2001. Measuring the whole or the parts? Validity, reliability, and responsiveness 
of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper 
extremity. J Hand Ther 14(2), pp. 128-146.  
 
Beggs, I. 2011. Shoulder ultrasound. Semin Ultrasound CT MR 32(2), pp. 101-113.   
 
Beggs, I. et al. 2010. Musculoskeletal Ultrasound Technical Guidelines I. Shoulder. Available at: 
http://www.essr.org/html/img/pool/shoulder.pdf [Accessed: 3/7/2014] 
 
Bekkering, G. E. et al. 2005. Prognostic factors for low back pain in patients referred for 
physiotherapy: comparing outcomes and varying modeling techniques. Spine 30(16), pp. 1881-1886.  
 
Bennell, K. et al. 2010. Efficacy of standardised manual therapy and home exercise programme for 
chronic rotator cuff disease: randomised placebo controlled trial. BMJ (7763), p. 82.  
 
Binder, A. I. et al. 1984. Frozen shoulder: a long-term prospective study. Ann Rheum Dis 43(3), pp. 
361-364.  
 
Bjorck-van Dijken, C. et al. 2008. Low back pain, lifestyle factors and physical activity: a population 
based-study. J Rehabil Med 40(10), pp. 864-869.   
 
Borstad, J. D. 2006. Resting position variables at the shoulder: evidence to support a posture-
impairment association. Phys Ther 86(4), pp. 549-557.  
 
Borstad, J. D. and Ludewig, P. M. 2002. Comparison of scapular kinematics between elevation and 
lowering of the arm in the scapular plane. Clin Biomech 17(9-10), pp. 650-659.  
 
Bot, S. D. et al. 2005. Predictors of outcome in neck and shoulder symptoms: a cohort study in 
general practice. Spine 30(16), pp. E459-470.  
 
Bouvier, B. et al. 2015. Upper Limb Kinematics Using Inertial and Magnetic Sensors: Comparison of 
Sensor-to-Segment Calibrations. Sensors (Basel) 15(8), pp. 18813-18833.   
 
Bowerman, B. and O'Connell, R. 2000. Linear Statistical Models: An Applied Approach. Duxbury 
Classic. 
251 
 
 
Braun, C. et al. 2016. Prognostic Models in Adults Undergoing Physical Therapy for Rotator Cuff 
Disorders: Systematic Review. Phys Ther 96(7), pp. 961-971. 
 
Brekke, M. et al. 2002. Severity of musculoskeletal pain: relations to socioeconomic inequality. Soc 
Sci Med 54(2), pp. 221-228.  
 
Brooks, R. 1996. EuroQol: the current state of play. Health Policy 37(1), pp. 53-72.  
 
Broughton, G., 2nd et al. 2006. The basic science of wound healing. Plast Reconstr Surg 117(7 Suppl), 
pp. 12s-34s.   
 
Butt, U. et al. 2015. Does arthroscopic subacromial decompression improve quality of life. Ann R Coll 
Surg Engl 97(3), pp. 221-223.   
 
Cadogan, A. et al. 2012. Clinical predictors of a positive response to guided diagnostic block into the 
subacromial bursa. J Rehabil Med 44(10), pp. 877-884.   
 
Calis, M. et al. 2000. Diagnostic values of clinical diagnostic tests in subacromial impingement 
syndrome. Ann Rheum Dis 59(1), pp. 44-47.  
 
Cardiff & Vale University Health Board. 2015a. Cardiff & Vale University Health Board - MSK 
Physiotherapy. Available at: http://www.cardiffandvaleuhb.wales.nhs.uk/page/77984 [Accessed: 
2/11/2015].  
 
Carr, A. J. et al. 2015. Clinical effectiveness and cost-effectiveness of open and arthroscopic rotator 
cuff repair [the UK Rotator Cuff Surgery (UKUFF) randomised trial]. Health Technol Assess 19(80), pp. 
1-218.   
 
Cassou, B. et al. 2002. Chronic neck and shoulder pain, age, and working conditions: longitudinal 
results from a large random sample in France. Occup Environ Med 59(8), pp. 537-544.  
 
Castoldi, F. et al. 2009. External rotation lag sign revisited: accuracy for diagnosis of full thickness 
supraspinatus tear. J Shoulder Elbow Surg 18(4), pp. 529-534.   
 
Cecchi, F. et al. 2014. Predictors of response to exercise therapy for chronic low back pain: result of a 
prospective study with one year follow-up. Eur J Phys Rehabil Med 50(2), pp. 143-151.  
 
Chard, M. D. et al. 1988. The long-term outcome of rotator cuff tendinitis - a review study. Br J 
Rheumatol 27(5), pp. 385-389.  
 
Chester, R. et al. 2016. Psychological factors are associated with the outcome of physiotherapy for 
people with shoulder pain: a multicentre longitudinal cohort study. Br J Sports Med, Published online 
first doi: 10.1136/bjsports-2016-096084 
 
Chester, R. et al. 2013. Predicting response to physiotherapy treatment for musculoskeletal shoulder 
pain: a systematic review. BMC Musculoskelet Disord 14, p. 203.   
 
Chien, C. W. et al. 2013. Comparative responsiveness of verbal and numerical rating scales to 
measure pain intensity in patients with chronic pain. J Pain 14(12), pp. 1653-1662.   
 
252 
 
Cloke, D. J. et al. 2005. A comparison of functional, patient-based scores in subacromial 
impingement. J Shoulder Elbow Surg 14(4), pp. 380-384.   
 
Cobb, E. M. et al. 2014. Public Interest in Medical Research Participation: Differences by Volunteer 
Status and Study Type. Clin Transl Sci. 
 
Cohen, J. et al. 2013. Applied multiple regression/correlation analysis for the behavioral sciences. 3rd 
edition ed. Mahwah, NJ: Lawrence Erlbaum Associates. 
 
Collins, N. J. et al. 2010. Predictors of short and long term outcome in patellofemoral pain syndrome: 
a prospective longitudinal study. BMC Musculoskelet Disord 11, p. 11.  
 
Conable, K. M. and Rosner, A. L. 2011. A narrative review of manual muscle testing and implications 
for muscle testing research. J Chiropr Med 10(3), pp. 157-165.   
 
Concato, J. et al. 1993. The risk of determining risk with multivariable models. Ann Intern Med 
118(3), pp. 201-210.  
 
Conroy, D. E. and Hayes, K. W. 1998. The effect of joint mobilization as a component of 
comprehensive treatment for primary shoulder impingement syndrome. J Orthop Sports Phys Ther 
28(1), pp. 3-14.   
 
Consortium for the Accreditation of Sonographic Education (CASE). Available at: http://www.case-
uk.org/ [Accessed 3/7/2014].  
 
Contreras, F. et al. 2013. Predictors of success of corticosteroid injection for the management of 
rotator cuff disease. Hss J 9(1), pp. 2-5.   
 
Cook, C. et al. 2014. The addition of cervical unilateral posterior-anterior mobilisation in the 
treatment of patients with shoulder impingement syndrome: a randomised clinical trial. Man Ther 
19(1), pp. 18-24.   
 
Cook, J. L. and Purdam, C. R. 2009. Is tendon pathology a continuum? A pathology model to explain 
the clinical presentation of load-induced tendinopathy. Br J Sports Med 43(6), pp. 409-416.   
 
Cook, K. F. et al. 2003. Development and psychometric evaluation of the Flexilevel Scale of Shoulder 
Function. Med Care 41(7), pp. 823-835.   
 
Cools, A. M. et al. 2014. Measuring shoulder external and internal rotation strength and range of 
motion: comprehensive intra-rater and inter-rater reliability study of several testing protocols. J 
Shoulder Elbow Surg 23(10), pp. 1454-1461.   
 
Corazza, A. et al. 2015. Dynamic high-resolution ultrasound of the shoulder: how we do it. Eur J 
Radiol 84(2), pp. 266-277.   
 
Crane, P. K. et al. 2006. A 37-item shoulder functional status item pool had negligible differential 
item functioning. J Clin Epidemiol 59(5), pp. 478-484.   
 
Croft, P. et al. 1996. The clinical course of shoulder pain: prospective cohort study in primary care. 
Primary Care Rheumatology Society Shoulder Study Group. BMJ 313(7057), pp. 601-602.  
 
253 
 
Cummins, C. A. et al. 2009. Impingement syndrome: temporal outcomes of nonoperative treatment. 
J Shoulder Elbow Surg 18(2), pp. 172-177.   
 
Dawson, J. et al. 1996. Questionnaire on the perceptions of patients about shoulder surgery. J Bone 
Joint Surg Br 78(4), pp. 593-600.  
 
Dawson, J. et al. 2001. The benefits of using patient-based methods of assessment. Medium-term 
results of an observational study of shoulder surgery. J Bone Joint Surg Br 83(6), pp. 877-882.  
 
de Winter, A. F. et al. 2004. Inter-observer reproducibility of measurements of range of motion in 
patients with shoulder pain using a digital inclinometer. BMC Musculoskelet Disord 5, p. 18.   
 
Dean, B. J. et al. 2013. Why does my shoulder hurt? A review of the neuroanatomical and 
biochemical basis of shoulder pain. Br J Sports Med 47(17), pp. 1095-1104. 
 
den Boeft, M. et al. 2016. The association between medically unexplained physical symptoms and 
health care use over two years and the influence of depressive and anxiety disorders and personality 
traits: a longitudinal study. BMC Health Serv Res 16, p. 100.   
 
Derogatis, L. R. et al. 1974. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. 
Behav Sci 19(1), pp. 1-15.  
 
Desai, A. S. et al. 2010. Critical appraisal of subjective outcome measures used in the assessment of 
shoulder disability. Ann R Coll Surg Engl 92(1), pp. 9-13.   
 
Desjardins-Charbonneau, A. et al. 2015. The efficacy of manual therapy for rotator cuff 
tendinopathy: a systematic review and meta-analysis. J Orthop Sports Phys Ther 45(5), pp. 330-350. 
 
Deutscher, D. et al. 2008. Implementing an integrated electronic outcomes and electronic health 
record process to create a foundation for clinical practice improvement. Phys Ther 88(2), pp. 270-
285.   
 
Deutscher, D. et al. 2009. Associations between treatment processes, patient characteristics, and 
outcomes in outpatient physical therapy practice. Arch Phys Med Rehabil 90(8), pp. 1349-1363.   
 
Diercks, R. et al. 2014. Guideline for diagnosis and treatment of subacromial pain syndrome: a 
multidisciplinary review by the Dutch Orthopaedic Association. Acta Orthop 85(3), pp. 314-322.   
 
Digi-Pas UK 2016. Available at: http://www.digipas.co.uk/products/digital-level-module/dwl-
180.php [Accessed: 02/11/2016].  
 
Dinant, G. J. et al. 2007. The necessary shift from diagnostic to prognostic research. BMC Fam Pract 
8, p. 53.   
 
Ditre, J. W. et al. 2011. Pain, Nicotine, and Smoking: Research Findings and Mechanistic 
Considerations. Psychol Bull 137(6), pp. 1065-1093.   
 
Dixon, J. et al. 1998. Assessment of the reproducibility of clinical coding in routinely collected 
hospital activity data: a study in two hospitals. J Public Health Med 20(1), pp. 63-69.  
 
254 
 
Dogu, B. et al. 2012. Blind or ultrasound-guided corticosteroid injections and short-term response in 
subacromial impingement syndrome: a randomized, double-blind, prospective study. Am J Phys Med 
Rehabil 91(8), pp. 658-665.  
 
Dong, W. et al. 2015. Treatments for shoulder impingement syndrome: a PRISMA systematic review 
and network meta-analysis. Medicine 94(10), p. e510.   
 
Dorrestijn, O. et al. 2011. Patients with shoulder complaints in general practice: Consumption of 
medical care. Rheumatology 50(2), pp. 389-395.   
 
Downie, W. W. et al. 1978. Studies with pain rating scales. Ann Rheum Dis 37(4), pp. 378-381.  
 
Dragesund, T. and Kvale, A. 2016. Study protocol for Norwegian Psychomotor Physiotherapy versus 
Cognitive Patient Education in combination with active individualized physiotherapy in patients with 
long-lasting musculoskeletal pain - a randomized controlled trial. BMC Musculoskelet Disord 17, p. 
325.   
 
Ekeberg, O. M. et al. 2010a. Clinical, socio-demographic and radiological predictors of short-term 
outcome in rotator cuff disease. BMC Musculoskelet Disord 11, p. 239.   
 
Ekeberg, O. M. et al. 2010b. A questionnaire found disease-specific WORC index is not more 
responsive than SPADI and OSS in rotator cuff disease. J Clin Epidemiol 63(5), pp. 575-584.   
 
Ekeberg, O. M. et al. 2008. Agreement, reliability and validity in 3 shoulder questionnaires in patients 
with rotator cuff disease. BMC Musculoskelet Disord 9(68),    
 
Engebretsen, K. et al. 2010. Predictors of shoulder pain and disability index (SPADI) and work status 
after 1 year in patients with subacromial shoulder pain. BMC Musculoskelet Disord 11, p. 218.   
 
Ettinger, L. et al. 2014. Subacromial Injection Results in Further Scapular Dyskinesis. Orthop J Sports 
Med 2(8) 
 
Factor, D. and Dale, B. 2014. Current concepts of rotator cuff tendinopathy. Int J Sports Phys Ther 
9(2), pp. 274-288.  
 
Ferraz, M. B. et al. 1990. Reliability of pain scales in the assessment of literate and illiterate patients 
with rheumatoid arthritis. J Rheumatol 17(8), pp. 1022-1024.  
 
Ferreira-Valente, M. A. et al. 2011. Validity of four pain intensity rating scales. Pain 152(10), pp. 
2399-2404.  
 
Field, A. 2009. Discovering statistics using SPSS. Sage publications. 
 
Fillingim, R. B. et al. 2009. Sex, gender, and pain: a review of recent clinical and experimental 
findings. J Pain 10(5), pp. 447-485.   
 
Gartner, J. and Heyer, A. 1995. Calcific tendinitis of the shoulder. Orthopade 24(3), pp. 284-302.  
 
Gartsman, G. M. et al. 1998. Self-assessment of general health status in patients with five common 
shoulder conditions. J Shoulder Elbow Surg 7(3), pp. 228-237.  
 
255 
 
George, S. Z. et al. 2008. Investigation of elevated fear-avoidance beliefs for patients with low back 
pain: a secondary analysis involving patients enrolled in physical therapy clinical trials. J Orthop 
Sports Phys Ther 38(2), pp. 50-58.   
 
George, S. Z. et al. 2006. Sex differences in predictors of outcome in selected physical therapy 
interventions for acute low back pain. J Orthop Sports Phys Ther 36(6), pp. 354-363.   
 
Ginn, K. A. and Cohen, M. L. 2004. Conservative treatment for shoulder pain: prognostic indicators of 
outcome. Arch Phys Med Rehabil 85(8), pp. 1231-1235.   
 
Girish, G. et al. 2011. Ultrasound of the shoulder: asymptomatic findings in men. AJR Am J 
Roentgenol 197(4), pp. W713-719.   
 
Godfrey, J. et al. 2007. Reliability, validity, and responsiveness of the simple shoulder test: 
psychometric properties by age and injury type. J Shoulder Elbow Surg 16(3), pp. 260-267.   
 
Godin, G. and Shephard, R. J. 1985. A simple method to assess exercise behavior in the community. 
Can J Appl Sport Sci 10(3), pp. 141-146.  
 
Gorski, J. M. and Schwartz, L. H. 2003. Shoulder impingement presenting as neck pain. J Bone Joint 
Surg Am 85-a(4), pp. 635-638.  
 
Gosens, T. and Hofstee, D. J. 2009. Calcifying tendinitis of the shoulder: advances in imaging and 
management. Curr Rheum Rep 11(2), pp. 129-134.  
 
Green, S. et al. 2003. Physiotherapy interventions for shoulder pain. Cochrane Database Syst Rev 
(2):CD004258.   
 
Gregg, C. D. et al. 2014. Prognostic factors associated with low back pain outcomes. J Prim Health 
Care 6(1), pp. 23-30.  
 
Greving, K. et al. 2012. Incidence, prevalence, and consultation rates of shoulder complaints in 
general practice. Scand J Rheumatol 41(2), pp. 150-155.   
 
Griggs, S. M. et al. 2000. Idiopathic adhesive capsulitis. A prospective functional outcome study of 
nonoperative treatment. J Bone Joint Surg Am 82-a(10) 
 
Gruson, K. I. et al. 2008. Subacromial corticosteroid injections. J Shoulder Elbow Surg 17(1 Suppl), pp. 
118s-130s.   
 
Haghighat, S. et al. 2016. Effectiveness of Blind & Ultrasound Guided Corticosteroid Injection in 
Impingement Syndrome. Glob J Health Sci 8(7), pp. 179-184.   
 
Hanchard, N. C. et al. 2013. Physical tests for shoulder impingements and local lesions of bursa, 
tendon or labrum that may accompany impingement. Cochrane Database Syst Rev (4), p. Cd007427.   
 
Harniman, E. et al. 2004. Extracorporeal shock wave therapy for calcific and noncalcific tendonitis of 
the rotator cuff: A systematic review. J Hand Ther 17(2), pp. 132-151.  
 
Harrington, S. et al. 2013. Upper extremity strength and range of motion and their relationship to 
function in breast cancer survivors. Physiother Theory Pract 29(7), pp. 513-520.   
256 
 
 
Hart, D. L. et al. 2006. Simulated computerized adaptive test for patients with shoulder impairments 
was efficient and produced valid measures of function. J Clin Epidemiol 59(3), pp. 290-298.   
 
Hart, D. L. et al. 2010. A computerized adaptive test for patients with shoulder impairments 
produced responsive measures of function. Phys Ther 90(6), pp. 928-938.   
 
Hart, D. L. et al. 2009. Screening for elevated levels of fear-avoidance beliefs regarding work or 
physical activities in people receiving outpatient therapy. Phys Ther 89(8), pp. 770-785.   
 
Hawker, G. A. et al. 2011. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric 
Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain 
Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 
BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res 63 
Suppl 11, pp. S240-252.  
 
Hayden, J. A. et al. 2006. Evaluation of the quality of prognosis studies in systematic reviews. Ann 
Intern Med 144(6), pp. 427-437.  
 
Hayes, K. et al. 2002. Shoulder instability: management and rehabilitation. J Orthop Sports Phys Ther 
32(10), pp. 497-509.   
 
Heald, S. L. et al. 1997. The shoulder pain and disability index: the construct validity and 
responsiveness of a region-specific disability measure. Phys Ther 77(10), pp. 1079-1089.  
 
Hegedus, E. J. et al. 2008. Physical examination tests of the shoulder: a systematic review with meta-
analysis of individual tests. Br J Sports Med 42(2), pp. 80-92 
 
Hegedus, E. J. et al. 2012. Which physical examination tests provide clinicians with the most value 
when examining the shoulder? Update of a systematic review with meta-analysis of individual tests. 
Br J Sports Med 46(14), pp. 964-978.   
 
Hemingway, H. et al. 2013. Prognosis research strategy (PROGRESS) 1: a framework for researching 
clinical outcomes. BMJ 346, p. e5595.   
 
Hemingway, H. et al. 2009. Ten steps towards improving prognosis research. BMJ 339, p. b4184.   
 
Henkus, H. E. et al. 2009. Bursectomy compared with acromioplasty in the management of 
subacromial impingement syndrome: a prospective randomised study. J Bone Joint Surg Br 91(4), pp. 
504-510.   
 
Hill, J. C. and Fritz, J. M. 2011. Psychosocial influences on low back pain, disability, and response to 
treatment. Phys Ther 91(5), pp. 712-721.   
 
Hingorani, A. D. et al. 2013. Prognosis research strategy (PROGRESS) 4: stratified medicine research. 
BMJ 346, p. e5793.   
 
Hjermstad, M. J. et al. 2011. Studies comparing Numerical Rating Scales, Verbal Rating Scales, and 
Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J 
Pain Symptom Manage 41(6), pp. 1073-1093.   
 
257 
 
Hoggan Health 2016. Available at: http://www.hogganhealth.net/pdfs/microfet2.pdf [Accessed: 
28/10/2016].  
 
Holmgren, T. et al. 2012. Effect of specific exercise strategy on need for surgery in patients with 
subacromial impingement syndrome: randomised controlled study. BMJ 344, p. e787.   
 
Holtby, R. and Razmjou, H. 2004. Validity of the supraspinatus test as a single clinical test in 
diagnosing patients with rotator cuff pathology. J Ortho Sports Phys Ther 34(4), pp. 194-200.  
 
Holtermann, A. et al. 2010. Prognostic factors for long-term sickness absence among employees with 
neck-shoulder and low-back pain. Scand J Work Environ Health 36(1), pp. 34-41.  
 
Horn, M. E. et al. 2014. Fear of severe pain mediates sex differences in pain sensitivity responses to 
thermal stimuli. Pain Res Treat 2014, p. 897953.   
 
Hsu, Y. H. et al. 2009. The effects of taping on scapular kinematics and muscle performance in 
baseball players with shoulder impingement syndrome. J Electromyogr Kinesiol 19(6), pp. 1092-1099.   
 
http://www.strobe-statement.org. ; accessed 25th January 2018 
 
Huber, W. et al. 2004. The German version of the Oxford Shoulder Score--cross-cultural adaptation 
and validation. Arch Orthop Trauma Surg 124(8), pp. 531-536.   
 
Hughes, P. 2011. The Neer sign and Hawkins-Kennedy test for shoulder impingement. J Physiother 
57(4), p. 260.   
 
Hung, C. J. et al. 2010. Scapular kinematics and impairment features for classifying patients with 
subacromial impingement syndrome. Man Ther 15(6), pp. 547-551.   
 
Hurst, N. P. et al. 1997. Measuring health-related quality of life in rheumatoid arthritis: validity, 
responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 36(5), pp. 551-559.  
 
Iagnocco, A. et al. 2003. Sonographic study of painful shoulder. Clin Exp Rheumatol 21(3), pp. 355-
358.  
 
Ingwersen, K. G. et al. 2016. Ultrasound assessment for grading structural tendon changes in 
supraspinatus tendinopathy: an inter-rater reliability study. BMJ Open 6(5), p. e011746.   
 
J Tech Medical 2016. Available at: http://www.jtechmedical.com/phocadownload/manuals/MN084-
CommanderMuscleTesterManual.pdf [Accessed: 31/10/2016].  
 
Jacobson, J. A. 2011. Shoulder US: anatomy, technique, and scanning pitfalls. Radiology 260(1), pp. 
6-16.   
 
Jaeschke, R. et al. 1989. Measurement of health status. Ascertaining the minimal clinically important 
difference. Control Clin Trials 10(4), pp. 407-415.  
 
Jellema, P. et al. 2005. Why is a treatment aimed at psychosocial factors not effective in patients 
with (sub)acute low back pain? Pain 118(3), pp. 350-359.  
 
258 
 
Jensen, M. P. et al. 1986. The measurement of clinical pain intensity: a comparison of six methods. 
Pain 27(1), pp. 117-126.  
 
Jeyam, M. et al. 2008. Are shoulder surgeons any good at diagnosing rotator cuff tears using 
ultrasound?: A comparative analysis of surgeon vs radiologist. Int J Shoulder Surg 2(1), pp. 4-6.   
 
Jia, X. et al. 2009. Examination of the shoulder: the past, the present, and the future. J Bone Joint 
Surg Am 91 Suppl 6, pp. 10-18.   
 
Johansson, K. et al. 2002. A combination of systematic review and clinicians' beliefs in interventions 
for subacromial pain. Br J Gen Pract 52(475), pp. 145-152.  
 
Joseph, M. F. and Denegar, C. R. 2015. Treating tendinopathy: perspective on anti-inflammatory 
intervention and therapeutic exercise. Clin Sports Med 34(2), pp. 363-374.   
 
Joyce, C. R. et al. 1975. Comparison of fixed interval and visual analogue scales for rating chronic 
pain. Eur J Clin Pharmacol 8(6), pp. 415-420.  
 
Kaergaard, A. and Andersen, J. H. 2000. Musculoskeletal disorders of the neck and shoulders in 
female sewing machine operators: prevalence, incidence, and prognosis. Occup Environ Med 57(8), 
pp. 528-534.  
 
Kalter, J. et al. 2011. Taping patients with clinical signs of subacromial impingement syndrome: The 
design of a randomized controlled trial. BMC Musc Disord 12(188) 
 
Karels, C. H. et al. 2007. Social and psychological factors influenced the course of arm, neck and 
shoulder complaints. J Clin Epidemiol 60(8), pp. 839-848.   
 
Katz, J. N. 2006. Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. 
J Bone Joint Surg Am 88 Suppl 2, pp. 21-24.   
 
Kelly, S. M. et al. 2010. The value of physical tests for subacromial impingement syndrome: a study 
of diagnostic accuracy. Clin Rehabil 24(2), pp. 149-158.   
 
Kendall, F. P. et al. 1993. Muscles: Testing and Function. 4th ed. ed. Baltimore, MD: Williams &amp; 
Wilkins. 
 
Kennedy, C. A. et al. 2006. Prognosis in soft tissue disorders of the shoulder: predicting both change 
in disability and level of disability after treatment. Phys Ther 86(7), pp. 1013-1032 
 
Kent, P. et al. 2010. Research methods for subgrouping low back pain. BMC Med Res Methodol 10, p. 
62.   
 
Kessel, L. and Watson, M. 1977. The painful arc syndrome. Clinical classification as a guide to 
management. J Bone Joint Surg Br 59(2), pp. 166-172.  
 
Khan, Y. et al. 2013. The Painful Shoulder: Shoulder Impingement Syndrome. Open Orthop J 7, pp. 
347-351.   
 
Kibler, W. B. 1998. The role of the scapula in athletic shoulder function. Am J Sports Med 26(2), pp. 
325-337.  
259 
 
 
Kibler, W. B. et al. 2002. Qualitative clinical evaluation of scapular dysfunction: a reliability study. J 
Shoulder Elbow Surg 11(6), pp. 550-556.   
 
Kim, S. H. et al. 2004. Painful jerk test: a predictor of success in nonoperative treatment of 
posteroinferior instability of the shoulder. Am J Sports Med 32(8), pp. 1849-1855.  
 
Kindler, L. L. et al. 2011. Sex differences in experimental and clinical pain sensitivity for patients with 
shoulder pain. Eur J Pain 15(2), pp. 118-123.   
 
Koester, M. C. et al. 2005. Shoulder impingement syndrome. Am J Med 118(5), pp. 452-455.   
 
Kohli, E. et al. 2009. Variability in the Hawthorne effect with regard to hand hygiene performance in 
high- and low-performing inpatient care units. Infect Control Hosp Epidemiol 30(3), pp. 222-225.   
 
Kolber, M. J. et al. 2012. The reliability and concurrent validity of scapular plane shoulder elevation 
measurements using a digital inclinometer and goniometer. Physiother Theory Pract 28(2), pp. 161-
168.   
 
Kolber, M. J. et al. 2011. The reliability and minimal detectable change of shoulder mobility 
measurements using a digital inclinometer. Physiother Theory Pract 27(2), pp. 176-184.   
 
Kooijman, M. et al. 2013. Patients with shoulder syndromes in general and physiotherapy practice: 
an observational study. BMC Musculoskelet Disord 14, p. 128.   
 
Kooijman, M. K. et al. 2015. Pain intensity, neck pain and longer duration of complaints predict 
poorer outcome in patients with shoulder pain – a systematic review. BMC Musc Disord 16(1), p. 
288.   
 
Koorevaar, R. C. et al. 2016. Validation of the four-dimensional symptom questionnaire (4DSQ) and 
prevalence of psychological symptoms in orthopedic shoulder patients. J Orthop Res 34(4), pp. 683-
691.   
 
Koslow, P. A. et al. 2003. Specificity of the lateral scapular slide test in asymptomatic competitive 
athletes. J Orthop Sports Phys Ther 33(6), pp. 331-336.   
 
Kottner, J. et al. 2011a. Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were 
proposed. J Clin Epidemiol 64(1), pp. 96-106. 
 
Kromer, T. O. et al. 2010. Effectiveness of individualized physiotherapy on pain and functioning 
compared to a standard exercise protocol in patients presenting with clinical signs of subacromial 
impingement syndrome. A randomized controlled trial. BMC Musc Disord 11(114) 
 
Kromer, T. O. et al. 2013. Physiotherapy in patients with clinical signs of shoulder impingement 
syndrome: a randomized controlled trial. J Rehabil Med 45(5), pp. 488-497.   
 
Kromer, T. O. et al. 2014. Influence of fear-avoidance beliefs on disability in patients with 
subacromial shoulder pain in primary care: a secondary analysis. Phys Ther 94(12), pp. 1775-1784.   
 
Kuijpers, T. et al. 2006a. Clinical prediction rules for the prognosis of shoulder pain in general 
practice. Pain 120(3), pp. 276-285.   
260 
 
 
Kuijpers, T. et al. 2004. Systematic review of prognostic cohort studies on shoulder disorders. Pain 
109(3), pp. 420-431.   
 
Kuijpers, T. et al. 2006b. A prediction rule for shoulder pain related sick leave: a prospective cohort 
study. BMC Musculoskelet Disord 7, p. 97.   
 
Kuroda, S. et al. 2001. The natural course of atraumatic shoulder instability. J Shoulder Elbow Surg 
10(2), pp. 100-104.  
 
Lakke, S. E. et al. 2009. Risk and prognostic factors for non-specific musculoskeletal pain: a synthesis 
of evidence from systematic reviews classified into ICF dimensions. Pain 147(1-3), pp. 153-164.   
 
Lalkhen, A. G. and McCluskey, A. 2008. Clinical tests: sensitivity and specificity.  Contin Educ Anaesth 
Crit Care Pain 8 (6): 221-223 
 
Landis, J. R. and Koch, G. G. 1977. The measurement of observer agreement for categorical data. 
Biometrics 33(1), pp. 159-174.  
 
Laslett, M. et al. 2015. Shoulder pain in primary care--part 2: predictors of clinical outcome to 12 
months. J Rehabil Med 47(1), pp. 66-71.   
 
Lewis, J. S. 2009. Rotator cuff tendinopathy/subacromial impingement syndrome: is it time for a new 
method of assessment? Br J Sports Med 43(4), pp. 259-264  
 
Lewis, J. S. 2010. Rotator cuff tendinopathy: a model for the continuum of pathology and related 
management. Br J Sports Med 44(13), pp. 918-923.   
 
Lewis, J. S. 2012. A specific exercise program for patients with subacromial impingement syndrome 
can improve function and reduce the need for surgery. J Physiother 58(2), p. 127.   
 
Linaker, C. H. and Walker-Bone, K. 2015. Shoulder disorders and occupation. Best Pract Res Clin 
Rheumatol 29(3), pp. 405-423.   
 
Littlewood, C. et al. 2013. Epidemiology of Rotator Cuff Tendinopathy: A Systematic Review. 
Shoulder & Elbow 5(4). 
 
Littlewood, C. et al. 2015. Therapeutic exercise for rotator cuff tendinopathy: a systematic review of 
contextual factors and prescription parameters. Int J Rehabil Res 38(2), pp. 95-106. 
 
Littlewood, C. et al. 2016. A self-managed single exercise programme versus usual physiotherapy 
treatment for rotator cuff tendinopathy: a randomised controlled trial (the SELF study). Clin Rehabil 
30(7), pp. 686-696.   
 
Lopes, A. D. et al. 2015. Visual scapular dyskinesis: kinematics and muscle activity alterations in 
patients with subacromial impingement syndrome. Arch Phys Med Rehabil 96(2), pp. 298-306.   
 
Lorig, K. et al. 1989. Development and evaluation of a scale to measure perceived self-efficacy in 
people with arthritis. Arthritis Rheum 32(1), pp. 37-44.  
 
261 
 
Lu, T. W. et al. 2007. Enhancing the examiner's resisting force improves the reliability of manual 
muscle strength measurements: comparison of a new device with hand-held dynamometry. J 
Rehabil Med 39(9), pp. 679-684.   
 
Ludewig, P. M. et al. 2013. What's in a name? Using movement system diagnoses versus 
pathoanatomic diagnoses. J Orthop Sports Phys Ther 43(5), pp. 280-283.   
 
Luime, J. J. et al. 2004. Prevalence and incidence of shoulder pain in the general population; a 
systematic review. Scand J Rheumatol 33(2), pp. 73-81.  
 
Macfarlane, G. J. et al. 1998. Predictors of chronic shoulder pain: a population based prospective 
study. J Rheumatol 25(8), pp. 1612-1615.  
 
Macznik, A. K. et al. 2015. Online technology use in physiotherapy teaching and learning: a 
systematic review of effectiveness and users' perceptions. BMC Med Educ 15, p. 160.   
 
Mallows, A. et al. 2017. Association of psychological variables and outcome in tendinopathy: a 
systematic review. Br J Sports Med 51(9), pp. 743-748. 
 
Mao, C. Y. et al. 1997. Frozen shoulder: correlation between the response to physical therapy and 
follow-up shoulder arthrography. Arch Phys Med Rehabil 78(8), pp. 857-859.  
 
McClinton, S. M. et al. 2015. Predictors of response to physical therapy intervention for plantar heel 
pain. Foot Ankle Int 36(4), pp. 408-416.   
 
McClure, P. et al. 2009. A Clinical Method for Identifying Scapular Dyskinesis, Part 1: Reliability. J Athl 
Train 44(2), pp. 160-164.  
 
McClure, P. W. et al. 2006. Shoulder function and 3-dimensional scapular kinematics in people with 
and without shoulder impingement syndrome. Phys Ther 86(8), pp. 1075-1090.  
 
McCreesh, K. M. et al. 2016. Ultrasound measures of supraspinatus tendon thickness and 
acromiohumeral distance in rotator cuff tendinopathy are reliable. J Clin Ultrasound 44(3), pp. 159-
166.   
 
McDonald, S. et al. 2010. Basic appearance of ultrasound structures and pitfalls. Phys Med Rehabil 
Clin N Am 21(3), pp. 461-479.   
 
McHorney, C. A. et al. 1994. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data 
quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32(1), pp. 40-66.  
 
McHugh, M. L. 2012. Interrater reliability: the kappa statistic. Biochem Med 22(3), pp. 276-282.  
 
McNally, E. 2014. Practical Musculoskeletal Ultrasound. 2nd ed. Elsevier. 
 
Messina, C. et al. 2016. Ultrasound-guided interventional procedures around the shoulder. Br J 
Radiol 89(1057), p. 20150372.   
 
Michener, L. A. et al. 2003. Anatomical and biomechanical mechanisms of subacromial impingement 
syndrome. Clin Biomech 18(5), pp. 369-379.  
 
262 
 
Michener, L. A. et al. 2009. Reliability and Diagnostic Accuracy of 5 Physical Examination Tests and 
Combination of Tests for Subacromial Impingement. Arch Phys Med Rehabil 90(11), pp. 1898-1903.   
 
Micheroli, R. et al. 2015. Correlation of findings in clinical and high resolution ultrasonography 
examinations of the painful shoulder. J Ultrason 15(60), pp. 29-44.   
 
Miles, J. and Shevlin, M. 2001. Applying Regression and Correlation: A Guide for Students and 
Researchers. SAGE. 
 
Min, K. S. et al. 2013. A double-blind randomized controlled trial comparing the effects of 
subacromial injection with corticosteroid versus NSAID in patients with shoulder impingement 
syndrome. J Shoulder Elbow Surg 22(5), pp. 595-601.  
 
Minns Lowe, C. J. et al. 2014. Living with a symptomatic rotator cuff tear 'bad days, bad nights': a 
qualitative study. BMC Musculoskelet Disord 15, p. 228.   
 
Mintken, P. E. et al. 2010. Some factors predict successful short-term outcomes in individuals with 
shoulder pain receiving cervicothoracic manipulation: a single-arm trial. Phys Ther 90(1), pp. 26-42.   
 
Miranda, H. et al. 2001. A prospective study of work related factors and physical exercise as 
predictors of shoulder pain. Occup Environ Med 58(8), pp. 528-534.  
 
Mitchell, C. et al. 2005. Shoulder pain: Diagnosis and management in primary care. BMJ 331(7525), 
pp. 1124-1128.  
 
Mole, D. et al. 1993. Results of endoscopic treatment of non-broken tendinopathies of the rotator 
cuff. 2. Calcifications of the rotator cuff. Rev Chir Orthop Reparatrice Appar Mot 79(7), pp. 532-541.  
 
Moons, K. G. et al. 2009a. Prognosis and prognostic research: application and impact of prognostic 
models in clinical practice. BMJ 338, p. b606.   
 
Moons, K. G. et al. 2009b. Prognosis and prognostic research: what, why, and how? BMJ 338, p. 
b375.   
 
Mori, B. et al. 2016. Canadian Physiotherapy Assessment of Clinical Performance: Face and Content 
Validity. Physiother Can 68(1), pp. 64-72.   
 
Morrison, D. S. et al. 1997. Non-operative treatment of subacromial impingement syndrome. J Bone 
Joint Surg Am 79(5), pp. 732-737.  
 
Mullaney, M. J. et al. 2010. Reliability of shoulder range of motion comparing a goniometer to a 
digital level. Physiother Theory Pract 26(5), pp. 327-333. 
 
Myers, R. 2000. Classical and Modern Regression with Applications. Duxbury Classic. 
 
Naredo, E. et al. 2002. Painful shoulder: comparison of physical examination and ultrasonographic 
findings. Ann Rheum Dis 61(2), pp. 132-136.  
 
Ndlovu, M. et al. 2014. Pain medication management of musculoskeletal conditions at first 
presentation in primary care: analysis of routinely collected medical record data. BMC Musculoskelet 
Disord 15, p. 418.   
263 
 
 
Neer, C. S. 1972. Anterior acromioplasty for the chronic impingement syndrome in the shoulder: a 
preliminary report. J Bone Joint Surg Am 54(1), pp. 41-50.  
 
Neer, C. S., 2nd. 1983. Impingement lesions. Clin Orthop Relat Res (173), pp. 70-77.  
 
NHMRC. 2000. How to use the evidence: assessment and application of scientific evidence. Canberra: 
National Health and Medical Research Council. Available at: https://www.nhmrc.gov.au/guidelines-
publications/cp69 [Accessed: 4/4/2016] 
 
Nicholas, M. K. 2007. The pain self-efficacy questionnaire: Taking pain into account. Eur J Pain 11(2), 
pp. 153-163.  
 
Ogon, P. et al. 2009. Prognostic factors in nonoperative therapy for chronic symptomatic calcific 
tendinitis of the shoulder. Arthritis Rheum 60(10), pp. 2978-2984.  
 
Ostor, A. J. et al. 2005. Diagnosis and relation to general health of shoulder disorders presenting to 
primary care. Rheumatology 44(6), pp. 800-805.  
 
Ottenheijm, R. P. et al. 2010. Accuracy of diagnostic ultrasound in patients with suspected 
subacromial disorders: A systematic review and meta-analysis. Arch Phys Med Rehabil 91(10), pp. 
1616-1625.   
 
Pandey, V. et al. 2016. Does scapular morphology affect the integrity of the rotator cuff? J Shoulder 
Elbow Surg 25(3), pp. 413-421.   
 
Park, H. B. et al. 2005. Diagnostic accuracy of clinical tests for the different degrees of subacromial 
impingement syndrome. J Bone Joint Surg Am 87(7), pp. 1446-1455.   
 
Parsons, I. M. t. et al. 2004. Glenohumeral arthritis and its management. Phys Med Rehabil Clin N 
Am 15(2), pp. 447-474. doi: 10.1016/j.pmr.2003.12.001 
 
Payne, C. and Michener, L. A. 2014. Physiotherapists use of and perspectives on the importance of 
patient-reported outcome measures for shoulder dysfunction. Shoulder Elbow 6(3), pp. 204-214.   
 
Peduzzi, P. et al. 1996. A simulation study of the number of events per variable in logistic regression 
analysis. J Clin Epidemiol 49(12), pp. 1373-1379.  
 
Phillips, B. et al. 2016. Oxford Centre for Evidence-Based Medicine Levels of Evidence. Oxford: 
Centre for Evidence-Based Medicine. Available at: http://www.cebm.net/oxford-centre-evidence-
based-medicine-levels-evidence-march-2009/ [Accessed: 4/11/2016].  
 
Phyomaung, P. P. et al. 2014. Are depression, anxiety and poor mental health risk factors for knee 
pain? A systematic review. BMC Musculoskelet Disord 15, p. 10.   
 
Pincus, T. et al. 2002. A systematic review of psychological factors as predictors of 
chronicity/disability in prospective cohorts of low back pain. Spine 27(5), pp. E109-120.  
 
Portney, L. G. and Watkins, M. P. 2007. Foundations of Clinical Research: Applications to Practice. 
Prentice Hall, Lebanon, Indiana, U.S.A. 
 
264 
 
Rangan, A. et al. 2015. Surgical vs nonsurgical treatment of adults with displaced fractures of the 
proximal humerus: the PROFHER randomized clinical trial. JAMA 313(10), pp. 1037-1047.   
 
Read, J. W. and Perko, M. 1998. Shoulder ultrasound: diagnostic accuracy for impingement 
syndrome, rotator cuff tear, and biceps tendon pathology. J Shoulder Elbow Surg 7(3), pp. 264-271.  
 
Reilingh, M. L. et al. 2008. Course and prognosis of shoulder symptoms in general practice. 
Rheumatology 47(5), pp. 724-730.   
 
Reinold, M. M. et al. 2004. Electromyographic analysis of the rotator cuff and deltoid musculature 
during common shoulder external rotation exercises. J Orthop Sports Phys Ther 34(7), pp. 385-394.   
 
Rihn, J. A. et al. 2011. Duration of symptoms resulting from lumbar disc herniation: effect on 
treatment outcomes: analysis of the Spine Patient Outcomes Research Trial (SPORT). J Bone Joint 
Surg Am 93(20), pp. 1906-1914.   
 
Riley, R. D. et al. 2013. Prognosis Research Strategy (PROGRESS) 2: prognostic factor research. PLoS 
Med 10(2), p. e1001380.   
 
Roach, K. E. et al. 1991. Development of a shoulder pain and disability index. Arthritis Care Res 4(4), 
pp. 143-149.  
 
Roddey, T. S. et al. 2000. Comparison of the University of California-Los Angeles Shoulder Scale and 
the Simple Shoulder Test with the shoulder pain and disability index: single-administration reliability 
and validity. Phys Ther 80(8), pp. 759-768.  
 
Roe, Y. et al. 2013. A systematic review of measures of shoulder pain and functioning using the 
International classification of functioning, disability and health (ICF). BMC Musculoskelet Disord 14, 
p. 73.   
 
Roll, S. C. et al. 2016. Clinical utilization of musculoskeletal sonography involving non-physician 
rehabilitation providers: A scoping review. Eur J Phys Rehabil Med 52(2), pp. 253-262.  
 
Royston, P. et al. 2009. Prognosis and prognostic research: Developing a prognostic model. BMJ 338, 
p. b604.   
 
Ryall, C. et al. 2007. A prospective cohort study of arm pain in primary care and physiotherapy--
prognostic determinants. Rheumatology 46(3), pp. 508-515.   
 
Saltychev, M. et al. 2015. Conservative treatment or surgery for shoulder impingement: systematic 
review and meta-analysis. Disabil Rehabil 37(1), pp. 1-8.   
 
Schellingerhout, J. M. et al. 2008. Lack of uniformity in diagnostic labeling of shoulder pain: time for 
a different approach. Man Ther 13(6), pp. 478-483.   
 
Schmidt, S. et al. 2014. Evaluation of shoulder-specific patient-reported outcome measures: a 
systematic and standardized comparison of available evidence. J Shoulder Elbow Surg 23(3), pp. 434-
444.   
 
265 
 
Schmitz, C. et al. 2015. Efficacy and safety of extracorporeal shock wave therapy for orthopedic 
conditions: a systematic review on studies listed in the PEDro database. Br Med Bull 116, pp. 115-
138.   
 
Schrama, P. P. et al. 2014. Intraexaminer reliability of hand-held dynamometry in the upper 
extremity: a systematic review. Arch Phys Med Rehabil 95(12), pp. 2444-2469.   
 
Seitz, A. L. et al. 2011. Mechanisms of rotator cuff tendinopathy: intrinsic, extrinsic, or both? Clin 
Biomech 26(1), pp. 1-12.   
 
Selfe, J. et al. 2016. Are there three main subgroups within the patellofemoral pain population? A 
detailed characterisation study of 127 patients to help develop targeted intervention (TIPPs). Br J 
Sports Med 50(14), pp. 873-880.   
 
Senbursa, G. et al. 2007. Comparison of conservative treatment with and without manual physical 
therapy for patients with shoulder impingement syndrome: A prospective, randomized clinical trial. 
Knee Surg Sport Traum Arthro 15(7), pp. 915-921.   
 
Shaffer, B. et al. 1992. Frozen shoulder. A long-term follow-up. J Bone Joint Surg Am 74(5), pp. 738-
746.  
 
Shrout, P. E. and Fleiss, J. L. 1979. Intraclass correlations: uses in assessing rater reliability. Psychol 
Bull 86(2), pp. 420-428.  
 
Sim, J. and Wright, C. C. 2005. The kappa statistic in reliability studies: use, interpretation, and 
sample size requirements. Phys Ther 85(3), pp. 257-268.  
 
Sindhu, B. S. et al. 2012. Influence of fear-avoidance beliefs on functional status outcomes for people 
with musculoskeletal conditions of the shoulder. Phys Ther 92(8), pp. 992-1005.   
 
Smith, A. M. et al. 2005. Rotator cuff repair in patients with rheumatoid arthritis. J Bone Joint Surg 
Am 87(8), pp. 1782-1787.   
 
Smith, M. et al. 2009. Upper and lower trapezius muscle activity in subjects with subacromial 
impingement symptoms: Is there imbalance and can taping change it? Phys Ther Sport 10(2), pp. 45-
50.   
 
Smith, M. J. et al. 2015. A training, assessment and feedback package for the trainee shoulder 
sonographer. Ultrasound 23(1), pp. 29-41.   
 
Solomon, D. H. et al. 2001. Referrals for musculoskeletal disorders: patterns, predictors, and 
outcomes. J Rheumatol 28(9), pp. 2090-2095.  
 
Soslowsky, L. J. et al. 2002. Rotator cuff tendinosis in an animal model: role of extrinsic and overuse 
factors. Ann Biomed Eng 30(8), pp. 1057-1063.  
 
Spiegl, U. J. et al. 2014. Symptomatic internal impingement of the shoulder in overhead athletes. 
Sports Med Arthrosc 22(2), pp. 120-129.   
 
Steffens, D. et al. 2014. Prognosis of chronic low back pain in patients presenting to a private 
community-based group exercise program. Eur Spine J 23(1), pp. 113-119.   
266 
 
Steuri, R. et al. 2017. Effectiveness of conservative interventions including exercise, manual therapy 
and medical management in adults with shoulder impingement: a systematic review and meta-
analysis of RCTs. Br J Sports Med 51(18), pp. 1340-1347. 
 
Steyerberg, E. W. et al. 2001. Prognostic modeling with logistic regression analysis: in search of a 
sensible strategy in small data sets. Med Decis Making 21(1), pp. 45-56.  
 
Struyf, F. and Meeus, M. 2014. Current evidence on physical therapy in patients with adhesive 
capsulitis: what are we missing? Clin Rheumatol 33(5), pp. 593-600.   
 
Sullivan, M. J. et al. 2008. Stage of chronicity and treatment response in patients with 
musculoskeletal injuries and concurrent symptoms of depression. Pain 135(1-2), pp. 151-159.   
 
Sullivan, M. J. L. et al. 1995. The Pain Catastrophizing Scale: Development and validation. Psych 
Assess 7(4), p. 524.   
 
Sun, G. W. et al. 1996. Inappropriate use of bivariable analysis to screen risk factors for use in 
multivariable analysis. J Clin Epidemiol 49(8), pp. 907-916.  
 
Tanaka, K. et al. 2010. Joint mobilization versus self-exercises for limited glenohumeral joint 
mobility: randomized controlled study of management of rehabilitation. Clin Rheumatol 29(12), pp. 
1439-1444.   
 
Tashjian, R. Z. et al. 2009. Minimal clinically important differences (MCID) and patient acceptable 
symptomatic state (PASS) for visual analog scales (VAS) measuring pain in patients treated for 
rotator cuff disease. J Shoulder Elbow Surg 18(6), pp. 927-932.   
 
Tate, A. et al. 2004. Validity of a visual classification system for scapular motion. J Orthop Sport Phys 
Ther 34(1), p. A42.  
 
Tate, A. R. et al. 2009. A Clinical Method for Identifying Scapular Dyskinesis, Part 2: Validity. J Athl 
Train 44(2), pp. 165-173.  
 
Tebbe, B. B. et al. 2013. Assessing psychological health in midwifery practice: a validation study of 
the Four-Dimensional Symptom Questionnaire (4DSQ), a Dutch primary care instrument. Midwifery 
29(6), pp. 608-615.   
 
Tempelaere, C. et al. 2016. Dynamic Three-Dimensional Shoulder Mri during Active Motion for 
Investigation of Rotator Cuff Diseases. PLoS One 11(7), p. e0158563.   
 
Terluin, B. et al. 2014a. To what extent does the anxiety scale of the Four-Dimensional Symptom 
Questionnaire (4DSQ) detect specific types of anxiety disorder in primary care? A psychometric 
study. BMC Psychiatry 14, p. 121.   
 
Terluin, B. et al. 2014b. The English version of the four-dimensional symptom questionnaire (4DSQ) 
measures the same as the original Dutch questionnaire: a validation study. Eur J Gen Pract 20(4), pp. 
320-326.   
 
Terluin, B. et al. 2006. The Four-Dimensional Symptom Questionnaire (4DSQ): a validation study of a 
multidimensional self-report questionnaire to assess distress, depression, anxiety and somatization. 
BMC Psychiatry 6, p. 34.   
267 
 
 
The Royal College of Radiologists. 2012. Ultrasound training recommendations for medical and 
surgical specialities, Second edition. London. Available at: 
https://www.rcr.ac.uk/sites/default/files/publication/BFCR(12)17_ultrasound_training.pdf 
[Accessed 4/12/13] 
 
Thoomes-de Graaf, M. et al. 2014. Inter-professional agreement of ultrasound-based diagnoses in 
patients with shoulder pain between physical therapists and radiologists in the Netherlands. Man 
Ther 19(5), pp. 478-483.   
 
Timmons, M. K. et al. 2012. Scapular kinematics and subacromial-impingement syndrome: a meta-
analysis. J Sport Rehabil 21(4), pp. 354-370.  
 
Turchin, D. C. et al. 1998. Validity of observer-based aggregate scoring systems as descriptors of 
elbow pain, function, and disability. J Bone Joint Surg Am 80(2), pp. 154-162.  
 
Turman, K. A. et al. 2010. Massive Rotator Cuff Tear in an Adolescent Athlete: A Case Report. Sports 
Health 2(1), pp. 51-55.   
 
Tyler, T. F. et al. 2010. Correction of posterior shoulder tightness is associated with symptom 
resolution in patients with internal impingement. Am J Sports Med 38(1), pp. 114-119.   
 
UK Government Web Archive – The National Archives.  Available at: 
http://webarchive.nationalarchives.gov.uk/20160105160709/http://www.ons.gov.uk/ons/rel/censu
s/2011-census-analysis/local-area-analysis-of-qualifications-across-england-and-wales/rpt---local-
area-analysis-of-qualifications-across-england-and-wales.html [Accessed: 17 02 2017].  
 
Vahlensieck, M. 2000. MRI of the shoulder. Eur Radiol 10(2), pp. 242-249.   
 
van der Heijden, G. J. 1999. Shoulder disorders: a state-of-the-art review. Best Pract Res Clin 
Rheumatol 13(2), pp. 287-309.   
 
van der Linde, J. A. et al. 2015. The Oxford Shoulder Instability Score; validation in Dutch and first-
time assessment of its smallest detectable change. J Orthop Surg Res 10, p. 146.   
 
van der Windt, D. A. et al. 1996. Shoulder disorders in general practice: prognostic indicators of 
outcome. Br J Gen Pract 46(410), pp. 519-523.  
 
van der Windt, D. A. et al. 1995. Shoulder disorders in general practice: incidence, patient 
characteristics, and management. Ann Rheum Dis 54(12), pp. 959-964.  
 
van der Windt, D. A. et al. 2007. Do psychological factors predict outcome in both low-back pain and 
shoulder pain? Ann Rheum Dis 66(3), pp. 313-319.   
 
van Eijsden-Besseling, M. D. et al. 2010. The influence of work and treatment related factors on 
clinical status and disability in patients with non-specific work-related upper limb disorders. Work 
37(4), pp. 425-432.   
 
van Rijn, R. M. et al. 2010. Associations between work-related factors and specific disorders of the 
shoulder--a systematic review of the literature. Scand J Work Environ Health 36(3), pp. 189-201.  
 
268 
 
Vargas-Prada, S. and Coggon, D. 2015. Psychological and psychosocial determinants of 
musculoskeletal pain and associated disability. Best Pract Res Clin Rheumatol 29(3), pp. 374-390.    
 
Verbunt, J. A. et al. 2005. Pain-related factors contributing to muscle inhibition in patients with 
chronic low back pain: an experimental investigation based on superimposed electrical stimulation. 
Clin J Pain 21(3), pp. 232-240.  
 
Verkerk, K. et al. 2015. Prognosis and course of pain in patients with chronic non-specific low back 
pain: A 1-year follow-up cohort study. Eur J Pain 19(8), pp. 1101-1110.   
 
Vermeulen, H. M. et al. 2006. Comparison of high-grade and low-grade mobilization techniques in 
the management of adhesive capsulitis of the shoulder: randomized controlled trial. Phys Ther 86(3), 
pp. 355-368.  
 
Viera, A. J. and Garrett, J. M. 2005. Understanding interobserver agreement: the kappa statistic. Fam 
Med 37(5), pp. 360-363.  
 
Viester, L. et al. 2013. The relation between body mass index and musculoskeletal symptoms in the 
working population. BMC Musculoskelet Disord 14, p. 238.   
 
Viikari-Juntura, E. et al. 2000. Predictive validity of symptoms and signs in the neck and shoulders. J 
Clin Epidemiol 53(8), pp. 800-808.  
 
Viikari-Juntura, E. et al. 2008. Risk factors of atherosclerosis and shoulder pain--is there an 
association? A systematic review. Eur J Pain 12(4), pp. 412-426.  
 
Virta, L. et al. 2009. How many patients with subacromial impingement syndrome recover with 
physiotherapy? A follow-up study of a supervised exercise programme. Adv Physiother 11(3), pp. 
166-173.   
 
Vlaeyen, J. W. and Linton, S. J. 2000. Fear-avoidance and its consequences in chronic 
musculoskeletal pain: a state of the art. Pain 85(3), pp. 317-332.  
 
Vranceanu, A. M. et al. 2009. Psychosocial aspects of disabling musculoskeletal pain. J Bone Joint 
Surg Am 91(8), pp. 2014-2018.   
 
Waddell, G. 2004. The Back Pain Revolution. Churchill Livingstone. 
 
Waddell, G. et al. 1993. A Fear-Avoidance Beliefs Questionnaire (FABQ) and the role of fear-
avoidance beliefs in chronic low back pain and disability. Pain 52(2), pp. 157-168.  
 
Walker-Bone, K. E. et al. 2003. Criteria for assessing pain and nonarticular soft-tissue rheumatic 
disorders of the neck and upper limb. Semin Arthritis Rheum 33(3), pp. 168-184.  
 
Wang, Y. C. et al. 2010. Translating shoulder computerized adaptive testing generated outcome 
measures into clinical practice. J Hand Ther 23(4), pp. 372-382; quiz 383.   
 
Ware, J. E., Jr. et al. 1995. Comparison of methods for the scoring and statistical analysis of SF-36 
health profile and summary measures: summary of results from the Medical Outcomes Study. Med 
Care 33(4 Suppl), pp. As264-279.  
 
269 
 
Westrick, R. B. et al. 2013. Isometric shoulder strength reference values for physically active 
collegiate males and females. Sports Health 5(1), pp. 17-21.   
 
Winokur, A. et al. 1984. Symptoms of emotional distress in a family planning service: stability over a 
four-week period. Br J Psychiatry 144, pp. 395-399.  
 
Winters, J. C. et al. 1999. The long-term course of shoulder complaints: a prospective study in 
general practice. Rheumatology 38(2), pp. 160-163.  
 
Woby, S. R. et al. 2005. Psychometric properties of the TSK-11: a shortened version of the Tampa 
Scale for Kinesiophobia. Pain 117(1-2), pp. 137-144.   
 
World Health Organization 2016. International Classification of Functioning, Disability and Health 
(ICF). Available at: http://www.who.int/classifications/icf/en/ [Accessed 02/11/2016]. 
 
Yang, J. L. et al. 2008. Shoulder kinematic features using arm elevation and rotation tests for 
classifying patients with frozen shoulder syndrome who respond to physical therapy. Man Ther 
13(6), pp. 544-551.   
 
Yang, J. L. and Lin, J. J. 2006. Reliability of function-related tests in patients with shoulder 
pathologies. J Orthop Sports Phys Ther 36(8), pp. 572-576.   
 
Younis, F. et al. 2011. The range of the Oxford Shoulder Score in the asymptomatic population: a 
marker for post-operative improvement. Ann R Coll Surg Engl 93(8), pp. 629-633.   
 
Zheng, X. et al. 2005. Data from a study of effectiveness suggested potential prognostic factors 
related to the patterns of shoulder pain. J Clin Epidemiol 58(8), pp. 823-830.   
 
Zuckerman, J. D. and Rokito, A. 2011. Frozen shoulder: a consensus definition. J Shoulder Elbow Surg 
20(2), pp. 322-325.   
  
270 
 
10 Appendix II: Literature Review 
 
Characteristics of the relevant studies, summarised in table form.  
 
PROBAST process 
 
PROBAST outcomes 
 
PROBAST Overall judgement  
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10.1 Characteristics of the relevant studies, summarised in table form  
 
Bartolozzi et al. (1994) 
 
Study design Retrospective cohort study 
Pathology; 
inclusion/exclusion 
‘Rotator cuff disease’ 
All pts had X-rays, 101 had MRI; for other 35 patients diagnosis was 
based entirely on history and clinical examination – comprising 
painful arc, +ve impingement sign, +ve impingement test, specific 
rotator cuff weakness. None of the 35 had a +ve drop arm test or 
clinically evident RC weakness 
Patient care pathway and 
clinical setting 
Patients attending orthopaedic department with impingement 
syndrome treated non-operatively  
Sample size and nature of 
those not consenting 
226 consecutive patients. 90 excluded (inadequate f/u (34), 
radiographic or clinical evidence of GH or ACJ OA (32), h/o neurologic 
disease (incl diabetes and cervical radiculopathy) (18), h/o frozen 
shoulder (4), h/o prox humeral # (2). Thus 136 patients were 
included.  
No information on those who did or did not consent 
Potential prognostic 
factors and how they 
were measured (A-E) 
 Demographics factors: Age, gender, occupation 
 Clinical history factors: Side-related symptoms: dominant arm 
involvement, Reason for symptom onset, Symptom duration 
 Patient reported measures: Pain (none), Psychological symptoms 
(none), Function / Disability (UCLA) 
 Clinical measures: Strength (shoulder girdle weakness), ROM 
(active abduction and flexion ROM), Scapular movement and 
control (none) 
 Structural pathology: Imaging (MRI: Rotator cuff pathology), 
Orthopaedic tests (none) 
Treatment (type; duration 
and frequency) 
Type: rotator cuff strengthening and ROM exercises 
Outcome (how defined; 
timing; loss to follow up) 
Outcome via combination of UCLA score at discharge and perceived 
improvement at average of 20 months 
Loss to follow up, failed to compare the baseline characteristics of 
those who were and those who were not followed up 
Analysis (how candidate 
variables selected, incl no 
cases per variable) 
(Multivariate regression 
analysis approach) 
No attempt made to trim the number of candidate variables 
Number of cases per variable = 10 
R2 values not presented 
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Chester et al. (2016) 
 
Study design Prospective cohort study 
Pathology; 
inclusion/exclusion 
Non-specific shoulder pain 
Patients were eligible if they were aged 18 years or older and 
described shoulder or arm pain aggravated by shoulder movements. 
Patients with significant reproduction of shoulder pain on spinal 
movement, or greater reproduction on spinal movement compared 
to shoulder movement, were excluded from the study. Patients with 
the following aetiology for shoulder pain were excluded: 
radiculopathy, postsurgery, postfracture, posttraumatic dislocation 
or systemic source. 
Patient care pathway and 
clinical setting 
Patients referred to physiotherapy for the management of 
musculoskeletal shoulder pain at 11 NHS trusts  and social 
enterprises in the East of England were recruited 
Participating physiotherapy departments were located within 
primary and secondary care 
Sample size and nature of 
those not consenting 
Based on analysis with a general linear model, 780 participants 
provided 90% statistical power to detect an effect size of <0.25 SDs 
adjusted for other variables with a coefficient of determination with 
the outcome of up to 0.5. 
n=1030 
Yes - the characteristics of those who did and did not consent should 
be considered, so as to avoid potential selection bias 
Potential prognostic 
factors and how they 
were measured (A-E) 
 Demographics factors: Age, Social deprivation: index of multiple 
deprivation, BMI, Smoker status, Work status: currently off work 
due to shoulder pain; not being in employment due to 
redundancy, unemployment or disability, compared with being in 
employment or education, Occupation: nature of employment; 
type of work or regular activity, Gender, Physical activity levels: 
most strenuous weekly exercise classified as ‘none’ compared to 
‘moderate’ 
 Clinical history factors: Reason for symptom onset, Timing of 
onset of symptoms, History of previous shoulder pain, 
Paraesthesia in arm, Taking pain medication, Previously receiving 
treatment: physiotherapy helpful for previous shoulder 
problems, Side-related symptoms: presence of pain in the 
opposite upper quadrant; both shoulder affected or patient 
stated ‘ambidextrous’, Symptom duration, Co-morbidities: 
additional health problems 
 Patient reported measures: Pain (pain intensity), Psychological 
symptoms (Self-efficacy for pain, Patient expectation, Anxiety 
and depression in the previous 7 days), Function / Disability 
(SPADI, QuickDASH) 
 Clinical measures: Strength (shoulder force (abduction, ER)), 
ROM (reduced range of active shoulder abduction, increasing 
difference between the range of active and passive shoulder 
abduction, AROM (flexion), PROM (flexion, abduction, ER)), 
Scapular movement and control (change in shoulder pain/ range  
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during manual facilitation of the scapula around the chest wall 
during arm elevation) 
 Structural pathology: Imaging (none), Orthopaedic tests (External 
lag sign) 
Treatment (type; duration 
and frequency) 
Type: entirely clinician directed; no details of how categorised 
Outcome (how defined; 
timing; loss to follow up) 
Disability via absolute Quick DASH score at 6 weeks post baseline and 
6 months post baseline; Pain and disability via absolute SPADI score 
at 6 weeks post baseline and 6 months post baseline 
Loss to follow up: %; analysis of differences between groups = 
younger patients as being lost to follow up as well as those not 
partaking in leisure time physical activity 
Analysis (how candidate 
variables selected, incl no 
cases per variable) 
(Multivariate regression 
analysis approach) 
No attempt made to trim the number of candidate variables 
Number of cases per variable = 11.8 
Most parsimonious model via forward selection and backward 
elimination 
R2 value = 30%; 34%; 43%; 48% 
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Conroy and Hayes (1998) 
 
Study design Randomised control trial 
Pathology; 
inclusion/exclusion 
‘Shoulder impingement syndrome’ 
Subject selection criteria included pain about the superolateral 
shoulder region and one or more of the following findings: active 
range of motion deficits in humeral elevation, painful subacromial 
compression (Neer), Hawkins and Kennedy test.  
Exclusion: shoulder instability, primary scapule thoracic dysfunction, 
stage II and III adhesive capsulitis, third degree musculotendinous 
tears, advanced acromioclavicular joint disease, advanced calcific 
tendinitis or bursitis, severe degenerative bony or ligamentous 
changes, neurological involvement and unstable fracture of the 
humerus, scapula, or clavicle.  
Patient care pathway and 
clinical setting 
n/a 
Sample size and nature of 
those not consenting 
n=14; no details 
Potential prognostic 
factors and how they 
were measured (A-E) 
 Demographics factors: Age 
 Clinical history factors: Side-related symptoms: dominant arm 
involvement, Symptom duration 
 Patient reported measures: Pain (none) , Psychological symptoms 
(none), Function / Disability (none) 
 Clinical measures: Strength (none), ROM (none), Scapular 
movement and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none) 
Treatment (type; duration 
and frequency) 
Type: standardised interventions (muscle strengthening, joint 
mobilisation) 
Duration: 3 weeks; Frequency: three times a week 
Outcome (how defined; 
timing; loss to follow up) 
VAS pain score; upon completion of treatment 
No details 
Analysis (how candidate 
variables selected, incl no 
cases per variable) 
(Multivariate regression 
analysis approach) 
No attempt made to trim the number of candidate variables 
Two tailed, independent sample t tests or Mann-Whitney U tests 
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Deutscher et al. (2009) 
 
Study design Prospective cohort study 
Pathology; 
inclusion/exclusion 
Non-specific shoulder pain 
‘Shoulder pain’ 
Patient care pathway and 
clinical setting 
Fifty-four community-based outpatient physical therapy clinics in 
Israel 
Sample size and nature of 
those not consenting 
n=5,000 
No data 
Potential prognostic 
factors and how they 
were measured (A-E) 
 Demographics factors: Age, gender, smoker status, physical 
activity levels 
 Clinical history factors: Symptom duration: chronic symptoms, 
Taking antidepressant medication, Taking pain medication, Co-
morbidities: number of co-morbidities 
 Patient reported measures: Pain (none), Psychological symptoms 
(none), Function / Disability (CAT) 
 Clinical measures: Strength (none), ROM (none), Scapular 
movement and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none) 
Treatment (type; duration 
and frequency) 
Type: entirely clinician directed; categorised using electronic 
database system 
Response to intervention n/a 
Outcome (how defined; 
timing; loss to follow up) 
Functional status via absolute CAT score at discharge; upon 
completion of treatment 
Loss to follow up: 60%; analysis of differences between groups = 
reported their missing cohort subjects as comprising a higher 
percentage of patients with a chronic condition at intake and a higher 
number of comorbidities 
Analysis (how candidate 
variables selected, incl no 
cases per variable) 
(Multivariate regression 
analysis approach) 
Reduced number of candidate variables by collapsing of variables 
within a category if distributions were too low in any one variable; 
the variable with the greatest clinical relevance was retained where 
collinearity amongst independent variables was identified. 
Most parsimonious model via forward selection and backward 
elimination 
R2 value = 30%; 36% 
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Engebretsen et al. (2010) 
 
Study design Randomised control trial 
Pathology; 
inclusion/exclusion 
‘Subacromial shoulder pain’ 
Patients between 18 and 70 years old with subacromial shoulder pain 
for at least 3 months.  
The inclusion criteria were: dysfunction or pain on abduction; a 
normal passive glenohumeral range of  motion; pain on two of three 
isometric tests (abduction at 0° or 30°, external or internal rotation); 
and a positive impingement sign.  
The exclusion criteria were: bilateral shoulder pain, previous surgery 
on the affected shoulder, instability, referred pain from neck, 
rheumatoid arthritis, clinical and radiological signs of glenohumeral- 
or acromioclavicular arthritis, serious somatic or psychiatric disorder 
or inability to understand Norwegian 
Patient care pathway and 
clinical setting 
Recruited from orthopaedic clinics and university hospital outpatient 
departments, Norway 
Sample size and nature of 
those not consenting 
n=104 
Sample size calculations were presented these related to determining 
the sample required for differences to be identified in RCTs 
Potential prognostic 
factors and how they 
were measured (A-E) 
 Demographics factors: Age, gender, Work status, Occupation: 
frequency of working above shoulder height; frequency of 
carrying heavy loads at work, educational attainment 
 Clinical history factors: Recurrent shoulder pain: previous 
shoulder pain, Symptom duration, Associated neck pain, Side-
related symptoms: dominant arm involvement, Previously 
receiving treatment: previous physiotherapy, Taking medication 
 Patient reported measures: Pain (pain intensity), Psychological 
symptoms (General health status, Emotional distress: Hopkins 
Symptom checklist, self-efficacy for pain), Function / Disability 
(SPADI) 
 Clinical measures: Strength (none), ROM (AROM – HBB, flexion 
on the affected side), Scapular movement and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none) 
Treatment (type; duration 
and frequency) 
Type: standardised interventions (treated with either supervised 
exercises or radial extracorporeal shockwave therapy or supervised 
exercises which emphasised relearning of normal movement patterns 
with an initial focus on unloading the rotator cuff via postural 
correction and manual techniques, patient education) 
Duration: maximum of 12 weeks; Frequency: once a week 
Response to intervention Worsening with physiotherapy = 3% 
Outcome (how defined; 
timing; loss to follow up) 
Pain and disability via absolute SPADI score; ‘not working’ status at 
12 months post baseline 
Loss to follow up: 10%; analysis of differences between groups = 
missing subjects older and with a higher level of functional 
impairment at baseline compared to those for whom follow up at 1 
year was possible 
Analysis (how candidate 
variables selected, incl no 
cases per variable) 
Reduced number of candidate variables via statistical methods – 
looking at univariate relationships between variables; the variable 
277 
 
(Multivariate regression 
analysis approach) 
with the greatest clinical relevance was retained where collinearity 
amongst independent variables was identified. 
Number of cases per variable = 5.5 
Age, gender and treatment group controlled for 
Most parsimonious model via variables with p ≥ 0.05 removed 
Logistic regression 
R2 value = 30% 
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Hung et al. (2010) 
 
Study design Prospective cohort study 
Pathology; 
inclusion/exclusion 
‘Subacromial impingement’ 
Subjects had to demonstrate at least 3 of the following: (1) a positive 
Neer impingement test, (2) a positive Hawkins impingement test, (3) 
a painful arc, (4 pain with isometric resisted abduction, (5) pain with 
palpation of the rotator cuff tendons, and (6) pain with active 
shoulder elevation. Subjects were excluded if they demonstrated 
signs of a complete rotator cuff tear or acute inflammation.   
Patient care pathway and 
clinical setting 
Recruited patients with SAIS from the orthopedics clinic in National 
Taiwan University Hospital and also through general announcements 
in local Internet media 
Sample size and nature of 
those not consenting 
n=33 
Based on pilot study data, a sample size of 33 subjects was calculated 
to provide 80% power to detect differences of 6° of scapular 
kinematic variables with 6° standard deviation between the 
improvement and non-improvement groups 
58 patients with SAIS recruited; after screening of the patients with 
the tests (criteria), 33 subjects met the criteria for the study. No 
details on potential bias 
Potential prognostic 
factors and how they 
were measured (A-E) 
 Demographics factors: Age 
 Clinical history factors: None 
 Patient reported measures: Pain (none), Psychological symptoms 
(none), Function / Disability (FLEX-SF) 
 Clinical measures: Strength (scapular protractor force, ER, IR and 
abduction), ROM (PROM IR, ER; posterior shoulder tightness 
(PST)), Scapular movement and control (Scapular kinematics (UR, 
IR and scapular tilt) at 30°, 60°, 90°, 120° elevation during both 
the ascending and descending phases in loaded and unloaded 
conditions) 
 Structural pathology: Imaging (none), Orthopaedic tests (none) 
Treatment (type; duration 
and frequency) 
Type: stretching, strengthening and ROM exercises along with 
manual therapy 
Duration: 6 weeks; Frequency: twice a week 
Response to intervention Successful outcome = 70% 
Outcome (how defined; 
timing; loss to follow up) 
‘Improvement’ via GROC score => 4 at discharge; upon completion of 
treatment 
Loss to follow up: 3% but failed to compare the baseline 
characteristics of those who were and those who were not followed 
up 
Analysis (how candidate 
variables selected, incl no 
cases per variable) 
(Multivariate regression 
analysis approach) 
Reduced number of candidate variables via statistical methods – 
looking at univariate relationships between variables 
Number of cases per variable = 0.5 
Most parsimonious model via forward selection and backward 
elimination 
Logistic regression 
R2 values not presented 
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Kennedy et al. (2006) 
 
Study design Prospective cohort study 
Pathology; 
inclusion/exclusion 
Non-specific shoulder pain 
Soft tissue shoulder disorders: Shoulder complaints were defined as 
any condition of pain or discomfort, including instances where there 
had been surgical treatment of the soft tissue shoulder disorder (eg, 
rotator cuff repair). 8% post-surgery.  
Patients were excluded from the study if they: (1) had fractures or 
dislocations associated with soft tissue pain, (2) received physical 
therapy for only one visit (eg, referred for equipment or single 
education session), or (3) were unable to read and write English and 
thus could not complete the questionnaire package independently 
Patient care pathway and 
clinical setting 
Patients beginning treatment at a large number of different 
physiotherapy practices; Canada 
Sample size and nature of 
those not consenting 
n=361 
Yes - compared demographic variables describing participants and 
those considered nonparticipants (exclusion by eligibility criteria or 
the patient refused to participate) and did not find any statistically 
significant differences between the 2 groups. There were no sex and 
age differences between the participants group and nonparticipants 
group (P >= 0.4). Although nonparticipants had their symptoms for a 
longer time before starting therapy than participants (381 versus 229 
days), the difference was marginally (non)significant (unpaired t test, 
P=.07) 
Potential prognostic 
factors and how they 
were measured (A-E) 
 Demographics factors: Age, gender, Work status, workers 
compensation claim 
 Clinical history factors: Symptom duration: shorter duration in 
symptoms, Post-surgical case, Recurrent shoulder pain, Reason 
for symptom onset, Co-morbidities: number of co-morbidities 
and number that limit activity, Taking pain medication 
 Patient reported measures: Pain (pain intensity), Psychological 
symptoms (Patient expectation, Mental Component Score (MCS) 
from the 36-Item Short-Form Health Survey (SF-36)), Function / 
Disability (DASH, Physical Component Score (PCS) from the 36-
Item Short-Form Health Survey (SF-36), Global rating of disability 
score) 
 Clinical measures: Strength (muscle wasting and muscle 
weakness), ROM (active and passive ROM), Scapular movement 
and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none) 
Treatment (type; duration 
and frequency) 
Type: no details 
Mean 14.8 sessions (SD=8.7), duration of Rx = mean of 64.9 days 
(SD=25.6). 
Response to intervention Worsening with physiotherapy = 7% 
Outcome (how defined; 
timing; loss to follow up) 
Disability via absolute DASH score at discharge / 12 weeks; change in 
disability via change from DASH score at baseline to discharge / 12 
weeks 
Loss to follow up:  failed to compare the baseline characteristics of 
those who were and those who were not followed up 
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Analysis (how candidate 
variables selected, incl no 
cases per variable) 
(Multivariate regression 
analysis approach) 
Reduced number of candidate variables via statistical methods – 
looking at univariate relationships between variables; also collapsing 
of variables within a category if distributions were too low in any one 
variable; the variable with the greatest clinical relevance was 
retained where collinearity amongst independent variables was 
identified.  
Number of cases per variable = 10 
Most parsimonious model via variables with p ≥ 0.05 removed 
R2 value = 23% 
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Kromer et al. (2014) 
 
Study design Randomised control trial 
Pathology; 
inclusion/exclusion 
‘Subacromial pain syndrome’ 
Inclusion criteria set for this trial were: (1) age between 18 and 75 
years; (2) symptoms for at least 4 weeks; (3) main complaints in the 
glenohumeral joint region or the proximal segments of the arm; (4) 
presence of one of the following signs indicating SPS: Neer 
impingement sign, Hawkins- Kennedy impingement test, or painful 
arc with active abduction or flexion; and (5) pain during one of the 
following resistance tests: external rotation, internal rotation, 
abduction, or flexion.     
Exclusion criteria were: (1) average 24-hour pain of 8/10 or more on 
a visual numeric rating scale (VNRS); (2) primary scapulothoracic 
dysfunction due to paresis; (3) diagnosed instability or previous 
history of dislocation; (4) frozen shoulder; (5) more than one-third 
restriction of elevation compared with the unaffected side; (6) 
substantial shoulder weakness or loss of active shoulder function; (7) 
shoulder surgery on the involved side in the previous 12  months; (8) 
reproduction of symptoms with active or passive cervical 
movements; (9) neurological involvement with sensory or muscular 
deficits; (10) inflammatory joint disease (eg, rheumatoid arthritis); 
(11) diabetes mellitus; (12) intake of  psychotherapeutic drugs; (13) 
compensation claims; and (14) inability to understand written or 
spoken German. 
Patient care pathway and 
clinical setting 
Germany, outpatient. Presentation to a physical therapist following 
referral by general practitioner or orthopedic surgeon (duration of 
symptoms >=4 wk) 
Outpatient physiotherapy clinics, GPs and orthopaedic surgeons 
Sample size and nature of 
those not consenting 
n=90; sample size calculations were presented these related to 
determining the sample required for differences to be identified in 
RCTs 
Potential prognostic 
factors and how they 
were measured (A-E) 
 Demographics factors: Age and gender were controlled for in the 
regression model 
 Clinical history factors: Symptom duration 
 Patient reported measures: Pain (pain intensity), Psychological 
symptoms (Fear Avoidance Beliefs Questionnaire (physical 
activity subscale), Pain catastrophising scale), Function / 
Disability (Function / disability as measured by the function 
element of the SPADI) 
 Clinical measures: Strength (none), ROM (none), Scapular 
movement and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none) 
Treatment (type; duration 
and frequency) 
Type: standardised interventions (shoulder girdle and thoracic spine 
stretching and strengthening exercises, manual mobilisation 
techniques for the shoulder complex and cervical spine, patient 
education) 
Duration: 5 weeks of clinician directed rehabilitation followed by 7 
weeks of home based exercises; Frequency: twice a week 
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Outcome (how defined; 
timing; loss to follow up) 
Change in functional status via change in functional subscale of SPADI 
(SPADI-F) between baseline and 3 months post baseline 
Loss to follow up: 2% but failed to compare the baseline 
characteristics of those who were and those who were not followed 
up 
Analysis (how candidate 
variables selected, incl no 
cases per variable) 
(Multivariate regression 
analysis approach) 
Number of cases per variable = 18 
Reduced number of candidate variables via variable with the greatest 
clinical relevance was retained where collinearity amongst 
independent variables was identified. 
Hierarchical regression: first step (variables (age and gender) 
controlling for),  second step explored clinical variables and third step 
explored psychological variables 
Most parsimonious model via variables with p ≥ 0.05 removed 
R2 value = 48% 
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Mintken et al. (2010) 
 
Study design Prospective cohort study 
Pathology; 
inclusion/exclusion 
Non-specific shoulder pain 
Inclusion criteria: between ages of 18 and 65 years, with a primary 
report of shoulder pain and a baseline Shoulder Pain and Disability 
Index (SPADI) score of 20% or greater.  
Exclusion criteria: any medical “red flags” suggestive of a non-
musculoskeletal aetiology of symptoms, acute fractures in the 
shoulder region, acute severe trauma in the cervical or thoracic 
region in the previous 6 weeks, a diagnosis of cervical spinal stenosis 
or bilateral upper-extremity symptoms, osteoporosis, prior surgery to 
the cervical or thoracic region, evidence of central nervous system 
involvement, insufficient English language skills to complete the 
questionnaires, or signs consistent with nerve root compression 
(defined as impairment in at least 2 of the following: myotomal 
strength, sensation, or reflexes). “Red flags” were ruled out by a 
combination of a medical screening questionnaire, a neurological 
examination, and a patient history.   
Patient care pathway and 
clinical setting 
Outpatient physiotherapy clinics 
Sample size and nature of 
those not consenting 
n=80 
No details on n=8 who declined to participate 
Potential prognostic 
factors and how they 
were measured (A-E) 
 Demographics factors: Age, gender, work status 
 Clinical history factors: Symptom duration, Taking pain 
medication, Reason for symptom onset, Recurrent shoulder pain: 
number of previous episodes, Previously receiving treatment: 
treatment for previous episodes, past medical history 
 Patient reported measures: Pain (pain intensity), Psychological 
symptoms (Patient expectation, Fear Avoidance Beliefs 
Questionnaire, Tampa Scale for Kinesiophobia), Function / 
Disability (SPADI) 
 Clinical measures: Strength (Serratus Anterior, Middle trapezius, 
Lower trapezius, Rhomboid, Deltoid, External and internal 
shoulder rotator muscle strength), ROM (pain-free shoulder 
flexion, passive shoulder IR at 90° abduction, Passive shoulder 
abduction, Passive shoulder ER at 90° abduction, Battery of 3 
functional tests), Scapular movement and control (Lateral slide 
test and scapula index, Qualitative assessment of scapular 
function) 
 Structural pathology: Imaging (none), Orthopaedic tests (13 
orthopaedic tests including the Hawkins-Kennedy impingement 
test, the empty can and full can test and the drop sign Neer's 
sign) 
Treatment (type; duration 
and frequency) 
Type: thrust manipulations of the cervicothoracic spine 
Duration: days 
Response to intervention Successful outcome = 61%; Worsening with physiotherapy = 4% 
Outcome (how defined; 
timing; loss to follow up) 
‘Improvement’ via GROC score => 4 at discharge; upon completion of 
treatment 
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At the beginning of the second session, the participants completed 
the GROC and the other outcome measures. If their score on the 
GROC did not exceed the +4 cutoff at the second session, they 
received the same intervention program again and were scheduled 
for a follow-up within 2 to 4 days. Participants again completed the 
GROC along with the other outcome measures. If they scored +4 or 
better on the GROC, they were categorized as having a successful 
outcome; if they scored below +4, they were categorized as not 
having a successful outcome. At this point, their participation in the 
study was complete, and the therapist could administer further 
treatment as needed. 
F/up was at 2nd or 3rd apt – over a period of a few days 
Loss to f/u = 1 
Analysis (how candidate 
variables selected, incl no 
cases per variable) 
(Multivariate regression 
analysis approach) 
Reduced number of candidate variables via statistical methods – 
looking at univariate relationships between variables 
Variables with a significance level of P<.10 were retained as potential 
prognostic variables. For continuous variables with a significant 
univariate relationship, sensitivity and specificity values were 
calculated for all possible cutoff points and then plotted as a receiver 
operator characteristic (ROC) curve.   
Number of cases per variable = 6 
Logistic regression 
  
285 
 
Morrison et al. (1997) 
 
Study design Retrospective cohort study 
Pathology; 
inclusion/exclusion 
‘Subacromial impingement’ 
Diagnosis made on the basis of a positive impingement sign and the 
absence of other abnormalities of the shoulder, such as full thickness 
tears of the rotator cuff, osteoarthrosis of the acromioclavicular joint, 
instability of the glenohumeral joint, or adhesive capsulitis. 
Diagnosis made on the basis of a history, a clinical examination, and a 
positive Neer impingement sign.  
Patients who had concomitant adhesive capsulitis, cervical 
radiculopathy, or suprascapular nerve palsy were excluded, as were 
patients who had major weakness on testing of the rotator cuff or a 
full-thickness tear of the rotator  cuff on magnetic resonance 
imaging.  
Patient care pathway and 
clinical setting 
Investigation performed at the Southern California Centre for Sports 
Medicine, Long Beach 
Sample size and nature of 
those not consenting 
n=616 
No data 
Potential prognostic 
factors and how they 
were measured (A-E) 
 Demographics factors: Age, gender 
 Clinical history factors: Symptom duration, Side-related 
symptoms: dominant arm involvement 
 Patient reported measures: Pain (none), Psychological symptoms 
(none), Function / Disability (none) 
 Clinical measures: Strength (none), ROM (none), Scapular 
movement and control (none) 
 Structural pathology: Imaging (Acromion morphology type 1 on 
X-ray), Orthopaedic tests (none) 
Treatment (type; duration 
and frequency) 
Type: physiotherapy programme consisting of stretching and then 
strengthening 
Response to intervention Successful outcome = 67% 
Outcome (how defined; 
timing; loss to follow up) 
Pain, function, active ROM, strength and overall satisfaction via 
absolute UCLA score at average of 27 months 
Loss to follow up: 8 % but failed to compare the baseline 
characteristics of those who were and those who were not followed 
up 
Analysis (how candidate 
variables selected, incl no 
cases per variable) 
(Multivariate regression 
analysis approach) 
No attempt made to trim the number of candidate variables 
Chi-square 
Number of cases per variable = 123 
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Ogon et al. (2009) 
 
Study design Prospective cohort study 
Pathology; 
inclusion/exclusion 
‘Calcific tendonitis’ 
Inclusion criteria were the presence of radiographically and 
sonographically proven calcific deposits in a rotator cuff tendon and 
the presence of clinically symptomatic calcific tendinitis of the 
shoulder requiring continuation of treatment at the time of 
presentation at the institution.  
Exclusion criteria were previous surgical interventions, needling, 
application of ultrasound therapy, or extracorporeal shock wave 
therapy (ESWT), as well as the presence of rheumatoid arthritis or 
concomitant diseases of the affected shoulder 
Patient care pathway and 
clinical setting 
All patients had previously received nonoperative treatment from 
general practitioners, rheumatologists, or orthopedic surgeons, 
which included physical therapy, manual therapy, electrotherapy, 
iontophoresis, systemic use of analgesics and nonsteroidal 
antiinflammatory drugs (NSAIDs), and up to 3 subacromial injections 
of corticosteroids. The patients were then referred to the 
Orthopaedic Outpatient Clinic because of the persistence of clinically 
symptomatic calcific tendinitis of the shoulder.     
Sample size and nature of 
those not consenting 
N=420 
No data 
Potential prognostic 
factors and how they 
were measured (A-E) 
 Demographics factors: Age, gender, occupation 
 Clinical history factors: Periods of professional disability, Reason 
for symptom onset, Symptom duration, Side-related symptoms: 
dominant arm involvement, Past medical history 
 Patient reported measures: Pain (none), Psychological symptoms 
(none), Function / Disability (none) 
 Clinical measures: Strength (none), ROM (none), Scapular 
movement and control (none) 
 Structural pathology: Imaging (Calcific deposits: X-ray and 
sonographic), Orthopaedic tests (none) 
Treatment (type; duration 
and frequency) 
Type: physiotherapy treatment algorithm including heat or cold and 
manual therapy 
Duration: minimum of 3 months 
Response to intervention Successful outcome = 73% 
Outcome (how defined; 
timing; loss to follow up) 
‘Success of non-operative therapy’ via no progression to advanced 
therapeutic measures after a minimum of 6 months non-operative 
treatment (including minimum of 3 months treatment at the study 
location) 
Loss to follow up: failed to compare the baseline characteristics of 
those who were and those who were not followed up 
Analysis (how candidate 
variables selected, incl no 
cases per variable) 
(Multivariate regression 
analysis approach) 
No attempt made to trim the number of candidate variables 
Number of cases per variable = 25 
Most parsimonious model via variables with p ≥ 0.05 removed 
Prognostic factors were determined at P < 0.05 by chi-square test 
Logistic regression 
R2 values not presented 
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Sindhu et al. (2012) 
 
Study design Retrospective cohort study 
Pathology; 
inclusion/exclusion 
Non-specific shoulder pain 
Clinical staff entered necessary medical information at intake, such as 
diagnosis codes based on the International Classification of Diseases, 
Ninth Revision (ICD-9). 
Patient care pathway and 
clinical setting 
People with musculoskeletal conditions of the shoulder who 
attended outpatient rehabilitation clinics throughout the United 
States 
Data were collected from people with musculoskeletal conditions of 
the shoulder receiving rehabilitation. 
Sample size and nature of 
those not consenting 
N=3362 
N/a 
Potential prognostic 
factors and how they 
were measured (A-E) 
 Demographics factors: None 
 Clinical history factors: None 
 Patient reported measures: Pain (none), Psychological symptoms 
(Fear Avoidance Beliefs Questionnaire), Function / Disability 
(none) 
 Clinical measures: Strength (none), ROM (none), Scapular 
movement and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none) 
Treatment (type; duration 
and frequency) 
Type: no details 
Outcome (how defined; 
timing; loss to follow up) 
Functional change via change in CAT score between baseline and 
discharge; upon completion of treatment 
Loss to follow up: 43%; analysis of differences between groups = 
identified differences between those available for and lost to follow 
up in terms of age, pain levels and function but provided no details 
on the direction of difference 
Analysis (how candidate 
variables selected, incl no 
cases per variable) 
(Multivariate regression 
analysis approach) 
General linear model (GLM) used to describe how change in function 
is affected by fear avoidance  
3362 
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Tyler et al. (2010) 
 
Study design Prospective cohort study 
Pathology; 
inclusion/exclusion 
‘Internal impingement’ 
Diagnostic criteria for internal impingement was used.  
Specific inclusion criteria based on physical examination were 
positive relocation test, positive posterior impingement sign, and 
posterior glenohumeral joint line tenderness. Specific inclusion 
criteria based on MRI findings were the presence of a 
posterosuperior glenoid labral lesion.  
Exclusion criteria were anterior instability, full-thickness rotator cuff 
tear, and subacromial impingement as determined by physical 
examination and MRI. Additionally, all patients reported subjective 
clicking in their shoulder on active movement.  
Patient care pathway and 
clinical setting 
No details 
Sample size and nature of 
those not consenting 
n=22 
Potential prognostic 
factors and how they 
were measured (A-E) 
 Demographics factors: None 
 Clinical history factors: None 
 Patient reported measures: Pain (none), Psychological symptoms 
(none), Function / Disability (none) 
 Clinical measures: Strength (none), ROM (Improvement in PST at 
discharge, Improvement in passive ER ROM, Improvement in 
GIRD), Scapular movement and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none) 
Treatment (type; duration 
and frequency) 
Type: glenohumeral joint glides, sleeper stretches and cross-chest 
adduction 
Duration 7 ± 2 weeks; Frequency: three times a week 
Outcome (how defined; 
timing; loss to follow up) 
Symptom free via Simple Shoulder Test at discharge; upon 
completion of treatment 
Analysis (how candidate 
variables selected, incl no 
cases per variable) 
(Multivariate regression 
analysis approach) 
No attempt made to trim the number of candidate variables 
Number of cases per variable = 7 
Mixed model analysis of variance, with Treatment (pretreatment vs 
posttreatment) as the within-subjects factor and Group (patients 
with complete resolution of symptoms vs patients with residual 
symptoms) as the between-subjects factor. 
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Virta et al. (2009) 
 
Study design Prospective cohort study 
Pathology; 
inclusion/exclusion 
‘Subacromial impingement’ 
Diagnosis was confirmed with subacromial anaesthesia, with a few 
exceptions by the same doctor, and most of the patients had passed 
an MRI examination. Patients were included if diagnosis was 
confirmed 
Patient care pathway and 
clinical setting 
Recruited patients who were on a waiting list for orthopaedic surgery 
but had been referred for physiotherapy prior to surgery 
Sample size and nature of 
those not consenting 
n=97 
Potential prognostic 
factors and how they 
were measured (A-E) 
 Demographics factors: Age, gender 
 Clinical history factors: Symptom duration 
 Patient reported measures: Pain (none), Psychological symptoms 
(none), Function / Disability (none) 
 Clinical measures: Strength (none), ROM (none), Scapular 
movement and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none) 
Treatment (type; duration 
and frequency) 
Type: ROM and strengthening exercises 
Duration: 8 weeks; Frequency: twice a week 
Response to intervention Successful outcome = 87% 
Outcome (how defined; 
timing; loss to follow up) 
UCLA; upon completion of treatment 
Loss to follow up: 26% but failed to compare the baseline 
characteristics of those who were and those who were not followed 
up 
Analysis (how candidate 
variables selected, incl no 
cases per variable) 
(Multivariate regression 
analysis approach) 
No attempt made to trim the number of candidate variables 
No details of analysis 
Number of cases per variable = 18 
R2 values not presented 
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10.2 PROBAST process 
 
The following is adapted from PROBAST: Prediction Risk of Bias Tool 2017. York, United Kingdom: 
Kleijnen Systematic Reviews Ltd. 2017. Available at: http://www.systematic-reviews.com/ probast. 
Accessed October 6, 2017. 
 
PROBAST includes five steps. 
Step Task When to complete 
1 Specify your systematic review 
question 
Once per systematic review 
2 Classify the type of prediction 
model evaluation 
Once for each model of interest in each publication 
being assessed, for each relevant outcome 
3 Assess risk of bias and 
applicability 
Once for each evaluation (development and/or 
validation) of each distinct model 
4 Overall judgement Once for each evaluation (development and/or 
validation) of each distinct model 
5 Usability of the model Once for each distinct model 
 
 
Step 1: Specify your systematic review question 
State your systematic review question to facilitate the assessment of the applicability of the 
evaluated models to your question. The following table should be completed once per systematic 
review. 
 
Specify your systematic review question 
 
Participants (e.g. setting, main inclusion criteria, prior treatments): 
 
Outcome(s) to be predicted: 
 
Intended use of the model(s):  
 
When will the model(s) be used, e.g. at presentation with signs/ symptoms, staging severity of 
disease, pre-operatively? 
 
 
 
Step 2: Classify the type of prediction model evaluation 
Different signalling questions apply for different types of prediction model evaluation. Use the 
following table to classify the evaluation as model development, model validation or both. If the 
evaluation does not fit one of these classifications then PROBAST should not be used. 
 
Type of model evaluation Tick as appropriate PROBAST classification 
 
   
 
 
Step 3: Assess risk of bias and applicability 
PROBAST is structured as five key domains. Each domain is judged for risk of bias (low, high or 
unclear) and includes signalling questions to help make judgements. Signalling questions are rated as 
yes (Y), probably yes (PY), probably no (PN), no (N) or no information (NI). All signalling questions are 
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phrased so that “yes” indicates absence of bias. Any signalling question rated as “no” or “probably 
no” flags the potential for bias; you will need to use your judgement to determine whether the 
domain should be rated as “high”, “low” or “unclear” risk of bias.  
 
DOMAIN 1: Participant selection  
 
A. Risk of Bias 
Describe the sources of data and criteria for participant selection: 
 
 
1. Were appropriate data sources used, e.g. cohort, RCT or nested 
case-control study data? 
 
 
2. Were all inclusions and exclusions of participants appropriate? 
 
 
3. Were participants enrolled at a similar state of health, or were 
predictors considered to account for any dissimilarities? 
 
 
Risk of bias introduced by selection of participants 
 
RISK: 
(low/ high/ unclear) 
 
 
B. Applicability 
Describe included participants, setting and dates: 
 
 
Concern that the included participants and setting do not match the 
review question  
CONCERN: 
(low/ high/ unclear) 
 
 
 
DOMAIN 2: Predictors  
 
A. Risk of Bias 
List and describe predictors assessed, e.g. definition, timing and knowledge of other predictors: 
 
 
1. Were predictors defined and assessed in a similar way for all 
participants? 
 
 
3. Were predictor assessments made without knowledge of 
outcome data? 
 
 
4. Are all predictors available at the time the model is intended to be 
used? 
 
5. Were all relevant predictors analysed? 
 
 
Risk of bias introduced by predictors or their assessment RISK: 
(low/ high/ unclear) 
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Note: question 2 pertained to model validation studies only 
 
B. Applicability 
Concern that the definition, assessment or timing of assessment of 
predictors in the model do not match the review question 
CONCERN: 
(low/ high/ unclear) 
 
 
 
DOMAIN 3: Outcome 
 
A. Risk of Bias 
Describe the outcome and how it was defined and determined: 
 
 
1. Was a pre-specified outcome definition used? 
 
 
2. Were predictors excluded from the outcome definition? 
 
 
3. Was the outcome defined and determined in a similar way for all 
participants? 
 
 
5. Was the outcome determined without knowledge of predictor 
information? 
 
 
Risk of bias introduced by the outcome or its determination RISK: 
(low/ high/ unclear) 
 
Note: question 4 pertained to model validation studies only 
 
B. Applicability 
At what time point was the outcome determined: 
 
If a composite outcome was used, describe the relative frequency/distribution of each 
contributing outcome: 
 
Concern that the outcome, its definition, timing or determination do 
not match the review question 
CONCERN: 
(low/ high/ unclear) 
 
 
 
DOMAIN 4: Sample size and participant flow 
 
A. Risk of Bias 
Describe numbers of participants, outcome events and events per predictor: 
 
Describe the time interval between predictor assessment and outcome determination: 
 
Describe any participants who were excluded from the model: 
 
Describe missing data on predictors and outcomes as well as methods used for missing data: 
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1. Were there a reasonable number of outcome events? 
 
 
2. Was the time interval between predictor assessment and 
outcome determination appropriate? 
 
 
3. Were all enrolled participants included in the analysis? 
 
 
4. Were participants with missing data handled appropriately? 
 
 
Risk of bias introduced by sample size or participant flow RISK: 
(low/ high/ unclear) 
 
 
 
DOMAIN 5: Analysis 
 
A. Risk of Bias 
Describe how the model was developed (predictor selection, fitting and optimism, risk groups, 
model performance): 
 
Describe whether and how the model was validated, either internally (e.g. bootstrapping, cross 
validation, random split sample) or externally (e.g. temporal validation, geographical validation, 
different setting, different type of participants): 
 
Describe the performance measures of the model, e.g. calibration, discrimination, 
(re)classification, net benefit: 
 
1. Were non-binary predictors handled appropriately? 
 
 
2. Was selection of predictors based on univariable analysis 
avoided? 
 
 
3. Was model overfitting (optimism in model performance) 
accounted for, e.g. using bootstrapping or shrinkage techniques? 
 
 
4. Were any complexities in the data (e.g. competing risks, multiple 
events per individual) accounted for appropriately? 
 
5. Do predictors and their assigned weights in the final model 
correspond to the results from multivariable analysis? 
 
6. Were relevant model performance measures evaluated, e.g. 
calibration, discrimination, (re)classification and net benefit? 
 
Risk of bias introduced by the analysis RISK: 
(low/ high/ unclear) 
 
Note: question 7 pertained to model validation studies only 
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Step 4: Overall judgement 
Use the following tables to reach overall judgements about risk of bias and applicability of the 
prediction model evaluation (development and/ or validation) across all assessed domains. 
Complete for each evaluation of a distinct model. 
 
Reaching an overall judgement about risk of bias of the prediction model evaluation 
Low risk of bias If all domains were rated low risk of bias. 
If a prediction model was developed without any external validation, and it 
was rated as low risk of bias for all domains, consider downgrading to high risk 
of bias. Such model can only be considered as low risk of bias, if the 
development was based on a very large data set and included some form of 
internal validation. 
High risk of bias If at least one domain is judged to be at high risk of bias. 
Unclear risk of 
bias 
If an unclear risk of bias was noted in at least one domain and it was low risk 
for all other domains. 
 
Reaching an overall judgement about applicability of the prediction model evaluation 
Low concerns 
regarding 
applicability 
If low concerns regarding applicability for all domains, the prediction model 
evaluation is judged to have low concerns regarding applicability. 
High concerns 
regarding 
applicability 
If high concerns regarding applicability for at least one domain, the prediction 
model evaluation is judged to have high concerns regarding applicability. 
Unclear 
concerns 
regarding 
applicability 
If unclear concerns (but no “high concern”) regarding applicability for at least 
one domain, the prediction model evaluation is judged to have unclear 
concerns regarding applicability overall. 
 
 
Overall judgement about risk of bias and applicability of the prediction model evaluation 
Overall judgement of risk of bias RISK: 
(low/ high/ unclear) 
 
Overall judgement of applicability CONCERN: 
(low/ high/ unclear) 
 
 
Step 5: Usability of the model 
The following question assesses whether the model was presented in enough detail to be usable in 
the targeted individuals and context. Note that this is different from the applicability assessment 
above, which refers to the extent to which the prediction model evaluation matches your review 
question. 
Complete for each evaluation of a distinct model or simplified score. 
 
Assess the usability of the model 
Is the model presented with sufficient detail to be used in the 
intended context and target population? 
RATING: 
(yes/ no) 
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10.3 New 10.3 PROBAST Outcomes 
 
Step 1: Specify your systematic review question 
 
Specify your systematic review question 
What are the prognostic indicators of successful rehabilitation outcome in patients with 
Subacromial Impingement Syndrome / Rotator Cuff Tendinopathy? 
Participants (e.g. setting, main inclusion criteria, prior treatments): 
Patients in the Cardiff & Vale region who have been referred for out-patient physiotherapy in the 
NHS, secondary care setting. 
Patients with a clinical diagnosis of Subacromial Impingement Syndrome / Rotator Cuff 
Tendinopathy. 
No recent shoulder surgery; otherwise no restriction placed upon previous treatment. 
Treatment defined as non-invasive, multimodal physiotherapy. 
Outcome(s) to be predicted: 
Change in shoulder function from baseline. 
Intended use of the model(s): Prognosis 
When will the model(s) be used, e.g. at presentation with signs/ symptoms, staging severity of 
disease, pre-operatively? 
Upon referral to NHS out-patient physiotherapy in a secondary care setting. 
 
Step 2: Classify the type of prediction model evaluation 
 
Type of model evaluation Tick as appropriate PROBAST classification 
 
Prediction model development 
without testing its predictive 
performance in other 
individuals, i.e. no external 
validation. Model 
development should ideally 
include internal validation, 
such as bootstrapping or cross-
validation. 
All studies included in the 
review were of this type 
Development only 
 
 
Bartolozzi et al. (1994) 
 
Step 3: Assess risk of bias and applicability 
 
DOMAIN 1: Participant selection  
 
A. Risk of Bias 
Describe the sources of data and criteria for participant selection: 
 Patients attending orthopaedic department with impingement syndrome treated non-
operatively  
 All pts had X-rays, 101 had MRI; for other 35 patients diagnosis was based entirely on history 
and clinical examination – comprising painful arc, +ve impingement sign, +ve impingement 
test, specific rotator cuff weakness. None of the 35 had a +ve drop arm test or clinically 
evident RC weakness.   
1. Were appropriate data sources used, e.g. cohort, RCT or nested 
case-control study data? 
Yes 
296 
 
  
2. Were all inclusions and exclusions of participants appropriate? 
Diagnosis not typically made based on X-ray and MRI imaging in 
isolation 
 
No  
3. Were participants enrolled at a similar state of health, or were 
predictors considered to account for any dissimilarities? 
 
Unclear  
Risk of bias introduced by selection of participants 
 
RISK: High 
 
 
B. Applicability 
Describe included participants and setting: 
n=136 
Patients attending orthopaedic department with impingement syndrome treated non-operatively  
Concern that the included participants and setting do not match the 
review question  
CONCERN: Low 
 
 
 
DOMAIN 2: Predictors  
 
A. Risk of Bias 
List and describe predictors assessed, e.g. definition, timing and knowledge of other predictors: 
 Demographics factors: Age, gender, occupation 
 Clinical history factors: Side-related symptoms: dominant arm involvement, Reason for 
symptom onset, Symptom duration 
 Patient reported measures: Pain (none), Psychological symptoms (none), Function / Disability 
(UCLA) 
 Clinical measures: Strength (shoulder girdle weakness), ROM (active abduction and flexion 
ROM), Scapular movement and control (none) 
 Structural pathology: Imaging (MRI: Rotator cuff pathology), Orthopaedic tests (none) 
All recorded at initiation of the study 
1. Were predictors defined and assessed in a similar way for all 
participants? 
 
Yes 
3. Were predictor assessments made without knowledge of 
outcome data? 
 
Yes 
4. Are all predictors available at the time the model is intended to be 
used? 
Yes 
5. Were all relevant predictors analysed? 
 
Yes 
Risk of bias introduced by predictors or their assessment RISK: Low 
 
B. Applicability 
Concern that the definition, assessment or timing of assessment of 
predictors in the model do not match the review question 
CONCERN: Low 
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DOMAIN 3: Outcome 
 
A. Risk of Bias 
Describe the outcome and how it was defined and determined: 
Combination of UCLA score at discharge and perceived improvement 
1. Was a pre-specified outcome definition used? 
 
Yes 
2. Were predictors excluded from the outcome definition? 
UCLA both predictor and outcome 
No 
 
3. Was the outcome defined and determined in a similar way for all 
participants? 
 
Yes 
5. Was the outcome determined without knowledge of predictor 
information? 
 
Yes 
Risk of bias introduced by the outcome or its determination RISK: High 
 
 
B. Applicability 
At what time point was the outcome determined: 
At average of 20 months   
If a composite outcome was used, describe the relative frequency/distribution of each 
contributing outcome: 
n/a 
Concern that the outcome, its definition, timing or determination do 
not match the review question 
CONCERN: Low 
 
 
 
DOMAIN 4: Sample size and participant flow 
 
A. Risk of Bias 
Describe numbers of participants and events per predictor: 
 n=136; 10 
Describe the time interval between predictor assessment and outcome determination: 
 Average of 20 months   
Describe any participants who were excluded from the model: 
 unknown 
Describe missing data on predictors and outcomes as well as methods used for missing data: 
 n/a 
 
1. Were there a reasonable number of outcome events? 
  
Yes 
2. Was the time interval between predictor assessment and 
outcome determination appropriate? 
Overly long time from initiation of study 
No 
3. Were all enrolled participants included in the analysis? 
 
NI 
4. Were participants with missing data handled appropriately? 
 
NI 
Risk of bias introduced by sample size or participant flow RISK: High 
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DOMAIN 5: Analysis 
 
A. Risk of Bias 
Describe how the model was developed (predictor selection, fitting and optimism, risk groups, 
model performance): 
 No attempt made to trim the number of candidate variables 
 No details on model construction 
Describe whether and how the model was validated, either internally (e.g. bootstrapping, cross 
validation, random split sample) or externally (e.g. temporal validation, geographical validation, 
different setting, different type of participants): 
 n/a 
Describe the performance measures of the model, e.g. calibration, discrimination, 
(re)classification, net benefit: 
 n/a 
1. Were non-binary predictors handled appropriately? 
 
NI 
2. Was selection of predictors based on univariable analysis 
avoided? 
 
NI 
3. Was model overfitting (optimism in model performance) 
accounted for, e.g. using bootstrapping or shrinkage techniques? 
 
No 
4. Were any complexities in the data (e.g. competing risks, multiple 
events per individual) accounted for appropriately? 
No 
5. Do predictors and their assigned weights in the final model 
correspond to the results from multivariable analysis? 
No 
6. Were relevant model performance measures evaluated, e.g. 
calibration, discrimination, (re)classification and net benefit? 
No 
Risk of bias introduced by the analysis RISK: High 
 
 
 
Step 4: Overall judgement 
 
Overall judgement about risk of bias and applicability of the prediction model evaluation 
Overall judgement of risk of bias RISK: High 
 
Overall judgement of applicability CONCERN: Low 
 
 
Step 5: Usability of the model 
 
Assess the usability of the model 
Is the model presented with sufficient detail to be used in the 
intended context and target population? 
RATING: No 
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Chester et al (2016) 
 
Step 3: Assess risk of bias and applicability 
 
DOMAIN 1: Participant selection  
 
A. Risk of Bias 
Describe the sources of data and criteria for participant selection: 
 Patients referred to physiotherapy for the management of musculoskeletal shoulder pain at 
11 NHS trusts and social enterprises in the East of England were recruited. Participating 
physiotherapy departments were located within primary and secondary care 
 Patients were eligible if they were aged 18 years or older and described shoulder or arm pain 
aggravated by shoulder movements. Patients with significant reproduction of shoulder pain 
on spinal movement, or greater reproduction on spinal movement compared to shoulder 
movement, were excluded from the study. Patients with the following aetiology for shoulder 
pain were excluded: radiculopathy, postsurgery, postfracture, posttraumatic dislocation or 
systemic source.   
1. Were appropriate data sources used, e.g. cohort, RCT or nested 
case-control study data? 
 
Yes 
2. Were all inclusions and exclusions of participants appropriate? 
 
Yes  
3. Were participants enrolled at a similar state of health, or were 
predictors considered to account for any dissimilarities? 
 
Unclear  
Risk of bias introduced by selection of participants 
 
RISK: Low 
 
 
B. Applicability 
Describe included participants and setting: 
n=1030 
Patients referred to physiotherapy for the management of musculoskeletal shoulder pain at 11 
NHS trusts and social enterprises in the East of England were recruited. Participating 
physiotherapy departments were located within primary and secondary care 
Concern that the included participants and setting do not match the 
review question  
CONCERN: High 
 
 
 
DOMAIN 2: Predictors  
 
A. Risk of Bias 
List and describe predictors assessed, e.g. definition, timing and knowledge of other predictors: 
 Demographics factors: Age, Social deprivation: index of multiple deprivation, BMI, Smoker 
status, Work status: currently off work due to shoulder pain; not being in employment due to 
redundancy, unemployment or disability, compared with being in employment or education, 
Occupation: nature of employment; type of work or regular activity, Gender, Physical activity 
levels: most strenuous weekly exercise classified as ‘none’ compared to ‘moderate’ 
 Clinical history factors: Reason for symptom onset, Timing of onset of symptoms, History of 
previous shoulder pain, Paraesthesia in arm, Taking pain medication, Previously receiving 
treatment: physiotherapy helpful for previous shoulder problems, Side-related symptoms: 
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presence of pain in the opposite upper quadrant; both shoulder affected or patient stated 
‘ambidextrous’, Symptom duration, Co-morbidities: additional health problems 
 Patient reported measures: Pain (pain intensity), Psychological symptoms (Self-efficacy for 
pain, Patient expectation, Anxiety and depression in the previous 7 days), Function / Disability 
(SPADI, QuickDASH) 
 Clinical measures: Strength (shoulder force (abduction, ER)), ROM (reduced range of active 
shoulder abduction, increasing difference between the range of active and passive shoulder 
abduction, AROM (flexion), PROM (flexion, abduction, ER)), Scapular movement and control 
(change in shoulder pain/ range  during manual facilitation of the scapula around the chest 
wall during arm elevation) 
 Structural pathology: Imaging (none), Orthopaedic tests (External lag sign) 
All recorded at initiation of the study 
1. Were predictors defined and assessed in a similar way for all 
participants? 
 
Yes 
3. Were predictor assessments made without knowledge of 
outcome data? 
 
Yes 
4. Are all predictors available at the time the model is intended to be 
used? 
Yes 
5. Were all relevant predictors analysed? 
 
Yes 
Risk of bias introduced by predictors or their assessment RISK: Low 
 
B. Applicability 
Concern that the definition, assessment or timing of assessment of 
predictors in the model do not match the review question 
CONCERN: Low 
 
 
DOMAIN 3: Outcome 
 
A. Risk of Bias 
Describe the outcome and how it was defined and determined: 
Disability via absolute Quick DASH score at 6 weeks post baseline and 6 months post baseline; 
Pain and disability via absolute SPADI score at 6 weeks post baseline and 6 months post baseline 
1. Was a pre-specified outcome definition used? 
 
Yes 
2. Were predictors excluded from the outcome definition? 
SPADI and QuickDASH were both predictors and outcome 
determinants 
No  
 
3. Was the outcome defined and determined in a similar way for all 
participants? 
 
Yes 
5. Was the outcome determined without knowledge of predictor 
information? 
 
Yes 
Risk of bias introduced by the outcome or its determination RISK: High 
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B. Applicability 
At what time point was the outcome determined: 
6 weeks post baseline and 6 months post baseline  
If a composite outcome was used, describe the relative frequency/distribution of each 
contributing outcome: 
n/a 
Concern that the outcome, its definition, timing or determination do 
not match the review question 
CONCERN: Low 
 
 
 
DOMAIN 4: Sample size and participant flow 
 
A. Risk of Bias 
Describe numbers of participants and events per predictor: 
 n=1030; 11.8 
Describe the time interval between predictor assessment and outcome determination: 
 6 weeks post baseline and 6 months post baseline  
Describe any participants who were excluded from the model: 
 Younger patients as being lost to follow up as well as those not partaking in leisure time 
physical activity  
Describe missing data on predictors and outcomes as well as methods used for missing data: 
 
1. Were there a reasonable number of outcome events? 
  
Yes 
2. Was the time interval between predictor assessment and 
outcome determination appropriate? 
 
Yes 
3. Were all enrolled participants included in the analysis? 
 
Yes 
4. Were participants with missing data handled appropriately? 
 
n/a 
Risk of bias introduced by sample size or participant flow RISK: Low 
 
 
 
DOMAIN 5: Analysis 
 
A. Risk of Bias 
Describe how the model was developed (predictor selection, fitting and optimism, risk groups, 
model performance): 
 No attempt made to trim the number of candidate variables  
 Most parsimonious model via forward selection and backward elimination  
Describe whether and how the model was validated, either internally (e.g. bootstrapping, cross 
validation, random split sample) or externally (e.g. temporal validation, geographical validation, 
different setting, different type of participants): 
 n/a 
Describe the performance measures of the model, e.g. calibration, discrimination, 
(re)classification, net benefit: 
 n/a 
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1. Were non-binary predictors handled appropriately? 
 
Yes 
2. Was selection of predictors based on univariable analysis 
avoided? 
 
Yes 
3. Was model overfitting (optimism in model performance) 
accounted for, e.g. using bootstrapping or shrinkage techniques? 
 
No 
4. Were any complexities in the data (e.g. competing risks, multiple 
events per individual) accounted for appropriately? 
No 
5. Do predictors and their assigned weights in the final model 
correspond to the results from multivariable analysis? 
Yes 
6. Were relevant model performance measures evaluated, e.g. 
calibration, discrimination, (re)classification and net benefit? 
No 
Risk of bias introduced by the analysis RISK: High 
 
 
 
Step 4: Overall judgement 
 
Overall judgement about risk of bias and applicability of the prediction model evaluation 
Overall judgement of risk of bias RISK: High 
 
Overall judgement of applicability CONCERN: High 
 
 
Step 5: Usability of the model 
 
Assess the usability of the model 
Is the model presented with sufficient detail to be used in the 
intended context and target population? 
RATING: No 
 
 
 
Conroy and Hayes (1998) 
 
Step 3: Assess risk of bias and applicability 
 
DOMAIN 1: Participant selection  
 
A. Risk of Bias 
Describe the sources of data and criteria for participant selection: 
 No data on care setting 
 Subject selection criteria included pain about the superolateral shoulder region and one or 
more of the following findings: active range of motion deficits in humeral elevation, painful 
subacromial compression (Neer), Hawkins and Kennedy test.  
Exclusion: shoulder instability, primary scapule thoracic dysfunction, stage II and III adhesive 
capsulitis, third degree musculotendinous tears, advanced acromioclavicular joint disease, 
advanced calcific tendinitis or bursitis, severe degenerative bony or ligamentous changes, 
neurological involvement and unstable fracture of the humerus, scapula, or clavicle. 
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1. Were appropriate data sources used, e.g. cohort, RCT or nested 
case-control study data? 
 
Yes 
2. Were all inclusions and exclusions of participants appropriate? 
 
Yes  
3. Were participants enrolled at a similar state of health, or were 
predictors considered to account for any dissimilarities? 
 
Unclear  
Risk of bias introduced by selection of participants 
 
RISK: Low 
 
 
B. Applicability 
Describe included participants and setting: 
n=14 
No data on care setting 
 
Concern that the included participants and setting do not match the 
review question  
CONCERN: High 
 
 
 
DOMAIN 2: Predictors  
 
A. Risk of Bias 
List and describe predictors assessed, e.g. definition, timing and knowledge of other predictors: 
 Demographics factors: Age 
 Clinical history factors: Side-related symptoms: dominant arm involvement, Symptom 
duration 
 Patient reported measures: Pain (none) , Psychological symptoms (none), Function / Disability 
(none) 
 Clinical measures: Strength (none), ROM (none), Scapular movement and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none) 
All recorded at initiation of the study 
1. Were predictors defined and assessed in a similar way for all 
participants? 
 
Yes 
3. Were predictor assessments made without knowledge of 
outcome data? 
 
Yes 
4. Are all predictors available at the time the model is intended to be 
used? 
Yes 
5. Were all relevant predictors analysed? 
 
Yes 
Risk of bias introduced by predictors or their assessment RISK: Low 
 
B. Applicability 
Concern that the definition, assessment or timing of assessment of 
predictors in the model do not match the review question 
CONCERN: Low 
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DOMAIN 3: Outcome 
 
A. Risk of Bias 
Describe the outcome and how it was defined and determined: 
VAS pain score; upon completion of treatment 
1. Was a pre-specified outcome definition used? 
 
Yes 
2. Were predictors excluded from the outcome definition? 
 
Yes 
 
3. Was the outcome defined and determined in a similar way for all 
participants? 
 
Yes 
5. Was the outcome determined without knowledge of predictor 
information? 
 
Yes 
Risk of bias introduced by the outcome or its determination RISK: Low 
 
 
B. Applicability 
At what time point was the outcome determined: 
3 weeks; upon completion of treatment 
If a composite outcome was used, describe the relative frequency/distribution of each 
contributing outcome: 
n/a 
Concern that the outcome, its definition, timing or determination do 
not match the review question 
CONCERN: Low 
 
 
 
DOMAIN 4: Sample size and participant flow 
 
A. Risk of Bias 
Describe numbers of participants and events per predictor: 
 n=14; 4.7 
Describe the time interval between predictor assessment and outcome determination: 
 3 weeks  
Describe any participants who were excluded from the model: 
 No data 
Describe missing data on predictors and outcomes as well as methods used for missing data: 
 No data 
1. Were there a reasonable number of outcome events? 
 Less than half of the recommended (10) 
No 
2. Was the time interval between predictor assessment and 
outcome determination appropriate? 
 
Yes 
3. Were all enrolled participants included in the analysis? 
 
NI 
4. Were participants with missing data handled appropriately? 
 
NI 
Risk of bias introduced by sample size or participant flow RISK: High 
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DOMAIN 5: Analysis 
 
A. Risk of Bias 
Describe how the model was developed (predictor selection, fitting and optimism, risk groups, 
model performance): 
 No attempt made to trim the number of candidate variables  
 No data on model construction  
Describe whether and how the model was validated, either internally (e.g. bootstrapping, cross 
validation, random split sample) or externally (e.g. temporal validation, geographical validation, 
different setting, different type of participants): 
 n/a 
Describe the performance measures of the model, e.g. calibration, discrimination, 
(re)classification, net benefit: 
 n/a 
1. Were non-binary predictors handled appropriately? 
 
NI 
2. Was selection of predictors based on univariable analysis 
avoided? 
 
NI 
3. Was model overfitting (optimism in model performance) 
accounted for, e.g. using bootstrapping or shrinkage techniques? 
 
No 
4. Were any complexities in the data (e.g. competing risks, multiple 
events per individual) accounted for appropriately? 
No 
5. Do predictors and their assigned weights in the final model 
correspond to the results from multivariable analysis? 
No 
6. Were relevant model performance measures evaluated, e.g. 
calibration, discrimination, (re)classification and net benefit? 
No 
Risk of bias introduced by the analysis RISK: High 
 
 
 
Step 4: Overall judgement 
 
Overall judgement about risk of bias and applicability of the prediction model evaluation 
Overall judgement of risk of bias RISK: High 
 
Overall judgement of applicability CONCERN: High 
 
 
Step 5: Usability of the model 
 
Assess the usability of the model 
Is the model presented with sufficient detail to be used in the 
intended context and target population? 
RATING: No 
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Deutscher et al. (2009) 
 
Step 3: Assess risk of bias and applicability 
 
DOMAIN 1: Participant selection  
 
A. Risk of Bias 
Describe the sources of data and criteria for participant selection: 
 Fifty-four community-based outpatient physical therapy clinics in Israel  
 Non-specific shoulder pain. 
1. Were appropriate data sources used, e.g. cohort, RCT or nested 
case-control study data? 
 
Yes 
2. Were all inclusions and exclusions of participants appropriate? 
No details provided 
NI  
3. Were participants enrolled at a similar state of health, or were 
predictors considered to account for any dissimilarities? 
 
Unclear  
Risk of bias introduced by selection of participants 
 
RISK: High 
 
 
B. Applicability 
Describe included participants and setting: 
n=5000 
Fifty-four community-based outpatient physical therapy clinics in Israel  
Concern that the included participants and setting do not match the 
review question  
CONCERN: High 
 
 
 
DOMAIN 2: Predictors  
 
A. Risk of Bias 
List and describe predictors assessed, e.g. definition, timing and knowledge of other predictors: 
 Demographics factors: Age, gender, smoker status, physical activity levels 
 Clinical history factors: Symptom duration: chronic symptoms, Taking antidepressant 
medication, Taking pain medication, Co-morbidities: number of co-morbidities 
 Patient reported measures: Pain (none), Psychological symptoms (none), Function / Disability 
(CAT) 
 Clinical measures: Strength (none), ROM (none), Scapular movement and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none) 
All recorded at initiation of the study 
1. Were predictors defined and assessed in a similar way for all 
participants? 
 
Yes 
3. Were predictor assessments made without knowledge of 
outcome data? 
 
Yes 
4. Are all predictors available at the time the model is intended to be 
used? 
Yes 
5. Were all relevant predictors analysed? Yes 
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Risk of bias introduced by predictors or their assessment RISK: Low 
 
B. Applicability 
Concern that the definition, assessment or timing of assessment of 
predictors in the model do not match the review question 
CONCERN: Low 
 
 
DOMAIN 3: Outcome 
 
A. Risk of Bias 
Describe the outcome and how it was defined and determined: 
Functional status via absolute CAT score at discharge; upon completion of treatment 
 
1. Was a pre-specified outcome definition used? 
 
Yes 
2. Were predictors excluded from the outcome definition? 
CAT score was both a predictor and a determinant of outcome 
No 
 
3. Was the outcome defined and determined in a similar way for all 
participants? 
 
Yes 
5. Was the outcome determined without knowledge of predictor 
information? 
 
Yes 
Risk of bias introduced by the outcome or its determination RISK: High 
 
 
B. Applicability 
At what time point was the outcome determined: 
Upon completion of treatment 
If a composite outcome was used, describe the relative frequency/distribution of each 
contributing outcome: 
n/a 
Concern that the outcome, its definition, timing or determination do 
not match the review question 
CONCERN: Low 
 
 
 
DOMAIN 4: Sample size and participant flow 
 
A. Risk of Bias 
Describe numbers of participants and events per predictor: 
 n=5000; 238 
Describe the time interval between predictor assessment and outcome determination: 
 n/a  
Describe any participants who were excluded from the model: 
 No data 
Describe missing data on predictors and outcomes as well as methods used for missing data: 
 No data 
1. Were there a reasonable number of outcome events? Yes 
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2. Was the time interval between predictor assessment and 
outcome determination appropriate? 
 
NI 
3. Were all enrolled participants included in the analysis? 
 
NI 
4. Were participants with missing data handled appropriately? 
 
NI 
Risk of bias introduced by sample size or participant flow RISK: High 
 
 
 
DOMAIN 5: Analysis 
 
A. Risk of Bias 
Describe how the model was developed (predictor selection, fitting and optimism, risk groups, 
model performance): 
 Reduced number of candidate variables by collapsing of variables within a category if 
distributions were too low in any one variable; the variable with the greatest clinical relevance 
was retained where collinearity amongst independent variables was identified. 
 Most parsimonious model via forward selection and backward elimination 
 
Describe whether and how the model was validated, either internally (e.g. bootstrapping, cross 
validation, random split sample) or externally (e.g. temporal validation, geographical validation, 
different setting, different type of participants): 
 n/a 
Describe the performance measures of the model, e.g. calibration, discrimination, 
(re)classification, net benefit: 
 n/a 
1. Were non-binary predictors handled appropriately? 
 
Yes 
2. Was selection of predictors based on univariable analysis 
avoided? 
 
Yes 
3. Was model overfitting (optimism in model performance) 
accounted for, e.g. using bootstrapping or shrinkage techniques? 
 
No 
4. Were any complexities in the data (e.g. competing risks, multiple 
events per individual) accounted for appropriately? 
No 
5. Do predictors and their assigned weights in the final model 
correspond to the results from multivariable analysis? 
NI 
6. Were relevant model performance measures evaluated, e.g. 
calibration, discrimination, (re)classification and net benefit? 
No 
Risk of bias introduced by the analysis RISK: High 
 
 
 
Step 4: Overall judgement 
 
Overall judgement about risk of bias and applicability of the prediction model evaluation 
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Overall judgement of risk of bias RISK: High 
 
Overall judgement of applicability CONCERN: High 
 
 
Step 5: Usability of the model 
 
Assess the usability of the model 
Is the model presented with sufficient detail to be used in the 
intended context and target population? 
RATING: No 
 
 
Engebretsen et al. (2010) 
 
Step 3: Assess risk of bias and applicability 
 
DOMAIN 1: Participant selection  
 
A. Risk of Bias 
Describe the sources of data and criteria for participant selection: 
 Recruited from orthopaedic clinics and university hospital outpatient departments, Norway  
 Patients between 18 and 70 years old with subacromial shoulder pain for at least 3 months.  
The inclusion criteria were: dysfunction or pain on abduction; a normal passive glenohumeral range of  
motion; pain on two of three isometric tests (abduction at 0° or 30°, external or internal rotation); and 
a positive impingement sign.  
The exclusion criteria were: bilateral shoulder pain, previous surgery on the affected shoulder, 
instability, referred pain from neck, rheumatoid arthritis, clinical and radiological signs of 
glenohumeral- or acromioclavicular arthritis, serious somatic or psychiatric disorder or inability to 
understand Norwegian. 
1. Were appropriate data sources used, e.g. cohort, RCT or nested case-
control study data? 
 
Yes 
2. Were all inclusions and exclusions of participants appropriate? 
 
Yes  
3. Were participants enrolled at a similar state of health, or were predictors 
considered to account for any dissimilarities? 
 
Unclear  
Risk of bias introduced by selection of participants 
 
RISK: Low 
 
 
B. Applicability 
Describe included participants and setting: 
n=104 
Recruited from orthopaedic clinics and university hospital outpatient departments, Norway 
Concern that the included participants and setting do not match the review 
question  
CONCERN: Low 
 
 
 
DOMAIN 2: Predictors  
 
A. Risk of Bias 
List and describe predictors assessed, e.g. definition, timing and knowledge of other predictors: 
 Demographics factors: Age, gender, Work status, Occupation: frequency of working above shoulder 
height; frequency of carrying heavy loads at work, educational attainment 
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 Clinical history factors: Recurrent shoulder pain: previous shoulder pain, Symptom duration, Associated 
neck pain, Side-related symptoms: dominant arm involvement, Previously receiving treatment: 
previous physiotherapy, Taking medication 
 Patient reported measures: Pain (pain intensity), Psychological symptoms (General health status, 
Emotional distress: Hopkins Symptom checklist, self-efficacy for pain), Function / Disability (SPADI) 
 Clinical measures: Strength (none), ROM (AROM – HBB, flexion on the affected side), Scapular 
movement and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none) 
All recorded at initiation of the study 
1. Were predictors defined and assessed in a similar way for all 
participants? 
 
Yes 
3. Were predictor assessments made without knowledge of outcome data? 
 
Yes 
4. Are all predictors available at the time the model is intended to be used? Yes 
5. Were all relevant predictors analysed? 
 
Yes 
Risk of bias introduced by predictors or their assessment RISK: Low 
 
B. Applicability 
Concern that the definition, assessment or timing of assessment of 
predictors in the model do not match the review question 
CONCERN: Low 
 
 
DOMAIN 3: Outcome 
 
A. Risk of Bias 
Describe the outcome and how it was defined and determined: 
Pain and disability via absolute SPADI score; ‘not working’ status at 12 months post baseline 
 
1. Was a pre-specified outcome definition used? 
 
Yes 
2. Were predictors excluded from the outcome definition? 
SPADI was both a predictor and a determinant of outcome 
No 
 
3. Was the outcome defined and determined in a similar way for all 
participants? 
 
Yes 
5. Was the outcome determined without knowledge of predictor 
information? 
 
Yes 
Risk of bias introduced by the outcome or its determination RISK: High 
 
 
B. Applicability 
At what time point was the outcome determined: 
12 months post baseline  
If a composite outcome was used, describe the relative frequency/distribution of each contributing 
outcome: 
n/a 
Concern that the outcome, its definition, timing or determination do not 
match the review question 
CONCERN: Low 
 
 
 
DOMAIN 4: Sample size and participant flow 
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A. Risk of Bias 
Describe numbers of participants and events per predictor: 
 n=1.4; 5.5 
Describe the time interval between predictor assessment and outcome determination: 
 12 months  
Describe any participants who were excluded from the model: 
 10%; analysis of differences between groups = missing subjects older and with a higher level of 
functional impairment at baseline compared to those for whom follow up at 1 year was possible 
Describe missing data on predictors and outcomes as well as methods used for missing data: 
 No data 
1. Were there a reasonable number of outcome events? 
  Almost half of the recommended 10 
No 
2. Was the time interval between predictor assessment and outcome 
determination appropriate? 
 
Yes 
3. Were all enrolled participants included in the analysis? 
 
Yes 
4. Were participants with missing data handled appropriately? 
 
NI 
Risk of bias introduced by sample size or participant flow RISK: High 
 
 
 
DOMAIN 5: Analysis 
 
A. Risk of Bias 
Describe how the model was developed (predictor selection, fitting and optimism, risk groups, model 
performance): 
 Reduced number of candidate variables via statistical methods – looking at univariate relationships 
between variables; the variable with the greatest clinical relevance was retained where collinearity 
amongst independent variables was identified. 
 Most parsimonious model via variables with p ≥ 0.05 removed  
 
Describe whether and how the model was validated, either internally (e.g. bootstrapping, cross validation, 
random split sample) or externally (e.g. temporal validation, geographical validation, different setting, 
different type of participants): 
 n/a 
Describe the performance measures of the model, e.g. calibration, discrimination, (re)classification, net 
benefit: 
 n/a 
1. Were non-binary predictors handled appropriately? 
 
Yes 
2. Was selection of predictors based on univariable analysis avoided? 
 
No 
3. Was model overfitting (optimism in model performance) accounted for, 
e.g. using bootstrapping or shrinkage techniques? 
 
No 
4. Were any complexities in the data (e.g. competing risks, multiple events 
per individual) accounted for appropriately? 
No 
5. Do predictors and their assigned weights in the final model correspond 
to the results from multivariable analysis? 
Yes 
6. Were relevant model performance measures evaluated, e.g. calibration, 
discrimination, (re)classification and net benefit? 
No 
Risk of bias introduced by the analysis RISK: High 
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Step 4: Overall judgement 
 
Overall judgement about risk of bias and applicability of the prediction model evaluation 
Overall judgement of risk of bias RISK: High 
 
Overall judgement of applicability CONCERN: High 
 
 
Step 5: Usability of the model 
 
Assess the usability of the model 
Is the model presented with sufficient detail to be used in the intended 
context and target population? 
RATING: No 
 
 
Hung et al (2010) 
 
Step 3: Assess risk of bias and applicability 
 
DOMAIN 1: Participant selection  
 
A. Risk of Bias 
Describe the sources of data and criteria for participant selection: 
 Recruited patients with SAIS from the orthopedics clinic in National Taiwan University Hospital and also 
through general announcements in local Internet media 
 Subjects had to demonstrate at least 3 of the following: (1) a positive Neer impingement test, (2) a 
positive Hawkins impingement test, (3) a painful arc, (4 pain with isometric resisted abduction, (5) pain 
with palpation of the rotator cuff tendons, and (6) pain with active shoulder elevation. Subjects were 
excluded if they demonstrated signs of a complete rotator cuff tear or acute inflammation.   
1. Were appropriate data sources used, e.g. cohort, RCT or nested case-
control study data? 
 
Yes 
2. Were all inclusions and exclusions of participants appropriate? 
 
Yes  
3. Were participants enrolled at a similar state of health, or were predictors 
considered to account for any dissimilarities? 
 
Unclear  
Risk of bias introduced by selection of participants 
 
RISK: Low 
 
 
B. Applicability 
Describe included participants and setting: 
n=33 
From orthopedics clinic in National Taiwan University Hospital and also through general announcements in 
local Internet media  
Concern that the included participants and setting do not match the review 
question  
CONCERN: Low 
 
 
 
DOMAIN 2: Predictors  
 
A. Risk of Bias 
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List and describe predictors assessed, e.g. definition, timing and knowledge of other predictors: 
 Demographics factors: Age 
 Clinical history factors: None 
 Patient reported measures: Pain (none), Psychological symptoms (none), Function / Disability (FLEX-SF) 
 Clinical measures: Strength (scapular protractor force, ER, IR and abduction), ROM (PROM IR, ER; 
posterior shoulder tightness (PST)), Scapular movement and control (Scapular kinematics (UR, IR and 
scapular tilt) at 30°, 60°, 90°, 120° elevation during both the ascending and descending phases in loaded 
and unloaded conditions) 
 Structural pathology: Imaging (none), Orthopaedic tests (none) 
All recorded at initiation of the study 
1. Were predictors defined and assessed in a similar way for all 
participants? 
 
Yes 
3. Were predictor assessments made without knowledge of outcome data? 
 
Yes 
4. Are all predictors available at the time the model is intended to be used? No 
FASTRAK motion analysis 
system prohibitive in clinical 
setting 
5. Were all relevant predictors analysed? 
 
Yes 
Risk of bias introduced by predictors or their assessment RISK: High 
 
B. Applicability 
Concern that the definition, assessment or timing of assessment of 
predictors in the model do not match the review question 
CONCERN: High 
3 dimensional movement 
analysis system prohibitive in 
clinical setting 
 
 
DOMAIN 3: Outcome 
 
A. Risk of Bias 
Describe the outcome and how it was defined and determined: 
‘Improvement’ via GROC score => 4 at discharge; upon completion of treatment 
1. Was a pre-specified outcome definition used? 
 
Yes 
2. Were predictors excluded from the outcome definition? 
 
Yes 
 
3. Was the outcome defined and determined in a similar way for all 
participants? 
 
Yes 
5. Was the outcome determined without knowledge of predictor 
information? 
 
Yes 
Risk of bias introduced by the outcome or its determination RISK: Low 
 
 
B. Applicability 
At what time point was the outcome determined: 
At end of 6 weeks of treatment 
If a composite outcome was used, describe the relative frequency/distribution of each contributing 
outcome: 
n/a 
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Concern that the outcome, its definition, timing or determination do not 
match the review question 
CONCERN: Low 
 
 
 
DOMAIN 4: Sample size and participant flow 
 
A. Risk of Bias 
Describe numbers of participants and events per predictor: 
 n=33; 0.5 
Describe the time interval between predictor assessment and outcome determination: 
 6 weeks 
Describe any participants who were excluded from the model: 
 1; no data 
Describe missing data on predictors and outcomes as well as methods used for missing data: 
 n/a 
 
1. Were there a reasonable number of outcome events? 
Substantially below the 10 threshold 
No 
2. Was the time interval between predictor assessment and outcome 
determination appropriate? 
 
Yes 
3. Were all enrolled participants included in the analysis? 
 
No 
4. Were participants with missing data handled appropriately? 
 
n/a 
Risk of bias introduced by sample size or participant flow RISK: High 
 
 
 
DOMAIN 5: Analysis 
 
A. Risk of Bias 
Describe how the model was developed (predictor selection, fitting and optimism, risk groups, model 
performance): 
 Reduced number of candidate variables via statistical methods – looking at univariate relationships 
between variables 
Describe whether and how the model was validated, either internally (e.g. bootstrapping, cross validation, 
random split sample) or externally (e.g. temporal validation, geographical validation, different setting, 
different type of participants): 
 n/a 
Describe the performance measures of the model, e.g. calibration, discrimination, (re)classification, net 
benefit: 
 n/a 
1. Were non-binary predictors handled appropriately? 
 
Yes 
2. Was selection of predictors based on univariable analysis avoided? 
 
No 
3. Was model overfitting (optimism in model performance) accounted for, 
e.g. using bootstrapping or shrinkage techniques? 
 
No 
4. Were any complexities in the data (e.g. competing risks, multiple events 
per individual) accounted for appropriately? 
No 
5. Do predictors and their assigned weights in the final model correspond 
to the results from multivariable analysis? 
No 
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6. Were relevant model performance measures evaluated, e.g. calibration, 
discrimination, (re)classification and net benefit? 
No 
Risk of bias introduced by the analysis RISK: High 
 
 
 
Step 4: Overall judgement 
 
Overall judgement about risk of bias and applicability of the prediction model evaluation 
Overall judgement of risk of bias RISK: High 
 
Overall judgement of applicability CONCERN: High 
 
 
Step 5: Usability of the model 
 
Assess the usability of the model 
Is the model presented with sufficient detail to be used in the intended 
context and target population? 
RATING: No 
 
 
Kennedy et al. (2006) 
 
Step 3: Assess risk of bias and applicability 
 
DOMAIN 1: Participant selection  
 
A. Risk of Bias 
Describe the sources of data and criteria for participant selection: 
 Patients beginning treatment at a large number of different physiotherapy practices; Canada  
 Non-specific shoulder pain 
Soft tissue shoulder disorders: Shoulder complaints were defined as any condition of pain or 
discomfort, including instances where there had been surgical treatment of the soft tissue shoulder 
disorder (eg, rotator cuff repair). 8% post-surgery.  
Patients were excluded from the study if they: (1) had fractures or dislocations associated with soft 
tissue pain, (2) received physical therapy for only one visit (eg, referred for equipment or single 
education session), or (3) were unable to read and write English and thus could not complete the 
questionnaire package independently.   
1. Were appropriate data sources used, e.g. cohort, RCT or nested case-
control study data? 
 
Yes 
2. Were all inclusions and exclusions of participants appropriate? 
 
Yes  
3. Were participants enrolled at a similar state of health, or were predictors 
considered to account for any dissimilarities? 
 
Unclear  
Risk of bias introduced by selection of participants 
 
RISK: Low 
 
 
B. Applicability 
Describe included participants and setting: 
n=361 
Patients beginning treatment at a large number of different physiotherapy practices; Canada 
Concern that the included participants and setting do not match the review 
question  
CONCERN: High 
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DOMAIN 2: Predictors  
 
A. Risk of Bias 
List and describe predictors assessed, e.g. definition, timing and knowledge of other predictors: 
 Demographics factors: Age, gender, Work status, workers compensation claim 
 Clinical history factors: Symptom duration: shorter duration in symptoms, Post-surgical case, Recurrent 
shoulder pain, Reason for symptom onset, Co-morbidities: number of co-morbidities and number that 
limit activity, Taking pain medication 
 Patient reported measures: Pain (pain intensity), Psychological symptoms (Patient expectation, Mental 
Component Score (MCS) from the 36-Item Short-Form Health Survey (SF-36)), Function / Disability 
(DASH, Physical Component Score (PCS) from the 36-Item Short-Form Health Survey (SF-36), Global 
rating of disability score) 
 Clinical measures: Strength (muscle wasting and muscle weakness), ROM (active and passive ROM), 
Scapular movement and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none) 
All recorded at initiation of the study 
1. Were predictors defined and assessed in a similar way for all 
participants? 
 
Yes 
3. Were predictor assessments made without knowledge of outcome data? 
 
Yes 
4. Are all predictors available at the time the model is intended to be used? Yes 
5. Were all relevant predictors analysed? 
 
Yes 
Risk of bias introduced by predictors or their assessment RISK: Low 
 
B. Applicability 
Concern that the definition, assessment or timing of assessment of 
predictors in the model do not match the review question 
CONCERN: Low 
 
 
DOMAIN 3: Outcome 
 
A. Risk of Bias 
Describe the outcome and how it was defined and determined: 
Disability via absolute DASH score at discharge / 12 weeks; change in disability via change from DASH score 
at baseline to discharge / 12 weeks 
 
1. Was a pre-specified outcome definition used? 
 
Yes 
2. Were predictors excluded from the outcome definition? 
DASH both predictor and determinant of outcome 
No 
 
3. Was the outcome defined and determined in a similar way for all 
participants? 
 
Yes 
5. Was the outcome determined without knowledge of predictor 
information? 
 
Yes 
Risk of bias introduced by the outcome or its determination RISK: High 
 
 
B. Applicability 
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At what time point was the outcome determined: 
Discharge or 12 weeks post baseline 
If a composite outcome was used, describe the relative frequency/distribution of each contributing 
outcome: 
n/a 
Concern that the outcome, its definition, timing or determination do not 
match the review question 
CONCERN: Low 
 
 
 
DOMAIN 4: Sample size and participant flow 
 
A. Risk of Bias 
Describe numbers of participants and events per predictor: 
 n=361; 10 
Describe the time interval between predictor assessment and outcome determination: 
 Discharge or 12 weeks post baseline  
Describe any participants who were excluded from the model: 
 no data 
Describe missing data on predictors and outcomes as well as methods used for missing data: 
 n/a 
 
1. Were there a reasonable number of outcome events? 
  
Yes 
2. Was the time interval between predictor assessment and outcome 
determination appropriate? 
 
Yes 
3. Were all enrolled participants included in the analysis? 
 
No 
4. Were participants with missing data handled appropriately? 
 
n/a 
Risk of bias introduced by sample size or participant flow RISK: High 
 
 
 
DOMAIN 5: Analysis 
 
A. Risk of Bias 
Describe how the model was developed (predictor selection, fitting and optimism, risk groups, model 
performance): 
 Reduced number of candidate variables via statistical methods – looking at univariate relationships 
between variables; also collapsing of variables within a category if distributions were too low in any one 
variable; the variable with the greatest clinical relevance was retained where collinearity amongst 
independent variables was identified  
Describe whether and how the model was validated, either internally (e.g. bootstrapping, cross validation, 
random split sample) or externally (e.g. temporal validation, geographical validation, different setting, 
different type of participants): 
 n/a 
Describe the performance measures of the model, e.g. calibration, discrimination, (re)classification, net 
benefit: 
 n/a 
1. Were non-binary predictors handled appropriately? 
 
Yes 
2. Was selection of predictors based on univariable analysis avoided? 
 
No 
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3. Was model overfitting (optimism in model performance) accounted for, 
e.g. using bootstrapping or shrinkage techniques? 
 
No 
4. Were any complexities in the data (e.g. competing risks, multiple events 
per individual) accounted for appropriately? 
No 
5. Do predictors and their assigned weights in the final model correspond 
to the results from multivariable analysis? 
Yes 
6. Were relevant model performance measures evaluated, e.g. calibration, 
discrimination, (re)classification and net benefit? 
No 
Risk of bias introduced by the analysis RISK: High 
 
 
 
Step 4: Overall judgement 
 
Overall judgement about risk of bias and applicability of the prediction model evaluation 
Overall judgement of risk of bias RISK: High 
 
Overall judgement of applicability CONCERN: High 
 
 
Step 5: Usability of the model 
 
Assess the usability of the model 
Is the model presented with sufficient detail to be used in the intended 
context and target population? 
RATING: No 
 
 
 
Kromer et al (2014) 
 
Step 3: Assess risk of bias and applicability 
 
DOMAIN 1: Participant selection  
 
A. Risk of Bias 
Describe the sources of data and criteria for participant selection: 
 Germany, outpatient. Presentation to a physical therapist following referral by general practitioner or 
orthopedic surgeon (duration of symptoms >=4 wk) 
Outpatient physiotherapy clinics, GPs and orthopaedic surgeons 
 Inclusion criteria set for this trial were: (1) age between 18 and 75 years; (2) symptoms for at least 4 
weeks; (3) main complaints in the glenohumeral joint region or the proximal segments of the arm; (4) 
presence of one of the following signs indicating SPS: Neer impingement sign, Hawkins- Kennedy 
impingement test, or painful arc with active abduction or flexion; and (5) pain during one of the 
following resistance tests: external rotation, internal rotation, abduction, or flexion.     
Exclusion criteria were: (1) average 24-hour pain of 8/10 or more on a visual numeric rating scale 
(VNRS); (2) primary scapulothoracic dysfunction due to paresis; (3) diagnosed instability or previous 
history of dislocation; (4) frozen shoulder; (5) more than one-third restriction of elevation compared 
with the unaffected side; (6) substantial shoulder weakness or loss of active shoulder function; (7) 
shoulder surgery on the involved side in the previous 12  months; (8) reproduction of symptoms with 
active or passive cervical movements; (9) neurological involvement with sensory or muscular deficits; 
(10) inflammatory joint disease (eg, rheumatoid arthritis); (11) diabetes mellitus; (12) intake of  
psychotherapeutic drugs; (13) compensation claims; and (14) inability to understand written or spoken 
German. 
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1. Were appropriate data sources used, e.g. cohort, RCT or nested case-
control study data? 
 
Yes 
2. Were all inclusions and exclusions of participants appropriate? 
 
Yes  
3. Were participants enrolled at a similar state of health, or were predictors 
considered to account for any dissimilarities? 
 
Yes  
Risk of bias introduced by selection of participants 
 
RISK: Low 
 
 
B. Applicability 
Describe included participants and setting: 
n=90 
Germany, outpatient. Presentation to a physical therapist following referral by general practitioner or 
orthopedic surgeon (duration of symptoms >=4 wk) 
Outpatient physiotherapy clinics, GPs and orthopaedic surgeons 
Concern that the included participants and setting do not match the review 
question  
CONCERN: Low 
 
 
 
DOMAIN 2: Predictors  
 
A. Risk of Bias 
List and describe predictors assessed, e.g. definition, timing and knowledge of other predictors: 
 Demographics factors: Age and gender were controlled for in the regression model 
 Clinical history factors: Symptom duration 
 Patient reported measures: Pain (pain intensity), Psychological symptoms (Fear Avoidance Beliefs 
Questionnaire (physical activity subscale), Pain catastrophising scale), Function / Disability (Function / 
disability as measured by the function element of the SPADI) 
 Clinical measures: Strength (none), ROM (none), Scapular movement and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none) 
All recorded at initiation of the study 
1. Were predictors defined and assessed in a similar way for all 
participants? 
 
Yes 
3. Were predictor assessments made without knowledge of outcome data? 
 
Yes 
4. Are all predictors available at the time the model is intended to be used? Yes 
5. Were all relevant predictors analysed? 
 
Yes 
Risk of bias introduced by predictors or their assessment RISK: Low 
 
B. Applicability 
Concern that the definition, assessment or timing of assessment of 
predictors in the model do not match the review question 
CONCERN: Low 
 
 
DOMAIN 3: Outcome 
 
A. Risk of Bias 
Describe the outcome and how it was defined and determined: 
Change in functional status via change in functional subscale of SPADI (SPADI-F) between baseline and 3 
months post baseline  
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1. Was a pre-specified outcome definition used? 
 
Yes 
2. Were predictors excluded from the outcome definition? 
SPADI-F also one of the predictors 
 
No 
 
3. Was the outcome defined and determined in a similar way for all 
participants? 
 
Yes 
5. Was the outcome determined without knowledge of predictor 
information? 
 
Yes 
Risk of bias introduced by the outcome or its determination RISK: High 
 
 
B. Applicability 
At what time point was the outcome determined: 
3 months post baseline  
If a composite outcome was used, describe the relative frequency/distribution of each contributing 
outcome: 
n/a 
Concern that the outcome, its definition, timing or determination do not 
match the review question 
CONCERN: Low 
 
 
 
DOMAIN 4: Sample size and participant flow 
 
A. Risk of Bias 
Describe numbers of participants and events per predictor: 
 n=90; 18 
Describe the time interval between predictor assessment and outcome determination: 
 3 months 
Describe any participants who were excluded from the model: 
 2; no data 
Describe missing data on predictors and outcomes as well as methods used for missing data: 
 n/a 
 
1. Were there a reasonable number of outcome events? 
  
Yes 
2. Was the time interval between predictor assessment and outcome 
determination appropriate? 
 
Yes 
3. Were all enrolled participants included in the analysis? 
 
No 
4. Were participants with missing data handled appropriately? 
 
n/a 
Risk of bias introduced by sample size or participant flow RISK: High 
 
 
 
DOMAIN 5: Analysis 
 
A. Risk of Bias 
Describe how the model was developed (predictor selection, fitting and optimism, risk groups, model 
performance): 
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 Reduced number of candidate variables via variable with the greatest clinical relevance was retained 
where collinearity amongst independent variables was identified 
Describe whether and how the model was validated, either internally (e.g. bootstrapping, cross validation, 
random split sample) or externally (e.g. temporal validation, geographical validation, different setting, 
different type of participants): 
 n/a 
Describe the performance measures of the model, e.g. calibration, discrimination, (re)classification, net 
benefit: 
 n/a 
1. Were non-binary predictors handled appropriately? 
 
Yes 
2. Was selection of predictors based on univariable analysis avoided? 
 
Yes 
3. Was model overfitting (optimism in model performance) accounted for, 
e.g. using bootstrapping or shrinkage techniques? 
 
No 
4. Were any complexities in the data (e.g. competing risks, multiple events 
per individual) accounted for appropriately? 
No 
5. Do predictors and their assigned weights in the final model correspond 
to the results from multivariable analysis? 
No 
6. Were relevant model performance measures evaluated, e.g. calibration, 
discrimination, (re)classification and net benefit? 
No 
Risk of bias introduced by the analysis RISK: High 
 
 
 
Step 4: Overall judgement 
 
Overall judgement about risk of bias and applicability of the prediction model evaluation 
Overall judgement of risk of bias RISK: High 
 
Overall judgement of applicability CONCERN: Low 
 
 
Step 5: Usability of the model 
 
Assess the usability of the model 
Is the model presented with sufficient detail to be used in the intended 
context and target population? 
RATING: No 
 
 
 
Mintken et al. (2010) 
 
Step 3: Assess risk of bias and applicability 
 
DOMAIN 1: Participant selection  
 
A. Risk of Bias 
Describe the sources of data and criteria for participant selection: 
 Outpatient physiotherapy clinics  
 Non-specific shoulder pain 
Inclusion criteria: between ages of 18 and 65 years, with a primary report of shoulder pain and a 
baseline Shoulder Pain and Disability Index (SPADI) score of 20% or greater.  
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Exclusion criteria: any medical “red flags” suggestive of a non-musculoskeletal aetiology of symptoms, 
acute fractures in the shoulder region, acute severe trauma in the cervical or thoracic region in the 
previous 6 weeks, a diagnosis of cervical spinal stenosis or bilateral upper-extremity symptoms, 
osteoporosis, prior surgery to the cervical or thoracic region, evidence of central nervous system 
involvement, insufficient English language skills to complete the questionnaires, or signs consistent 
with nerve root compression (defined as impairment in at least 2 of the following: myotomal strength, 
sensation, or reflexes). “Red flags” were ruled out by a combination of a medical screening 
questionnaire, a neurological examination, and a patient history. 
1. Were appropriate data sources used, e.g. cohort, RCT or nested case-
control study data? 
 
Yes 
2. Were all inclusions and exclusions of participants appropriate? 
 
Yes  
3. Were participants enrolled at a similar state of health, or were predictors 
considered to account for any dissimilarities? 
 
Uncertain  
Risk of bias introduced by selection of participants 
 
RISK: Low 
 
 
B. Applicability 
Describe included participants and setting: 
n=80 
Outpatient physiotherapy clinics 
Concern that the included participants and setting do not match the review 
question  
CONCERN: Low 
 
 
 
DOMAIN 2: Predictors  
 
A. Risk of Bias 
List and describe predictors assessed, e.g. definition, timing and knowledge of other predictors: 
 Demographics factors: Age, gender, work status 
 Clinical history factors: Symptom duration, Taking pain medication, Reason for symptom onset, 
Recurrent shoulder pain: number of previous episodes, Previously receiving treatment: treatment for 
previous episodes, past medical history 
 Patient reported measures: Pain (pain intensity), Psychological symptoms (Patient expectation, Fear 
Avoidance Beliefs Questionnaire, Tampa Scale for Kinesiophobia), Function / Disability (SPADI) 
 Clinical measures: Strength (Serratus Anterior, Middle trapezius, Lower trapezius, Rhomboid, Deltoid, 
External and internal shoulder rotator muscle strength), ROM (pain-free shoulder flexion, passive 
shoulder IR at 90° abduction, Passive shoulder abduction, Passive shoulder ER at 90° abduction, Battery 
of 3 functional tests), Scapular movement and control (Lateral slide test and scapula index, Qualitative 
assessment of scapular function) 
 Structural pathology: Imaging (none), Orthopaedic tests (13 orthopaedic tests including the Hawkins-
Kennedy impingement test, the empty can and full can test and the drop sign Neer's sign)  
All recorded at initiation of the study 
1. Were predictors defined and assessed in a similar way for all 
participants? 
 
Yes 
3. Were predictor assessments made without knowledge of outcome data? 
 
Yes 
4. Are all predictors available at the time the model is intended to be used? Yes 
5. Were all relevant predictors analysed? 
 
Yes 
Risk of bias introduced by predictors or their assessment RISK: Low 
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B. Applicability 
Concern that the definition, assessment or timing of assessment of 
predictors in the model do not match the review question 
CONCERN: Low 
 
 
DOMAIN 3: Outcome 
 
A. Risk of Bias 
Describe the outcome and how it was defined and determined: 
‘Improvement’ via GROC score => 4 at discharge; upon completion of treatment 
At the beginning of the second session, the participants completed the GROC and the other outcome 
measures. If their score on the GROC did not exceed the +4 cutoff at the second session, they received the 
same intervention program again and were scheduled for a follow-up within 2 to 4 days. Participants again 
completed the GROC along with the other outcome measures. If they scored +4 or better on the GROC, they 
were categorized as having a successful outcome; if they scored below +4, they were categorized as not 
having a successful outcome. At this point, their participation in the study was complete, and the therapist 
could administer further treatment as needed. 
F/up was at 2nd or 3rd apt – over a period of a few days 
1. Was a pre-specified outcome definition used? 
 
Yes 
2. Were predictors excluded from the outcome definition? 
 
Yes 
 
3. Was the outcome defined and determined in a similar way for all 
participants? 
 
Yes 
5. Was the outcome determined without knowledge of predictor 
information? 
 
Yes 
Risk of bias introduced by the outcome or its determination RISK: Low 
 
 
B. Applicability 
At what time point was the outcome determined: 
At completion of 2nd or 3rd appointment – over a period of a few days 
If a composite outcome was used, describe the relative frequency/distribution of each contributing 
outcome: 
n/a 
Concern that the outcome, its definition, timing or determination do not 
match the review question 
CONCERN: High 
 
 
 
DOMAIN 4: Sample size and participant flow 
 
A. Risk of Bias 
Describe numbers of participants and events per predictor: 
 n=80; 6 
Describe the time interval between predictor assessment and outcome determination: 
 a few days  
Describe any participants who were excluded from the model: 
 1; no data 
Describe missing data on predictors and outcomes as well as methods used for missing data: 
 n/a 
 
1. Were there a reasonable number of outcome events? No 
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 Just over half of the recommended number 
2. Was the time interval between predictor assessment and outcome 
determination appropriate? 
Very limited clinical relevance of a few days post commencement of 
treatment 
No 
3. Were all enrolled participants included in the analysis? 
 
No 
4. Were participants with missing data handled appropriately? 
 
n/a 
Risk of bias introduced by sample size or participant flow RISK: High 
 
 
 
DOMAIN 5: Analysis 
 
A. Risk of Bias 
Describe how the model was developed (predictor selection, fitting and optimism, risk groups, model 
performance): 
 Reduced number of candidate variables via statistical methods – looking at univariate relationships 
between variables 
 Variables with a significance level of P<.10 were retained as potential prognostic variables. For 
continuous variables with a significant univariate relationship, sensitivity and specificity values were 
calculated for all possible cutoff points and then plotted as a receiver operator characteristic (ROC) 
curve 
Describe whether and how the model was validated, either internally (e.g. bootstrapping, cross validation, 
random split sample) or externally (e.g. temporal validation, geographical validation, different setting, 
different type of participants): 
 n/a 
Describe the performance measures of the model, e.g. calibration, discrimination, (re)classification, net 
benefit: 
 n/a 
1. Were non-binary predictors handled appropriately? 
 
Yes 
2. Was selection of predictors based on univariable analysis avoided? 
 
No 
3. Was model overfitting (optimism in model performance) accounted for, 
e.g. using bootstrapping or shrinkage techniques? 
 
No 
4. Were any complexities in the data (e.g. competing risks, multiple events 
per individual) accounted for appropriately? 
No 
5. Do predictors and their assigned weights in the final model correspond 
to the results from multivariable analysis? 
Yes 
6. Were relevant model performance measures evaluated, e.g. calibration, 
discrimination, (re)classification and net benefit? 
No 
Risk of bias introduced by the analysis RISK: High 
 
 
 
Step 4: Overall judgement 
 
Overall judgement about risk of bias and applicability of the prediction model evaluation 
Overall judgement of risk of bias RISK: High 
 
Overall judgement of applicability CONCERN: High 
 
325 
 
 
Step 5: Usability of the model 
 
Assess the usability of the model 
Is the model presented with sufficient detail to be used in the intended 
context and target population? 
RATING: No 
 
 
 
Morrison et al. (1997) 
 
Step 3: Assess risk of bias and applicability 
 
DOMAIN 1: Participant selection  
 
A. Risk of Bias 
Describe the sources of data and criteria for participant selection: 
 Investigation performed at the Southern California Centre for Sports Medicine, Long Beach  
 ‘Subacromial impingement’ 
Diagnosis made on the basis of a positive impingement sign and the absence of other abnormalities of 
the shoulder, such as full thickness tears of the rotator cuff, osteoarthrosis of the acromioclavicular 
joint, instability of the glenohumeral joint, or adhesive capsulitis. 
Diagnosis made on the basis of a history, a clinical examination, and a positive Neer impingement sign.  
Patients who had concomitant adhesive capsulitis, cervical radiculopathy, or suprascapular nerve palsy 
were excluded, as were patients who had major weakness on testing of the rotator cuff or a full-
thickness tear of the rotator  cuff on magnetic resonance imaging.. 
1. Were appropriate data sources used, e.g. cohort, RCT or nested case-
control study data? 
 
Yes 
2. Were all inclusions and exclusions of participants appropriate? 
 
Yes  
3. Were participants enrolled at a similar state of health, or were predictors 
considered to account for any dissimilarities? 
 
Uncertain  
Risk of bias introduced by selection of participants 
 
RISK: Low 
 
 
B. Applicability 
Describe included participants and setting: 
n=616 
Investigation performed at the Southern California Centre for Sports Medicine, Long Beach  
 
Concern that the included participants and setting do not match the review 
question  
CONCERN: Low 
 
 
 
DOMAIN 2: Predictors  
 
A. Risk of Bias 
List and describe predictors assessed, e.g. definition, timing and knowledge of other predictors: 
 Demographics factors: Age, gender 
 Clinical history factors: Symptom duration, Side-related symptoms: dominant arm involvement 
 Patient reported measures: Pain (none), Psychological symptoms (none), Function / Disability (none) 
 Clinical measures: Strength (none), ROM (none), Scapular movement and control (none) 
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 Structural pathology: Imaging (Acromion morphology type 1 on X-ray), Orthopaedic tests (none)  
All recorded at initiation of the study 
1. Were predictors defined and assessed in a similar way for all 
participants? 
 
Yes 
3. Were predictor assessments made without knowledge of outcome data? 
 
Yes 
4. Are all predictors available at the time the model is intended to be used? 
Routine x-ray is not performed 
No 
5. Were all relevant predictors analysed? 
 
Yes 
Risk of bias introduced by predictors or their assessment RISK: High 
 
B. Applicability 
Concern that the definition, assessment or timing of assessment of 
predictors in the model do not match the review question 
CONCERN: Low 
 
 
DOMAIN 3: Outcome 
 
A. Risk of Bias 
Describe the outcome and how it was defined and determined: 
Pain, function, active ROM, strength and overall satisfaction via absolute UCLA score at average of 27 
months 
1. Was a pre-specified outcome definition used? 
 
Yes 
2. Were predictors excluded from the outcome definition? 
 
Yes 
 
3. Was the outcome defined and determined in a similar way for all 
participants? 
 
Yes 
5. Was the outcome determined without knowledge of predictor 
information? 
 
Yes 
Risk of bias introduced by the outcome or its determination RISK: Low 
 
 
B. Applicability 
At what time point was the outcome determined: 
At average of 27 months post baseline 
If a composite outcome was used, describe the relative frequency/distribution of each contributing 
outcome: 
n/a 
Concern that the outcome, its definition, timing or determination do not 
match the review question 
CONCERN: Low 
 
 
 
DOMAIN 4: Sample size and participant flow 
 
A. Risk of Bias 
Describe numbers of participants and events per predictor: 
 n=616; 123 
Describe the time interval between predictor assessment and outcome determination: 
 Average of 27 months  
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Describe any participants who were excluded from the model: 
 8%; no data 
Describe missing data on predictors and outcomes as well as methods used for missing data: 
 n/a 
 
1. Were there a reasonable number of outcome events? 
  
Yes 
2. Was the time interval between predictor assessment and outcome 
determination appropriate? 
 
Yes  
3. Were all enrolled participants included in the analysis? 
 
No 
4. Were participants with missing data handled appropriately? 
 
n/a 
Risk of bias introduced by sample size or participant flow RISK: High 
 
 
 
DOMAIN 5: Analysis 
 
A. Risk of Bias 
Describe how the model was developed (predictor selection, fitting and optimism, risk groups, model 
performance): 
 No attempt made to trim the number of candidate variables 
 Chi-square 
Describe whether and how the model was validated, either internally (e.g. bootstrapping, cross validation, 
random split sample) or externally (e.g. temporal validation, geographical validation, different setting, 
different type of participants): 
 n/a 
Describe the performance measures of the model, e.g. calibration, discrimination, (re)classification, net 
benefit: 
 n/a 
1. Were non-binary predictors handled appropriately? 
 
Yes 
2. Was selection of predictors based on univariable analysis avoided? 
 
No 
3. Was model overfitting (optimism in model performance) accounted for, 
e.g. using bootstrapping or shrinkage techniques? 
 
No 
4. Were any complexities in the data (e.g. competing risks, multiple events 
per individual) accounted for appropriately? 
No 
5. Do predictors and their assigned weights in the final model correspond 
to the results from multivariable analysis? 
No 
6. Were relevant model performance measures evaluated, e.g. calibration, 
discrimination, (re)classification and net benefit? 
No 
Risk of bias introduced by the analysis RISK: High 
 
 
 
Step 4: Overall judgement 
 
Overall judgement about risk of bias and applicability of the prediction model evaluation 
Overall judgement of risk of bias RISK: High 
 
Overall judgement of applicability CONCERN: Low 
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Step 5: Usability of the model 
 
Assess the usability of the model 
Is the model presented with sufficient detail to be used in the intended 
context and target population? 
RATING: No 
 
 
 
Ogon et al. (2009) 
 
Step 3: Assess risk of bias and applicability 
 
DOMAIN 1: Participant selection  
 
A. Risk of Bias 
Describe the sources of data and criteria for participant selection: 
 All patients had previously received nonoperative treatment from general practitioners, 
rheumatologists, or orthopedic surgeons, which included physical therapy, manual therapy, 
electrotherapy, iontophoresis, systemic use of analgesics and nonsteroidal antiinflammatory drugs 
(NSAIDs), and up to 3 subacromial injections of corticosteroids. The patients were then referred to the 
Orthopedic Outpatient Clinic because of the persistence of clinically symptomatic calcific tendinitis of 
the shoulder  
 ‘Calcific tendonitis’ 
Inclusion criteria were the presence of radiographically and sonographically proven calcific deposits in a 
rotator cuff tendon and the presence of clinically symptomatic calcific tendinitis of the shoulder 
requiring continuation of treatment at the time of presentation at the institution.  
Exclusion criteria were previous surgical interventions, needling, application of ultrasound therapy, or 
extracorporeal shock wave therapy (ESWT), as well as the presence of rheumatoid arthritis or 
concomitant diseases of the affected shoulder. 
1. Were appropriate data sources used, e.g. cohort, RCT or nested case-
control study data? 
 
Yes 
2. Were all inclusions and exclusions of participants appropriate? 
 
Yes  
3. Were participants enrolled at a similar state of health, or were predictors 
considered to account for any dissimilarities? 
 
Yes   
Risk of bias introduced by selection of participants 
 
RISK: Low 
 
 
B. Applicability 
Describe included participants and setting: 
n=420 
Orthopaedic Outpatient Clinic  
 
Concern that the included participants and setting do not match the review 
question  
CONCERN: High  
 
 
 
DOMAIN 2: Predictors  
 
A. Risk of Bias 
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List and describe predictors assessed, e.g. definition, timing and knowledge of other predictors: 
 Demographics factors: Age, gender, occupation 
 Clinical history factors: Periods of professional disability, Reason for symptom onset, Symptom 
duration, Side-related symptoms: dominant arm involvement, Past medical history 
 Patient reported measures: Pain (none), Psychological symptoms (none), Function / Disability (none) 
 Clinical measures: Strength (none), ROM (none), Scapular movement and control (none) 
 Structural pathology: Imaging (Calcific deposits: X-ray and sonographic), Orthopaedic tests (none)  
All recorded at initiation of the study 
1. Were predictors defined and assessed in a similar way for all 
participants? 
 
Yes 
3. Were predictor assessments made without knowledge of outcome data? 
 
Yes 
4. Are all predictors available at the time the model is intended to be used? 
Routine x-ray and ultrasound is not performed 
No 
5. Were all relevant predictors analysed? 
 
Yes 
Risk of bias introduced by predictors or their assessment RISK: High 
 
B. Applicability 
Concern that the definition, assessment or timing of assessment of 
predictors in the model do not match the review question 
CONCERN: High 
 
 
DOMAIN 3: Outcome 
 
A. Risk of Bias 
Describe the outcome and how it was defined and determined: 
‘Success of non-operative therapy’ via no progression to advanced therapeutic measures after a minimum 
of 6 months non-operative treatment (including minimum of 3 months treatment at the study location) 
1. Was a pre-specified outcome definition used? 
 
Yes 
2. Were predictors excluded from the outcome definition? 
 
Yes 
 
3. Was the outcome defined and determined in a similar way for all 
participants? 
 
Yes 
5. Was the outcome determined without knowledge of predictor 
information? 
 
Yes 
Risk of bias introduced by the outcome or its determination RISK: Low 
 
 
B. Applicability 
At what time point was the outcome determined: 
After a minimum of 6 months non-operative treatment  
If a composite outcome was used, describe the relative frequency/distribution of each contributing 
outcome: 
n/a 
Concern that the outcome, its definition, timing or determination do not 
match the review question 
CONCERN: High 
 
 
 
DOMAIN 4: Sample size and participant flow 
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A. Risk of Bias 
Describe numbers of participants and events per predictor: 
 n=420; 25 
Describe the time interval between predictor assessment and outcome determination: 
 After a minimum of 6 months  
Describe any participants who were excluded from the model: 
 no data 
Describe missing data on predictors and outcomes as well as methods used for missing data: 
 n/a 
 
1. Were there a reasonable number of outcome events? 
  
Yes 
2. Was the time interval between predictor assessment and outcome 
determination appropriate? 
 
Yes  
3. Were all enrolled participants included in the analysis? 
 
NI 
4. Were participants with missing data handled appropriately? 
 
n/a 
Risk of bias introduced by sample size or participant flow RISK: Uncertain 
 
 
 
DOMAIN 5: Analysis 
 
A. Risk of Bias 
Describe how the model was developed (predictor selection, fitting and optimism, risk groups, model 
performance): 
 No attempt made to trim the number of candidate variables 
 Most parsimonious model via variables with p ≥ 0.05 removed 
 Prognostic factors were determined at P < 0.05 by chi-square test 
Describe whether and how the model was validated, either internally (e.g. bootstrapping, cross validation, 
random split sample) or externally (e.g. temporal validation, geographical validation, different setting, 
different type of participants): 
 n/a 
Describe the performance measures of the model, e.g. calibration, discrimination, (re)classification, net 
benefit: 
 n/a 
1. Were non-binary predictors handled appropriately? 
 
Yes 
2. Was selection of predictors based on univariable analysis avoided? 
 
No 
3. Was model overfitting (optimism in model performance) accounted for, 
e.g. using bootstrapping or shrinkage techniques? 
 
No 
4. Were any complexities in the data (e.g. competing risks, multiple events 
per individual) accounted for appropriately? 
No 
5. Do predictors and their assigned weights in the final model correspond 
to the results from multivariable analysis? 
No 
6. Were relevant model performance measures evaluated, e.g. calibration, 
discrimination, (re)classification and net benefit? 
No 
Risk of bias introduced by the analysis RISK: High 
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Step 4: Overall judgement 
 
Overall judgement about risk of bias and applicability of the prediction model evaluation 
Overall judgement of risk of bias RISK: High 
 
Overall judgement of applicability CONCERN: High 
 
 
Step 5: Usability of the model 
 
Assess the usability of the model 
Is the model presented with sufficient detail to be used in the intended 
context and target population? 
RATING: No 
 
 
Sindhu et al. (2012) 
 
Step 3: Assess risk of bias and applicability 
 
DOMAIN 1: Participant selection  
 
A. Risk of Bias 
Describe the sources of data and criteria for participant selection: 
 Retrospective cohort study 
Non-specific shoulder pain 
Clinical staff entered necessary medical information at intake, such as diagnosis codes based on the 
International Classification of Diseases, Ninth Revision (ICD-9). 
1. Were appropriate data sources used, e.g. cohort, RCT or nested case-
control study data? 
 
Yes 
2. Were all inclusions and exclusions of participants appropriate? 
 
Yes  
3. Were participants enrolled at a similar state of health, or were predictors 
considered to account for any dissimilarities? 
 
Uncertain   
Risk of bias introduced by selection of participants 
 
RISK: Low 
 
 
B. Applicability 
Describe included participants and setting: 
n=3362 
Outpatient rehabilitation clinics throughout the United States  
Concern that the included participants and setting do not match the review 
question  
CONCERN: High  
 
 
 
DOMAIN 2: Predictors  
 
A. Risk of Bias 
List and describe predictors assessed, e.g. definition, timing and knowledge of other predictors: 
 Demographics factors: None 
 Clinical history factors: None 
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 Patient reported measures: Pain (none), Psychological symptoms (Fear Avoidance Beliefs 
Questionnaire), Function / Disability (none) 
 Clinical measures: Strength (none), ROM (none), Scapular movement and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none)  
All recorded at initiation of the study 
1. Were predictors defined and assessed in a similar way for all 
participants? 
 
Yes 
3. Were predictor assessments made without knowledge of outcome data? 
 
Yes 
4. Are all predictors available at the time the model is intended to be used? Yes 
5. Were all relevant predictors analysed? 
All variables were controlled for except for the single variable of fear 
avoidance 
No 
Risk of bias introduced by predictors or their assessment RISK: High 
 
B. Applicability 
Concern that the definition, assessment or timing of assessment of 
predictors in the model do not match the review question 
CONCERN: High 
 
 
DOMAIN 3: Outcome 
 
A. Risk of Bias 
Describe the outcome and how it was defined and determined: 
Functional change via change in CAT score between baseline and discharge; upon completion of treatment 
1. Was a pre-specified outcome definition used? 
 
Yes 
2. Were predictors excluded from the outcome definition? 
 
Yes 
 
3. Was the outcome defined and determined in a similar way for all 
participants? 
 
Yes 
5. Was the outcome determined without knowledge of predictor 
information? 
 
Yes 
Risk of bias introduced by the outcome or its determination RISK: Low 
 
 
B. Applicability 
At what time point was the outcome determined: 
Upon completion of treatment  
If a composite outcome was used, describe the relative frequency/distribution of each contributing 
outcome: 
n/a 
Concern that the outcome, its definition, timing or determination do not 
match the review question 
CONCERN: Low 
 
 
 
DOMAIN 4: Sample size and participant flow 
 
A. Risk of Bias 
Describe numbers of participants and events per predictor: 
 n=3362; 3362 
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Describe the time interval between predictor assessment and outcome determination: 
 Upon completion of treatment  
Describe any participants who were excluded from the model: 
 Loss to follow up: 43%; analysis of differences between groups = identified differences between those 
available for and lost to follow up in terms of age, pain levels and function but provided no details on 
the direction of difference 
Describe missing data on predictors and outcomes as well as methods used for missing data: 
 n/a 
 
1. Were there a reasonable number of outcome events? 
  
Yes 
2. Was the time interval between predictor assessment and outcome 
determination appropriate? 
 
Yes  
3. Were all enrolled participants included in the analysis? 
 
No 
4. Were participants with missing data handled appropriately? 
 
n/a 
Risk of bias introduced by sample size or participant flow RISK: High 
 
 
 
DOMAIN 5: Analysis 
 
A. Risk of Bias 
Describe how the model was developed (predictor selection, fitting and optimism, risk groups, model 
performance): 
 General linear model (GLM) used to describe how change in function is affected by fear avoidance  
Describe whether and how the model was validated, either internally (e.g. bootstrapping, cross validation, 
random split sample) or externally (e.g. temporal validation, geographical validation, different setting, 
different type of participants): 
 n/a 
Describe the performance measures of the model, e.g. calibration, discrimination, (re)classification, net 
benefit: 
 n/a 
1. Were non-binary predictors handled appropriately? 
 
Yes 
2. Was selection of predictors based on univariable analysis avoided? 
 
Yes 
3. Was model overfitting (optimism in model performance) accounted for, 
e.g. using bootstrapping or shrinkage techniques? 
 
No 
4. Were any complexities in the data (e.g. competing risks, multiple events 
per individual) accounted for appropriately? 
No 
5. Do predictors and their assigned weights in the final model correspond 
to the results from multivariable analysis? 
No 
6. Were relevant model performance measures evaluated, e.g. calibration, 
discrimination, (re)classification and net benefit? 
No 
Risk of bias introduced by the analysis RISK: High 
 
 
 
Step 4: Overall judgement 
 
Overall judgement about risk of bias and applicability of the prediction model evaluation 
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Overall judgement of risk of bias RISK: High 
 
Overall judgement of applicability CONCERN: High 
 
 
Step 5: Usability of the model 
 
Assess the usability of the model 
Is the model presented with sufficient detail to be used in the intended 
context and target population? 
RATING: No 
 
 
 
Tyler et al. (2010) 
 
Step 3: Assess risk of bias and applicability 
 
DOMAIN 1: Participant selection  
 
A. Risk of Bias 
Describe the sources of data and criteria for participant selection: 
 Prospective cohort study 
 ‘Internal impingement’ 
Diagnostic criteria for internal impingement was used.  
Specific inclusion criteria based on physical examination were positive relocation test, positive 
posterior impingement sign, and posterior glenohumeral joint line tenderness. Specific 
inclusion criteria based on MRI findings were the presence of a posterosuperior glenoid labral 
lesion.  
Exclusion criteria were anterior instability, full-thickness rotator cuff tear, and subacromial 
impingement as determined by physical examination and MRI. Additionally, all patients 
reported subjective clicking in their shoulder on active movement. 
1. Were appropriate data sources used, e.g. cohort, RCT or nested 
case-control study data? 
 
Yes 
2. Were all inclusions and exclusions of participants appropriate? 
 
Yes  
3. Were participants enrolled at a similar state of health, or were 
predictors considered to account for any dissimilarities? 
 
Uncertain   
Risk of bias introduced by selection of participants 
 
RISK: Low 
 
 
B. Applicability 
Describe included participants and setting: 
n=22 
No details  
Concern that the included participants and setting do not match the 
review question  
CONCERN: High  
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DOMAIN 2: Predictors  
 
A. Risk of Bias 
List and describe predictors assessed, e.g. definition, timing and knowledge of other predictors: 
 Demographics factors: None 
 Clinical history factors: None 
 Patient reported measures: Pain (none), Psychological symptoms (none), Function / Disability 
(none) 
 Clinical measures: Strength (none), ROM (Improvement in PST at discharge, Improvement in 
passive ER ROM, Improvement in GIRD), Scapular movement and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none)  
All recorded at initiation of the study 
1. Were predictors defined and assessed in a similar way for all 
participants? 
 
Yes 
3. Were predictor assessments made without knowledge of 
outcome data? 
 
Yes 
4. Are all predictors available at the time the model is intended to be 
used? 
No 
5. Were all relevant predictors analysed? 
 
Yes 
Risk of bias introduced by predictors or their assessment RISK: High 
 
B. Applicability 
Concern that the definition, assessment or timing of assessment of 
predictors in the model do not match the review question 
CONCERN: High 
 
 
DOMAIN 3: Outcome 
 
A. Risk of Bias 
Describe the outcome and how it was defined and determined: 
Symptom free via Simple Shoulder Test at discharge; upon completion of treatment 
1. Was a pre-specified outcome definition used? 
 
Yes 
2. Were predictors excluded from the outcome definition? 
 
Yes 
 
3. Was the outcome defined and determined in a similar way for all 
participants? 
 
Yes 
5. Was the outcome determined without knowledge of predictor 
information? 
 
Yes 
Risk of bias introduced by the outcome or its determination RISK: Low 
 
 
B. Applicability 
At what time point was the outcome determined: 
Upon completion of treatment  
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If a composite outcome was used, describe the relative frequency/distribution of each 
contributing outcome: 
n/a 
Concern that the outcome, its definition, timing or determination do 
not match the review question 
CONCERN: Low 
 
 
 
DOMAIN 4: Sample size and participant flow 
 
A. Risk of Bias 
Describe numbers of participants and events per predictor: 
 n=22; 7 
Describe the time interval between predictor assessment and outcome determination: 
 Upon completion of treatment  
Describe any participants who were excluded from the model: 
 No data 
Describe missing data on predictors and outcomes as well as methods used for missing data: 
 n/a 
 
1. Were there a reasonable number of outcome events? 
  
No 
2. Was the time interval between predictor assessment and 
outcome determination appropriate? 
 
Yes  
3. Were all enrolled participants included in the analysis? 
 
NI 
4. Were participants with missing data handled appropriately? 
 
n/a 
Risk of bias introduced by sample size or participant flow RISK: High 
 
 
 
DOMAIN 5: Analysis 
 
A. Risk of Bias 
Describe how the model was developed (predictor selection, fitting and optimism, risk groups, 
model performance): 
 Mixed model analysis of variance, with Treatment (pretreatment vs posttreatment) as the 
within-subjects factor and Group (patients with complete resolution of symptoms vs patients 
with residual symptoms) as the between-subjects factor  
Describe whether and how the model was validated, either internally (e.g. bootstrapping, cross 
validation, random split sample) or externally (e.g. temporal validation, geographical validation, 
different setting, different type of participants): 
 n/a 
Describe the performance measures of the model, e.g. calibration, discrimination, 
(re)classification, net benefit: 
 n/a 
1. Were non-binary predictors handled appropriately? 
 
Yes 
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2. Was selection of predictors based on univariable analysis 
avoided? 
 
Yes 
3. Was model overfitting (optimism in model performance) 
accounted for, e.g. using bootstrapping or shrinkage techniques? 
 
No 
4. Were any complexities in the data (e.g. competing risks, multiple 
events per individual) accounted for appropriately? 
No 
5. Do predictors and their assigned weights in the final model 
correspond to the results from multivariable analysis? 
NI 
6. Were relevant model performance measures evaluated, e.g. 
calibration, discrimination, (re)classification and net benefit? 
No 
Risk of bias introduced by the analysis RISK: High 
 
 
 
Step 4: Overall judgement 
 
Overall judgement about risk of bias and applicability of the prediction model evaluation 
Overall judgement of risk of bias RISK: High 
 
Overall judgement of applicability CONCERN: High 
 
 
Step 5: Usability of the model 
 
Assess the usability of the model 
Is the model presented with sufficient detail to be used in the 
intended context and target population? 
RATING: No 
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Virta et al. (2009) 
 
Step 3: Assess risk of bias and applicability 
 
DOMAIN 1: Participant selection  
 
A. Risk of Bias 
Describe the sources of data and criteria for participant selection: 
 Prospective cohort study 
 ‘Subacromial impingement’ 
Diagnosis was confirmed with subacromial anaesthesia, with a few exceptions by the same 
doctor, and most of the patients had passed an MRI examination. Patients were included if 
diagnosis was confirmed. 
1. Were appropriate data sources used, e.g. cohort, RCT or nested 
case-control study data? 
 
Yes 
2. Were all inclusions and exclusions of participants appropriate? 
 
Yes  
3. Were participants enrolled at a similar state of health, or were 
predictors considered to account for any dissimilarities? 
 
Uncertain   
Risk of bias introduced by selection of participants 
 
RISK: Low 
 
 
B. Applicability 
Describe included participants and setting: 
n=97 
Recruited patients who were on a waiting list for orthopaedic surgery but had been referred for 
physiotherapy prior to surgery 
Concern that the included participants and setting do not match the 
review question  
CONCERN: High  
 
 
 
DOMAIN 2: Predictors  
 
A. Risk of Bias 
List and describe predictors assessed, e.g. definition, timing and knowledge of other predictors: 
 Demographics factors: Age, gender 
 Clinical history factors: Symptom duration 
 Patient reported measures: Pain (none), Psychological symptoms (none), Function / Disability 
(none) 
 Clinical measures: Strength (none), ROM (none), Scapular movement and control (none) 
 Structural pathology: Imaging (none), Orthopaedic tests (none)  
All recorded at initiation of the study 
1. Were predictors defined and assessed in a similar way for all 
participants? 
 
Yes 
3. Were predictor assessments made without knowledge of 
outcome data? 
 
Yes 
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4. Are all predictors available at the time the model is intended to be 
used? 
Yes 
5. Were all relevant predictors analysed? 
 
Yes 
Risk of bias introduced by predictors or their assessment RISK: Low 
 
B. Applicability 
Concern that the definition, assessment or timing of assessment of 
predictors in the model do not match the review question 
CONCERN: Low 
 
 
DOMAIN 3: Outcome 
 
A. Risk of Bias 
Describe the outcome and how it was defined and determined: 
UCLA; upon completion of treatment 
1. Was a pre-specified outcome definition used? 
 
Yes 
2. Were predictors excluded from the outcome definition? 
 
Yes 
 
3. Was the outcome defined and determined in a similar way for all 
participants? 
 
Yes 
5. Was the outcome determined without knowledge of predictor 
information? 
 
Yes 
Risk of bias introduced by the outcome or its determination RISK: Low 
 
 
B. Applicability 
At what time point was the outcome determined: 
Upon completion of treatment  
If a composite outcome was used, describe the relative frequency/distribution of each 
contributing outcome: 
n/a 
Concern that the outcome, its definition, timing or determination do 
not match the review question 
CONCERN: Low 
 
 
 
DOMAIN 4: Sample size and participant flow 
 
A. Risk of Bias 
Describe numbers of participants and events per predictor: 
 n=97; 18 
Describe the time interval between predictor assessment and outcome determination: 
 Upon completion of treatment  
Describe any participants who were excluded from the model: 
 26% but failed to compare the baseline characteristics of those who were and those who 
were not followed up  
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Describe missing data on predictors and outcomes as well as methods used for missing data: 
 n/a 
 
1. Were there a reasonable number of outcome events? 
  
Yes  
2. Was the time interval between predictor assessment and 
outcome determination appropriate? 
 
Yes  
3. Were all enrolled participants included in the analysis? 
 
Yes  
4. Were participants with missing data handled appropriately? 
 
n/a 
Risk of bias introduced by sample size or participant flow RISK: Low 
 
 
 
DOMAIN 5: Analysis 
 
A. Risk of Bias 
Describe how the model was developed (predictor selection, fitting and optimism, risk groups, 
model performance): 
 No attempt made to trim the number of candidate variables 
 No details of analysis  
Describe whether and how the model was validated, either internally (e.g. bootstrapping, cross 
validation, random split sample) or externally (e.g. temporal validation, geographical validation, 
different setting, different type of participants): 
 n/a 
Describe the performance measures of the model, e.g. calibration, discrimination, 
(re)classification, net benefit: 
 n/a 
1. Were non-binary predictors handled appropriately? 
 
Yes 
2. Was selection of predictors based on univariable analysis 
avoided? 
 
NI 
3. Was model overfitting (optimism in model performance) 
accounted for, e.g. using bootstrapping or shrinkage techniques? 
 
No 
4. Were any complexities in the data (e.g. competing risks, multiple 
events per individual) accounted for appropriately? 
No 
5. Do predictors and their assigned weights in the final model 
correspond to the results from multivariable analysis? 
NI 
6. Were relevant model performance measures evaluated, e.g. 
calibration, discrimination, (re)classification and net benefit? 
No 
Risk of bias introduced by the analysis RISK: High 
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Step 4: Overall judgement 
 
Overall judgement about risk of bias and applicability of the prediction model evaluation 
Overall judgement of risk of bias RISK: High 
 
Overall judgement of applicability CONCERN: High 
 
 
Step 5: Usability of the model 
 
Assess the usability of the model 
Is the model presented with sufficient detail to be used in the 
intended context and target population? 
RATING: No 
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10.4 PROBAST Overall judgement 
 
 
Study 
Risk of bias Applicability concerns Overall judgements 
Partici
pant 
selecti
on 
Predi
ctors 
Outc
ome 
Samp
le 
size 
and 
flow 
Anal
ysis 
Partici
pant 
selecti
on 
Predi
ctors 
Outc
ome 
Ri
sk 
of 
bi
as 
Applica
bility 
Usab
ility 
of 
the 
mod
el 
Bartolo
zzi et 
al. 
(1994) 
High Low High High High Low Low Low Hi
gh 
Low No 
Cheste
r et al 
(2016) 
Low Low High Low High High Low Low  Hi
gh 
High No 
Conroy 
and 
Hayes 
(1998) 
Low Low Low High High High Low Low Hi
gh 
High No 
Deutsc
her et 
al. 
(2009) 
High Low High High High High Low Low Hi
gh 
High No 
Engebr
etsen 
et al. 
(2010) 
Low Low High High High Low Low Low Hi
gh 
Low No 
Hung 
et al 
(2010) 
Low High Low High High Low High Low Hi
gh 
High No 
Kenne
dy et 
al. 
(2006) 
Low Low High High High High Low Low Hi
gh 
High No 
Kromer 
et al 
(2014) 
Low Low High High High Low Low Low Hi
gh 
Low No 
Mintke
n et al. 
(2010) 
Low Low Low High High Low Low High Hi
gh 
High No 
Morris
on et 
al. 
(1997) 
Low High Low High High Low Low Low Hi
gh 
Low No 
Ogon 
et al. 
(2009) 
Low High Low Unce
rtain 
High High High High Hi
gh 
High No 
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Sindhu 
et al. 
(2012) 
Low High Low High High High High Low Hi
gh 
High No 
Tyler et 
al. 
(2010) 
Low High Low High High High High Low Hi
gh 
High No 
Virta et 
al. 
(2009) 
Low Low Low Low High High Low Low Hi
gh 
High No 
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11 Appendix IV: PreMethods chapter 
 
GRRAS checklist for reporting of studies of reliability and agreement 
 
D1. Clinical measures: Strength 
 Demographics of strength (and ROM) intra-rater reliability study subjects 
 Strength (and ROM) intra-rater reliability study data collection form 
 Strength intra-rater reliability study: Raw data  
 
D2. Clinical measures: ROM 
 ROM intra-rater reliability study: Raw data  
 
D3. Clinical measures: Scapular movement and control 
 Demographics of scapular movement and control inter-rater reliability study subjects 
 Scapular dyskinesis gradings for each rater: raw data  
 
E1. Structural pathology via imaging 
 Diagnostic ultrasound PgC training 
 Shoulder ultrasound reproducibility study patient information sheet 
 Shoulder ultrasound reproducibility study patient consent sheet 
 European Society of Skeletal Radiology technical guidelines for the shoulder  
 Ultrasound differential diagnoses and record scan findings 
 Demographics and clinical data of ultrasound inter-rater reliability study subjects 
 Structural pathology findings from ultrasound inter-rater reliability study 
 
Treatment 
 Preliminary version of proforma for collecting patient treatment information 
 Final version of proforma for collecting patient treatment information 
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11.1 GRRAS checklist for reporting of studies of reliability and agreement  
 
Version based on Table I in: Kottner, J. et al.  2011. Guidelines for reporting reliability and agreement 
studies (GRRAS) were proposed. J Clin Epidemiol. 64(1):96-106 
 
4.1.1 D1. Clinical measures: Strength 
 
Section 
Item 
# 
Checklist item Details 
Title / 
Abstract 
1 Identify in title or abstract that 
interrater/intrarater reliability 
or agreement was investigated. 
Strength intra-rater reliability study 
Introduction 2 Name and describe the 
diagnostic or measurement 
device of interest explicitly. 
Handheld dynamometer (Commander 
Muscle Tester, JTech Medical, USA) 
 3 Specify the subject population 
of interest. 
12 healthy subjects 
 4 Specify the rater population of 
interest (if applicable). 
A single rater (MS) who performed the 
prognostic cohort study strength 
measurements 
 5 Describe what is already 
known about reliability and 
agreement and provide a 
rationale for the study (if 
applicable). 
Comparable study by Awatani et al. 
(2016); ICC between 0.850 and 0.980 
As a single rater (MS) performed the 
prognostic cohort study strength 
measurements, it was deemed necessary 
to assess the absolute accuracy of the 
strength measures taken in the same test 
positions using the same measurement 
tool as for the prognostic cohort study 
Methods 6 Explain how the sample size 
was chosen. State the 
determined number of raters, 
subjects/objects, and replicate 
observations. 
Sample size chosen to align with previous 
comparable publication (Awatani et al. 
2016).  
Raters = 1 
Subjects = 12 
Replicate observations = 2 
 7 Describe the sampling method. Convenience sample 
 8 Describe the 
measurement/rating process 
(e.g. time interval between 
repeated measurements, 
availability of clinical 
information, blinding). 
Time interval between repeated 
measurements = within session; precise 
timing not controlled 
Availability of clinical information = n/a 
Blinding = data stored on dynamometer; 
rater did not observe the readings during 
testing.  
 9 State whether 
measurements/ratings were 
conducted independently. 
Measurements were taken independently 
of the previous value.   
 10 Describe the statistical 
analysis. 
Intraclass correlation coefficient (ICC(3,1)) 
Results 11 State the actual number of 
raters and subjects/objects 
which were included and the 
Raters = 1 
Subjects = 12 
Replicate observations = 2 
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number of replicate 
observations which were 
conducted. 
 12 Describe the sample 
characteristics of raters and 
subjects (e.g. training, 
experience). 
Rater = experienced MSK clinician and 
researcher 
Subjects = n/a 
 13 Report estimates of reliability 
and agreement including 
measures of statistical 
uncertainty. 
See table 4.3 for ICC(3,1) results, including 
95 % CI 
Discussion 14 Discuss the practical relevance 
of results. 
The intra-rater reliability findings for the 
left and right side for IR, ER and Scaption 
are all in the very good range (Landis and 
Koch 1977; Altman 1991). Therefore the 
data collection method can be considered 
to be reliable and so the tool could be 
used in the same format in the prognostic 
cohort study. 
Auxiliary 
material 
15 Provide detailed results if 
possible (e.g. online). 
See appendix 11 , tables 11.2 to 11.7 
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4.1.2 D2. Clinical measures: ROM 
 
Section 
Item 
# 
Checklist item Details 
Title / 
Abstract 
1 Identify in title or abstract that 
interrater/intrarater reliability 
or agreement was investigated. 
ROM intra-rater reliability study  
Introduction 2 Name and describe the 
diagnostic or measurement 
device of interest explicitly. 
Digital inclinometer (DigiPas DWL-180s, 
JSB Tech Pte Ltd, Singapore) 
 3 Specify the subject population 
of interest. 
12 healthy subjects 
 4 Specify the rater population of 
interest (if applicable). 
A single rater (MS) who performed the 
prognostic cohort study ROM 
measurements 
 5 Describe what is already 
known about reliability and 
agreement and provide a 
rationale for the study (if 
applicable). 
Comparable study by Mullaney et al. 
(2010); ICC between 0.94 and 0.98 
As a single rater (MS) performed the 
prognostic cohort study ROM 
measurements, it was deemed necessary 
to assess the absolute accuracy of the 
ROM measures taken in the same test 
positions using the same measurement 
tool as for the prognostic cohort study 
Methods 6 Explain how the sample size 
was chosen. State the 
determined number of raters, 
subjects/objects, and replicate 
observations. 
Sample size chosen to align with previous 
comparable publication (Mullaney et al. 
2010) and make efficient use of strength 
intra-rater reliability study sample.  
Raters = 1 
Subjects = 12 
Replicate observations = 2 
 7 Describe the sampling method. Convenience sample 
 8 Describe the 
measurement/rating process 
(e.g. time interval between 
repeated measurements, 
availability of clinical 
information, blinding). 
Time interval between repeated 
measurements = within session; precise 
timing not controlled 
Availability of clinical information = n/a 
Blinding = none.  
 9 State whether 
measurements/ratings were 
conducted independently. 
Measurements were taken independently 
of the previous value.   
 10 Describe the statistical 
analysis. 
Intraclass correlation coefficient (ICC(3,1)) 
Results 11 State the actual number of 
raters and subjects/objects 
which were included and the 
number of replicate 
observations which were 
conducted. 
Raters = 1 
Subjects = 12 
Replicate observations = 2 
 12 Describe the sample 
characteristics of raters and 
Rater = experienced MSK clinician and 
researcher 
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subjects (e.g. training, 
experience). 
Subjects = n/a 
 13 Report estimates of reliability 
and agreement including 
measures of statistical 
uncertainty. 
See table 4.5 for ICC(3,1) results, including 
95 % CI 
Discussion 14 Discuss the practical relevance 
of results. 
The intra-rater reliability findings for both 
<90° elevation and >90° elevation are 
both in the very good range (Landis and 
Koch 1977; Altman 1991). Therefore the 
data collection method can be considered 
to be reliable and so the tool could be 
used in the same format in the prognostic 
cohort study. 
Auxiliary 
material 
15 Provide detailed results if 
possible (e.g. online). 
See appendix 11 , table 11.8  
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4.1.3 D3. Clinical measures: scapular movement and control  
 
Section 
Item 
# 
Checklist item Details 
Title / 
Abstract 
1 Identify in title or abstract that 
interrater/intrarater reliability 
or agreement was investigated. 
Inter-rater reliability of the Scapular 
Dyskinesis Test (SDT) 
Introduction 2 Name and describe the 
diagnostic or measurement 
device of interest explicitly. 
The scapular dyskinesis test (SDT) which is 
a qualitative assessment of scapular 
position and movement based upon 
descriptive criteria and subsequently 
rating patients according to normal, 
subtle or obvious dyskinesis (McClure et 
al. 2009). 
 3 Specify the subject population 
of interest. 
The reliability study was undertaken on a 
subset of patients (n=30) from the main 
cohort 
 4 Specify the rater population of 
interest (if applicable). 
Level of agreement in rating the 
symptomatic side was established with 
one of the treating musculoskeletal 
clinicians in the study. This was Kevin 
Nicholas (KN) who worked at the 
Whitchurch hospital (WHI) site and had 
10 years’ experience working in 
musculoskeletal outpatients. 
 5 Describe what is already 
known about reliability and 
agreement and provide a 
rationale for the study (if 
applicable). 
Comparable study by McClure et al. 
(2009); Right side Kappa = 0.61, left side 
Kappa = 0.48; both weighted Kappa 
 
The SDT was developed on overhead 
athletes whilst the current study is 
concerned with NHS patients who were a 
non-athletic population. The likely greater 
heterogeneity of NHS patients in terms of 
body habitus and range of movement at 
the shoulder complex meant that 
establishing the level of agreement 
between the MS and another experienced 
musculoskeletal clinician using a sample 
of such patients was necessary 
Methods 6 Explain how the sample size 
was chosen. State the 
determined number of raters, 
subjects/objects, and replicate 
observations. 
Sample size chosen to align with previous 
comparable study by McClure et al. 
(2009); where each pair of raters rated 30 
different participants.  
Raters = 2 
Subjects = 30 
Replicate observations = 2 
 7 Describe the sampling method. 30 subjects who were not used in the 
training phase and who were not treated 
at the same site where KN worked.  
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 8 Describe the 
measurement/rating process 
(e.g. time interval between 
repeated measurements, 
availability of clinical 
information, blinding). 
Time interval between repeated 
measurements = n/a; measurements 
performed in different locations 
Availability of clinical information = KN 
blinded to clinical information 
Blinding = absolute; measurements 
performed in different locations.  
 9 State whether 
measurements/ratings were 
conducted independently. 
Measurements were taken independently 
as measurements performed in different 
locations.   
 10 Describe the statistical 
analysis. 
Weighted Kappa was also performed; 0, 
1, 2 for same grade, one grade disparity 
and two grades disparity; respectively. 
Results 11 State the actual number of 
raters and subjects/objects 
which were included and the 
number of replicate 
observations which were 
conducted. 
Raters = 2 
Subjects = 30 
Replicate observations = 2 
 12 Describe the sample 
characteristics of raters and 
subjects (e.g. training, 
experience). 
Rater = KN and MS undertook 
standardised training, which comprised 
the operational definitions, rating scale 
and photographic examples provided in 
the original publication. As the SDT is 
based upon interpretation of descriptive 
terminology, it was considered essential 
that the training and familiarisation 
process included applying the SDT to 
footage of scapular movement. Twenty 
videos of scapular movement patterns 
from patients with SIS/RCTendinopathy 
from both loaded (i.e. holding a weight in 
each hand) and un-loaded (i.e. not 
holding a weight) trials which 
demonstrated a spectrum of scapular 
movement patterns were therefore 
selected from the prognostic cohort. KN 
and MS viewed these videos and had the 
opportunity to discuss the interpretation 
and application of the descriptive 
terminology and recording process. This 
mirrored a typical, peer-supported clinical 
training environment (Baertschi et al. 
2013). 
Subjects = n/a 
 13 Report estimates of reliability 
and agreement including 
measures of statistical 
uncertainty. 
Kappa = 0.329, p<0.002 
Discussion 14 Discuss the practical relevance 
of results. 
The linear weighted Kappa results confirm 
fair agreement (Kappa 0.21 to 0.40) (Viera 
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and Garrett 2005) for inter-rater reliability 
of Scapular grading. Therefore the SDT 
must be applied with caution in the main 
cohort study. 
Auxiliary 
material 
15 Provide detailed results if 
possible (e.g. online). 
See appendix 11 , table 11.10  
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4.2.1 E1. Structural pathology via imaging  
 
 
Section 
Item 
# 
Checklist item Details 
Title / 
Abstract 
1 Identify in title or 
abstract that 
interrater/intrarater 
reliability or 
agreement was 
investigated. 
Shoulder ultrasound reproducibility study 
Introduction 2 Name and describe the 
diagnostic or 
measurement device 
of interest explicitly. 
Diagnostic ultrasound scan performed by 
Sonographer 
 3 Specify the subject 
population of interest. 
Sample of patients referred for ultrasound scans 
of their shoulder in the Radiology department at 
the University Hospital of Wales 
 4 Specify the rater 
population of interest 
(if applicable). 
Reproducibility study was undertaken comparing 
scans performed by MS against an experienced 
musculoskeletal ultrasound practitioner, Dr Peter 
Mullaney (PM). PM has been a Consultant 
Radiologist since 2007 and is a level 3 ultrasound 
practitioner (The Royal College of Radiologists 
2012). 
 5 Describe what is 
already known about 
reliability and 
agreement and 
provide a rationale for 
the study (if 
applicable). 
Comparable study by Thoomes-de Graaf et al. 
(2014); 65 patients were scanned by 1 physical 
therapist and 1 radiologist (total of 13 physical 
therapists and 9 radiologists).  
 
As a highly operator dependent modality it was 
deemed necessary for MS to undergo formal 
training in diagnostic ultrasound and to undertake 
an inter-rater reliability study. 
Methods 6 Explain how the 
sample size was 
chosen. State the 
determined number of 
raters, 
subjects/objects, and 
replicate observations. 
Sample size chosen to align with previous 
comparable study by Thoomes-de Graaf et al. 
(2014); sample size also influenced by pragmatic 
limitations, i.e. the option to include a particular 
subject in the study was dependent upon clinical 
service demands during that particular clinical 
session.   
 
Raters = 2 
Subjects = 35 
Replicate observations = 2 
 7 Describe the sampling 
method. 
Convenience sample 
 8 Describe the 
measurement/rating 
process (e.g. time 
interval between 
Time interval between repeated measurements = 
within session; precise timing not controlled  
Availability of clinical information = neither rater 
was blinded to clinical information 
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repeated 
measurements, 
availability of clinical 
information, blinding). 
Blinding = MS blinded to PM diagnosis 
 9 State whether 
measurements/ratings 
were conducted 
independently. 
MS diagnosis performed independently of PM.   
 10 Describe the statistical 
analysis. 
Kappa  
Results 11 State the actual 
number of raters and 
subjects/objects which 
were included and the 
number of replicate 
observations which 
were conducted. 
Raters = 2 
Subjects = 35 
Replicate observations = 2 
 12 Describe the sample 
characteristics of 
raters and subjects 
(e.g. training, 
experience). 
MS: School of Medicine in Cardiff University 2 year 
Postgraduate Certificate (PgC) in Medical 
ultrasound was undertaken as part of the training 
component of his PhD. The training was extensive 
and included formal assessments of theoretical 
knowledge, image optimisation and sonographic 
diagnosis (http://www.case-uk.org/; accessed 
24/04/2017). Further details of the course 
requirements are provided in appendix 4. MS 
successfully completed the PgC (Distinction grade) 
and is on the voluntary register of Sonographers 
operated by the Society of Radiography 
(http://www.sor.org/practice/ultrasound/register-
sonographers ; accessed 24/04/2017). 
PM: an experienced musculoskeletal ultrasound 
practitioner, Dr Peter Mullaney (PM). PM has 
been a Consultant Radiologist since 2007 and is a 
level 3 ultrasound practitioner (The Royal College 
of Radiologists 2012). 
Subjects = n/a 
 13 Report estimates of 
reliability and 
agreement including 
measures of statistical 
uncertainty. 
See table 4.13  
Discussion 14 Discuss the practical 
relevance of results. 
Based upon the Kappa values it can therefore be 
concluded that when compared to an experienced 
musculoskeletal radiologist, MS demonstrated 
acceptable agreement for all categories except for 
the sonographic diagnosis of tendinopathy. 
Auxiliary 
material 
15 Provide detailed 
results if possible (e.g. 
online). 
See appendix 11 , table 11.12  
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11.2 Demographics of strength (and ROM) intra-rater reliability study subjects 
 
 
Table 11-1: Demographics of strength (and ROM) intra-rater reliability study subjects 
Subject 
number 
Gender 
1=M, 2=F 
Age 
(years) 
Height 
(metres) 
Weight 
(kg) 
BMI 
(kg/m2) 
Arm 
Dom 
1=L, 2=R 
OSS 
1 2 40 1.71 69.6 23.8 2 48 
2 2 67 1.72 65.3 22.1 2 46 
3 1 38 1.79 83.2 26.0 2 48 
4 1 27 1.91 93.6 25.7 2 48 
5 2 55 1.57 63.3 25.7 2 45 
6 2 37 1.67 67.9 24.3 2 48 
7 1 40 1.89 78.8 22.1 2 48 
8 1 39 1.83 93.4 27.9 2 48 
9 2 27 1.60 81.3 31.8 2 48 
10 2 43 1.69 71.6 25.1 1 48 
11 2 29 1.59 66.7 26.4 2 48 
12 2 21 1.73 65.5 21.9 2 47 
Key: M = male, F = female, Kg = kilograms, m = metres, BMI = body mass index, L = left, R = right, OSS = Oxford 
shoulder score 
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11.3 Strength (and ROM) intra-rater reliability study data collection form 
 
Subject (Initial + date)   Gender (1=M, 2=F)   Age 
 
Height    Weight   Arm dominance (1=L, 2=R, 3=ambidextrous) 
 
Inclinometer 
 
< 90 = L or R    > 90 = L or R 
 
 Left Right 
Trial 1 
 
 
 
Trial 2 
 
 
 
Trial 3 
 
 
 
 
HHD  
 
Distance elbow to radial styloid =    Distance GHJ to radial styloid = 
 
IR 
 Left Right 
Trial 1 
 
 
 
Trial 2 
 
 
 
Trial 3 
 
 
 
 
ER 
 Left Right 
Trial 1 
 
 
 
Trial 2 
 
 
 
Trial 3 
 
 
 
 
Scaption 
 Left Right 
Trial 1 
 
 
 
Trial 2 
 
 
 
Trial 3 
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11.4 Strength intra-rater reliability study: Raw data  
 
Table 11-2: Strength intra-rater reliability study: Raw data – Left internal rotation 
Subject 
number 
Length of 
lever arm 
(m)   
Left internal rotation Force (N)   
Left internal rotation Moment 
(Nm) 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
1 0.26 79.2 74.8 70.4 20.6 19.4 18.3 
2 0.27 44.0 44.0 44.0 11.9 11.9 11.9 
3 0.25 140.0 140.0 140.0 35.0 35.0 35.0 
4 0.27 99.0 101.0 101.0 26.7 27.3 27.3 
5 0.22 44.0 55.0 44.0 9.7 12.1 9.7 
6 0.24 99.0 101.0 105.0 23.8 24.2 25.2 
7 0.29 105.0 114.0 105.0 30.5 33.1 30.5 
8 0.28 105.0 94.6 105.0 29.4 26.5 29.4 
9 0.24 88.0 79.2 79.2 21.1 19.0 19.0 
10 0.23 61.6 59.4 61.6 14.2 13.7 14.2 
11 0.25 70.4 63.8 79.2 17.6 16.0 19.8 
12 0.27 61.6 55.0 66.0 16.6 14.9 17.8 
Key: m = metres, N = Newtons, Nm = Newton metres 
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Table 11-3: Strength intra-rater reliability study: Raw data – Right internal rotation 
Subject 
number 
Length of 
lever arm 
(m) 
Right internal rotation Force (N)   
Right internal rotation Moment 
(Nm) 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
1 0.26 79.2 79.2 77.0 20.6 20.6 20.0 
2 0.27 41.8 44.0 44.0 11.3 11.9 11.9 
3 0.25 149.0 140.0 132.0 37.3 35.0 33.0 
4 0.27 105.0 99.0 90.2 28.4 26.7 24.4 
5 0.22 39.6 44.0 44.0 8.7 9.7 9.7 
6 0.24 105.0 96.8 90.2 25.2 23.2 21.6 
7 0.29 101.0 105.0 105.0 29.3 30.5 30.5 
8 0.28 101.0 114.0 123.0 28.3 31.9 34.4 
9 0.24 79.2 77.0 77.0 19.0 18.5 18.5 
10 0.23 44.0 44.0 44.0 10.1 10.1 10.1 
11 0.25 61.6 70.4 70.4 15.4 17.6 17.6 
12 0.27 59.4 59.4 57.2 16.0 16.0 15.4 
Key: m = metres, N = Newtons, Nm = Newton metres 
  
358 
 
Table 11-4: Strength intra-rater reliability study: Raw data - Left external rotation 
Subject 
number 
Length of 
lever arm 
(m)   
Left external rotation Force (N)   
Left external rotation Moment 
(Nm) 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
1 0.26 70.4 79.2 79.2 18.3 20.6 20.6 
2 0.27 59.4 44.0 59.4 16.0 11.9 16.0 
3 0.25 70.4 70.4 70.4 17.6 17.6 17.6 
4 0.27 94.6 74.8 105.0 25.5 20.2 28.4 
5 0.22 44.0 44.0 44.0 9.7 9.7 9.7 
6 0.24 44.0 55.0 44.0 10.6 13.2 10.6 
7 0.29 79.2 79.2 70.4 23.0 23.0 20.4 
8 0.28 96.8 101.0 114.0 27.1 28.3 31.9 
9 0.24 61.6 61.6 66.0 14.8 14.8 15.8 
10 0.23 52.8 52.8 46.2 12.1 12.1 10.6 
11 0.25 70.4 79.2 66.0 17.6 19.8 16.5 
12 0.27 50.6 66.0 52.8 13.7 17.8 14.3 
Key: m = metres, N = Newtons, Nm = Newton metres 
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Table 11-5: Strength intra-rater reliability study: Raw data - Right external rotation 
Subject 
number 
Length of 
lever arm 
(m)   
Right external rotation Force (N)   
Right external rotation Moment 
(Nm) 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
1 0.26 74.8 70.4 70.4 19.4 18.3 18.3 
2 0.27 61.6 52.8 46.2 16.6 14.3 12.5 
3 0.25 61.6 66.0 70.4 15.4 16.5 17.6 
4 0.27 96.8 99.0 99.0 26.1 26.7 26.7 
5 0.22 44.0 44.0 44.0 9.7 9.7 9.7 
6 0.24 55.0 61.6 63.8 13.2 14.8 15.3 
7 0.29 99.0 88.0 101.0 28.7 25.5 29.3 
8 0.28 105.0 105.0 105.0 29.4 29.4 29.4 
9 0.24 63.8 61.6 59.4 15.3 14.8 14.3 
10 0.23 61.6 48.4 61.6 14.2 11.1 14.2 
11 0.25 66.0 66.0 70.4 16.5 16.5 17.6 
12 0.27 52.8 52.8 44.0 14.3 14.3 11.9 
Key: m = metres, N = Newtons, Nm = Newton metres 
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Table 11-6: Strength intra-rater reliability study: Raw data - Left scaption 
Subject 
number 
Length of 
lever arm 
(m)   
Left scaption Force (N)   Left scaption Moment (Nm) 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
1 0.50 55.0 52.8 61.6 27.5 26.4 30.8 
2 0.60 28.6 19.8 26.4 17.2 11.9 15.8 
3 0.52 59.4 66.0 70.4 30.9 34.3 36.6 
4 0.54 57.2 44.0 61.6 30.9 23.8 33.3 
5 0.44 37.4 44.0 44.0 16.5 19.4 19.4 
6 0.50 55.0 46.2 52.8 27.5 23.1 26.4 
7 0.52 44.0 44.0 61.6 22.9 22.9 32.0 
8 0.53 66.0 66.0 61.6 35.0 35.0 32.6 
9 0.47 70.4 70.4 66.0 33.1 33.1 31.0 
10 0.47 35.2 35.2 35.2 16.5 16.5 16.5 
11 0.48 44.0 44.0 48.4 21.1 21.1 23.2 
12 0.52 35.2 35.2 35.2 18.3 18.3 18.3 
Key: m = metres, N = Newtons, Nm = Newton metres 
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Table 11-7: Strength intra-rater reliability study: Raw data - Right scaption 
Subject 
number 
Length of 
lever arm 
(m)  
Right scaption Force (N)  Right scaption Moment (Nm) 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
1 0.50 44.0 46.2 61.6 22.0 23.1 30.8 
2 0.60 19.8 19.8 24.2 11.9 11.9 14.5 
3 0.52 55.0 70.4 70.4 28.6 36.6 36.6 
4 0.54 63.8 61.6 61.6 34.5 33.3 33.3 
5 0.44 35.2 41.8 44.0 15.5 18.4 19.4 
6 0.50 63.8 63.8 70.4 31.9 31.9 35.2 
7 0.52 30.8 35.2 44.0 16.0 18.3 22.9 
8 0.53 70.4 61.6 61.6 37.3 32.6 32.6 
9 0.47 61.6 61.6 66.0 29.0 29.0 31.0 
10 0.47 30.8 33.0 35.2 14.5 15.5 16.5 
11 0.48 44.0 55.0 57.2 21.1 26.4 27.5 
12 0.52 44.0 35.2 44.0 22.9 18.3 22.9 
Key: m = metres, N = Newtons, Nm = Newton metres 
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11.5 ROM intra-rater reliability study: Raw data  
 
Table 11-8: ROM intra-rater reliability study: Raw data 
Subject 
number 
< 90° (°) > 90° (°) 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
1 50.0 47.4 49.4 144.2 144.6 139.8 
2 41.6 39.4 44.0 128.3 128.3 130.5 
3 39.4 40.3 37.2 139.8 136.5 133.6 
4 33.2 31.8 32.8 124.5 123.2 119.5 
5 62.3 62.1 61.5 131.1 136.6 136.9 
6 53.4 51.8 52.6 135.2 133.4 131.2 
7 30.0 30.8 31.3 131.5 130.6 128.7 
8 28.0 29.1 26.6 136.3 135.5 134.2 
9 47.0 48.0 49.0 147.0 149.0 151.0 
10 44.5 47.4 46.3 140.1 142.0 142.1 
11 45.4 50.0 49.8 140.3 141.9 142.7 
12 46.3 46.9 47.7 132.7 130.5 132.0 
Key: ° = degrees 
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11.6 Demographics of scapular movement and control inter-rater reliability study 
subjects 
 
Table 11-9: Demographics of scapular movement and control inter-rater reliability study subjects 
Subject 
code 
Gender 
1=M, 2=F 
Symptomatic 
side 
1=L, 2=R 
Weighted 
trial? 
1=Y, 2=N 
BMI 
/kgm-2 
Maximum range of 
movement on 
symptomatic side /° 
F6847h 2 2 2 35.4 132 
F7047h 2 2 2 26.3 150 
M2146h 1 2 1 37.3 146 
F5446h 2 2 1 18.2 163 
F4417h 2 1 1 50.5 75 
M0379h 1 1 2 26.4 145 
F7849h 2 2 1 23.8 168 
F4583h 2 2 2 26.5 94 
M0825h 1 2 1 29.5 150 
M0061h 1 2 2 31.2 146 
F8486h 2 2 1 32.2 155 
F2520h 2 1 2 40.3 115 
M1586h 1 2 1 27.2 166 
F0165h 2 2 2 25.6 148 
M8878h 1 1 1 23.0 136 
F6416h 2 2 2 27.4 137 
F7405h 2 1 1 20.5 154 
M9819h 1 2 2 23.0 134 
F9939h 2 2 1 24.3 121 
F0809h 2 1 2 32.0 107 
M5703h 1 1 1 30.5 146 
M1518h 1 1 2 31.0 138 
M1243h 1 1 1 31.3 108 
M3288h 1 1 2 31.3 142 
F4943h 2 2 1 24.1 149 
M0519h 1 1 2 26.7 150 
F1669h 2 2 1 30.0 164 
F9261h 2 1 2 25.6 74 
F5690h 2 2 1 24.4 160 
M9287h 1 2 2 33.1 174 
Key: M = male, F = female, L = left, R = right, Y = yes, N = no, Kg = kilograms, m = metres, BMI = body mass 
index, ° = degrees 
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11.7 Scapular dyskinesis gradings for each rater: raw data 
 
 
Table 11-10: Scapular dyskinesis gradings for each rater: raw data 
Subject 
code 
MS rating KN rating 
F6847h 2 2 
F7047h 3 3 
M2146h 3 3 
F5446h 3 2 
F4417h 3 3 
M0379h 2 3 
F7849h 2 2 
F4583h 1 3 
M0825h 2 2 
M0061h 2 3 
F8486h 2 2 
F2520h 3 3 
M1586h 2 2 
F0165h 1 3 
M8878h 2 2 
F6416h 1 3 
F7405h 3 1 
M9819h 2 3 
F9939h 1 3 
F0809h 1 1 
M5703h 3 3 
M1518h 2 1 
M1243h 2 3 
M3288h 2 2 
F4943h 1 1 
M0519h 3 3 
F1669h 2 2 
F9261h 3 3 
F5690h 1 1 
M9287h 1 2 
Key: 1 = Normal, 2 = Subtle abnormality, 3 = Obvious abnormality 
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11.8 Diagnostic ultrasound PgC training 
 
The PgC was a CASE (Consortium for the Accreditation of Sonographic Education) approved course 
and included a foundation science module which covered the physics of ultrasound as applied to 
medicine, including image optimisation and safety implications. Assessment was through 4 essays (4 
x 10% of module mark), 2 online assessments (2 x 10% of module mark) and a written examination 
(40% of module mark) was sat at the end of the first year.  
 
The musculoskeletal ultrasound module covered the fundamentals of ultrasound examination of 
normal and pathological musculoskeletal tissue. It was assessed through a written examination (40% 
of module mark) and practical skills assessments covering communication, clinical evaluation, 
machine and imaging-related skills (40% of module mark). A log book of standardised images of the 
2 anatomical regions (1 upper limb and 1 lower limb) which the researcher specialised in was also 
required: these were the shoulder and the foot and ankle, along with soft tissue differentiation (e.g. 
tumours, masses, swelling).  
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11.9 Shoulder ultrasound reproducibility study patient information sheet 
 
PATIENT INFORMATION SHEET 
 
Diagnostic ultrasound scanning of the shoulder 
Version 2 30/01/2013 
 
Part one 
 
You are being invited to take part in a research study with Cardiff University’s Arthritis Research 
Campaign Biomechanics and Bioengineering Centre.  Before you decide, it is important for you to 
understand why the research is being done and what it will involve.  Please take time to read the 
following information carefully and discuss it with others if you wish.  One of our team will go 
through the information sheet with you.  Ask us if there is anything that is not clear or if you would 
like more information.  Take time to decide whether or not you wish to participate.  Part 1 tells you 
about the purpose of this study and what will happen to you if you take part.  Part 2 gives you more 
detailed information about the conduct of the study. 
 
What is the purpose of this trial? 
The aim of the trial is to use an ultrasound scanner to look at the soft tissues (e.g. muscle, tendon, 
etc) of your shoulder. These tissues can be injured or damaged as part of the shoulder problem that 
you have. Such information is one of the factors that are being looked at to see if we can predict 
which people with shoulder pain can be helped with rehabilitation and which people are not helped 
with rehabilitation. Eventually this will help us to direct patients for the right treatment at the right 
time.  
 
Do I have to take part?          
It is up to you to whether or not to take part.  If you do decide to take part you will be given this 
information sheet to keep and after you have had enough time to read through it, be asked to sign a 
consent form.  If you decide to take part, you are still free to withdraw at any time or without giving 
a reason.  A decision not to take part or to withdraw at any time will not affect the standard of care 
you receive.  Should you decide not to take part, you do not have to provide a reason for this 
decision. 
 
What will happen to me if I take part? 
You have been asked to take part in this as you are a person with shoulder pain who have been 
referred to radiology or to physiotherapy.  
 
If you wish to take part you will assessed on site in the NHS. If you have been referred for 
Physiotherapy then you may be invited to come back for subsequent scans at the Cardiff University 
School of Healthcare Studies (SOHCS) Research Centre for Clinical Kinaesiology (RCCK). The number 
of times we would ask you to attend will be discussed with you when going through this information 
sheet.  The sessions will last a maximum of thirty minutes. 
 
Data will be kept securely for a minimum of 15 years in accordance with good research practice and 
data protection regulations imposed by Cardiff University in accordance with the Data Protection Act 
1998.  All data obtained during the study will remain confidential.  Access to data will only be 
available to the investigators attached to the Arthritis Research UK Biomechanics and Bioengineering 
Centre at Cardiff University. 
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If new information becomes available, we may invite you to take part in a follow-up study in the 
future, please indicate on the consent sheet if you do not mind us contacting you.   
 
What will I have to do? 
At the beginning of your visit, we will explain the full study to you and ask for your consent, bearing 
in mind that you are free to withdraw at any time.  
 
Before your first assessment you will be asked to sign a consent form which includes the following 
clause: I understand that I may withdraw from the study at any time without it affecting any ongoing 
treatment in any way.   
 
As with routine radiology and physiotherapy assessment of the shoulder, the shoulder and 
surrounding area need to be exposed so that the assessment can be accurately performed. You will 
be offered a special apron to wear that leaves your shoulder visible, but covers your chest.  
 
For the scan procedure you will be seated with your hands either resting on your thighs in a 
comfortable position or your hands on your hips. A water-based contact medium (gel) will be 
applied to your skin in the shoulder region to allow for optimal transmission of ultrasound waves. An 
ultrasound transducer head will be placed on your skin and from this an image of the tissues of your 
shoulder will be generated and displayed on a screen. The position and movement of the transducer 
head, along with an audio-commentary of the scan, will be recorded using a digital camcorder. 
Following the assessment the water-based contact gel will be wiped off and you will be asked to 
return to your original clothing.  
 
All data files, including audiovisual files will be stored in encrypted folders on Cardiff University 
password protected computers. Cardiff University and NHS members of staff who are directly 
involved with the study will have access to the files. The audiovisual files will be electronically 
destroyed up to 15 years from the commencement of the study.  
 
Are there any risks in participating in this trial? 
Ultrasound scanning is routinely used in clinical practice and as noted by the Safety Group of the 
British Medical Ultrasound Society (BMUS) “there is no evidence that diagnostic ultrasound has 
produced any harm to patients in the four decades that it has been in use” 
(http://www.bmus.org/policies-guides/pg-safety04.asp). Nonetheless, safety principles issued by 
BMUS will be strictly adhered to.  
 
Are there any benefits in participating in this trial? 
Whilst ultrasound can provide useful information about injured or damaged tissues around the 
shoulder, such findings can also occur in people who do not have any shoulder problems. If you are a 
patient who has been referred for Physiotherapy then your Doctor has referred you for 
rehabilitation based on a number of factors 
 
However the ultrasound findings from this study will be one of multiple factors that will be looked at 
to see if we can identify and predict those patients with shoulder pain that can be helped with 
rehabilitation and which people are not helped with rehabilitation. Eventually this will help us to 
direct patients for the right treatment at the right time.  If we do find an undiagnosed tear we will 
write to your GP and other clinicians and inform them. 
 
If the information in Part 1 has interested you and you are considering participation, please read 
the additional information in Part 2 before making a decision. 
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Part Two 
 
What if new information becomes available? 
Sometimes during the course of a research project, new information becomes available about the 
investigation.  If you decide to withdraw, it will not affect your any care in the NHS.  If you decide to 
continue, you will be asked to sign an updated consent form. 
 
What will happen if I do not want to carry on with the study? 
If you withdraw from the study, we will erase all identifiable material, but we will need to use the 
data collected up to your withdrawal. 
 
What if something goes wrong? 
If you are harmed by taking part in this research project, there are no special compensation 
arrangements.  If you are harmed due to someone’s negligence, then you may have grounds for a 
legal action but you may have to pay for it.  Regardless of this, if you wish to complain, or have any 
concerns about any aspect of the way you have been approached or treated during the course of 
this study, the normal National Health Service complaints mechanisms should be available to you. 
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept strictly 
confidential.  Any information about you which leaves the Cardiff University or the University 
Hospital of Wales will have your name and address removed so that you cannot be recognised from 
it. The video footage of the transducer position will be edited to ensure that you cannot be 
identified. 
 
Will my GP be informed of my involvement in the study? 
With your permission, we will send a letter to your General Practitioner informing him or her of your 
involvement in the study. 
 
What will happen to the results of the research study? 
The measurements taken will provide information about the movement of your joint.  The results of 
the study will be presented at meetings of orthopaedic surgeons, clinical scientists, physiotherapists 
and engineers, and if accepted, published in medical and engineering journals. If interested, a copy 
of the published article can be made available to you.  The video footage may be used in 
educational, clinical and research material and presentations. You will not be identified in any 
report/publication and the video footage will be anonymised so that you cannot be identified. 
 
Who is organising and funding the research? 
Research staff at the Arthritis Research UK Biomechanics and Bioengineering Centre at Cardiff 
University and Consultant Orthopaedic Surgeons at the University Hospital of Wales are carrying out 
the study.  The study is part of the Arthritis Research UK Biomechanics and Bioengineering Centre at 
Cardiff University; it is not funded by commercial sources and runs alongside research in the Cardiff 
Gait and Motion Analysis Laboratory at Cardiff University School of Engineering and Research Centre 
for Clinical Kinaesiology at Cardiff University School of Healthcare Studies.   
 
Who has reviewed the study? 
This study has been reviewed by the Research Ethics Committee (REC) for Wales. 
 
What if I wish to lodge a complaint? 
If you wish to make a minor complaint regarding the way you were approached or treated during 
the trial, please contact the Arthritis Research UK Biomechanics and Bioengineering Centre Research 
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Coordinator at the contact details below or you can contact the Cardiff University Research 
Governance Team on 029 208 79277. 
 
Contact for further information 
Research Coordinator 
Arthritis Research UK Biomechanics and Bioengineering Centre  
Cardiff School of Biosciences 
Cardiff University 
Cardiff  
CF10 3AX 
Tel: 029 2087 5419 
Email: Robertshc@cf.ac.uk or Longmanaj@cf.ac.uk 
 
This completes Part 2. Thank you for reading this information sheet. 
 
If you agree to take part in this study then you will be given a copy of the information sheet and a 
signed consent form to keep.   
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11.10 Shoulder ultrasound reproducibility study patient consent sheet 
 
PATIENT CONSENT FORM 
 
Diagnostic ultrasound scanning of the shoulder 
 
Study Number 
Patient Identification Number for this trial: 
 
You DO NOT have to sign this document. Please DO NOT sign this document unless you fully 
understand it. If there is ANYTHING which you do not understand please do not hesitate to ask for a 
full explanation. 
 
To confirm agreement with each of the statements below, please initial each box and amend as 
applicable: 
 
 
1. I confirm that I have read and understand the information sheet dated 30/01/2013  
(Version 2) for the above study and have had the opportunity to ask questions.  
 
 
2. I understand that my participation in the study is voluntary and that I am free to withdraw  
at any time, without giving any reason, and without my medical care or legal rights being  
affected.   
 
3. You may/may not contact me in the future to take part in other research projects or surveys. 
 
4. I do/do not agree to my hospital number being used to track my data on your  
secure system. 
 
5. I do/do not agree to my GP and other clinicians being informed of my participation  
in the study. 
 
6. I agree to my scan being videoed using a digital camcorder 
 
7. I do/do not agree to the anonymised video images being used for clinical,  
educational and research purposes 
 
8. I agree to take part in the above study. 
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Name of Patient: ______________________________________________________ 
(Please print) 
 
Signature: ___________________________   Date: ___________________________ 
I confirm that I have fully explained the experimental protocol and purpose of the study 
 
Name of Researcher: __________________________________________________ 
 
Signature: ___________________________   Date: ___________________________ 
 
 
Name of person taking consent: _________________________________________ 
(If different from researcher) 
 
Signature: ___________________________   Date: ___________________________ 
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11.11 European Society of Skeletal Radiology technical guidelines for the shoulder  
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11.12 Ultrasound differential diagnoses and record scan findings 
 
Taken from the publication: 
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11.12.1 Section 1b – for differential diagnosis 
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11.12.2 Section 1c – for scan findings recording  
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11.13 Demographics and clinical data of ultrasound inter-rater reliability study 
subjects 
 
Table 11-11: Demographics and clinical data of ultrasound inter-rater reliability study subjects 
Pt code 
Gender 
1=M, 2=F 
Age 
(years) 
Sx side  
1=L, 
2=R 
Referral 
source 
(coding 
below) 
Onset 
(coding 
below) 
Chronicity 
(months) 
Prev 
episodes 
(coding 
below) 
F4589 2 73 2 1 1 5 0 
F4793 2 25 2 1 2 8 0 
F1953 2 82 2 1 2 36 1 
M3535 1 25 2 1 1 6 0 
F3577 2 65 2 1 3 8 0 
F3317 2 63 2 4 2 1 0 
M6133 1 51 1 1 2 12 0 
F7185 2 47 1 1 2 9 0 
F2815 2 56 1 1 2 9 0 
F5545 2 35 2 1 3 60 0 
M0833 1 63 2 1 2 216 1 
F1194 2 28 2 1 4 22 0 
F4814 2 45 1 1 2 24 0 
M5213 1 52 1 1 1 4 0 
M3023 1 69 2 1 2 12 0 
F7914 2 57 1 1 2 9 0 
F8687 2 76 1 2 5 36 0 
F1706 2 59 2 1 5 18 0 
M9997 1 42 1 2 n/r 30 1 
M7087 1 57 2 1 2 36 0 
F7537 2 47 2 1 3 3 0 
M2353 1 54 2 1 2 8 0 
M3933 1 57 2 1 2 24 0 
F0842 2 57 2 1 3 12 0 
F5937 2 44 2 1 2 96 0 
M8858 1 61 2 1 2 3 0 
F0962 2 82 2 1 2 6 0 
M4929 1 77 2 1 2 7 0 
F3183 2 76 1 1 2 24 0 
M0454 1 40 1 1 1 8 0 
M5901 1 45 2 1 2 15 0 
M0902 1 50 1 1 2 24 0 
F8015 2 52 2 n/r 2 18 0 
M5381 1 21 1 4 1 2 0 
F9032 2 58 2 1 2 24 0 
Key: M = male, F = female, L = left, R = right, Referral source: 1 = GP; 2 = Rheumatology; 3 = Orthopaedics; 4 = 
Trauma/ fracture clinic, Onset: 1=Trauma; 2=Insidious; 3=combination of 1 & 2; 4=overuse; 5 = Rheumatoid 
Arthritis, Previous episodes: 0 = none; 1 = multiple, n/r = not recorded 
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11.14 Structural pathology findings from ultrasound inter-rater reliability study 
 
Table 11-12: Structural pathology findings from ultrasound inter-rater reliability study 
Rater MS PM MS PM MS PM MS PM MS PM MS PM 
Pt code 
Cuff path 
1=Y, 2=N 
Cuff path 
1=Y, 2=N 
Tendino 
pathic 
1=Y, 2=N 
Tendino 
pathic 
1=Y, 2=N 
Calcific 
deposit 
1=Y, 2=N 
Calcific 
deposit 
1=Y, 2=N 
Bursitis 
1=Y, 2=N 
Bursitis 
1=Y, 2=N 
PTT 
1=Y, 2=N 
PTT 
1=Y, 2=N 
FTT 
1=Y, 2=N 
FTT 
1=Y, 2=N 
F4589 1 1 1 1 2 2 2 2 2 2 1 2 
F4793 2 2 2 2 2 2 1 1 2 2 2 2 
F1953 1 2 1 2 2 2 2 2 2 2 2 2 
M3535 2 2 2 2 2 2 1 2 2 2 2 2 
F3577 1 2 1 2 2 2 1 1 2 2 2 2 
F3317 1 2 1 2 2 2 2 2 2 2 2 2 
M6133 2 2 2 2 2 2 2 2 2 2 2 2 
F7185 2 1 2 1 2 2 1 2 2 2 2 2 
F2815 2 2 2 2 2 2 2 2 2 2 2 2 
F5545 2 2 2 2 2 2 1 1 2 2 2 2 
M0833 1 1 1 1 2 2 1 1 2 2 1 1 
F1194 1 1 1 1 2 2 1 n/r 2 2 2 2 
F4814 2 1 2 1 2 2 2 n/r 2 2 2 2 
M5213 1 1 2 1 2 2 2 2 2 2 1 1 
M3023 1 2 1 2 2 2 1 1 2 2 2 2 
F7914 1 1 1 1 2 2 1 n/r 2 2 2 2 
F8687 1 1 1 1 1 2 2 n/r 2 1 2 2 
F1706 1 1 1 1 2 2 2 n/r 2 2 2 2 
M9997 2 1 2 1 2 2 2 n/r 2 2 2 2 
M7087 1 2 1 2 2 2 2 2 2 2 2 2 
F7537 2 1 2 1 2 2 1 n/r 2 2 2 2 
M2353 1 1 1 1 1 2 2 n/r 2 2 2 2 
M3933 1 1 1 2 2 2 2 n/r 2 2 1 1 
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F0842 1 1 2 1 1 1 n/r n/r 2 2 2 2 
F5937 1 2 1 2 1 2 1 n/r 2 2 2 2 
M8858 1 1 1 1 n/r 1 1 2 2 2 2 2 
F0962 1 1 1 1 2 2 1 1 2 1 2 2 
M4929 1 1 2 1 2 2 1 n/r 1 1 2 2 
F3183 1 1 1 1 2 2 n/r n/r 2 2 2 2 
M0454 n/r 1 n/r 1 n/r 2 2 2 n/r 2 n/r 2 
M5901 2 2 2 2 2 2 1 n/r 2 2 2 2 
M0902 1 1 1 1 2 2 1 n/r 2 2 2 2 
F8015 1 1 1 1 2 2 1 2 2 2 2 2 
M5381 2 2 2 2 2 2 1 n/r 2 2 2 2 
F9032 1 1 1 1 1 2 1 2 2 2 2 2 
Key: Y = yes, N = no, Cuff path = Rotator cuff pathology, PTT = Partial Thickness Tear; FTT = Full Thickness Tear, n/r = not recorded  
Note: Pathology findings are collapsed for all rotator cuff tendons 
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11.15 Preliminary version of proforma for collecting patient treatment information 
Please place patient sticky here 
 
1. Date of first patient appointment (i.e. assessment): 
 
2. Name and grade of clinician: 
 
Treatment delivered 
 “Modality” Delivered during appointment? If so, the approximate number of 
minutes you spent with the patient doing this 
Given as a home exercise 
programme? 
Advice (including explanation about pathology, 
etc) 
 
  
Manual therapy (Glenohumeral mobilisation; 
spinal mobilisation) 
  
Exercise therapy: Glenohumeral stability – 
including rotator cuff strengthening 
  
Exercise therapy: Scapulothoracic stability
   
  
Exercise therapy: Glenohumeral mobility / 
range of movement    
  
Taping: what technique? 
 
  
Electrotherapy: what modality? 
 
  
Stretching:  Anterior shoulder / pec major / pec 
minor      
  
Stretching: Posterior shoulder / sleeper stretch 
 
  
Other: 
 
  
Any other comments? 
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11.16 Final version of proforma for collecting patient treatment information 
 
Patient treatment information 
 
Dear Colleague,  
 
 Your patient is participating in the Shoulder Prognosis Study that xxx and 
I are leading here in the Department.  
 
 As part of the study, please use this proforma to record the content of 
each treatment session (including home exercises) with your patient. This 
information will only be used in secondary analysis and will be anonymised. 
 
 Treatment is entirely clinician directed – i.e. you treat the patient as 
many times and using whatever modalities you feel is appropriate. From a 
clinician perspective the study is NOT about making a judgement on whether 
you use the “right” or “wrong” modalities or whether many or few of your 
patients improve. The study is only concerned with whether specific 
characteristics can predict which of the patients we see can be helped with 
Physiotherapy. 
 
 Thank you very much for your support.  
 
 Best wishes 
Mike 
 
Email: Smithmj2@cf.ac.uk  Telephone: (029) 2068 7927 
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Date of first patient 
appointment (i.e. 
assessment) 
 
 
 
Please place patient sticky here 
 Name of clinician 
 
 
 
Clinician D&T code  
(and therefore grade) 
 
 
 
Clinic-based treatment – please circle all that apply 
 
 
Education 
and advice 
 
Explanation about 
pathology 
Avoiding certain 
movements / 
activities 
Postural / 
ergonomic / 
functional advice 
 
Other….. 
 
 
Manual 
therapy 
 
Glenohumeral / ACJ 
mobilisation / 
manipulation 
Spinal mobilisation / 
manipulation 
Soft tissue massage / 
release, e.g. trigger 
point, hold-relax 
 
 
Exercise 
therapy 
 
Shoulder ROM 
e.g. pendulum, 
active-assisted 
Shoulder 
flexibility 
e.g. anterior or 
posterior 
stretches 
Shoulder 
strengthening 
incl rotator 
cuff 
Scapular 
stabiliser 
control and/or 
strength 
Core 
stability 
exercises 
 
 
Taping 
 
Inhibitory / facilitatory 
e.g. upper / lower traps 
Postural  
e.g. scapular or thoracic 
Relocation / support  
e.g. “Adidas” technique 
 
 
Electrotherapy 
 
Ultrasound TENS Interferential 
Short wave 
diathermy 
 
 
Other 
interventions 
 
Heat Cold Acupuncture Hydrotherapy Injection 
 
Additional details (if required) regarding treatment: 
 
 
Home exercise programme – please circle all that apply 
 
 
Exercise 
therapy 
 
Shoulder ROM 
e.g. pendulum, 
active-assisted 
Shoulder 
flexibility 
e.g. anterior or 
posterior 
stretches 
Shoulder 
strengthening 
incl rotator 
cuff 
Scapular 
stabiliser 
control and/or 
strength 
Core 
stability 
exercises 
 
Any other comments? 
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12 Appendix V: Methods chapter 
 
Prognostic cohort study subjects: 
 Study invitation pack  
 Order of testing  
 
C1. Patient reported measures: Pain 
 Visual Analogue Scale 
 
C2. Patient reported measures: 4DSQ 
 4DSQ: Patient to complete 
 4DSQ: Scoring and interpretation 
 
C3. Patient reported measures: Function / disability 
 SPADI 
 
Outcome 
 OSS: Questionnaire 
 OSS: Scoring 
 
Treatment  
 Patient data collection form 
 
D3. Clinical measures: Scapular movement and control 
 SDT assessment criteria  
 
E1. Structural pathology via imaging 
 Specific criteria relating to the sonographic appearance of cuff tendinopathy and bursitis. 
 Philips CX-50 
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12.1 Study invitation pack  
This comprised a covering letter for each site (UHW or WHI), a patient self-screening form and 
patient information sheets 1 and 2 
 
12.1.1 Covering letter to patient for UHW site 
Dear                                         ,  
 
We are contacting you as you have been referred for Physiotherapy at the University Hospital Wales 
in the Heath. 
 
The Physiotherapy Department is collaborating with Cardiff University to look at how information 
from shoulder pain patients can be used to predict which patients will respond to Physiotherapy. We 
would therefore like to invite you to participate in the study.  
 
The data collection will involve performing an ultrasound scan of your shoulder, measuring your 
shoulder strength and videoing your shoulder movements. The data collection will occur immediately 
prior to your first Physiotherapy appointment so there will be no additional travelling or attendance 
and will last no longer than 45 minutes. Your Physiotherapy assessment and treatment will occur as 
normal.  
 
We would be grateful if you would read the enclosed information sheet, please. The one entitled “Are 
your shoulder symptoms suitable for our study?” will help you to identify if you are eligible to be 
included in the study.  
 
If you are interested in participating in the study then – once you have received your letter from 
the Physiotherapy Department asking you to call to make an appointment – please telephone the 
Physiotherapy Department on (029) 2074 5884, tell the receptionist that you are in the “Mike 
Smith Shoulder Study” and make your first appointment for either a Monday or a Tuesday. 
 
If you have any questions, queries or concerns about the study then please contact the researcher 
(Mike Smith) via email (smithmj2@cf.ac.uk) or phone / text (07531 711 508). One of the research team 
will contact you prior to your first appointment to explain the study and answer any questions that 
you may have.  
 
Thank you for considering participating in this study.  
 
Yours sincerely, 
 
Adrian Broad 
Strategic Lead Outpatient Physiotherapy  
Ysbyty Athrofaol Cymru 
University Hospital of Wales 
 
Heath Park,   Parc Y Mynydd Bychan, 
Cardiff, CF14 4XW  Caerdydd, CF14 4XW 
Eich cyf/Your ref  
Ein cyf/Our ref 
Welsh Health Telephone Network 1872 
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12.1.2 Covering letter to patient for WHI site 
 
Dear                                      ,  
 
We are contacting you as you have been referred for Physiotherapy at Whitchurch hospital. 
 
The Physiotherapy Department is collaborating with Cardiff University to look at how information 
from shoulder pain patients can be used to predict which patients will respond to Physiotherapy. We 
would therefore like to invite you to participate in the study.  
 
The data collection will involve performing an ultrasound scan of your shoulder, measuring your 
shoulder strength and videoing your shoulder movements. The data collection will occur immediately 
prior to your first Physiotherapy appointment so there will be no additional travelling or attendance 
and will last no longer than 45 minutes. Your Physiotherapy assessment and treatment will occur as 
normal.  
 
We would be grateful if you would read the enclosed information sheet, please. The one entitled “Are 
your shoulder symptoms suitable for our study?” will help you to identify if you are eligible to be 
included in the study.  
 
If you are interested in participating in the study then – once you have received your letter from 
the Physiotherapy Department asking you to call to make an appointment – please telephone the 
Physiotherapy Department on (029) 2033 6345, tell the receptionist that you are in the “Mike 
Smith Shoulder Study” and make your first appointment for a Thursday. 
 
If you have any questions, queries or concerns about the study then please contact the researcher 
(Mike Smith) via email (smithmj2@cf.ac.uk) or phone / text (07531 711 508). One of the research team 
will contact you prior to your first appointment to explain the study and answer any questions that 
you may have.  
 
Thank you for considering participating in this study.  
 
Yours sincerely, 
 
Adrian Broad 
Strategic Lead Outpatient Physiotherapy  
  
Ysbyty Athrofaol Cymru 
University Hospital of Wales 
 
Heath Park,   Parc Y Mynydd Bychan, 
Cardiff, CF14 4XW  Caerdydd, CF14 4XW 
Eich cyf/Your ref  
Ein cyf/Our ref 
Welsh Health Telephone Network 1872 
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12.1.3 Patient self-screening form  
 
Are your shoulder symptoms suitable for our study? 
 
Your Name Today’s Date 
Thank you for helping us with our shoulder study.  
Please complete the questions below to see whether you have the 
type of shoulder problem that we are investigating in our study.  
The questions are about the shoulder problem for which you have 
been referred to physiotherapy. The questions are not about your 
other shoulder.  
Please tick one box to indicate your answer for each question.  
1. Have you been referred to physiotherapy for a 
problem with your shoulder? 
Yes  No  
2. Is your shoulder pain worse when you move into a 
particular position or do specific tasks? 
Yes  No  
 
I answered “Yes” to questions 1 and 2. What do I do now? 
Please continue and answer questions 3 to 8 on the other side of this 
sheet of paper 
I answered “No” to question 1 or 2. What do I do now? 
You do not have the type of shoulder problem that we are investigating 
in our study. Please do not answer any further questions. Please 
attend your first physiotherapy appointment as usual. Your treatment 
will be unaffected. Thank you for your time and interest in the study. 
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3. Have you had an operation on your shoulder in the 
last five years? 
Yes 
 
No  
4. Have you broken or fractured one of the bones in 
your shoulder in the last five years? 
Yes 
 
No  
5. Has your shoulder “popped out of joint” or 
dislocated in the last five years?  
Yes 
 
No  
6. Is stiffness in your shoulder much more of a 
problem for you than pain in your shoulder? 
Yes 
 
No  
7. Did your shoulder pain come on suddenly following 
an accident that happened in the last 4 weeks? 
Yes 
 
No  
8. Do your shoulder symptoms get worse when you 
move your neck rather than your shoulder in a 
particular position? 
Yes 
 
No  
 
I answered “No” to questions 3 to 8. What do I do now?  
You have the type of shoulder symptoms we are investigating in 
our study.  
Please open the envelope and read the information sheets. Please 
wait until close to the date of your first appointment before filling in the 
questionnaire booklet.  
Please bring the completed questionnaire booklet to your first 
appointment 
I answered “Yes” to one or more questions from 3 to 8. What do I 
do now? 
You do not have the type of shoulder problem that we are investigating 
in our study. Please do not answer any further questions. Please 
attend your first physiotherapy appointment as usual. Your treatment 
will be unaffected. Thank you for your time and interest in the study. 
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12.1.4 Patient information sheet 1 
 
PATIENT INFORMATION SHEET 
 
Assessment of joint function in patients with joint problems using three dimensional motion 
analysis techniques 
Version 7 21/02/2013 
 
Part one 
 
You are being invited to take part in a research study with Cardiff University’s Arthritis Research UK 
Biomechanics and Bioengineering Centre.  Before you decide, it is important for you to understand 
why the research is being done and what it will involve.  Please take time to read the following 
information carefully and discuss it with others if you wish.  One of our team will go through the 
information sheet with you.  Ask us if there is anything that is not clear or if you would like more 
information.  Take time to decide whether or not you wish to participate.  Part 1 tells you about the 
purpose of this study and what will happen to you if you take part.  Part 2 gives you more detailed 
information about the conduct of the study. 
 
What is the purpose of this trial? 
The aim of the trial is to investigate the function of joints for people with joint problems and people 
with healthy joints. The data can be used to develop new treatments, improve the design of joint 
replacements, improve rehabilitation and improve the way that motion is analysed clinically. 
The study is designed to examine the effects of joint problems and any subsequent operation or 
other treatment (where appropriate), on the joints ability to perform daily tasks (such as walking, 
lifting a cup etc).  
 
Do I have to take part? 
It is up to you to whether or not to take part.  If you do decide to take part you will be given this 
information sheet to keep and after you have had enough time to read through it, be asked to sign a 
consent form.  If you decide to take part, you are still free to withdraw at any time or without giving 
a reason.  A decision not to take part or to withdraw at any time will not affect the standard of care 
you receive.  Should you decide not to take part, you do not have to provide a reason for this 
decision. 
 
What will happen to me if I take part? 
You have been asked to take part in this as you have a problem with your joint that we are 
interested in looking at with this technique.  It will allow us further insight into the nature of joint 
function and pain that people with your joint problem encounter. You may also been asked to take 
part so we can examine a non affected joint so we can compare it to the joint problem. 
 
If you wish to take part you will assessed either in the Cardiff University School of Engineering, 
Human Motion Analysis Laboratory or in the Cardiff University School of Healthcare studies (SOHCS) 
Research Centre for Clinical Kinaesiology (RCCK) or in the relevant clinical settings. The number of 
times we would ask you to attend would depend on the joint problem; we will discuss this with you 
when going through this information sheet.   
 
Data will be kept securely for a minimum of 15 years in accordance with good research practice and 
data protection regulations imposed by Cardiff University in accordance with the Data Protection Act 
1998.  All data obtained during the study will remain confidential.  Access to data will only be 
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available to the investigators attached to the Arthritis Research UK Biomechanics and Bioengineering 
Centre at Cardiff University. 
 
If new information becomes available, we may invite you to take part in a follow-up study in the 
future, please indicate on the consent sheet if you do not mind us contacting you.   
 
What will I have to do? 
Before your first assessment you will be asked to sign a patient consent form which includes the 
following clause: I understand that I may withdraw from the study at any time without it affecting 
my ongoing treatment in any way.   
 
At the beginning of your visit, we will explain the study in full and ask for your consent, bearing in 
mind that you are free to withdraw at any time.  
 
We will ask you to complete questionnaires that will ask you questions about how the problem 
affects your activities of daily living. 
 
Prior to the start of the assessment, you may be asked to change into appropriate clothing 
depending on the joint we want to examine (for example shorts for knee, well fitting vest, sports 
bra, swimming costume, vest or special apron that leave your chest covered and back bare for 
shoulder and spine, etc).  This process will be conducted with the upmost professionalism and a 
screened off area is provided for changing. During laboratory sessions, access to the laboratory is 
limited and a sign is placed on the door advising other staff not to enter whilst the trial is in progress.   
 
You will have a number of very light polystyrene or cork round markers attached to the skin and the 
locations of the markers will be dependent on the joint type under examination. 
 
You will be asked to perform a range of activities of daily living as appropriate (such as walking, 
standing, climbing stairs, combing hair, taking hand to mouth).  You will be free to stop for a break at 
any time. The position of the markers on the skin will provide a series of recordings by using cameras 
that record the position of the markers. 
 
You may be asked to perform some of these tasks in a virtual reality environment on a special 
treadmill.  The treadmill is set at floor level and can rotate in an upward/downward direction, move 
sideways or judder. These movements are controlled and you will be informed if the treadmill will 
move or rotate. There will be a screen in front of you that can display a variety of images to give the 
impression of walking on a forest path or kicking a ball, for example. You will be asked to wear a 
special harness whilst on the treadmill to prevent you from falling in case you stumble. 
 
When appropriate to the joint under study, muscle activity, muscle function and joint strength may 
also be determined during these sessions. This will involve placement of electromyography (EMG) 
electrodes onto the surface of the skin to record muscle activity during joint movement. The 
locations of the electrodes will be dependent on the muscle groups under examination. Particularly 
hairy skin may sometimes need a small patch shaving for the sensors to attach (approximately 
2x2cm).  In order to determine muscle function electrical muscle stimulation will be used. This 
involves placing similar electrodes to the EMG on your skin. During certain movements a small 
stimulus will be applied via the electrode on your skin, this will make your muscle contract more and 
change your movement slightly. This may cause a strange sensation but will not cause any pain. 
 
Throughout the sessions your joint movement will be recorded using standard audiovisual 
equipment.  We may ask if we can cover any identifying tattoos or birthmarks with a bandage.  Your 
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face and any identifying tattoos or birthmarks not covered will be digitally masked from these files 
so that nobody can identify you from the videos. All data files, including audiovisual files will be 
stored in encrypted folders on Cardiff University password protected computers. Cardiff University 
and NHS members of staff who are directly involved with the study will have access to the files.  
 
For studies investigating back pain we will ask you to perform a selection of tasks consisting of 
everyday functional tasks such as bending, stretching, lifting a cup from a table and finding the best 
position to sit and stand in. Spinal movements and how muscles work when walking may also be 
assessed whilst you are walking on a treadmill at different speeds and different inclinations.  
 
We will be looking at which targeted exercise treatments using different instructions are the most 
beneficial for patients with back pain.  These will be compared to treatments currently being used 
such as general advice and general group exercises.   
 
For studies investigating patient with joint osteoarthritis we will determine the best  muscle 
strengthening programmes including how often and how much exercise a patient needs to get an 
improvement in their joint  pain.  
 
For studies investigating wrist osteoarthritis, we will ask you to have a series of measurements and 
clinical tests performed on both of your wrists, these will include assessing your grip, range of 
motion and muscle strength.   
 
For studies investigating shoulder pain, we will ask you to perform a series of actions to measure 
the movement of your shoulder.   
 
Regular rest and toilet breaks will be provided as often as you need them to assure maximum 
comfort. 
 
Are there any risks in participating in this trial? 
The measurements taken during the trial involve the placement of very light polystyrene or cork 
round markers onto the skin or EMG electrodes in various places of the body depending on what 
joint we will be examining.  The markers/electrodes are placed with sticky tape which may cause 
some mild discomfort when it is being removed, similar to removing a small sticking plaster.  
 
Are there any benefits in participating in this trial? 
We hope to be able to better understand how joint problems affect the motion of the joint. There is 
no intended clinical benefit to the participant from taking part in the study.  The information we get 
from this study may help us to provide future patients who have joint disease or injury with 
improved treatment options. 
 
 
If the information in Part 1 has interested you and you are considering participation, please read 
the additional information in Part 2 before making a decision. 
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Part Two 
 
What if new information becomes available? 
Sometimes during the course of a research project, new information becomes available about the 
investigation.  If you decide to withdraw, it will not affect your any care in the NHS.  If you decide to 
continue, you will be asked to sign an updated consent form. 
 
What will happen if I do not want to carry on with the study? 
If you withdraw from the study, we will erase all identifiable material, but we will need to use the 
data collected up to your withdrawal. 
 
What if something goes wrong? 
If you are harmed by taking part in this research project, there are no special compensation 
arrangements.  If you are harmed due to someone’s negligence, then you may have grounds for a 
legal action but you may have to pay for it.  Regardless of this, if you wish to complain, or have any 
concerns about any aspect of the way you have been approached or treated during the course of 
this study, the normal National Health Service complaints mechanisms should be available to you. 
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept strictly 
confidential.  Any information about you which leaves the Cardiff University or the University 
Hospital of Wales will have your name and address removed so that you cannot be recognised from 
it. We may share information (including related medical findings such as radiological images) with 
external collaborators but all this information will contain no identifiable information about you. 
 
Will my GP be informed of my involvement in the study? 
With your permission, we will send a letter to your General Practitioner informing him or her of your 
involvement in the study. 
 
What will happen to the results of the research study? 
The measurements taken will provide information about the movement of your joint.  The results of 
the study will be presented at meetings of orthopaedic surgeons, clinical scientists, physiotherapists 
and engineers, and if accepted, published in medical and engineering journals. If interested, a copy 
of the published article can be made available to you.  You will not be identified in any 
report/publication. 
 
 
Who is organising and funding the research? 
Research staff at the Arthritis Research UK Biomechanics and Bioengineering Centre at Cardiff 
University and Consultant Orthopaedic Surgeons at the University Hospital of Wales are carrying out 
the study.  The study is part of the Arthritis Research UK Biomechanics and Bioengineering Centre at 
Cardiff University; it is not funded by commercial sources and runs alongside research in the Cardiff 
Gait and Motion Analysis Laboratory at Cardiff University School of Engineering and Research Centre 
for Clinical Kinaesiology at Cardiff University School of Healthcare Studies.   
 
Who has reviewed the study? 
This study has been reviewed by the Research Ethics Committee (REC) for Wales. 
 
What if I wish to lodge a complaint? 
If you wish to make a minor complaint regarding the way you were approached or treated during 
the trial, please contact the Arthritis Research UK Biomechanics and Bioengineering Centre Research 
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Coordinator at the contact details below or you can contact the Cardiff University Research 
Governance Team on 029 208 79277. 
 
Contact for further information 
Research Coordinator 
Arthritis Research UK Biomechanics and Bioengineering Centre  
Cardiff School of Biosciences 
Cardiff University 
Cardiff  
CF10 3AX 
Tel: 029 2087 5419 
Email: Robertshc@cf.ac.uk or Longmanaj@cf.ac.uk 
 
This completes Part 2. Thank you for reading this information sheet. 
 
If you agree to take part in this study then you will be given a copy of the information sheet and a 
signed consent form to keep.   
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12.1.5 Patient information sheet 2 
 
See appendix 4 (Pre methods) “Shoulder ultrasound reproducibility study patient information sheet” 
 
12.1.6 Patient consent form 1  
 
PATIENT CONSENT FORM 
 
Assessment of joint function in patients with joint problems using three 
dimensional motion analysis techniques 
 
Study Number 
Patient Identification Number for this trial: 
 
You DO NOT have to sign this document. Please DO NOT sign this document unless you fully 
understand it. If there is ANYTHING which you do not understand please do not hesitate to ask for a 
full explanation. 
 
To confirm agreement with each of the statements below, please initial each box and amend as 
applicable: 
 
1. I confirm that I have read and understand the information sheet dated 21/02/2013 (Version 7) for 
the above study and have had the opportunity to ask questions.  
 
 
2. I understand that my participation in the study is voluntary and that I am free to withdraw at any 
time, without giving any reason, and without my medical care or legal rights being affected.   
 
 
3. You may/may not contact me in the future to take part in other research projects or surveys. 
 
 
4. I do/do not agree to you accessing appropriate related medical information (such as radiological 
images) for the purposes of this study. 
 
 
5. I do/do not agree for you to share my anonymised information  
with external collaborators. 
 
 
6. I do/do not agree to my hospital number being used to track my data on your secure system. 
 
 
7. I do/do not agree to my GP being informed of my participation in the study. 
 
 
8. I agree to take part in the above study. 
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Name of Patient: ______________________________________________________ 
(Please print) 
 
Signature: ___________________________   Date: ___________________________ 
I confirm that I have fully explained the experimental protocol and purpose of the study 
 
Name of Researcher: __________________________________________________ 
 
Signature: ___________________________   Date: ___________________________ 
 
 
Name of person taking consent: _________________________________________ 
(If different from researcher) 
 
Signature: ___________________________   Date: ___________________________ 
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12.1.7 Patient consent form 2 
 
See appendix 4 (Pre methods) “Shoulder ultrasound reproducibility study patient consent form” 
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12.2 Patient data collection form 
 
Section 1:  
 
Patient code  
 
 
Date of 1st appointment 
 
 
Treating clinician name 
 
 
Site:                      UHW = 1                                              W’church = 2 
Gender 1 = Male                           2 = Female 
Age 
 
 
 
Referral source 
 
GP=1            Rheum=2             Ortho=3                Other = 4 
If referral source is “Other”, then 
who? 
 
 
Section 2:  
Demographics 
 
Currently working? 
Circle all that apply 
            1 = full time work                2 = part time work,               3 = retired 
     4 = full time carer           5 = part time carer      6 = student or unemployed 
What is their paid job name  
 
 
 
Occupational factors: 
How often carry 10 kilos at work? 
             1 = seldom/never                 2 = sometimes        3 = extremely/often  
888=Not applicable (as not working) 
Occupational factors: 
How often work above shoulder level? 
 
      1 = seldom/never                 2 = sometimes        3 = extremely/often 
888=Not applicable (as not working) 
Education           
    1 = College/University,                   2 = ≤ 12 years in school 
Sports – overhead? (e.g. tennis, 
swimming, basketball, etc) 
                            1=Yes                      2=No 
Type of overhead Sport?  
Level of overhead Sport?         1 = doesn’t play         2 = recreational          3 = club         4 = elite         
Additional recreational activity that 
involves overhead activity? 
                           
                                1=Yes                      2=No 
If so, what? 
Free hand description 
 
 
 
 Arm side 
 
Handed                1=L                      2=R                  3=Ambidextrous 
Side of symptoms(Sx)                              1=L                      2=R            3=Bilateral 
If bilateral, which is the side they have been referred for / 
worst side? 
1=L       2=R            3= L&R equally      888=not applicable 
Involvement of the dominant side?  
 
  
                            1=Yes                      2=No 
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Presenting Condition 
Duration of current episode at 
presentation to Physiotherapy 
 
         1 = 0-3 months       2 = 3-6 months         3 = 6-12 months         
                4 = 12-24 months                    5 = >24 months 
Previous shoulder pain (prior to this 
episode?)   
                                                1=Yes                 2=No 
Precipitating cause 
 
 
1 = Unknown / insidious / gradual onset                           2 = Injury / trauma 
3 = Strain, overuse: unusual activities          4 = Strain, overuse: usual activities 
Precipitating cause 
Free hand description 
 
Course: Is it getting……..                        1= Worse               2= Same                  3= Better 
 
Associated neck pain?                             1=Yes                      2=No 
Neurological symptoms? 1=None          2 = Pins and needles / Tingling                   3 = Distal symptoms 
 
 
Investigations (previous or booked): 
 
Type 1=None,       2 = Ultrasound,        3 = MRI,       4= X-ray,       5= Other (if so what?) 
 
Details / findings  
 
 
 
Previous treatment: 
 
Treatment via GP                          1 = no contact                            2 = advice only,            
3 = oral medication and/or topical medication (Analg / NSAIDs) (+/- advice)                                                                                                    
  4 = oral medication + injection               5 = injection only         6=referral only 
Number of injections via GP 
 
 
Injection by non-GP                             1=Yes                      2=No 
 
Previous rehab (specifically for the 
shoulder)? 
 0=None,     1=Physio,           2 = Chiro,            3 = Osteo,            4 = Combination 
What type / frequency of rehab and 
how successful? 
 
 
 
Previous Medical History 
 
Diabetes mellitus                                                 1=Yes                 2=No 
 
Other medical condition? 
(e.g. Cancer, heart disease, 
Osteoarthritis, Rheumatoid arthritis, 
etc) 
If so, what? 
                                               
                                               1=Yes                 2=No 
Smoker?                      
            1=Current                   2=Previous                       3=Never 
 
DH: 
 
Currently taking pain killers / NSAIDs on 
“regular” basis (specifically for the 
shoulder pain they have been referred to 
Physiotherapy for)? 
                                               1=Yes                 2=No 
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Section 3 
Anthropometrics 
Height (m):  
 
Weight: BMI (kg/m2): 
 
Circle painful side  
ROM 
 Left Right 
End of 
range (EoR) 
  
Onset of Sx: 
 
  
Painful during movement: 
 
 
Scapular videoing  
Weighted performed?            1=Yes            2=No 
Weight =  
(Anything of note……) 
 
 
Strength (Anything of note) 
Distance elbow to 
 radial styloid (m): 
Distance GHJ to  
radial styloid (m): 
 
Circle painful side  
 
                Left                                 Mean                       Right                          Mean 
IR  
 
   
ER  
 
   
Scaption  
 
   
 
Ortho 
Hawkins-Kennedy   Neer  
 
                        1= +ve                   2= -ve                         1= +ve                   2= -ve 
 
Empty can / resisted isometric 
abduction/scaption 
Painful arc 
 
Pain with active sh elevation 
 
        1= +ve                   2= -ve         1= +ve                   2= -ve         1= +ve                   2= -ve 
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Shoulder diagnostic ultrasound scan patient findings 
Side: L R   
   
Biceps Tendon (Steps 1,2,3): 
 
1=Normal  2=Tendinosis  3=Tenosynovitis  4=Tear  5=Displaced / dislocating 
 
Subscapularis (Steps 4,5): 
 
1=Normal  2=Tendinosis   3= Partial tear  4 = Complete tear 
 
 
ACJ (Step 6): 
 
1=Normal  Osteophytic  2=mild   /   3=mod   /   4=severe         5=Tenosynovitis / Inflammation 
 
Supraspinatus (Steps 7,8): 
 
1=Normal  2=Tendinosis   3= Partial tear  4 = Complete tear 
 
Bursal thickening / increased fluid =  yes no 
 
 
Infraspinatus (Steps 9,10): 
 
1=Normal  2=Tendinosis   3= Partial tear  4 = Complete tear 
 
 
Overall: Tear presence / type 
 
Rotator cuff tear present:  1=Yes   2=No 
 
If present:   1=Partial thickness tear (PTT)  2=Full thickness tear (FTT)  
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12.3 Order of testing 
 
The series of questionnaires which were posted to patients at the same time as the invitation to be 
involved with the study are listed below.  
 
 C2. Patient reported measures: Psychological symptoms (4DSQ) 
 C3. Patient reported measures: Function / Disability (SPADI) 
 Outcome measure (OSS) 
 
Those patients who decided to participate in the study were instructed only to complete the 
questionnaires in the pack immediately prior to their first appointment. 
 
On day of data collection: 
 
1. Meet and greet patient; answer any questions regarding ethics and consent 
2. Complete ethics form 1 and form 2 
3. Check questionnaire pack: answer any questions, assist patient in completing any missing sections  
Where elevated 4DSQ scores recommend that patient makes follow up contact with their GP  
4. Complete VAS 
 
Physical measures: 
5. ROM 
6. Scapular dyskinesis +/- weighted 
7. Strength 
8. Orthopaedics tests 
9. Ultrasound scan 
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12.4 Visual Analogue Scale 
 
Pain is a complex aspect of human life, and measuring it is challenging. One way for us to quantify 
your pain is for you to represent your pain on the diagram below.  
 
The horizontal line is used as a sliding scale of your pain. The left hand side of the scale represents 
no pain and the right hand side represents the worst pain imaginable.  
 
We would like you to consider your pain and place a single mark along the scale at a point you feel 
represents your pain: 
 
On activity: 
(for example your painful movement) 
 
 
 
 
At rest: 
(for example when you are just resting with your arm by your side) 
 
 
 
 
At night over the last week: 
 
 
 
 
  
No 
Pain 
Worst 
Pain 
imaginable 
No 
Pain 
Worst 
Pain 
imaginable 
No 
Pain 
Worst 
Pain 
imaginable 
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12.5 4DSQ: Patient to complete 
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12.6 4DSQ: Scoring and interpretation 
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12.7 SPADI 
 
 
413 
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12.8 Strength testing 
Figure 12-1 IR testing position 
 
 
Figure 12-2 Scaption testing position 
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12.9 ROM testing 
 
Figure 12-3 ROM testing position 
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Figure 12-4 ROM testing 
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12.10 Scapular Dyskinesis test assessment criteria  
 
Operational definitions 
Normal scapulohumeral rhythm: The scapula is stable with minimal motion during the initial 30° to 
60° of humerothoracic elevation, then smoothly and continuously rotates upward during elevation 
and smoothly and continuously rotates downward during humeral lowering. No evidence of winging 
is present. 
Scapular dyskinesis: Either or both of the following motion abnormalities may be present. 
 Dysrhythmia: The scapula demonstrates premature or excessive elevation or protraction, 
nonsmooth or stuttering motion during arm elevation or lowering, or rapid downward 
rotation during arm lowering. 
 Winging: The medial border and/or inferior angle of the scapula are posteriorly displaced 
away from the posterior thorax. 
 
Rating Scale 
Each test movement (flexion and abduction) rated as 
a) Normal motion: no evidence of abnormality 
b) Subtle abnormality: mild or questionable evidence of abnormality, not consistently present 
c) Obvious abnormality: striking, clearly apparent abnormality, evident on at least 3/5 trials 
(dysrhythmias or winging of 1 in [2.54 cm] or greater displacement of scapula from thorax) 
 
Final rating  
This is based on combined flexion and abduction test movements: 
Normal: Both test motions are rated as normal or 1 motion is rated as normal and the other as 
having subtle abnormality. 
Subtle abnormality: Both flexion and abduction are rated as having subtle abnormalities. 
Obvious abnormality: Either flexion or abduction is rated as having obvious abnormality. 
 
McClure et al. (2009)  
  
418 
 
12.11 Specific criteria relating to the sonographic appearance of cuff tendinopathy 
and bursitis. 
 
Components of tendinopathy and their grading 
 
Normal tendon  Tendinosed tendon 
“Normal” thickness  
 Caveat = relative to the size of the 
patient / the activity levels of their 
shoulder / their uninvolved shoulder 
 “Abnormal” thickness = grossly thickened 
/ thinned 
 Caveat = relative to the size of the patient 
/ the activity levels of their shoulder / 
their uninvolved shoulder 
“Normal” echogenicity =  hyperechoic 
(bright)  
 Caveat = acknowledging how easily 
the patient’s tissues do or don’t 
image; also when accommodating 
anisotropy 
 “Abnormal” echogenicity =  grossly 
hypoechoic (dark) 
 Caveat = acknowledging how easily the 
patient’s tissues do or don’t image; also 
when accommodating anisotropy 
“Normal” echotexture =  
homogenous with an ordered fibre 
orientation  
 Caveat = acknowledging how easily 
the patient’s tissues do or don’t 
image; also when accommodating 
anisotropy 
 “Abnormal” echotexture =  grossly 
heterogenous; calcific deposits  
 Caveat = acknowledging how easily the 
patient’s tissues do or don’t image; also 
when accommodating anisotropy 
 
 
Components of bursal involvement and their grading 
 
Normal bursa  Abnormal bursa 
“Normal” thickness  
 Less than 2mm thick 
 “Abnormal” thickness = grossly thickened  
“Normal” fluid  
 Less than 2mm of hypoechoic fluid in 
the bursa 
 “Abnormal” fluid =  grossly increased 
“bursal effusion” 
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12.12 Orthopaedic tests 
 
Figure 12-5 Neer's sign 
 
 
Figure 12-6 Empty can test 
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Figure 12-7 Hawkins-Kennedy test 
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12.13 Philips CX-50 
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12.14 OSS: Questionnaire 
Please tick one box for every question. 
 
1. During the past 4 weeks… 
How would you describe the worst pain you had from your shoulder? 
None Mild Moderate Severe Unbearable 
     
 
2. During the past 4 weeks… 
Have you had any trouble dressing yourself because of your shoulder? 
No trouble 
at all 
A little bit of 
trouble 
Moderate 
trouble 
Extreme 
difficulty 
Impossible 
to do 
     
 
3. During the past 4 weeks… 
Have you had any trouble getting in and out of a car or using public transport because of 
your shoulder? 
No trouble 
at all 
A little bit of 
trouble 
Moderate 
trouble 
Extreme 
difficulty 
Impossible 
to do 
     
 
4. During the past 4 weeks… 
Have you been able to use a knife and fork - at the same time? 
Yes, 
easily 
With little 
difficulty 
With moderate 
difficulty 
With extreme 
difficulty 
No, 
impossible 
     
 
5. During the past 4 weeks… 
Could you do the household shopping on your own? 
Yes, 
easily 
With little 
difficulty 
With moderate 
difficulty 
With extreme 
difficulty 
No, 
impossible 
     
 
6. During the past 4 weeks… 
Could you carry a tray containing a plate of food across a room? 
Yes, 
easily 
With little 
difficulty 
With moderate 
difficulty 
With extreme 
difficulty 
No, 
impossible 
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7. During the past 4 weeks… 
Could you brush/comb your hair with the affected arm? 
Yes, 
easily 
With little 
difficulty 
With moderate 
difficulty 
With extreme 
difficulty 
No, 
impossible 
     
 
8. During the past 4 weeks… 
How would you describe the pain you usually had from your shoulder? 
None Very mild Mild Moderate Severe 
     
 
9. During the past 4 weeks… 
Could you hang your clothes up in a wardrobe, using the affected arm? 
Yes, 
easily 
With little 
difficulty 
With moderate 
difficulty 
With great 
difficulty 
No, 
impossible 
     
 
10. During the past 4 weeks… 
Have you been able to wash and dry yourself under both arms? 
Yes, 
easily 
With little 
difficulty 
With moderate 
difficulty 
With extreme 
difficulty 
No, 
impossible 
     
 
11. During the past 4 weeks… 
How much has pain from your shoulder interfered with your usual work (including 
housework)? 
Not at all A little bit Moderately Greatly Totally 
     
 
12. During the past 4 weeks… 
Have you been troubled by pain from your shoulder in bed at night? 
No nights 
Only 1 or 2 
nights 
Some nights Most nights Every night 
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12.15 OSS: Scoring 
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13 Appendix VI: Results chapter 
 
Prognostic cohort study subjects: 
 A. Demographics (raw data) 
 B. Clinical history (raw data)  
 
C1. Patient reported measures: Pain 
 
C2. Patient reported measures: 4DSQ 
 
C3. Patient reported measures: Function / disability 
 
D1. Clinical measures: Strength 
 
D2. Clinical measures: ROM 
 
D3. Clinical measures: Scapular movement and control 
 
E1. Structural pathology via imaging 
 
E2. Structural pathology via orthopaedic tests 
 Orthopaedic tests: 3 or more +ve tests 
 
Outcome 
 
Treatment 
 Raw treatment data  
 Number of weeks under treatment and discharge situation 
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13.1 A. Demographics (raw data) 
 
Table 13-1: Generic demographic variables (n = 76 at baseline) 
Subject code Age (years) BMI (kgm-2) Gender 
Education 
level 
Smoking 
history 
F6847h 51 35.4 2 2 3 
F7047h 47 26.3 2 1 3 
M2146h 54 37.3 1 2 n/r 
F5446h 48 18.2 2 1 n/r 
F4417h 50 50.5 2 1 3 
M0379h 62 26.4 1 2 2 
F4583h 63 26.5 2 1 3 
F7849h 50 23.8 2 1 3 
M0825h 57 29.5 1 1 3 
M0061h 62 31.2 1 1 3 
F2520h 47 40.3 2 1 3 
F8486h 50 32.2 2 1 3 
F1005w 45 35.1 2 1 1 
F6416h 68 27.4 2 1 3 
F4764h 52 22.1 2 1 3 
M4542h 49 29.4 1 1 2 
M8878h 57 23.0 1 2 2 
F0165h 66 25.6 2 1 2 
F5367w 64 35.5 2 1 3 
F7405h 38 20.5 2 1 2 
M2747w 50 27.7 1 1 3 
F1634w 30 42.2 2 1 3 
F0738w 47 33.0 2 1 3 
M0035w 44 25.5 1 1 3 
F5503w 38 40.2 2 1 2 
M9819h 29 23.0 1 2 3 
M7535w 25 21.4 1 2 1 
F0809h 48 32.0 2 2 3 
F4113w 35 28.8 2 1 3 
F9939h 50 24.3 2 2 1 
M5703h 49 30.5 1 1 3 
M1518h 64 31.0 1 1 3 
F8774w 65 25.9 2 1 2 
M8695h 37 27.1 1 1 2 
F7304h 50 30.7 2 1 3 
F2387h 66 31.7 2 2 2 
F8396w 52 25.7 2 1 3 
F4674w 63 23.1 2 1 3 
M1243h 62 31.3 1 1 3 
M2593w 44 30.3 1 1 2 
M3288h 63 31.3 1 1 3 
M0519h 31 26.7 1 1 3 
M2608w 26 26.8 1 1 3 
F8966w 64 28.3 2 1 3 
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F4943h 56 24.1 2 1 3 
F5204w 48 29.6 2 1 3 
M1662h 55 38.8 1 2 2 
M5465w 65 27.4 1 1 2 
M8305w 59 29.0 1 1 3 
F0732w 49 27.3 2 1 2 
F2122w 19 17.3 2 1 3 
M2028W 58 25.0 1 1 1 
F4142w 64 26.7 2 1 2 
F9240h 63 41.6 2 1 3 
F2573h 67 37.8 2 1 3 
F4735h 23 17.3 2 1 1 
F1965w 29 39.9 2 2 3 
M6858w 34 33.3 1 1 3 
F9830h 52 35.8 2 1 1 
M2279h 71 27.3 1 1 2 
M1543h 62 26.0 1 1 3 
F1188h 38 32.3 2 1 2 
M4091h 28 20.2 1 2 3 
F5706h 56 22.9 2 1 3 
F1669h 18 30.0 2 2 3 
F9261h 53 25.6 2 1 2 
M7524w 61 31.8 1 2 3 
F3795w 51 22.2 2 1 3 
M9231w 53 30.3 1 1 2 
F5690h 19 24.4 2 1 1 
M3609h 40 21.5 1 1 3 
F8809w 48 22.6 2 1 3 
F6914w 65 31.8 2 1 3 
M3960h 61 27.5 1 1 3 
M9287h 42 33.1 1 1 3 
F2197w 27 26.8 2 1 2 
Key: kgm-2 = mass in kilogrammes divided by height in meters squared, Gender: 1 = male; 2 = female, 
Education level: 1 = educated to college or university level; 2 = Less than 12 years in education, Smoking 
history: 1 = Current; 2 = Previous; 3 = Never, n/r = not recorded  
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Table 13-2: Work, recreational or functional task related demographic variables (n = 76 at 
baseline) 
Subject code 
Currently 
working 
Paid work 
type 
Carry 10Kg at 
work? 
Work above 
shoulder 
height? 
Play overhead 
sports? 
F6847h n/r 3 1 1 2 
F7047h 2 2 1 1 2 
M2146h 6 3 3 3 2 
F5446h 2 2 2 3 2 
F4417h 1 2 3 3 1 
M0379h 2 3 2 2 1 
F4583h 3 1 4 4 2 
F7849h 3 1 4 4 1 
M0825h 1 2 1 1 1 
M0061h 3 1 4 4 1 
F2520h 1 2 1 1 2 
F8486h 1 2 2 2 2 
F1005w 1 2 2 2 2 
F6416h 3 1 4 4 1 
F4764h 2 2 1 1 1 
M4542h 1 2 1 1 1 
M8878h 1 3 2 3 2 
F0165h 3 1 4 4 2 
F5367w 2 2 3 3 1 
F7405h 1 2 2 1 2 
M2747w 1 2 1 1 1 
F1634w 2 and 6 1 and 2 1 2 1 
F0738w 2 and 6 1 and 2 1 1 1 
M0035w 2 2 1 1 1 
F5503w 1 2 1 1 2 
M9819h 1 3 3 3 1 
M7535w 1 3 3 3 2 
F0809h 6 n/r 4 4 2 
F4113w 1 2 1 1 1 
F9939h 1 2 1 2 2 
M5703h 1 2 2 2 1 
M1518h 1 2 1 1 1 
F8774w 6 1 4 4 1 
M8695h 1 3 3 3 1 
F7304h 2 2 2 2 2 
F2387h 3 1 4 4 2 
F8396w 1 2 1 1 1 
F4674w 2 1 1 2 2 
M1243h 3 1 4 4 1 
M2593w 1 2 1 1 1 
M3288h 1 2 1 1 1 
M0519h 6 1 4 4 1 
M2608w 1 2 1 2 1 
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F8966w 3 1 4 4 1 
F4943h 2 2 2 1 1 
F5204w 1 2 1 1 1 
M1662h 6 1 4 4 2 
M5465w 1 2 1 1 2 
M8305w 1 2 1 1 2 
F0732w 1 2 1 1 1 
F2122w 6 1 1 1 2 
M2028W 6 1 4 4 2 
F4142w 3 1 4 4 2 
F9240h 4 2 1 1 2 
F2573h 3 1 4 4 2 
F4735h 1 2 3 3 1 
F1965w 6 1 4 4 1 
M6858w 1 2 1 1 1 
F9830h 1 2 1 1 1 
M2279h 3 1 4 4 2 
M1543h 2 1 1 1 1 
F1188h 1 2 1 1 1 
M4091h 1 3 3 1 1 
F5706h 2 2 1 1 1 
F1669h 4 1 2 1 2 
F9261h 1 2 2 2 1 
M7524w 2 2 1 1 1 
F3795w 1 2 2 2 1 
M9231w 1 2 1 1 1 
F5690h 6 1 1 2 1 
M3609h 1 2 1 1 1 
F8809w 2 2 1 1 1 
F6914w 3 1 4 4 1 
M3960h 3 1 4 4 2 
M9287h 1 2 1 1 1 
F2197w 1 2 2 2 1 
Key: Currently working: Full time = 1; Part time = 2; Retired = 3; Full time carer = 4; Part time carer = 5; Student 
or unemployed = 6, Paid work type: 1 = Not paid working; 2 = Professional / managerial / office; 3 = Manual / 
semi-manual / unskilled, How often carry 10Kg at work?: 1 = Seldom / never; 2 = Sometimes; 3 = Extremely / 
often; 4 = Not applicable, How often work above shoulder height?: 1 = Seldom / never; 2 = Sometimes; 3 = 
Extremely / often; 4 = Not applicable, Play overhead sports?: 1 = Yes, 2 = No, n/r = not recorded 
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13.2 B. Clinical history (raw data) 
 
Table 13-3: Current condition related variables (n = 76 at baseline) 
Subject 
code 
Duration 
current 
episode 
Involvement 
of dominant 
side 
Precipitating 
cause 
Previous 
shoulder 
pain 
Associated 
neck pain 
Neurological 
symptoms 
Course 
of 
condition 
F6847h 1 2 1 2 2 1 2 
F7047h 4 1 2 2 2 1 2 
M2146h 5 1 1 1 2 1 2 
F5446h 2 1 2 1 2 2 1 
F4417h 2 2 2 2 2 1 1 
M0379h 2 2 1 2 n/r n/r 1 
F4583h 3 1 n/r 1 1 2 3 
F7849h 2 1 2 2 2 1 3 
M0825h 2 2 1 2 2 1 3 
M0061h 2 1 1 2 1 n/r 1 
F2520h 2 2 1 2 1 1 2 
F8486h 5 1 3 2 2 1 1 
F1005w 2 2 1 1 2 1 1 
F6416h 4 1 1 2 1 1 1 
F4764h 3 2 1 2 1 1 1 
M4542h 1 1 3 2 2 1 1 
M8878h 3 2 1 2 2 3 2 
F0165h 2 1 1 1 1 2 3 
F5367w 2 2 2 2 1 1 3 
F7405h 1 2 1 1 2 2 2 
M2747w 5 1 4 2 1 1 2 
F1634w 3 2 2 2 1 3 2 
F0738w 3 1 2 2 2 1 2 
M0035w 3 2 1 1 1 3 2 
F5503w 3 2 1 2 2 3 2 
M9819h 2 1 4 2 2 1 2 
M7535w 3 1 4 2 2 1 1 
F0809h 2 2 1 2 2 1 3 
F4113w 4 1 1 2 1 2 2 
F9939h 3 2 1 2 2 2 2 
M5703h 3 2 1 2 2 1 2 
M1518h 2 2 1 2 1 3 2 
F8774w 3 2 1 2 2 1 2 
M8695h 1 1 4 1 2 2 1 
F7304h 4 1 1 2 1 1 2 
F2387h 2 2 1 2 1 2 3 
F8396w 3 1 1 2 1 2 1 
F4674w 3 2 1 2 2 1 3 
M1243h 2 2 1 2 2 1 2 
M2593w 4 1 3 2 2 1 3 
M3288h 2 1 1 2 2 1 n/r 
M0519h 4 2 3 2 2 1 1 
M2608w 3 1 1 2 2 1 2 
F8966w 2 1 2 2 2 3 2 
F4943h 2 1 2 and 3 1 2 2 3 
F5204w 3 2 1 2 2 1 3 
M1662h 2 1 1 2 2 3 1 
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M5465w 2 2 1 1 2 1 1 
M8305w 3 2 1 2 1 1 2 
F0732w 3 2 1 2 2 1 2 
F2122w 5 2 1 2 2 1 2 
M2028W 1 2 1 2 2 4 2 
F4142w 5 2 1 2 2 n/r 2 
F9240h 3 2 1 2 2 3 1 
F2573h 5 1 1 2 2 1 2 
F4735h 2 2 1 2 2 3 3 
F1965w 5 1 2 2 1 2 2 
M6858w 4 2 4 2 2 1 2 
F9830h 3 2 3 2 2 1 2 
M2279h 1 2 1 1 2 1 2 
M1543h 3 2 3 2 2 1 2 
F1188h 3 2 1 2 2 1 2 
M4091h 5 Ambidextrous 2 2 2 1 2 
F5706h 5 2 4 2 2 2 2 
F1669h 5 1 2 2 2 1 2 
F9261h 2 2 1 2 2 1 1 
M7524w 5 1 4 2 2 1 2 
F3795w 3 1 1 1 2 1 2 
M9231w 3 1 1 1 1 1 1 
F5690h 3 1 1 2 1 2 3 
M3609h 5 1 4 2 2 1 2 
F8809w 3 1 1 2 2 1 1 
F6914w 2 1 1 1 1 1 1 
M3960h 2 2 1 2 2 1 2 
M9287h 3 1 4 2 1 2 3 
F2197w 4 2 1 1 2 2 1 
Key: Duration current episode?: 1 = 0-3 months; 2 = 3-6 months; 3 = 6-12 months; 4 = 12-24 months; 5 = More 
than 24 months, Involvement of dominant side?: 1 = Yes, 2 = No, Precipitating cause: 1 = Unknown / insidious / 
gradual onset; 2 = Injury / trauma; 3 = Strain / overuse: unusual activities; 4 = Strain / overuse: usual activities, 
Previous shoulder pain: 1 = Yes, 2 = No, Associated neck pain?: 1 = Yes, 2 = No, Neurological symptoms: 1 = 
None; 2 = Pins and needles / tingling; 3 = Distal symptoms; 4 = other, Course of condition: 1 = Worse; 2 = 
Same; 3 = Better, n/r = not recorded 
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Table 13-4: Treatment related variables (n = 76 at baseline) 
Subject 
code 
Previous 
rehabilitation 
This episode; 
currently taking 
analgesia/NSAIDS 
This 
episode; 
treatment 
via GP 
This 
episode; 
number 
of GP 
injections 
This 
episode; 
injection 
by non 
GP 
This episode; 
investigations 
F6847h 0 1 2 0 2 2 
F7047h 0 2 3 0 2 6 
M2146h 1 1 2 0 2 6 
F5446h 0 2 3 0 2 2 
F4417h 1 1 5 1 2 2 
M0379h 0 2 3 0 2 1 
F4583h 0 1 4 1 2 2 
F7849h 0 2 1 0 2 4 
M0825h 0 2 6 0 2 1 
M0061h 0 2 3 0 2 2 
F2520h 0 1 3 0 2 1 
F8486h 1 1 5 2 1 6 
F1005w 3 1 4 1 2 1 
F6416h 1 1 6 0 2 1 
F4764h 0 2 3 0 2 4 
M4542h 0 1 6 0 2 1 
M8878h 0 2 3 0 2 4 
F0165h 1 1 5 1 2 1 
F5367w 1 2 6 0 2 2 
F7405h 0 2 3 0 2 4 
M2747w 0 2 3 0 2 2 
F1634w 1 1 4 1 2 1 
F0738w 0 1 3 0 2 1 
M0035w 0 2 6 0 2 1 
F5503w 0 2 6 0 2 1 
M9819h 3 1 6 0 2 1 
M7535w 0 2 6 0 2 1 
F0809h 0 2 6 0 2 n/r 
F4113w 1 n/r 3 0 2 4 
F9939h 0 2 3 0 2 1 
M5703h 0 2 3 0 2 1 
M1518h 0 2 5 1 2 4 
F8774w 0 2 3 0 2 1 
M8695h 1 2 6 0 2 1 
F7304h 0 2 3 0 2 4 
F2387h 0 2 6 0 2 1 
F8396w 0 2 1 0 2 1 
F4674w 0 2 6 0 2 4 
M1243h 0 1 6 0 2 1 
M2593w 2 2 6 0 2 2 
M3288h 0 2 6 0 2 1 
M0519h 0 2 6 0 2 1 
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M2608w 0 2 6 0 2 1 
F8966w 0 1 6 0 2 4 
F4943h 2 2 6 0 2 4 
F5204w 0 2 3 0 2 1 
M1662h 0 1 4 2 2 4 
M5465w 0 2 6 0 2 4 
M8305w 0 2 6 0 2 1 
F0732w 0 1 4 2 2 6 
F2122w 0 2 6 0 2 1 
M2028W 1 2 3 0 2 1 
F4142w 0 2 3 0 2 1 
F9240h 1 1 5 1 2 2, 3 and 4 
F2573h 1 2 3 0 2 5 
F4735h 0 2 3 0 2 4 
F1965w 0 2 6 0 2 3 and 4 
M6858w 0 2 3 0 2 1 
F9830h 0 2 3 0 2 1 
M2279h 0 1 4 1 2 1 
M1543h 0 2 6 0 2 4 
F1188h 0 2 3 0 2 1 
M4091h 0 2 3 0 2 1 
F5706h 0 2 5 1 2 2 
F1669h 1 1 6 0 2 3 and 4 
F9261h 0 1 3 0 2 6 
M7524w 0 2 6 0 2 1 
F3795w 1 1 6 0 2 1 
M9231w 0 1 6 0 2 4 
F5690h 0 1 6 0 2 1 
M3609h 0 2 6 0 1 2 
F8809w 0 2 6 0 2 1 
F6914w 0 1 1 0 2 6 
M3960h 0 2 3 0 2 1 
M9287h 0 2 6 0 2 4 
F2197w 0 1 3 0 2 4 
Key: Previous rehabilitation: 0 = None; 1 = Physiotherapy; 2 = Chiropractic; 3 = Private massage, This episode; 
currently taking analgesia/NSAIDS?: 1 = Yes, 2 = No, This episode; treatment via GP: 1 = No contact; 2 = Advice 
only; 3 = oral or topical medication (Analg / NSAIDs) (+/- advice); 4 = oral medication + injection; 5 = injection 
only; 6 = referral only, This episode; number of GP injections, This episode; injection by non GP?: 1 = Yes, 2 = 
No, This episode; investigations: 1 = None; 2 = U/S; 3 = MRI; 4 = Xray; 5 = U/S and Xray, n/r = not recorded 
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13.3 C1. Patient reported measures: Pain 
 
Table 13-5: Visual Analogue Scale (cm) (n = 76 at baseline) 
Subject code 
“On activity” 
 
“At rest” 
 
” At night over 
the last week” 
Mean of 3 scores 
 
F6847h n/r n/r 7.8 n/a 
F7047h n/r n/r 8.1 n/a 
M2146h 5.1 0.0 0.0 1.7 
F5446h 2.5 0.0 4.4 2.3 
F4417h 8.0 1.0 5.7 4.9 
M0379h 4.9 2.5 1.2 2.9 
F4583h 7.9 3.0 9.4 6.8 
F7849h 1.1 1.1 2.6 1.6 
M0825h 4.3 2.2 0.9 2.5 
M0061h 8.2 6.6 8.0 7.6 
F2520h 7.1 4.6 5.3 5.7 
F8486h 2.4 1.5 1.6 1.8 
F1005w 7.6 0.7 6.8 5.0 
F6416h 7.4 5.1 5.9 6.1 
F4764h 6.5 0.1 3.2 3.3 
M4542h 8.4 2.4 8.4 6.4 
M8878h 6.5 0.1 4.5 3.7 
F0165h 6.6 4.7 7.3 6.2 
F5367w 5.2 3.4 1.8 3.5 
F7405h 1.7 1.0 0.2 1.0 
M2747w 8.3 0.0 0.0 2.8 
F1634w 6.5 4.9 5.4 5.6 
F0738w 6.4 0.2 1.7 2.8 
M0035w 6.7 2.3 3.5 4.2 
F5503w 1.3 0.2 0.4 0.6 
M9819h 7.0 0.0 0.8 2.6 
M7535w 9.1 2.6 7.0 6.2 
F0809h 6.3 4.1 5.3 5.2 
F4113w 6.1 3.2 2.3 3.9 
F9939h 7.7 1.1 8.1 5.6 
M5703h 5.9 0.0 1.5 2.5 
M1518h 7.4 2.8 7.4 5.9 
F8774w 7.7 0.2 1.3 3.1 
M8695h 0.2 1.2 0.1 0.5 
F7304h 5.3 1.5 1.9 2.9 
F2387h 3.1 0.8 0.8 1.6 
F8396w 3.8 0.7 5.7 3.4 
F4674w 7.2 0.7 3.7 3.9 
M1243h 5.8 0.4 6.4 4.2 
M2593w 2.8 0.3 4.4 2.5 
M3288h 8.1 0.4 7.0 5.2 
M0519h 6.6 1.3 7.4 5.1 
M2608w 7.4 1.2 0.7 3.1 
F8966w 7.9 5.8 8.2 7.3 
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F4943h 4.9 1.2 1.1 2.4 
F5204w 3.3 0.6 0.1 1.3 
M1662h 9.0 7.3 9.0 8.4 
M5465w 2.8 0.7 0.7 1.4 
M8305w 4.6 4.5 5.4 4.8 
F0732w 2.0 0.4 2.0 1.5 
F2122w 4.0 0.0 0.0 1.3 
M2028W 8.1 2.9 8.4 6.5 
F4142w 3.6 0.0 3.7 2.4 
F9240h 6.4 1.5 9.1 5.7 
F2573h 5.6 0.4 5.7 3.9 
F4735h 2.1 0.3 4.7 2.4 
F1965w 9.0 5.3 6.6 7.0 
M6858w 6.0 1.1 3.6 3.6 
F9830h 5.4 2.5 5.6 4.5 
M2279h 8.6 8.7 8.9 8.7 
M1543h 6.0 3.2 3.1 4.1 
F1188h 6.5 4.6 6.8 6.0 
M4091h 5.4 1.8 4.3 3.8 
F5706h 4.7 1.8 2.8 3.1 
F1669h 6.8 2.4 5.5 4.9 
F9261h 8.5 2.3 5.6 5.5 
M7524w 5.9 0.0 5.0 3.6 
F3795w 7.6 3.3 7.6 6.2 
M9231w 4.3 0.4 2.9 2.5 
F5690h 5.5 0.2 4.0 3.2 
M3609h 4.4 1.9 0.5 2.3 
F8809w 8.1 0.9 4.6 4.5 
F6914w 8.6 3.5 8.1 6.7 
M3960h 7.2 1.2 7.8 5.4 
M9287h 8.7 0.2 5.4 4.8 
F2197w 3.6 7.1 1.3 4.0 
Key: n/r = not recorded, n/a = not applicable 
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13.4 C2. Patient reported measures: Psychological symptoms 
 
 
Table 13-6: 4DSQ: absolute score (n = 76 at baseline) 
Subject 
code 
Distress 
/ absolute score 
Depression 
/ absolute score 
Anxiety 
/ absolute score 
Somatisation 
/ absolute score 
F6847h n/r n/r n/r n/r 
F7047h 14 1 4 12 
M2146h n/r n/r n/r n/r 
F5446h 8 1 2 2 
F4417h 3 0 0 4 
M0379h 0 0 0 1 
F4583h 10 1 0 24 
F7849h 21 5 2 12 
M0825h 7 0 0 2 
M0061h 8 1 1 8 
F2520h 10 0 0 8 
F8486h 5 0 0 5 
F1005w 3 0 0 0 
F6416h 5 0 2 7 
F4764h 2 0 2 4 
M4542h 11 0 0 3 
M8878h 3 1 1 0 
F0165h 3 0 0 1 
F5367w 2 0 0 2 
F7405h 2 0 0 6 
M2747w 0 0 0 6 
F1634w 32 10 2 16 
F0738w 9 0 1 7 
M0035w 22 2 3 10 
F5503w 17 2 0 9 
M9819h 5 0 0 1 
M7535w 3 0 0 5 
F0809h 30 12 11 13 
F4113w 8 0 0 7 
F9939h 0 0 0 0 
M5703h 1 1 0 3 
M1518h 19 5 4 12 
F8774w 3 0 0 1 
M8695h 5 0 0 5 
F7304h 2 0 0 7 
F2387h 3 0 0 11 
F8396w 12 0 1 6 
F4674w 0 0 0 4 
M1243h 3 0 0 4 
M2593w 3 0 0 3 
M3288h 6 0 0 4 
M0519h 20 3 10 9 
M2608w 6 0 0 0 
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F8966w 7 0 0 6 
F4943h 0 0 0 6 
F5204w 5 0 0 4 
M1662h 18 6 7 15 
M5465w 0 0 0 1 
M8305w 6 0 0 9 
F0732w 2 0 0 1 
F2122w 5 0 6 6 
M2028W 2 0 0 3 
F4142w 8 0 0 2 
F9240h 29 7 15 13 
F2573h 2 0 0 0 
F4735h 8 0 5 13 
F1965w 5 0 2 3 
M6858w 20 4 6 8 
F9830h 5 0 0 3 
M2279h 8 0 1 8 
M1543h 2 0 0 1 
F1188h 7 0 0 7 
M4091h 1 0 0 3 
F5706h 14 4 3 11 
F1669h 10 0 0 13 
F9261h 13 2 4 5 
M7524w 16 2 6 11 
F3795w 18 1 1 4 
M9231w 0 0 0 3 
F5690h 6 0 0 11 
M3609h 1 0 0 0 
F8809w 9 0 0 5 
F6914w 3 0 0 16 
M3960h 7 0 2 4 
M9287h 12 2 2 16 
F2197w 5 0 0 2 
Key: n/r = not recorded 
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Table 13-7: 4DSQ: categorised score (n = 76 at baseline) 
Subject 
code 
Distress 
/ categorised 
Depression 
/ categorised 
Anxiety 
/ categorised 
Somatisation 
/ categorised 
F6847h n/r n/r n/r n/r 
F7047h 2 1 2 2 
M2146h n/r n/r n/r n/r 
F5446h 1 1 1 1 
F4417h 1 1 1 1 
M0379h 1 1 1 1 
F4583h 1 1 1 3 
F7849h 3 2 1 2 
M0825h 1 1 1 1 
M0061h 1 1 1 1 
F2520h 1 1 1 1 
F8486h 1 1 1 1 
F1005w 1 1 1 1 
F6416h 1 1 1 1 
F4764h 1 1 1 1 
M4542h 2 1 1 1 
M8878h 1 1 1 1 
F0165h 1 1 1 1 
F5367w 1 1 1 1 
F7405h 1 1 1 1 
M2747w 1 1 1 1 
F1634w 3 3 1 2 
F0738w 1 1 1 1 
M0035w 3 1 1 1 
F5503w 2 1 1 1 
M9819h 1 1 1 1 
M7535w 1 1 1 1 
F0809h 3 3 3 2 
F4113w 1 1 1 1 
F9939h 1 1 1 1 
M5703h 1 1 1 1 
M1518h 2 2 2 2 
F8774w 1 1 1 1 
M8695h 1 1 1 1 
F7304h 1 1 1 1 
F2387h 1 1 1 2 
F8396w 2 1 1 1 
F4674w 1 1 1 1 
M1243h 1 1 1 1 
M2593w 1 1 1 1 
M3288h 1 1 1 1 
M0519h 2 2 3 1 
M2608w 1 1 1 1 
F8966w 1 1 1 1 
F4943h 1 1 1 1 
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F5204w 1 1 1 1 
M1662h 2 3 2 2 
M5465w 1 1 1 1 
M8305w 1 1 1 1 
F0732w 1 1 1 1 
F2122w 1 1 2 1 
M2028W 1 1 1 1 
F4142w 1 1 1 1 
F9240h 3 3 3 2 
F2573h 1 1 1 1 
F4735h 1 1 2 2 
F1965w 1 1 1 1 
M6858w 2 2 2 1 
F9830h 1 1 1 1 
M2279h 1 1 1 1 
M1543h 1 1 1 1 
F1188h 1 1 1 1 
M4091h 1 1 1 1 
F5706h 2 2 1 2 
F1669h 1 1 1 2 
F9261h 2 1 2 1 
M7524w 2 1 2 2 
F3795w 2 1 1 1 
M9231w 1 1 1 1 
F5690h 1 1 1 2 
M3609h 1 1 1 1 
F8809w 1 1 1 1 
F6914w 1 1 1 2 
M3960h 1 1 1 1 
M9287h 2 1 1 2 
F2197w 1 1 1 1 
Key: n/r = not recorded 
 Distress:  
o Score 0 to 10 = “not elevated”; coded as 1 
o Score 11 to 20 = “moderately elevated”; coded as 2 
o Score 21 to 32 = “strongly elevated”; coded as 3 
 Depression:  
o Score 0 to 2 = “not elevated”; coded as 1 
o Score 3 to 5 = “moderately elevated”; coded as 2 
o Score 6 to 12 = “strongly elevated”; coded as 3 
 Anxiety:  
o Score 0 to 3 = “not elevated”; coded as 1 
o Score 4 to 8 = “moderately elevated”; coded as 2 
o Score 9 to 24 = “strongly elevated”; coded as 3 
 Somatisation:  
o Score 0 to 10 = “not elevated”; coded as 1 
o Score 11 to 20 = “moderately elevated”; coded as 2 
o Score 21 to 32 = “strongly elevated”; coded as 3 
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Table 13-8: 4DSQ: dichotomised score (n = 76 at baseline) 
Subject 
code 
Distress 
/ categorised 
Depression 
/ categorised 
Anxiety 
/ categorised 
Somatisation 
/ categorised 
Dichotomised 
score 
F6847h n/r n/r n/r n/r n/a 
F7047h 2 1 2 2 1 
M2146h n/r n/r n/r n/r n/a 
F5446h 1 1 1 1 0 
F4417h 1 1 1 1 0 
M0379h 1 1 1 1 0 
F4583h 1 1 1 3 1 
F7849h 3 2 1 2 1 
M0825h 1 1 1 1 0 
M0061h 1 1 1 1 0 
F2520h 1 1 1 1 0 
F8486h 1 1 1 1 0 
F1005w 1 1 1 1 0 
F6416h 1 1 1 1 0 
F4764h 1 1 1 1 0 
M4542h 2 1 1 1 1 
M8878h 1 1 1 1 0 
F0165h 1 1 1 1 0 
F5367w 1 1 1 1 0 
F7405h 1 1 1 1 0 
M2747w 1 1 1 1 0 
F1634w 3 3 1 2 1 
F0738w 1 1 1 1 0 
M0035w 3 1 1 1 1 
F5503w 2 1 1 1 1 
M9819h 1 1 1 1 0 
M7535w 1 1 1 1 0 
F0809h 3 3 3 2 1 
F4113w 1 1 1 1 0 
F9939h 1 1 1 1 0 
M5703h 1 1 1 1 0 
M1518h 2 2 2 2 1 
F8774w 1 1 1 1 0 
M8695h 1 1 1 1 0 
F7304h 1 1 1 1 0 
F2387h 1 1 1 2 1 
F8396w 2 1 1 1 1 
F4674w 1 1 1 1 0 
M1243h 1 1 1 1 0 
M2593w 1 1 1 1 0 
M3288h 1 1 1 1 0 
M0519h 2 2 3 1 1 
M2608w 1 1 1 1 0 
F8966w 1 1 1 1 0 
F4943h 1 1 1 1 0 
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F5204w 1 1 1 1 0 
M1662h 2 3 2 2 1 
M5465w 1 1 1 1 0 
M8305w 1 1 1 1 0 
F0732w 1 1 1 1 0 
F2122w 1 1 2 1 1 
M2028W 1 1 1 1 0 
F4142w 1 1 1 1 0 
F9240h 3 3 3 2 1 
F2573h 1 1 1 1 0 
F4735h 1 1 2 2 1 
F1965w 1 1 1 1 0 
M6858w 2 2 2 1 1 
F9830h 1 1 1 1 0 
M2279h 1 1 1 1 0 
M1543h 1 1 1 1 0 
F1188h 1 1 1 1 0 
M4091h 1 1 1 1 0 
F5706h 2 2 1 2 1 
F1669h 1 1 1 2 1 
F9261h 2 1 2 1 1 
M7524w 2 1 2 2 1 
F3795w 2 1 1 1 1 
M9231w 1 1 1 1 0 
F5690h 1 1 1 2 1 
M3609h 1 1 1 1 0 
F8809w 1 1 1 1 0 
F6914w 1 1 1 2 1 
M3960h 1 1 1 1 0 
M9287h 2 1 1 2 1 
F2197w 1 1 1 1 0 
Key: n/r = not recorded, n/a = not applicable 
Dichotomised score: No categories with elevated = 0; 1 or more category with elevated = 1  
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13.5 C3. Patient reported measures: Function / Disability 
 
 
Table 13-9: SPADI (%) (n = 76 at baseline) 
Subject code Total pain score Total disability score Total SPADI score 
F6847h 77.5 14.3 37.3 
F7047h 58.0 63.8 61.5 
M2146h 54.0 28.0 41.0 
F5446h 24.0 24.3 24.2 
F4417h 76.0 75.0 75.4 
M0379h 44.0 33.8 37.7 
F4583h 72.0 82.0 77.0 
F7849h 56.0 65.0 61.5 
M0825h 42.0 11.3 23.1 
M0061h 96.0 65.0 76.9 
F2520h 84.0 52.5 64.6 
F8486h 26.0 8.8 15.4 
F1005w 58.0 52.5 54.6 
F6416h 76.0 55.0 63.1 
F4764h 32.0 32.5 32.3 
M4542h 66.0 46.3 53.8 
M8878h 68.0 40.0 50.8 
F0165h 66.0 58.8 61.5 
F5367w 56.0 27.5 38.5 
F7405h 22.0 12.5 16.2 
M2747w 36.0 5.0 16.9 
F1634w 54.0 55.0 54.6 
F0738w 40.0 43.8 42.3 
M0035w 56.0 31.4 41.7 
F5503w 14.0 8.8 10.8 
M9819h 78.0 27.5 46.9 
M7535w 70.0 66.3 67.7 
F0809h 78.0 58.8 66.2 
F4113w 38.0 8.8 20.0 
F9939h 58.0 41.3 47.7 
M5703h 46.0 28.8 35.4 
M1518h 70.0 28.8 44.6 
F8774w 64.0 53.8 57.7 
M8695h 6.0 0.0 2.3 
F7304h 30.0 37.5 34.6 
F2387h 40.0 20.0 27.7 
F8396w 54.0 23.1 43.9 
F4674w 18.0 13.8 15.4 
M1243h 50.0 41.3 44.6 
M2593w 50.0 23.8 33.9 
M3288h 62.0 31.3 43.8 
M0519h 60.0 57.5 58.5 
M2608w 46.0 23.8 32.3 
F8966w 92.0 76.3 82.3 
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F4943h 42.0 20.0 28.5 
F5204w 28.0 8.8 16.2 
M1662h 96.0 86.3 90.0 
M5465w 14.0 7.5 10.0 
M8305w 54.0 23.8 35.4 
F0732w 22.0 13.8 16.9 
F2122w 8.0 0.0 3.1 
M2028W 68.0 46.3 54.6 
F4142w 26.0 16.3 20.0 
F9240h 100.0 95.0 96.9 
F2573h 58.0 30.0 40.8 
F4735h 36.0 3.8 16.2 
F1965w 88.0 63.8 73.1 
M6858w 72.0 31.3 46.9 
F9830h 22.0 17.5 19.2 
M2279h 76.0 76.3 76.2 
M1543h 60.0 46.3 51.5 
F1188h 48.0 28.8 36.2 
M4091h 46.0 2.5 19.2 
F5706h 50.0 43.8 46.2 
F1669h 68.0 55.0 60.0 
F9261h 76.0 72.5 73.9 
M7524w 72.0 38.8 51.5 
F3795w 56.0 58.8 57.7 
M9231w 46.0 23.8 32.3 
F5690h 32.0 3.8 14.6 
M3609h 56.0 33.8 42.3 
F8809w 44.0 37.5 40.0 
F6914w 74.0 66.3 69.2 
M3960h 58.0 45.0 50.0 
M9287h 68.0 40.0 50.8 
F2197w 20.0 1.3 8.5 
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13.6 D1. Clinical measures: Strength 
 
 
Table 13-10: Internal Rotation: raw and moment data (n = 76 at baseline) 
Subject 
code 
Distance 
elbow to 
radius (m)  
Symptomatic side Asymptomatic side 
Mean Internal 
Rotation Force  
(N)  
Mean Internal 
Rotation 
Moment  
(Nm)  
Mean Internal 
Rotation Force  
(N)  
Mean Internal 
Rotation 
Moment  
(Nm)  
F6847h 0.24 29.3 7.0 41.8 10.0 
F7047h 0.25 22.7 5.7 64.5 16.1 
M2146h 0.29 38.1 11.0 52.8 15.3 
F5446h 0.26 18.3 4.8 29.3 7.6 
F4417h 0.27 19.1 5.2 35.2 9.5 
M0379h 0.25 33.7 8.4 27.1 6.8 
F4583h 0.24 8.8 2.1 24.9 6.0 
F7849h 0.25 32.3 8.1 23.5 5.9 
M0825h 0.29 44.0 12.8 44.0 12.8 
M0061h 0.29 51.3 14.9 60.9 17.7 
F2520h 0.24 14.7 3.5 79.2 19.0 
F8486h 0.26 30.7 8.0 24.2 6.3 
F1005w 0.25 44.0 11.0 72.6 18.2 
F6416h 0.23 29.3 6.7 29.3 6.7 
F4764h 0.28 19.8 5.5 29.3 8.2 
M4542h 0.29 38.1 11.0 61.6 17.9 
M8878h 0.28 44.0 12.3 55.0 15.4 
F0165h 0.28 47.7 13.4 73.3 20.5 
F5367w 0.24 50.6 12.1 80.7 19.4 
F7405h 0.24 32.3 7.8 41.1 9.9 
M2747w 0.32 164.7 52.7 181.3 58.0 
F1634w 0.25 30.1 7.5 30.1 7.5 
F0738w 0.26 37.4 9.7 33.7 8.8 
M0035w 0.27 100.1 27.0 123.7 33.4 
F5503w 0.28 38.1 10.7 63.8 17.9 
M9819h 0.31 46.9 14.5 35.2 10.9 
M7535w 0.28 103.7 29.0 100.2 28.1 
F0809h 0.24 14.7 3.5 28.6 6.9 
F4113w 0.25 30.1 7.5 33.7 8.4 
F9939h 0.22 33.7 7.4 30.1 6.6 
M5703h 0.27 75.5 20.4 65.3 17.6 
M1518h 0.25 60.1 15.0 63.8 16.0 
F8774w 0.22 29.3 6.4 28.6 6.3 
M8695h 0.26 117.7 30.6 109.7 28.5 
F7304h 0.25 68.9 17.2 96.1 24.0 
F2387h 0.25 12.5 3.1 27.9 7.0 
F8396w 0.24 44.0 10.6 72.6 17.4 
F4674w 0.27 33.0 8.9 35.2 9.5 
M1243h 0.28 100.9 28.3 120.7 33.8 
M2593w 0.25 38.9 9.7 49.1 12.3 
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M3288h 0.26 125.7 32.7 149.0 38.7 
M0519h 0.25 33.7 8.4 53.5 13.4 
M2608w 0.28 70.4 19.7 106.0 29.7 
F8966w 0.25 15.4 3.9 32.3 8.1 
F4943h 0.25 33.7 8.4 46.9 11.7 
F5204w 0.25 30.8 7.7 34.5 8.6 
M1662h 0.27 19.1 5.2 60.1 16.2 
M5465w 0.28 41.1 11.5 44.0 12.3 
M8305w 0.29 60.1 17.4 55.0 16.0 
F0732w 0.26 44.0 11.4 38.1 9.9 
F2122w 0.22 24.2 5.3 29.3 6.4 
M2028W 0.27 41.1 11.1 41.8 11.3 
F4142w 0.26 35.2 9.2 34.5 9.0 
F9240h 0.23 27.9 6.4 35.2 8.1 
F2573h 0.21 44.0 9.2 35.9 7.5 
F4735h 0.25 44.0 11.0 44.0 11.0 
F1965w 0.25 15.4 3.9 44.0 11.0 
M6858w 0.27 85.1 23.0 74.1 20.0 
F9830h 0.24 54.3 13.0 50.6 12.1 
M2279h n/r n/r n/r n/r n/r 
M1543h 0.28 44.0 12.3 50.6 14.2 
F1188h 0.26 16.1 4.2 38.9 10.1 
M4091h 0.31 37.4* 11.6* 44.0* 13.6* 
F5706h 0.27 35.2 9.5 37.4 10.1 
F1669h 0.26 39.6 10.3 38.9 10.1 
F9261h 0.28 30.1 8.4 34.5 9.7 
M7524w 0.28 76.3 21.4 70.4 19.7 
F3795w 0.28 19.8 5.5 44.0 12.3 
M9231w 0.27 48.4 13.1 79.2 21.4 
F5690h 0.26 34.5 9.0 34.5 9.0 
M3609h 0.27 30.1 8.1 56.5 15.3 
F8809w 0.25 30.1 7.5 27.9 7.0 
F6914w 0.23 20.5 4.7 44.0 10.1 
M3960h 0.25 50.6 12.7 66.0 16.5 
M9287h 0.28 38.1 10.7 76.3 21.4 
F2197w 0.25 9.5 2.4 19.1 4.8 
Key: m = metres, N = Newtons, Nm = Newton metres, n/r = not recorded, * = Symptoms on “Asymptomatic 
side” at time of testing 
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Table 13-11: External Rotation: raw and moment data (n = 76 at baseline) 
Subject 
code 
Distance 
elbow to 
radius /m  
Symptomatic side Asymptomatic side 
Mean External 
Rotation Force  
/ N  
Mean External 
Rotation 
Moment  
/ Nm  
Mean External 
Rotation Force  
/ N  
Mean External 
Rotation 
Moment  
/ Nm  
F6847h 0.24 35.2 8.4 41.1 9.9 
F7047h 0.25 9.3 2.3 52.1 13.0 
M2146h 0.29 34.5 10.0 27.9 8.1 
F5446h 0.26 26.4 6.9 24.9 6.5 
F4417h 0.27 20.5 5.5 41.8 11.3 
M0379h 0.25 32.3 8.1 35.9 9.0 
F4583h 0.24 8.8 2.1 27.1 6.5 
F7849h 0.25 32.3 8.1 32.3 8.1 
M0825h 0.29 33.7 9.8 41.1 11.9 
M0061h 0.29 46.9 13.6 45.5 13.2 
F2520h 0.24 30.8 7.4 70.4 16.9 
F8486h 0.26 30.1 7.8 30.1 7.8 
F1005w 0.25 39.6 9.9 76.3 19.1 
F6416h 0.23 30.8 7.1 24.2 5.6 
F4764h 0.28 23.5 6.6 27.1 7.6 
M4542h 0.29 30.8 8.9 46.9 13.6 
M8878h 0.28 36.7 10.3 41.1 11.5 
F0165h 0.28 35.2 9.9 58.7 16.4 
F5367w 0.24 44.0 10.6 62.9 15.1 
F7405h 0.24 30.8 7.4 36.7 8.8 
M2747w 0.32 111.0 35.5 113.3 36.3 
F1634w 0.25 16.9 4.2 23.5 5.9 
F0738w 0.26 29.3 7.6 30.8 8.0 
M0035w 0.27 92.4 24.9 111.0 30.0 
F5503w 0.28 36.7 10.3 46.9 13.1 
M9819h 0.31 41.8 13.0 47.7 14.8 
M7535w 0.28 86.5 24.2 79.9 22.4 
F0809h 0.24 8.8 2.1 25.7 6.2 
F4113w 0.25 44.0 11.0 38.9 9.7 
F9939h 0.22 19.1 4.2 19.8 4.4 
M5703h 0.27 66.0 17.8 70.4 19.0 
M1518h 0.25 51.3 12.8 55.7 13.9 
F8774w 0.22 32.3 7.1 28.6 6.3 
M8695h 0.26 73.3 19.1 74.8 19.4 
F7304h 0.25 68.2 17.1 68.9 17.2 
F2387h 0.25 11.7 2.9 12.5 3.1 
F8396w 0.24 52.8 12.7 64.5 15.5 
F4674w 0.27 31.5 8.5 41.1 11.1 
M1243h 0.28 97.4 27.3 111.0 31.1 
M2593w 0.25 50.6 12.7 62.3 15.6 
M3288h 0.26 76.3 19.8 108.0 28.1 
M0519h 0.25 35.2 8.8 63.1 15.8 
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M2608w 0.28 90.9 25.5 91.5 25.6 
F8966w 0.25 11.7 2.9 30.1 7.5 
F4943h 0.25 44.0 11.0 64.5 16.1 
F5204w 0.25 35.2 8.8 35.2 8.8 
M1662h 0.27 16.1 4.3 71.1 19.2 
M5465w 0.28 44.0 12.3 78.5 22.0 
M8305w 0.29 49.9 14.5 61.6 17.9 
F0732w 0.26 41.1 10.7 35.2 9.2 
F2122w 0.22 25.7 5.7 20.5 4.5 
M2028W 0.27 69.7 18.8 55.0 14.9 
F4142w 0.26 28.6 7.4 35.9 9.3 
F9240h 0.23 14.7 3.4 35.2 8.1 
F2573h 0.21 40.3 8.5 41.1 8.6 
F4735h 0.25 41.1 10.3 63.1 15.8 
F1965w 0.25 28.6 7.2 32.3 8.1 
M6858w 0.27 111.0 30.0 127.7 34.5 
F9830h 0.24 33.7 8.1 73.3 17.6 
M2279h n/r n/r n/r n/r n/r 
M1543h 0.28 44.0 12.3 46.9 13.1 
F1188h 0.26 16.1 4.2 33.7 8.8 
M4091h 0.31 44.7* 13.9* 43.3* 13.4* 
F5706h 0.27 33.7 9.1 53.5 14.4 
F1669h 0.26 33.7 8.8 38.1 9.9 
F9261h 0.28 8.8 2.5 35.2 9.9 
M7524w 0.28 68.9 19.3 67.5 18.9 
F3795w 0.28 24.9 7.0 44.0 12.3 
M9231w 0.27 61.6 16.6 76.3 20.6 
F5690h 0.26 34.5 9.0 40.3 10.5 
M3609h 0.27 32.3 8.7 75.5 20.4 
F8809w 0.25 11.7 2.9 15.4 3.9 
F6914w 0.23 27.1 6.2 43.3 10.0 
M3960h 0.25 36.7 9.2 68.2 17.1 
M9287h 0.28 38.1 10.7 64.5 18.1 
F2197w 0.25 8.8 2.2 8.8 2.2 
Key: m = metres, N = Newtons, Nm = Newton metres, n/r = not recorded, * = Symptoms on “Asymptomatic 
side” at time of testing 
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Table 13-12: Scaption: raw and moment data (n = 76 at baseline) 
Subject 
code 
Distance 
GHJ to 
radius /m  
Symptomatic side Asymptomatic side 
Mean Scaption 
Force  
/ N  
Mean Scaption 
Moment 
/ Nm  
Mean Scaption 
Force  
/ N  
Mean Scaption 
Moment  
/ Nm  
F6847h 0.52 24.2 12.6 33.7 17.5 
F7047h 0.50 8.8 4.4 61.6 30.8 
M2146h 0.60 8.8 5.3 26.4 15.8 
F5446h 0.55 8.8 4.8 24.9 13.7 
F4417h 0.53 0.0** 0.0** 30.8 16.3 
M0379h 0.53 31.5 16.7 34.5 18.3 
F4583h 0.52 5.9 3.1 19.1 9.9 
F7849h 0.53 13.9 7.4 24.2 12.8 
M0825h 0.54 22.0 11.9 35.2 19.0 
M0061h 0.60 30.8 18.5 44.0 26.4 
F2520h 0.50 14.7 7.4 62.3 31.2 
F8486h 0.50 16.1 8.1 18.3 9.2 
F1005w 0.48 8.8 4.2 44.0 21.1 
F6416h 0.47 8.8 4.1 13.9 6.5 
F4764h 0.59 8.8 5.2 11.0 6.5 
M4542h 0.59 19.8 11.7 38.1 22.5 
M8878h 0.59 25.7 15.2 30.8 18.2 
F0165h 0.55 22.7 12.5 41.8 23.0 
F5367w 0.51 35.2 18.0 47.7 24.3 
F7405h 0.51 29.3 14.9 30.8 15.7 
M2747w 0.57 106.7 60.8 100.3 57.2 
F1634w 0.50 8.8 4.4 23.5 11.8 
F0738w 0.54 12.5 6.8 22.0 11.9 
M0035w 0.53 55.7 29.5 79.9 42.3 
F5503w 0.51 13.2 6.7 44.0 22.4 
M9819h 0.63 27.9 17.6 35.2 22.2 
M7535w 0.51 44.0 22.4 44.0 22.4 
F0809h 0.51 7.7 3.9 8.8 4.5 
F4113w 0.53 27.9 14.8 32.3 17.1 
F9939h 0.47 27.1 12.7 25.7 12.1 
M5703h 0.51 46.9 23.9 46.9 23.9 
M1518h 0.50 31.5 15.8 30.1 15.1 
F8774w 0.49 8.8 4.3 18.3 9.0 
M8695h 0.50 66.7 33.4 66.7 33.4 
F7304h 0.51 31.5 16.1 66.0 33.7 
F2387h 0.53 8.8 4.7 8.8 4.7 
F8396w 0.50 13.9 7.0 37.4 18.7 
F4674w 0.52 9.5 4.9 18.3 9.5 
M1243h 0.52 61.6 32.0 69.7 36.2 
M2593w 0.50 32.3 16.2 41.1 20.6 
M3288h 0.50 77.0 38.5 68.2 34.1 
M0519h 0.55 13.2 7.3 41.1 22.6 
M2608w 0.55 52.1 28.7 85.8 47.2 
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F8966w 0.49 5.9 2.9 8.8 4.3 
F4943h 0.51 28.1 14.3 44.0 22.4 
F5204w 0.50 19.0 9.5 27.1 13.6 
M1662h 0.55 6.6 3.6 18.3 10.1 
M5465w 0.54 18.3 9.9 27.9 15.1 
M8305w 0.54 32.3 17.4 31.5 17.0 
F0732w 0.51 25.7 13.1 31.5 16.1 
F2122w 0.49 17.6 8.6 11.7 5.7 
M2028W 0.51 15.4 7.9 34.5 17.6 
F4142w 0.48 9.5 4.6 24.9 12.0 
F9240h 0.47 7.3 3.4 8.8 4.1 
F2573h 0.47 8.8 4.1 8.8 4.1 
F4735h 0.50 19.8 9.9 27.9 14.0 
F1965w 0.48 8.8 4.2 27.1 13.0 
M6858w 0.57 33.7 19.2 45.5 25.9 
F9830h 0.49 16.1 7.9 35.2 17.2 
M2279h n/r n/r n/r n/r n/r 
M1543h 0.56 18.3 10.2 32.3 18.1 
F1188h 0.49 8.1 4.0 8.8 4.3 
M4091h 0.58 19.1* 11.1* 22.7* 13.2* 
F5706h 0.53 8.8 4.7 18.3 9.7 
F1669h 0.50 14.7 7.4 22.7 11.4 
F9261h 0.55 8.1 4.5 8.8 4.8 
M7524w 0.55 42.5 23.4 71.1 39.1 
F3795w 0.51 5.9 3.0 30.1 15.4 
M9231w 0.52 24.9 12.9 44.0 22.9 
F5690h 0.48 24.2 11.6 25.7 12.3 
M3609h 0.53 28.6 15.2 50.6 26.8 
F8809w 0.51 8.8 4.5 8.8 4.5 
F6914w 0.47 8.8 4.1 8.8 4.1 
M3960h 0.49 8.8 4.3 31.5 15.4 
M9287h 0.52 33.0 17.2 41.1 21.4 
F2197w 0.48 8.8 4.2 8.8 4.2 
Key: m = metres, N = Newtons, Nm = Newton metres, n/r = not recorded, * = Symptoms on “Asymptomatic 
side” at time of testing, ** = Sub-threshold force 
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13.7 D2. Clinical measures: ROM 
 
Table 13-13: Clinical measures: ROM (n = 76 at baseline) 
Subject code 
Active scaption ROM (°)  
Symptomatic side Asymptomatic side 
Limit of ROM 
Point of symptom exacerbation 
by movement 
Limit of ROM 
F6847h 132.0 123.0 155.0 
F7047h 150.0 60.0 162.0 
M2146h 146.0 132.0 164.0 
F5446h 163.0 135.0 179.0 
F4417h 75.0 40.0 165.0 
M0379h 145.0 135.0 155.0 
F4583h 94.0 73.0 132.0 
F7849h 168.0 155.0 163.0 
M0825h 150.1 147.0 165.8 
M0061h 146.0 105.0 146.0 
F2520h 115.2 92.2 171.9 
F8486h 155.0 138.0 159.0 
F1005w 76.3 65.8 168.5 
F6416h 137.0 70.0 157.0 
F4764h 91.0 91.0 155.0 
M4542h 155.0 55.0 155.0 
M8878h 136.5 129.0 167.5 
F0165h 148.0 100.0 157.0 
F5367w 146.0 146.0 146.0 
F7405h 154.0 120.0 154.0 
M2747w 154.0 No symptoms during movement 154.0 
F1634w 124.0 86.0 159.0 
F0738w 166.0 150.0 166.0 
M0035w 135.0 70.0 132.0 
F5503w 124.0 104.0 155.2 
M9819h 134.0 127.0 166.0 
M7535w 147.0 107.0 164.0 
F0809h 107.4 75.0 143.2 
F4113w 152.0 130.0 152.0 
F9939h 121.2 86.0 165.2 
M5703h 146.0 132.0 161.0 
M1518h 138.0 125.0 156.0 
F8774w 99.5 96.0 153.2 
M8695h 169.0 138.0 169.0 
F7304h 131.0 121.0 168.4 
F2387h 96.0 96.0 135.0 
F8396w 111.5 106.0 163.7 
F4674w 112.5 70.0 135.7 
M1243h 108.0 108.0 161.0 
M2593w 176.7 No symptoms during movement 176.7 
M3288h 142.7 142.7 141.0 * 
M0519h 150.0 70.0 167.0 
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M2608w 170.0 127.0 170.0 
F8966w 70.0 65.0 155.0 
F4943h 149.0 120.0 163.0 
F5204w 157.0 132.0 157.0 
M1662h 59.0 34.0 146.0 
M5465w 162.0 91.0 155.0 
M8305w 136.0 132.0 149.0 
F0732w 160.0 105.0 169.0 
F2122w 163.0 No symptoms during movement 163.0 
M2028w 149.0 143.0 152.0 
F4142w 115.0 94.0 157.0 
F9240h 70.0 60.0 128.0 
F2573h 138.0 128.0 138.0 
F4735h 170.0 No symptoms during movement 170.0 
F1965w 165.0 No symptoms during movement 168.0 
M6858w 175.0 102.0 175.0 
F9830h 105.0 92.0 151.0 
M2279h 91.0 91.0 110.0 
M1543h 93.0 93.0 153.0 
F1188h 96.0 80.0 172.0 
M4091h 149.0 119.0 153.0 * 
F5706h 104.0 55.0 161.0 
F1669h 164.0 No symptoms during movement 162.0 
F9261h 74.0 74.0 162.0 
M7524w 107.0 107.0 153.0 
F3795w 84.0 84.0 158.0 
M9231w 178.0 Pain remains same through range 174.0 
F5690h 160.0 No symptoms during movement 160.0 
M3609h 122.0 70.0 157.0 
F8809w 101.5 101.5 164.0 
F6914w 82.0 75.0 145.0 
M3960h 77.0 Pain remains same through range 164.0 
M9287h 174.0 118.0 174.0 
F2197w 175.0 No symptoms during movement 174.0 
Key: * = Symptoms on “Asymptomatic side” at time of testing 
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13.8 D3. Clinical measures: Scapular movement and control 
 
 
Table 13-14: Scapular dyskinesis grading (n = 76 at baseline) 
Subject code 
Un-weighted trial 
grading 
Weighted trial 
performed? 
1=Y, 2=N 
If weighted trial, 
what weight 
used? (kg)  
Weighted trial 
grading 
F6847h 2 1 0.5 2 
F7047h 3 2 n/a n/a 
M2146h 3 1 1.0 3 
F5446h 3 1 0.5 3 
F4417h 3 1 0.5 3 
M0379h 2 1 1.0 2 
F4583h 1 2 n/a n/a 
F7849h 2 1 1.0 2 
M0825h 2 1 0.5 2 
M0061h 2 1 0.5 3 
F2520h 3 2 n/a n/a 
F8486h 2 1 0.5 2 
F1005w 1 2 n/a n/a 
F6416h 1 2 n/a n/a 
F4764h 1 2 n/a n/a 
M4542h 3 2 n/a n/a 
M8878h 1 1 0.5 2 
F0165h 1 1 0.5 2 
F5367w 2 1 0.5 2 
F7405h 3 1 0.5 3 
M2747w 2 1 1.0 2 
F1634w 3 2 n/a n/a 
F0738w 2 1 0.5 2 
M0035w 3 2 n/a n/a 
F5503w 2 1 0.5 2 
M9819h 2 1 1.0 2 
M7535w 1 2 n/a n/a 
F0809h 1 2 n/a n/a 
F4113w 1 1 0.5 2 
F9939h 1 1 0.5 1 
M5703h 3 1 0.5 3 
M1518h 2 1 0.5 2 
F8774w 2 1 0.5 2 
M8695h 2 1 1.0 2 
F7304h 2 2 n/a n/a 
F2387h 1 2 n/a n/a 
F8396w 3 2 n/a n/a 
F4674w 1 1 0.5 2 
M1243h 2 1 1.0 2 
M2593w 1 1 1.0 2 
M3288h 2 1 0.5 2 
M0519h 3 2 n/a n/a 
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M2608w 2 1 0.5 2 
F8966w 1 2 n/a n/a 
F4943h 1 1 0.5 1 
F5204w 1 1 0.5 1 
M1662h 3 2 n/a n/a 
M5465w 1 1 1.0 1 
M8305w 2 1 0.5 2 
F0732w 1 1 0.5 1 
F2122w 1 1 0.5 1 
M2028W 2 2 n/a n/a 
F4142w 2 1 0.5 2 
F9240h 3 2 n/a n/a 
F2573h 2 1 0.5 2 
F4735h 3 1 0.5 2 
F1965w 3 1 1.0 3 
M6858w 2 1 1.0 2 
F9830h 2 2 n/a n/a 
M2279h 2 2 n/a n/a 
M1543h 2 2 n/a n/a 
F1188h 2 1 0.5 1 
M4091h 1 1 1.0 1 
F5706h 1 2 n/a n/a 
F1669h 2 1 0.5 2 
F9261h 3 2 n/a n/a 
M7524w 3 2 n/a n/a 
F3795w 3 2 n/a n/a 
M9231w 2 1 1.0 3 
F5690h 1 1 0.5 1 
M3609h 1 2 n/a n/a 
F8809w 2 2 n/a n/a 
F6914w 1 2 n/a n/a 
M3960h 1 2 n/a n/a 
M9287h 1 2 n/a n/a 
F2197w 2 1 0.5 2 
Key: n/a = not applicable 
Scapular dyskinesis grading: 
1 = “Normal” 
2 = “Subtle abnormality” 
3 = “Obvious abnormality” 
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Examples of SDT grading 
 
Figure 13-1: SDT trial for subject F9939 
 
Subject F9939 demonstrating a scapular dyskinesis grading of 1 = “Normal” 
 
Figure 13-2: SDT trial for subject M8695 
 
Subject M8695 demonstrating a scapular dyskinesis grading of 2 = “Subtle abnormality” as 
evidenced by subtle prominence of the inferior angle of the scapular.  
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Figure 13-3: SDT trial for subject F3795 
 
Subject F3795 demonstrating a scapular dyskinesis grading of 3 = “Obvious abnormality” as 
evidenced by obvious prominence of the inferior angle and medial border of the scapular.  
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13.9 E1. Structural pathology via imaging 
 
 
Table 13-15: Sonographic diagnosis (findings for each component of the rotator cuff collapsed; 
composite grading) (n = 76 at baseline) 
Subject 
code 
Sonographic Diagnosis 
Cuff 
pathology 
1=Y, 2=N 
Tendino 
pathic 
1=Y, 2=N 
Calcific 
deposit 
1=Y, 2=N 
Bursitis 
1=Y, 2=N 
PTT 
1=Y, 2=N 
FTT 
1=Y, 2=N 
Composite 
grading 
(Codeing 
below) 
F6847h 2 2 2 1 2 2 1 
F7047h 1 1 2 1 1 2 2 
M2146h 1 1 2 1 2 2 2 
F5446h 2 1 2 2 2 2 1 
F4417h 1 1 2 1 2 1 2 
M0379h 1 1 2 1 2 2 2 
F4583h 1 1 2 2 2 2 1 
F7849h 1 2 1 1 2 2 2 
M0825h 2 2 2 1 2 2 1 
M0061h 1 1 1 1 2 2 2 
F2520h 2 2 2 1 2 2 1 
F8486h 2 2 2 1 2 2 1 
F1005w 1 1 2 1 2 2 2 
F6416h 1 1 2 1 2 2 2 
F4764h 2 2 2 2 2 2 0 
M4542h 1 1 2 1 2 2 2 
M8878h 2 2 2 2 2 2 0 
F0165h 1 2 2 1 2 1 2 
F5367w 1 1 2 2 2 2 1 
F7405h 1 1 2 2 2 2 1 
M2747w 2 2 2 1 2 2 1 
F1634w 2 2 2 1 2 2 1 
F0738w 1 1 2 1 2 2 2 
M0035w 2 2 1 1 2 2 1 
F5503w 1 1 2 2 2 2 1 
M9819h 2 2 2 2 2 2 2 
M7535w 1 1 2 2 2 2 1 
F0809h 1 1 2 2 2 2 1 
F4113w 1 1 2 2 2 2 1 
F9939h 1 1 2 1 2 2 2 
M5703h 2 2 2 2 2 2 0 
M1518h 2 2 2 1 2 2 1 
F8774w 2 2 2 1 2 2 1 
M8695h 2 2 2 2 2 2 0 
F7304h 1 2 1 2 2 2 1 
F2387h 1 1 2 2 2 2 1 
F8396w 2 2 2 2 2 2 0 
F4674w 1 1 2 2 2 2 1 
M1243h 1 1 2 1 2 2 2 
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M2593w 2 2 2 1 2 2 1 
M3288h 1 1 2 1 2 2 2 
M0519h 1 1 2 2 2 2 1 
M2608w 2 2 2 2 2 2 0 
F8966w 1 1 2 2 2 2 1 
F4943h 2 2 2 1 2 2 1 
F5204w 2 2 2 1 2 2 1 
M1662h 1 1 2 1 2 2 2 
M5465w 1 1 1 2 2 2 1 
M8305w 2 2 2 2 2 2 0 
F0732w 1 1 1 2 2 2 1 
F2122w 2 2 2 2 2 2 0 
M2028W 1 1 2 2 1 2 1 
F4142w 1 1 2 1 2 2 2 
F9240h 1 1 2 1 2 2 2 
F2573h 2 2 2 1 2 2 1 
F4735h 2 2 2 2 2 2 0 
F1965w 1 1 2 2 2 2 1 
M6858w 1 1 2 1 2 2 2 
F9830h 2 2 2 2 2 2 0 
M2279h 1 1 2 2 2 2 1 
M1543h 1 1 2 1 2 2 2 
F1188h 1 1 2 2 2 2 1 
M4091h 1 1 2 2 2 2 1 
F5706h 2 2 2 2 2 2 0 
F1669h 2 2 2 1 2 2 1 
F9261h 1 1 2 2 2 2 1 
M7524w 1 1 2 1 2 2 2 
F3795w 1 1 2 2 2 2 1 
M9231w 1 1 2 n/r 2 1 n/a 
F5690h 1 1 2 2 2 2 1 
M3609h 2 2 2 1 2 2 1 
F8809w 2 2 2 2 2 2 0 
F6914w 1 1 2 1 2 2 2 
M3960h 1 1 2 1 2 2 2 
M9287h 1 1 2 1 2 2 2 
F2197w 2 2 2 2 2 2 0 
Key: n/r = not recorded, n/a = not applicable, PTT = partial thickness tear; FTT = full thickness tear 
Composite grading: 0=no pathoplogy, 1 = 1 of bursal or cuff pathology, 2=both bursal and cuff pathology 
 
  
461 
 
Examples of using bilateral scanning as a mechanism to assist with tendinopathic differential 
diagnoses 
 
Figure 13-4: Transverse view of Supraspinatus tendon on symptomatic side for subject M3609h 
 
 
Figure 13-5: Transverse view of Supraspinatus tendon on asymptomatic side for subject M3609h 
 
The transverse view of the Supraspinatus tendon on the symptomatic side for subject M3609h 
appears to be abnormally thickened, which in isolation can be considered characteristic of 
tendinopathy. However, the comparable image on the asymptomatic side demonstrates identical 
thickness. Therefore relative to the asymptomatic side there is no thickening of the Supraspinatus 
tendon on the symptomatic side.  
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Figure 13-6: Transverse view of Supraspinatus tendon on symptomatic side for subject F1965w 
 
 
Figure 13-7: Transverse view of Supraspinatus tendon on asymptomatic side for subject F1965w 
 
 
The images for subject F1965w demonstrate a high level of subcutaneous adipose tissue and this 
aligns with the high BMI of 39.9 Kg/m2. The resulting attenuation of the ultrasound signal can impair 
image resolution, leading to reduced levels of differential diagnostic certainty. The use of bilateral 
scanning assisted with arriving at a diagnosis of tendinopathy as characterised by reduced 
echogenicity (increased darkness) on the symptomatic side, relative to the symptomatic side.   
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Figure 13-8: Transverse view of Supraspinatus tendon on symptomatic side for subject F9939h 
 
 
Figure 13-9: Transverse view of Supraspinatus tendon on asymptomatic side for subject F9939h 
 
 
The transverse view of the Supraspinatus tendon on the symptomatic side for subject F9939h 
appears to be mildly heterogenous, although arguably within normal limits. However, the 
comparable image on the asymptomatic side demonstrates a high degree of homogeneity. 
Therefore relative to the asymptomatic side there is heterogeneity of the Supraspinatus tendon on 
the symptomatic side.  
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13.10 E2. Structural pathology via orthopaedic tests 
 
 
Table 13-16: Orthopaedic tests (findings for each test; dichotomised for 3 or more +ve tests) (n = 
76 at baseline) 
Subject 
code 
Hawkins-
Kennedy 
1 = +ve, 2=-ve 
Neer & Walsh 
1 = +ve, 2=-ve 
Empty Can 
1 = +ve, 2=-ve 
Pain Active 
shoulder 
elevation 
1 = +ve, 2=-ve 
3 or more +ve 
tests 
F6847h 1 1 n/r 1 1 
F7047h 1 1 1 1 1 
M2146h 2 2 1 1 0 
F5446h 1 1 1 1 1 
F4417h 1 1 1 1 1 
M0379h 1 1 1 1 1 
F4583h 1 1 1 1 1 
F7849h 1 1 1 1 1 
M0825h 1 1 1 1 1 
M0061h 2 1 1 1 1 
F2520h 1 1 1 1 1 
F8486h 1 1 1 1 1 
F1005w 1 1 1 1 1 
F6416h 1 1 1 1 1 
F4764h 1 1 1 1 1 
M4542h 1 2 2 1 0 
M8878h 2 2 1 1 0 
F0165h 2 1 1 1 1 
F5367w 2 1 2 1 0 
F7405h 2 1 1 1 1 
M2747w 2 2 2 2 0 
F1634w 1 1 1 1 1 
F0738w 2 2 1 1 0 
M0035w 1 1 2 1 1 
F5503w 2 2 1 1 0 
M9819h 1 2 2 1 0 
M7535w 1 1 1 1 1 
F0809h 1 1 1 1 1 
F4113w 1 2 2 1 0 
F9939h 1 1 2 1 1 
M5703h 2 1 1 1 1 
M1518h 1 1 2 1 1 
F8774w 2 1 1 1 1 
M8695h 2 2 2 1 0 
F7304h 2 1 1 1 1 
F2387h 1 1 1 1 1 
F8396w 1 2 2 1 0 
F4674w 1 1 1 1 1 
M1243h 2 1 1 1 1 
M2593w 2 1 1 2 0 
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M3288h 1 1 2 1 1 
M0519h 1 1 1 1 1 
M2608w 1 2 1 1 1 
F8966w 1 1 1 1 1 
F4943h 2 1 1 1 1 
F5204w 1 2 2 1 0 
M1662h 1 1 1 1 1 
M5465w 1 1 2 1 1 
M8305w 1 1 1 1 1 
F0732w 2 1 1 1 1 
F2122w 2 2 2 2 0 
M2028W 1 1 1 1 1 
F4142w 1 1 1 1 1 
F9240h 1 1 1 1 1 
F2573h 2 1 1 1 1 
F4735h 1 1 1 2 1 
F1965w 1 1 2 2 0 
M6858w 1 1 1 1 1 
F9830h 2 1 1 1 1 
M2279h 1 1 1 1 1 
M1543h 1 1 1 1 1 
F1188h 1 1 1 1 1 
M4091h 1 2 2 1 0 
F5706h 1 1 1 1 1 
F1669h 1 1 1 2 1 
F9261h 2 2 2 1 0 
M7524w 1 1 2 1 1 
F3795w 1 1 1 1 1 
M9231w 1 1 1 1 1 
F5690h 2 1 1 2 0 
M3609h 2 1 1 1 1 
F8809w 2 1 1 1 1 
F6914w 1 1 1 1 1 
M3960h 1 2 1 1 1 
M9287h 2 1 2 1 0 
F2197w 2 2 2 2 0 
Key: n/r = not recorded 
Hawkins-Kennedy, Neer & Walsh, Empty Can and Pain Active shoulder elevation: 1 = +ve, 2=-ve 
3 or more +ve tests: 0 = no, 1 = yes
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13.11 Number of weeks under treatment and discharge situation 
 
 
Table 13-17: Number of weeks under treatment and discharge situation 
Patient 
code 
Total number of 
appointments 
Number of weeks 
between 1st and 
last appointment 
Discharge 
situation 
Details 
F6847h 1 0 B Referred to Orthopaedics for injection 
F7047h 5 9 A  
M2146h 2 3 A  
F5446h 8 35 A  
F4417h 11 21 A  
M0379h 5 11 A  
F4583h 7 26 A  
F7849h 4 10 A  
M0825h 5 12 A  
M0061h 8 14 A  
F2520h 5 15 A  
F8486h 5 12 A  
F1005w 5 19 A  
F6416h 2 3 C  
F4764h 6 16 A  
M4542h 9 32 A  
M8878h 4 9 A  
F0165h 5 13 A  
F5367w 4 7 A  
F7405h 4 8 A  
M2747w 4 20 A  
F1634w 8 42 B Referred for psychological treatment 
F0738w 1 0 C  
M0035w 2 13 C  
F5503w 4 12 A  
M9819h 2 1 C  
M7535w 8 19 A  
F0809h 4 5 A  
F4113w 6 15 A  
F9939h 5 19 C  
M5703h 4 19 C  
M1518h 7 17 A  
F8774w 2 2 A  
M8695h 2 9 A  
F7304h 4 13 A  
F2387h 3 7 A  
F8396w 10 28 A  
F4674w 7 27 A  
M1243h 5 9 A  
M2593 2 4 A  
M3288h 2 3 A  
M0519h 2 2 C  
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M2608w 6 11 A  
F8966w 5 9 A  
F4943h 3 9 A  
F5204w 6 25 A  
M1662h 1 0 C  
M5465w 3 6 A  
M8305w 10 32 A  
F0732w 5 32 A  
F2122w 2 5 A  
M2028W n/a n/a n/a*  
F4142w 7 17 A  
F9240h 8 26 A  
F2537h 4 9 A  
F4735h 5 11 A  
F1965w 1 0 C  
M6858w 1 0 C  
F9830h 2 8 A  
M2279h 5 15 A  
M1543h 3 8 B Referred back to GP for injection 
F1188h 1 0 C  
M4091h 5 17 A  
F5706h 8 20 A  
F1669h 3 7 A  
F9261h 6 22 A  
M7524w 3 7 A  
F3795w 13 37 A  
M9231w 8 34 B Referred to Orthopaedics for surgery 
F5690h 4 8 C  
M3609h 1 0 A  
F8809w 5 18 A  
F6914w 5 10 B Referred to Orthopaedics for surgery 
M3960h 4 6 A  
M9287h 2 2 A  
F2197w 3 32 C  
Key: A = Completed physiotherapy treatment and subsequently discharge from physiotherapy, B = Following 
physiotherapy treatment, care transferred to other speciality, C = Did not attend (DNA) or Unable to attend 
(UTA) and subsequently discharge from physiotherapy, n/a = not applicable, n/a* = Patient did not complete 
treatment for medical reasons unrelated to the shoulder 
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13.12 Outcome measure 
 
 
Table 13-18: Outcome measure: Baseline to discharge to 3 months post-discharge 
Subject 
code 
Baseline 
OSS 
Discharge 
OSS 
Numerical 
change from 
Baseline to 
Discharge 
Categorised 
change 
from 
Baseline to 
discharge 
 
3 month 
follow 
up OSS 
Numerical 
change from 
Baseline to 3 
month follow up 
Categorised 
change from 
Baseline to 3 
month follow up 
 Categorised 
change from 
Baseline to 
Discharge to 3 
month follow up 
F6847h 33 29 -4 2  35 2 2  2a 
F7047h 26 40 14 1  42 16 1  1a 
M2146h 36 40 4 2  Missing n/a n/a  n/a 
F5446h 37 43 6 1  48 11 1  1b 
F4417h 27 44 17 1  44 17 1  1a 
M0379h 37 40 3 2  42 5 1  3 
F4583h 27 15 -12 3  14 -13 3  2b 
F7849h 18 45 27 1  46 28 1  1a 
M0825h 35 46 11 1  46 11 1  1a 
M0061h 33 40 7 1  37 4 2  4 
F2520h 31 37 6 1  43 12 1  1b 
F8486h 43 41 -2 2  44 1 2  2a* 
F1005w 19 44 25 1  29 10 1  1c 
F6416h 22 36 14 1  36 14 1  1a 
F4764h 36 45 9 1  43 7 1  1a 
M4542h 25 45 20 1  46 21 1  1a 
M8878h 33 48 15 1  48 15 1  1a 
F0165h 32 31 -1 2  46 14 1  3 
F5367w 33 45 12 1  46 13 1  1a 
F7405h 39 44 5 1  41 2 2  4 
M2747w 40 48 8 1  48 8 1  1a 
F1634w 21 33 12 1  Missing n/a n/a  n/a 
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F0738w 40 44 4 2  46 6 1  3 
M0035w 34 41 7 1  39 5 1  1a 
F5503w 40 47 7 1  47 7 1  1a 
M9819h 34 Missing n/a n/a  Missing n/a n/a  n/a 
M7535w 26 47 21 1  42 16 1  1a 
F0809h 26 35 9 1  39 13 1  1a 
F4113w 35 41 6 1  41 6 1  1a 
F9939h 27 37 10 1  Missing n/a n/a  n/a 
M5703h 38 38 0 2  Missing n/a n/a  n/a 
M1518h 34 42 8 1  46 12 1  1a 
F8774w 33 48 15 1  48 15 1  1a 
M8695h 41 46 5 1  44 3 2  4 
F7304h 36 39 3 2  34 -2 2  2a 
F2387h 36 36 0 2  Missing n/a n/a  n/a 
F8396w 29 39 10 1  44 15 1  1b 
F4674w 38 40 2 2  42 4 2  2a 
M1243h 27 38 11 1  39 12 1  1a 
M2593w 37 42 5 1  43 6 1  1a 
M3288h 37 38 1 2  46 9 1  3 
M0519h 29 46 17 1  46 17 1  1a 
M2608w 36 45 9 1  47 11 1  1a 
F8966w 16 41 25 1  38 22 1  1a 
F4943h 36 45 9 1  48 12 1  1a 
F5204w 40 40 0 2  45 5 1  3 
M1662h 17 10 -7 3  19 2 2  2c 
M5465w 41 45 4 2  48 7 1  3 
M8305w 36 46 10 1  48 12 1  1a 
F0732w 40 47 7 1  Missing n/a n/a  n/a 
F2122w 42 46 4 2  43 1 2  2a 
M2028W 37 Missing n/a n/a  Missing n/a n/a  n/a 
F4142w 33 45 12 1  45 12 1  1a 
F9240h 8 17 9 1  15 7 1  1a 
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F2573h 32 40 8 1  34 2 2  4 
F4735h 41 43 2 2  45 4 2  2a 
F1965w 22 45 23 1  47 25 1  1a 
M6858w 34 40 6 1  Missing n/a n/a  n/a 
F9830h 36 44 8 1  43 7 1  1a 
M2279h 15 42 27 1  48 33 1  1b 
M1543h 32 31 -1 2  37 5 1  3 
F1188h 30 32 2 2  Missing n/a n/a  n/a 
M4091h 40 42 2 2  45 5 1  3 
F5706h 29 36 7 1  40 11 1  1a 
F1669h 19 45 26 1  Missing n/a n/a  n/a 
F9261h 17 46 29 1  48 31 1  1a 
M7524w 25 32 7 1  26 1 2  4 
F3795w 23 42 19 1  45 22 1  1a 
M9231w 38 26 -12 3  31 -7 3  2b 
F5690h 39 44 5 1  Missing n/a n/a  n/a 
M3609h 34 39 5 1  Missing n/a n/a  n/a 
F8809w 26 46 20 1  48 22 1  1a 
F6914w 23 12 -11 3  16 -7 3  2b 
M3960h 27 34 7 1  36 9 1  1a 
M9287h 34 45 11 1  48 14 1  1a 
F2197w 42 Missing n/a n/a  Missing n/a n/a  n/a 
Key: n/a = not applicable 
Change Baseline to discharge and Baseline to 3 month follow up: 
1 = “Improved” 
2 = “Same” 
3 = “Worse” 
Change to 3 month follow up: 
1a = “Improvement” from baseline to discharge and “Improvement” maintained at 3 month post-discharge 
1b = “Improvement” from baseline to discharge and further “Improvement” from discharge to 3 month post-discharge 
1c = “Improvement” from baseline to discharge; “worsening” (according to MCIC) from discharge to 3 month post-discharge, but 3 month post-discharge level still 
“Improved” relative to baseline 
2a = “Same” from baseline at any time point  
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2a* = “Same” from baseline at any time point; note baseline level meant that maximum OSS score required to demonstrate “Improvement”  
2b = “Worse” from baseline to discharge and “Worse” compared to baseline maintained at 3 month post-discharge 
2c = At discharge was “worse” compared to baseline; at 3 month post-discharge was within MCIC of baseline 
3 = “Same” at discharge but at 3 month post-discharge had “Improved” from baseline  
4 = “Improved” from baseline to discharge but within MCIC of baseline (i.e. same relative to baseline) at 3 month post-discharge 
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13.13 Testing for data normality for data reduction phase and differences between 
those lost to follow up and those where follow up data was available 
 
13.13.1 A. Demographics: Age 
 
Table 13-19: Kolmogorov-Smirnov and Shapiro-Wilk statistics for age variable 
 Kolmogorov-Smirnov Shapiro-Wilk 
 Statistic Degrees of 
freedom 
Significance Statistic Degrees of 
freedom 
Significance 
Age 0.130 76 0.003 0.937 76 0.001 
 
The Kolmogorov-Smirnov and Shapiro-Wilk statistics demonstrated that age was not normally 
distributed (Field 2009).  
 
13.13.2 C1. Patient reported measures: Pain 
 
Table 13-20: Kolmogorov-Smirnov and Shapiro-Wilk statistics for VAS variables 
 Kolmogorov-Smirnov Shapiro-Wilk 
VAS 
variable 
Statistic Degrees of 
freedom 
Significance Statistic Degrees of 
freedom 
Significance 
On activity 0.099 74 0.071 0.951 74 0.006 
At rest 0.167 74 <0.001 0.860 74 <0.001 
At night 0.102 76 0.048 0.942 76 0.002 
Mean 0.069 74 0.200 0.981 74 0.311 
 
The Kolmogorov-Smirnov and Shapiro-Wilk statistics demonstrated that whilst pain “On activity” 
(assessed via Kolmogorov-Smirnov) and mean of 3 scores (assessed via both tests) were normally 
distributed, the other variables were not (Field 2009).  
 
13.13.3 C3. Patient reported measures: Function / Disability 
 
Table 13-21: Kolmogorov-Smirnov and Shapiro-Wilk statistics for SPADI variables 
 Kolmogorov-Smirnov Shapiro-Wilk 
SPADI 
variable 
Statistic Degrees of 
freedom 
Significance Statistic Degrees of 
freedom 
Significance 
Total pain 0.079 76 0.200 0.985 76 0.505 
Total 
disability 
0.077 76 0.200 0.969 76 0.063 
Total SPADI 0.082 76 0.200 0.983 76 0.409 
 
The Kolmogorov-Smirnov and Shapiro-Wilk statistics demonstrated that all of the variables were 
normally distributed (Field 2009). 
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13.13.4 D1. Clinical measures: Strength  
 
Table 13-22: Kolmogorov-Smirnov and Shapiro-Wilk statistics for strength variables 
 Kolmogorov-Smirnov Shapiro-Wilk 
Strength 
variable 
Statistic Degrees of 
freedom 
Significance Statistic Degrees of 
freedom 
Significance 
IR mean 
moment 
0.210 75 <0.001 0.773 75 <0.001 
ER mean 
moment 
0.184 75 <0.001 0.869 75 <0.001 
Scap mean 
moment 
0.172 75 <0.001 0.787 75 <0.001 
 
The Kolmogorov-Smirnov and Shapiro-Wilk statistics demonstrated that none of the variables were 
normally distributed (Field 2009). 
 
13.13.5 D2. Clinical measures: ROM  
 
 
Table 13-23: Kolmogorov-Smirnov and Shapiro-Wilk statistics for ROM variables 
 Kolmogorov-Smirnov Shapiro-Wilk 
ROM variable Statistic Degrees 
of 
freedom 
Significance Statistic Degrees 
of 
freedom 
Significance 
Symptomatic side: 
limit of ROM 
0.132 66 0.006 0.950 66 0.010 
Symptomatic side: 
point of symptom 
exacerbation by 
movement 
0.098 66 0.185 0.971 66 0.128 
 
The Kolmogorov-Smirnov and Shapiro-Wilk statistics demonstrated that whilst point of symptom 
exacerbation by movement was normally distributed, limit of ROM was not (Field 2009).  
 
13.13.6 Outcome measure: OSS at baseline  
 
Table 13-24: Kolmogorov-Smirnov and Shapiro-Wilk statistics for OSS at baseline 
 Kolmogorov-Smirnov Shapiro-Wilk 
 Statistic Degrees of 
freedom 
Significance Statistic Degrees of 
freedom 
Significance 
OSS at baseline 0.152 76 <0.001 0.936 76 0.001 
 
The Kolmogorov-Smirnov and Shapiro-Wilk statistics demonstrated that OSS at baseline was not 
normally distributed (Field 2009).  
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13.14 Variable values for patients lost to follow  
Table 13-25: Lost to follow up at discharge 
Patient 
Baseline 
OSS 
Age 
Symptom 
duration 
4DSQ  
Total 
SPADI 
score 
Sx ER 
mean 
moment 
Unloaded 
SDT 
U/S 
pathology  
M2028w 37 58 1 0 54.6 18.8 2 1 
F2197w 42 27 4 0 8.5 2.2 2 0 
M9819h 34 29 2 0 46.9 13.0 2 0 
Key: Symptom duration: 1 = 0-3 months; 2 = 3-6 months; 3 = 6-12 months; 4 = 12-24 months; 5 = More than 24 
months, 4DSQ: No categories with elevated = 0; 1 or more category with elevated = 1 , Unloaded SDT: 1 = 
“Normal”, 2 = “Subtle abnormality”, 3 = “Obvious abnormality”, U/S pathology: 0=no pathoplogy, 1 = 1 of 
bursal or cuff pathology, 2=both bursal and cuff pathology 
 
Table 13-26: Lost to follow up at 3 months post discharge 
Patient 
Baseline 
OSS 
Age 
Symptom 
duration 
4DSQ  
Total 
SPADI 
score 
Sx ER 
mean 
moment 
Unloaded 
SDT 
U/S 
pathology  
M2146h 36 54 5 n/a 41.0 10.0 3 2 
F1634w 21 30 3 1 54.6 4.2 3 1 
F9939h 27 50 3 0 47.7 4.2 1 2 
M5703h 38 49 3 0 35.4 17.8 3 0 
F2387h 36 66 2 1 27.7 2.9 1 2 
F0732w 40 49 3 0 16.9 10.7 1 1 
M6858w 34 34 4 1 46.9 30.0 2 2 
F1188h 30 38 3 0 36.2 4.2 2 1 
F1669h 19 18 5 1 60.0 8.8 2 1 
F5690h 39 19 3 1 14.6 9.0 1 1 
M3609h 34 40 5 0 42.3 8.7 1 0 
Key: Symptom duration: 1 = 0-3 months; 2 = 3-6 months; 3 = 6-12 months; 4 = 12-24 months; 5 = More than 24 
months, 4DSQ: No categories with elevated = 0; 1 or more category with elevated = 1, Unloaded SDT: 1 = 
“Normal”, 2 = “Subtle abnormality”, 3 = “Obvious abnormality”,  U/S pathology: 0=no pathoplogy, 1 = 1 of 
bursal or cuff pathology, 2=both bursal and cuff pathology 
 
 
